Document

0000934549-17-000006.txt : 20170310 0000934549-17-000006.hdr.sgml : 20170310 20170309185914 ACCESSION NUMBER: 0000934549-17-000006 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170310 DATE AS OF CHANGE: 20170309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACACIA RESEARCH CORP CENTRAL INDEX KEY: 0000934549 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 954405754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37721 FILM NUMBER: 17679849 BUSINESS ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 9494808300 MAIL ADDRESS: STREET 1: 520 NEWPORT CENTER DRIVE STREET 2: 12TH FLOOR CITY: NEWPORT BEACH STATE: CA ZIP: 92660 10-K 1 actg2016123110-k.htm 10-K Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 10-K

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016

o TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO .

Commission File Number 0-26068

____________________

(Exact name of registrant as specified in its charter)



DELAWARE	95-4405754
(State or other jurisdiction of	(I.R.S. Employer
incorporation organization)	Identification No.)

520 NEWPORT CENTER DRIVE, 12TH FLOOR
NEWPORT BEACH, CA	92660
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 480-8300

Securities registered pursuant to Section 12(b) of the Act:



Title of Each Class	Name of Each Exchange on Which Registered
Common Stock, $0.001 par value	The NASDAQ Stock Market, LLC

Securities registered pursuant to Section 12(g) of the Act: None

____________________

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities

Act. Yes £ No R

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes £ No R

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes R No £

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes R No £

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. R

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer £		Accelerated filer R
Non-accelerated filer £ (Do not check if a smaller reporting company)		Smaller reporting company £

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes £ No R

The aggregate market value of the registrant’s voting and non-voting common stock held by non-affiliates of the registrant on June 30, 2016, the last business day of the registrant’s most recently completed second fiscal quarter, computed by reference to the last sale price of the registrant’s common stock as reported by The Nasdaq Global Select Market on such date, was approximately $216,379,000. This computation assumes that all executive officers and directors are affiliates of the registrant. Such assumption should not be deemed conclusive for any other purpose.

As of March 6, 2017, 50,466,611 shares of common stock were issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

In accordance with General Instruction G(3) to Form 10-K, portions of the registrant’s Definitive Proxy Statement on Schedule 14A for its Annual Meeting of Stockholders to be filed with the Commission within 120 days after the close of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III of this Annual Report on Form 10-K. Only those portions of the proxy statement that are specifically incorporated by reference herein shall constitute a part of this Annual Report on Form 10-K.

ACACIA RESEARCH CORPORATION

ANNUAL REPORT ON FORM 10-K

FISCAL YEAR ENDED DECEMBER 31, 2016

TABLE OF CONTENTS



		Page
PART I

Item 1.	Business	3
Item 1A.	Risk Factors	10
Item 1B.	Unresolved Staff Comments	19
Item 2.	Properties	20
Item 3.	Legal Proceedings	20
Item 4.	Mine Safety Disclosures	20


PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	21
Item 6.	Selected Financial Data	23
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	45
Item 8.	Financial Statements and Supplementary Data	45
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	45
Item 9A.	Controls and Procedures	45
Item 9B.	Other Information	47


PART III

Item 10.	Directors, Executive Officers and Corporate Governance	47
Item 11.	Executive Compensation	47
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	47
Item 13.	Certain Relationships and Related Transactions, and Director Independence	48
Item 14.	Principal Accounting Fees and Services	48


PART IV

Item 15.	Exhibits, Financial Statement Schedules	49

PART I

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

As used in this Annual Report on Form 10-K, “we,” “us” and “our” refer to Acacia Research Corporation and/or its wholly and majority-owned operating subsidiaries. All patent portfolio investments, development, licensing and enforcement activities are conducted solely by certain of our wholly owned operating subsidiaries.

This Annual Report on Form 10-K, or the annual report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which include, without limitation, statements about our future business operations and results, our strategies and competition, and other forward-looking statements included in this annual report. Such statements may be identified by the use of forward-looking terminology such as “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms, variations of such terms or the negative of such terms. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Such statements address future events and conditions concerning earnings, capital expenditures, litigation, competition, regulatory matters, stock price volatility, liquidity and capital resources and accounting matters. Actual results in each case could differ materially from those anticipated in such statements by reason of factors such as future economic conditions, legislative, regulatory and competitive developments in markets in which we and our subsidiaries operate, and other circumstances affecting anticipated revenues and costs, as more fully disclosed in our discussion of “Risk Factors” in Item 1A of Part I of this annual report. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Additional factors that could cause such results to differ materially from those described in the forward-looking statements are set forth in connection with the forward-looking statements.

ITEM 1. BUSINESS

General

Our operating subsidiaries partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. We are an intermediary in the patent marketplace, bridging the gap between invention and application, and facilitating efficiency in connection with the monetization of patent assets.

Our operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that our operating subsidiaries control or own. Our operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

We are a leader in licensing and enforcing patented technologies and have established a proven track record of licensing success with over 1,530 license agreements executed to date, across 192 patent portfolio licensing and enforcement programs. To date, we have generated gross licensing revenue of approximately $1.4 billion, and have returned more than $726 million to our patent partners.

Corporate Information

We were originally incorporated in California in January 1993 and reincorporated in Delaware in December 1999. Our website address is www.acaciaresearch.com. Reference in this annual report to this website address does not constitute incorporation by reference of the information contained on the website. We make our filings with the Securities and Exchange Commission, or the SEC, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, other reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, and amendments to the foregoing reports, available free of charge on or through our website as soon as reasonably practicable after we file these reports with, or furnish such reports to, the SEC. In addition, we post the following information on our website:


•	our corporate code of conduct, our code of conduct for our board of directors and our fraud policy;


•	charters for our audit committee, nominating and corporate governance committee, disclosure committee and compensation committee; and


•	applicable dividend related tax forms.

The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.

Also, the SEC maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers, including us, that file electronically with the SEC. The public can obtain any documents that we file with the SEC at http://www.sec.gov.

Patent Licensing and Enforcement Business

Refer to the section entitled “Patented Technologies” below for a partial summary of patent portfolios owned or controlled by certain of our operating subsidiaries.

Patents are an important asset class worldwide. Due to legislative and regulatory changes, licensing and enforcing patents has become increasingly difficult for patent holders, necessitating an experienced, well-capitalized, licensing partner. We focus on the patent marketplace, and have emerged as a leading outsourced patent licensing and enforcement company for patent owners that have made the important choice to outsource their patent licensing and enforcement activities.

We are a leader in patent licensing and enforcement and our operating subsidiaries have established a proven track record of licensing success with more than 1,530 license agreements executed to date. On a consolidated basis, to date, we have generated revenues from 192 patent portfolio licensing and enforcement programs. Our professional staff includes in-house patent attorneys, licensing, engineering and business development executives.

We have partnered with patent owners, including individual inventors, universities, and large multi-national corporations in several technology sectors. These patent owners may have limited internal resources and/or expertise to effectively address the unauthorized use of their patented technologies, or may seek to effectively and efficiently monetize their portfolio of patented technologies on an outsourced basis. In a typical arrangement, our operating subsidiary will partner with a patent portfolio owner, acquiring rights in the patent portfolio or acquiring the patent portfolio outright, and in exchange, the original patent portfolio owner receives (i) a percentage of our operating subsidiary’s net recoveries from the licensing and enforcement of the patent portfolio, which we refer to as our Partnering Model, or (ii) an upfront payment for the purchase of the patent portfolio rights or the patent portfolio, which we refer to as our Purchasing Model, or (iii) a combination of the two, which we refer to as our Hybrid Partnering Model.

Under U.S. law, a patent owner has the right to exclude others from making, selling or using their patented invention. A third-party infringes a patent by making, offering for sale, selling, or using a patented invention without a license from the patent owner. Unfortunately, in the majority of cases, infringers are generally unwilling, at least initially, to negotiate or pay reasonable license fees for their unauthorized use of third-party patents and will typically fight any allegations of patent infringement. Inventors and/or patent holders without sufficient legal, financial and/or expert technical resources to bring and continue the pursuit of costly and complex patent infringement actions are often blatantly ignored.

As a result of the common reluctance of patent infringers to negotiate and ultimately take a patent license for the use of patented technologies without at least the threat of legal action, patent licensing and enforcement often begins with the filing of patent enforcement litigation. However, most patent infringement litigation settles out of court at amounts that are related to

the strength of the patent and the value of the invention in the infringer’s products or services. We execute agreements that grant rights in our patents to users of our patented technologies. Our agreements can be negotiated without the filing of patent litigation, or negotiated within the context of ongoing patent litigation, depending on the specific facts and circumstances.

Patents and patent infringement are complex and highly technical subject areas. Our professionals seek to identify high-quality but undervalued patent portfolios in a variety of industries. We combine our legal expertise, technology expertise, and our extensive knowledge of, and experience in, the patent licensing ecosystem, seeking to uncover important patent assets and promote efficiency in the patent licensing and enforcement industry.

Our relationship with patent owners is the cornerstone of our operating subsidiaries’ corporate strategy. We assume all responsibility for advancing operational expenses while pursuing a patent licensing and enforcement program, and then, when applicable, share net licensing revenue with our patent partners as that program matures, on a pre-arranged and negotiated basis. We may also provide upfront capital to the patent owner as an advance against future licensing revenue. We are a principal in the licensing and enforcement effort, with our operating subsidiaries obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

Business Model and Strategy - Overview

We have the flexibility to structure arrangements in a number of ways to address the needs and specific sets of circumstances presented by each of our unique patent partners, examples of which include the following:

Generally, we maintain a 100% preferred rate of return until all deployed capital and advanced operational costs are recovered by us. Upon recovery of these costs, the net profit revenue share with patent partner commences, if applicable.

Key Elements of Business Strategy

Patent licensing and enforcement can be an effective and efficient way to maximize the profit potential of a patent, or patents, that are being practiced by third-parties without authorization . A patent license agreement grants a third-party user of an invention specific patent rights to the patented invention in exchange for patent license fees. Patent licensing can be critical for patents that are owned by those that have not to date converted their patented invention into a profitable product or service, and therefore, are not generating revenues from their patented inventions. These include owners of the following categories of patented inventions:


•	Inventions that were ahead of the technology curve and hence, there is no existing ecosystem to support the patented products or services at the time they are introduced to market;


•	Inventions that can only be deployed in very capital-intensive industries, such as semiconductor fabrication, energy, or medical sectors, but whose owners do not have sufficient amounts of capital to deploy; and


•	Inventions that, for one reason or another, are no longer being practiced by the patent owner.

Our patent licensing business provides patent holders with an opportunity to generate income from their patented inventions being practiced by third-parties without authorization and from third-parties that desire to practice their patented inventions with authorization. Our patent licensing and enforcement business strategy, conducted solely by our operating subsidiaries, includes three fundamental elements, as follows:


•	Patent Discovery - Discover potentially valuable patents or patent portfolios.


•	Assessment of Economic Value - Work internally and with external experts to evaluate the use of the patented invention(s) in the relevant marketplace and assess a patents or patent portfolios’ expected economic value.


•	Licensing and Enforcement - License those users wanting to utilize the patented invention with authorization. For unauthorized users of the patented invention, enter into license negotiations and, if necessary, litigation to monetize the patent based on its assessed value.

Patent Discovery. The patent process breeds, encourages and sustains innovation and invention by granting a limited monopoly to the inventor in exchange for sharing the invention with the public. Certain technologies, become core technologies in the way products and services are manufactured, sold or delivered by companies across a wide array of industries. Our operating subsidiaries seek to identify core, patented technologies that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture, sale or use of products and services. Patent discovery occurs when we reach out to patent holders who may be disenfranchised, or when patent holders approach us seeking assistance with the monetization and enforcement of their patent portfolios.

Assessment of Economic Value. Subsequent to the patent discovery process, our executives work internally and/or with external industry experts in the specific technology field, to evaluate the patented invention and its adoption and implementation in the marketplace. There are three key factors, among a number of factors, to consider when analyzing a patent and determining a patent’s value: (1) Infringement, (2) Validity and (3) Enforceability.

•

Infringement. To determine infringement, we must first identify third-parties that are practicing the invention(s) covered by the patent without obtaining permission from the patent owner to do so. A key tool in determining whether or not a company is infringing a patent is a claim chart. A claim chart demonstrates how the manufacture, sale, or use of an existing product compares against the claims of the patent.


•	Invalidity. The three main factors analyzed to determine invalidity are (1) anticipation, (2) obviousness, and (3) the existence of non-patentable subject matter.


◦	Anticipation occurs when the claims of the patent are entirely revealed within a single piece of prior art. “Prior art” is a technical term that generally refers to an invention that existed prior to the grant of the patent being analyzed.

◦

Even if the claims of the patent are not entirely revealed within a single piece of prior art, the patent may still be invalid if determined to be “obvious” under the law. “Obvious” essentially means that the differences between prior art and the patented invention are so slight such that they would have been obvious at the time of invention to one who is skilled in the subject matter being patented.


◦	Even if the patent lacks anticipation and obviousness, it may still be invalid if its subject matter is un-patentable by law. Un-patentable subject matter includes naturally occurring things, abstract concepts, or algorithms that perform an ordinary function.

•

Enforceability. A myriad of factors are analyzed to determine whether or not a patent is enforceable, including whether or not there has been patent misuse, or whether or not there are antitrust violations associated with the patent. Due to the inherently complex nature of patent law, only a court or specific administrative body, such as the International Trade Commission, can make a decision whether a patent is infringed, valid and enforceable; however, we employ our wealth of expertise to make the best assessment possible given a specific fact pattern and set of circumstances.

We estimate a patent’s economic value by evaluating the expected value of the license revenue stream based on past, present and future revenue of infringing products or services, and the risk that a court will disagree with our infringement, validity or enforcement assessments of the patent.

The processes and procedures employed in connection with the evaluation of a specific patent portfolio for future investment, licensing and enforcement are tailored and unique to each specific situation and can vary widely based on the specific facts and circumstances of a specific patent portfolio, such as the related technology, related industry and certain other factors. Some of the key components of our processes and procedures may include:


•	Utilizing our staff of in-house patent attorneys, licensing, engineering and business development executives to conduct our tailored patent investment and evaluation processes and procedures. We may also leverage the expertise of external specialists and technology consultants.


•	Identifying emerging growth areas where patented technologies will play a vital role in connection with the manufacture or sale of products and services.


•	Identifying core, patented technologies that have been or are anticipated to be widely adopted by third-parties in connection with the manufacture or sale of products and services.


•	Considering the impact of subtleties in the language of a patent, recorded interactions with the patent office, evaluating prior art and literature and considering the impact on the potential licensing and enforcement revenue that can be derived from a patent or patent portfolio.


•	Evaluating the strength of a patent portfolio, including consideration of the types of claims and the number of claims potentially infringed by third-parties, and the results of any prior art searches or analysis, before the decision is made to allocate resources to a patent portfolio investment or an effective licensing and enforcement effort.


•	Identifying and considering potential problem areas, if any, and determining whether potential problem areas can be overcome prior to acquiring a patent portfolio or launching an effective licensing program.


•	Identifying potential infringers, industries within which the potential infringers exist, longevity of the patented technology, and a variety of other factors that directly impact the magnitude and potential success of a licensing and enforcement program.

Licensing and Enforcement. The final step in the patent licensing and enforcement process is to seek to monetize the patent portfolio by securing license agreements based on the patents estimated value. While we prefer to convince unauthorized users of our patented inventions of the value of the patented invention and secure a license agreement in a non-litigious manner, many infringers refuse to take such licenses even when confronted with substantial and persuasive evidence of infringement, validity, enforceability and significant economic value. As a result, often we must resort to litigation to demonstrate and prove infringement and ultimately induce infringers to take a license. We have found it effective to negotiate licenses concurrently with litigation due to the fact that litigation necessitates and facilitates an information exchange that helps both sides assess the value of a patent and make informed decisions. Also, litigation eventually leads to a court’s judgment. When a court agrees with our assessment of a patent, this judgment stops recalcitrant infringers from utilizing our patented technology indefinitely, without appropriate authorization.

Our operating subsidiaries engage highly competent and experienced patent lawyers to prosecute their patent portfolio litigation. It is imperative to be persistent and patient throughout the litigation process as it typically takes 18-36 months from the filing date of a lawsuit to yield a license agreement from a potential licensee. Often, it takes longer to secure a final court judgment.

Patent license negotiations and litigation initiated by our operating subsidiaries usually lead to serious and thoughtful discussions with the unauthorized users of the patented inventions. The result can be quite favorable with the user being granted rights under the patents for the patented invention in its products and services in exchange for financial remuneration. This remuneration is typically shared between our operating subsidiary and the patent holder.

Patent Prosecution. Concurrent with our patent litigation and licensing negotiation activities, we often assist patent holders with the acquisition of additional rights associated with their inventions both in the United States and across the globe. This is referred to as “continued prosecution,” and is done to further define the boundaries of an invention. It can also be effective to correct technical deficiencies discovered within a patent that may have been identified in the negotiation and litigation process. These deficiencies, if not appropriately addressed, can limit the value of patents that are otherwise infringed, valid, and enforceable.

Investments in Patent Portfolios. Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents and inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then we may not be able to identify new technology-based opportunities for sustainable revenue and /or revenue growth.

of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

For example, for the year ended December 31, 2016, we obtained control of only 2 new patent portfolios. Further, in fiscal year 2015, we obtained control of 3 new patent portfolios, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. This decrease in our patent portfolio intake reflects in part our strategic decision in 2013 to shift the focus of our operating business to serving a smaller number of customers, each having higher quality patent portfolios. As a result, our gross number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. These industry trends have continued, and as a result, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our revenues will decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

Patented Technologies

Currently, on a consolidated basis, our operating subsidiaries own or control the rights to patent portfolios with future patent expiration dates ranging from 2017 to approximately 2033, covering technologies used in a variety of industries, a sample of which includes the following:



Operating Subsidiary	Industry	Description
American Vehicular Sciences, LLC	Transportation And Automotive	Patents from Automotive Technologies International, or ATI and Intelligent Technologies International, or ITI, relating to numerous automotive safety, navigation and diagnostics technologies.
Body Science, LLC	Peripheral Vascular Devices	Patents relating to apparatus for use in wireless physiological monitoring.
Cellular Communications Equipment, LLC	Telecommunications / Smartphones	Portfolio covers Wireless Infrastructure and User Equipment Technology relating to second (2G), third (3G) and fourth (4G) generation wireless technologies and to air interface technology used in 2G, 3G and 4G wireless networks.
Endotach, LLC	Peripheral Vascular Devices	Patents relating to stent grafts.
Innovative Display Technologies, LLC	Telecommunications / Smartphones	Portfolio generally relates to back-lighting for displays and the patented technology covers various improvements to LCD displays.
Lambda Optical Solutions, LLC	Communications	Patents relating to Optical Switching Technology.
LifePort Sciences, LLC	Peripheral Vascular Devices	Multiple patents and applications relating to, among other things, stent grafts, stent graft delivery systems and stent placement procedures.
LifeScreen Sciences, LLC	Peripheral Vascular Devices	Portfolio consists of multiple patents and applications relating to, among other things, vena cava filters, embolic protection and associated delivery systems.
LifeShield Sciences, LLC	Peripheral Vascular Devices	Portfolio consists of multiple patents and applications relating to stent grafts, and stent graft delivery systems.



Limestone Memory Systems LLC	Memory	This portfolio covers both DRAM and flash memory technologies used in virtually all electronic communications and computing devices.
Nexus Display Technologies, LLC	Consumer Electronics	Patent portfolio relating to high speed digital display interface technology used in industry standards such as DisplayPort and DisplayPort-related technologies and also MIPI DSI.
Optimum Content Protection, LLC and Super Interconnect Technologies, LLC	Telecommunications / Smartphones	Portfolios relate to high speed circuit interconnect, display control technology and content security used in consumer electronics, PCs and mobile devices such as smartphones, tablets, and laptops.
Parthenon Unified Memory Architecture, LLC	Semiconductor	Patents relate to the use of shared memory in multimedia processing systems such as mobile phones, tablets and other consumer electronic devices.
Power Optimized Memory Solutions LLC	Memory	This portfolio covers technologies and devices similar to those of the Limestone portfolio, as well as Solid State Drives (SSD’s).
Rapid Completions LLC	Energy Efficiency	Patents related to multi-zonal completion of horizontal wells including ball-drop, sliding sleeve and packer technology for use in the hydraulic fracturing of both tight and conventional oil and gas reservoirs. This technology has been applied in oilfields across North America and worldwide and has contributed significantly to the growth in oil and gas production from unconventional shale formations.
Roman Memory Solutions LLC	Memory	Patents covering circuits used in DRAM and Flash Memory.
Saint Lawrence Communications, LLC	Wireless	Patents relating to Speech Codecs used in Wireless and Wireline Systems.
Unified Messaging Solutions, LLC	Communications	Patent for Messaging Technology.

Revenues for the periods presented include revenues generated from several of the portfolios summarized above and other technology patent portfolios owned or controlled by us. Refer to Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Overview” for a summary of patent portfolios generating revenues for the applicable periods presented.

Competition

We expect to encounter increased competition in the area of patent portfolio investments and enforcement. This includes an increase in the number of competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. Non-practicing entities such as RPX, AST, Intellectual Ventures, Wi-LAN, Conversant, Round Rock Research LLC, IPvalue Management Inc., Vringo Inc., VirnetX and Pendrell Corporation compete in acquiring rights to patents, and we expect more entities to enter the market.

We also compete with financial firms, corporate buyers and others acquiring IP. Many of these competitors may have more financial and human resources than our operating subsidiaries. We may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to generate future revenue.

Companies or other entities may develop competing technologies that offer better or less expensive alternatives to our patented technologies that we may invest in and license. Many potential competitors may have significantly greater resources than the resources that our operating subsidiaries possess. Such technological advances or entirely different approaches developed by one or more of our competitors could render certain of the technologies owned or controlled by our operating subsidiaries obsolete and/or uneconomical.

Employees

As of December 31, 2016, on a consolidated basis, we had 27 full-time employees. Neither we, nor any of our subsidiaries, are a party to any collective bargaining agreement. We consider our employee relations to be good.

ITEM 1A. RISK FACTORS

The following is a summary of certain risks we face in our business. They are not the only risks we face. Additional risks that we do not yet know of or that we currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition and results of operations could be materially adversely affected, and the trading price of our common stock could decline significantly. All patent portfolio investments, development, licensing and enforcement activities are conducted solely by certain of our wholly and majority-owned operating subsidiaries.

Risks Related to Our Business

We have a history of losses and may incur additional losses in the future.

We reported a net loss of $54.1 million (includes $42.3 million of noncash patent impairment charges), $160.0 million (includes $104.9 million of noncash goodwill and patent impairment charges) and $66.0 million (includes $3.5 million of noncash patent impairment charges) for the years ended December 31, 2016, 2015 and 2014, and on a cumulative basis, we have sustained substantial losses since our inception. As of December 31, 2016, our accumulated deficit was $342.2 million. As of December 31, 2016, we had approximately $158.5 million in cash and cash equivalents, restricted cash and short-term investments and working capital of $160.3 million. We expect to continue incurring significant legal, general and administrative expenses in connection with our operations. As a result, we anticipate that we may incur losses in the future. We believe, however, that our current cash and cash equivalents and investments will be sufficient to finance our anticipated capital and operating requirements for at least the next twelve months.

Our ability to use net operating losses and certain other tax attributes is uncertain and may be limited.

Our ability to use our federal and state net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our generation of future taxable income before the expiration dates of the net operating losses, and we cannot predict with certainty when, or whether, we will generate sufficient taxable income to use all of our net operating losses. In addition, utilization of net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is subject to annual limitations under the “ownership change” provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and similar state provisions, which may result in the expiration of net operating losses before future utilization. In general, under the Code, if a corporation undergoes an “ownership change,” generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership, some of which may be outside of our control, could in the future result in an ownership change. Although we have completed studies to provide reasonable assurance that an ownership change limitation would not apply, we cannot be certain that a taxing authority would reach the same conclusion. If, after a review or audit, an ownership change limitation were to apply, utilization of our domestic net operating losses and tax credit carryforwards could be limited in future periods and a portion of the carryforwards could expire before being available to reduce future income tax liabilities.

If we encounter unforeseen difficulties with our business or operations in the future that require us to obtain additional working capital, and we cannot obtain additional working capital on favorable terms, or at all, our business may suffer.

Our consolidated cash and cash equivalents, restricted cash and short-term investments totaled $158.5 million and $145.9 million at December 31, 2016 and 2015, respectively. To date, we have relied primarily upon net cash flows from our operations and from the public and private sale of equity securities to generate the working capital needed to finance our operations.

We may encounter unforeseen difficulties with our business or operations in the future that may deplete our capital resources more rapidly than anticipated. As a result, we may be required to obtain additional working capital in the future through bank credit facilities, public or private debt or equity financings, or otherwise. If we are required to raise additional working capital in the future, such financing may be unavailable to us on favorable terms, if at all, or may be dilutive to our existing stockholders. If we fail to obtain additional working capital, as and when needed, such failure could have a material adverse impact on our business, results of operations and financial condition.

Failure to effectively manage our operational changes could strain our managerial, operational and financial resources and could adversely affect our business and operating results.

Our recent operational changes have placed, and are expected to continue to place, a strain on our managerial, operational and financial resources and systems. Operational changes primarily relate to the resignation of Matthew Vella, our former Chief Executive Officer and President in December 2015, the appointment of Marvin Key, Chief Executive Officer of Acacia Research Group LLC, to Chief Executive Officer of Acacia Research Corporation in December 2015, and reductions in employee headcount across our licensing, business development and engineering functions in 2015 and 2016. Further, as our operating subsidiary companies’ businesses grow or change, we will be required to continue to manage multiple relationships. Any further growth or change by us or our subsidiary companies, or an increase in the number of our strategic relationships, may place additional strain on our managerial, operational and financial resources and systems. Although we may not grow, if we fail to manage our growth or other operational changes effectively or to develop, expand or otherwise modify our managerial, operational and financial resources and systems, our business and financial results will be materially harmed.

Potential patent portfolio investments may present risks, and we may be unable to achieve the financial or other goals intended at the time of any potential investment.

Our future growth depends, in part, on our ability to invest in patented technologies, patent portfolios, or companies holding such patented technologies and patent portfolios. Accordingly, we have engaged in patent portfolio investments to expand our patent portfolios and we intend to continue to explore such investments. Such investments are subject to numerous risks, including the following:


•	our inability to enter into a definitive agreement with respect to any potential patent portfolio investment, or if we are able to enter into such agreement, our inability to consummate the potential investment transaction;


•	difficulty integrating the operations, technology and personnel of the acquired entity;


•	our inability to achieve the anticipated financial and other benefits of the specific patent portfolio investment;


•	our inability to retain key personnel from the acquired company, if necessary;


•	difficulty in maintaining controls, procedures and policies during the transition and integration process;


•	diversion of our management’s attention from other business concerns; and


•	failure of our due diligence process to identify significant issues, including issues with respect to patented technologies and patent portfolios, and other legal and financial contingencies.

If we are unable to manage these risks effectively as part of any patent portfolio investment, our business could be adversely affected.

Our revenues are unpredictable, and this may harm our financial condition.

We believe that our cash and cash equivalents and short-term investment balances, anticipated cash flow from operations, proceeds from prior offerings of our common stock (refer to “Liquidity and Capital Resources” below) and other external sources of available credit, will be sufficient to meet our cash requirements through at least March 2018 and for the foreseeable future. However, due to the nature of our licensing business and uncertainties regarding the amount and timing of the receipt of license and other fees from potential infringers, stemming primarily from uncertainties regarding the outcome of enforcement actions, rates of adoption of our patented technologies, the growth rates of our existing licensees and certain other factors, our revenues may vary significantly from quarter to quarter and period to period, which could make our business difficult to manage, adversely affect our business and operating results, cause our quarterly and periodic results to fall below market expectations and adversely affect the market price of our common stock.

Our operating subsidiaries depend upon relationships with others to provide technology-based opportunities that can develop into profitable royalty-bearing licenses, and if they are unable to maintain and generate new relationships, then they may not be able to sustain existing levels of revenue or increase revenue.

with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then we may not be able to identify new technology-based opportunities for sustainable revenue and /or revenue growth.

Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our licensing and enforcement business. In some cases, universities and other technology sources compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market our solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

The success of our operating subsidiaries depends in part upon their ability to retain the best legal counsel to represent them in patent enforcement litigation.

The success of our licensing business depends upon our operating subsidiaries’ ability to retain the best legal counsel to prosecute patent infringement litigation. As our operating subsidiaries’ patent enforcement actions increase, it will become more difficult to find the best legal counsel to handle all of our cases because many of the best law firms may have a conflict of interest that prevents their representation of our subsidiaries.

We spend a significant amount of our financial and management resources to pursue our current litigation matters. We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources. The counterparties to our litigation are sometimes large, well-financed companies with substantially greater resources than us. We cannot assure that any of our current or future litigation matters will result in a favorable outcome for us. In addition, in part due to the appeals process and other legal processes, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend. Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects which could encumber our ability to develop and commercialize products.

In connection with any of our patent enforcement actions, it is possible that a defendant may request and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and our financial position.

Our operating subsidiaries, in certain circumstances, rely on representations, warranties and opinions made by third-parties that, if determined to be false or inaccurate, may expose us and our operating subsidiaries to certain material liabilities.

From time to time, our operating subsidiaries may rely upon representations and warranties made by third-parties from whom our operating subsidiaries acquired patents or the exclusive rights to license and enforce patents. We also may rely upon the opinions of purported experts. In certain instances, we may not have the opportunity to independently investigate and verify the facts upon which such representations, warranties, and opinions are made. By relying on these representations, warranties and opinions, our operating subsidiaries may be exposed to liabilities in connection with the licensing and enforcement of certain patents and patent rights which could have a material adverse effect on our operating results and financial condition.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may rule that we or our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards, which may expose us and our operating subsidiaries to certain material liabilities.

In connection with any of our patent enforcement actions, it is possible that a defendant may request and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if we or our operating subsidiaries are required to pay such monetary sanctions, attorneys’ fees and/or expenses, such payment could materially harm our operating results and our financial position.

In connection with patent enforcement actions conducted by certain of our subsidiaries, a court may find the patents invalid, not infringed or unenforceable and/or the U.S. Patent and Trademark Office, or the USPTO, or other relevant patent office, may either invalidate the patents or materially narrow the scope of their claims during the course of a reexamination, opposition or other such proceeding.

Patent litigation is inherently risky and the outcome is uncertain. Some of the parties that we believe infringe on our patents are large and well-financed companies with substantially greater resources than ours. We believe that these parties would devote a substantial amount of resources in an attempt to avoid or limit a finding that they are liable for infringing on our patents or, in the event liability is found, to avoid or limit the amount of associated damages. In addition, there is a risk that these parties may file reexaminations or other proceedings with the USPTO or other government agencies in the United States or abroad in an attempt to invalidate, narrow the scope or render unenforceable the patents we own or control. If this were to occur, it may have a material adverse effect on the viability of our company and our operations.

In addition, it is difficult to predict the outcome of patent enforcement litigation at any level. In the United States, there is a higher rate of appeals in patent enforcement litigation than standard business litigation. The defendant to any case we bring, may file as many appeals as allowed by right, including to the first, second and/or final courts of appeal (in the United States those courts would be the Federal Circuit and Supreme Court, respectively). Such appeals are expensive and time-consuming, and the outcomes of such appeals are sometimes unpredictable, resulting in increased costs and reduced or delayed revenue.

Our licensing cycle is lengthy and costly, and our legal and sales efforts may be unsuccessful.

We expect our operating subsidiaries to incur significant general and administrative, legal and sales expenses prior to entering into license agreements and generating license revenues. We will also spend considerable resources educating prospective licensees on the benefits of a license arrangement with us. As such, we may incur significant losses in any particular period before any associated revenue stream begins.

If our efforts to educate prospective licensees on the benefits of a license arrangement are unsuccessful, we may need to pursue litigation or other enforcement action to protect our patent rights. We may also need to litigate to enforce the terms of our existing license agreements, protect our trade secrets, or determine the validity and scope of the proprietary rights of others. Enforcement proceedings are typically protracted and complex. The costs are typically substantial, and the outcomes are unpredictable. Enforcement actions will divert our managerial, technical, legal and financial resources from business operations.

Failure to maintain effective internal control over our financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could cause our financial reports to be inaccurate

We are required pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, to maintain internal control over financial reporting and to assess and report on the effectiveness of those controls. This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting. As a result of a material weakness identified in our internal control over financial reporting relating to the accounting for infrequent, unusual, or complex accounting matters, our management assessed the effectiveness of our disclosure controls and procedures and determined that our disclosure controls and procedures were not effective as of September 30, 2016. We developed a plan to address the material weakness and enhance our control procedures related to infrequent, unusual, or complex accounting matters and implemented the revised procedures in the fourth quarter of 2016. However, due to the short period of time and limited use of this new control as contemplated by the applicable Public Company Accounting Oversight Board standards, we are unable to conclude in this report as to the operating effectiveness of our enhanced review procedures and documentation standards as of December 31, 2016. Our goal is to remediate this material weakness as contemplated by the standards by the end of the first quarter of 2017, subject to there being sufficient opportunities to conclude, through testing, that the enhanced control is operating effectively.

While management believes the enhanced internal controls implemented will remediate the material weakness identified, there is no assurance that the changes will remediate the identified material weakness or that the controls will prevent or detect future material weaknesses. If we are not able to maintain effective internal control over financial reporting, our financial statements, including related disclosures, may be inaccurate, which could have a material adverse effect on our business.

Risks Related to Our Industry

Our exposure to uncontrollable outside influences, including new legislation, court rulings or actions by the USPTO, could adversely affect our licensing and enforcement business and results of operations.

Our licensing and enforcement business is subject to numerous risks from outside influences, including the following:

New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue.

Our operating subsidiaries invest in patents with enforcement opportunities and spend a significant amount of resources to enforce those patents. If new legislation, regulations or rules are implemented by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement process or the rights of patent holders, such changes could negatively affect our business. Recently, United States patent laws were amended with the enactment of the Leahy-Smith America Invents Act, or the America Invents Act, which took effect on March 16, 2013. The America Invents Act includes a number of significant changes to U.S. patent law. In general, the legislation attempts to address issues surrounding the enforceability of patents and the increase in patent litigation by, among other things, establishing new procedures for patent litigation. For example, the America Invents Act changes the way that parties may be joined in patent infringement actions, increasing the likelihood that such actions will need to be brought against individual allegedly-infringing parties by their respective individual actions or activities. In addition, the America Invents Act enacted a new inter-partes review process at the USPTO which can be, and often is, used by defendants, and other individuals and entities, to separately challenge the validity of any patent. The IPR process of the AIA has in many instances increased costs for licensing and litigation and has resulted in the loss of certain portfolio patents which in some cases may have negatively impacted the value of those portfolios. The America Invents Act and its implementation has increased the uncertainties and costs surrounding the enforcement of our patented technologies, which in certain circumstances could have a material adverse effect on our business and financial condition.

The U.S. Department of Justice, or the DOJ, has conducted reviews of the patent system to evaluate the impact of patent assertion entities on industries in which those patents relate. It is possible that the findings and recommendations of the DOJ could impact the ability to effectively license and enforce standards-essential patents and could increase the uncertainties and costs surrounding the enforcement of any such patented technologies. Also, in 2014, the Federal Trade Commission, or FTC, initiated a study under Section 6(b) of the Federal Trade Commission Act to evaluate the patent assertion practice and market impact of Patent Assertion Entities, or PAEs. The FTC’s initial notice and request for public comment relating to the PAE study appeared in the Federal Register on October 3, 2013. We received and responded to a request for information as part of this FTC study. The FTC study entitled, "Patent Assertion Entity Activity" was released in October 2016.

Finally, new rules regarding the burden of proof in patent enforcement actions could significantly increase the cost of our enforcement actions, and new standards or limitations on liability for patent infringement could negatively impact our revenue derived from such enforcement actions. In addition, recent federal court decisions have lowered the threshold for obtaining attorneys’ fees in patent infringement cases and increased the level of deference given to a district court’s fee-shifting determination. These decisions may make it easier for district courts to shift a prevailing party’s attorneys' fees to a non-prevailing party if the district court believes that the case was weak or conducted in an abusive manner. As a result, defendants in patent infringement actions brought by non-practicing entities may elect not to settle because these decisions make it much easier for defendants to get attorneys’ fees.

Changes in patent law could adversely impact our business.

Patent laws may continue to change, and may alter the historically consistent protections afforded to owners of patent rights. Such changes may not be advantageous for us and may make it more difficult to obtain adequate patent protection to enforce our patents against infringing parties. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States Congress has considered a bill that would require, among other things, non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met.

Trial judges and juries often find it difficult to understand complex patent enforcement litigation, and as a result, we may need to appeal adverse decisions by lower courts in order to successfully enforce our patents.

It is difficult to predict the outcome of patent enforcement litigation at the trial level. It is often difficult for juries and trial judges to understand complex, patented technologies, and as a result, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and delayed revenue. Although we diligently pursue enforcement litigation, we cannot predict with significant reliability the decisions made by juries and trial courts.

More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.

Certain of our operating subsidiaries hold and continue to invest in pending patents. We have identified a trend of increasing patent applications each year, which we believe is resulting in longer delays in obtaining approval of pending patent applications. The application delays could cause delays in recognizing revenue from these patents and could cause us to miss opportunities to license patents before other competing technologies are developed or introduced into the market.

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.

Our patent enforcement actions are almost exclusively prosecuted in federal court. Federal trial courts that hear our patent enforcement actions also hear criminal cases. Criminal cases always take priority over our actions. As a result, it is difficult to predict the length of time it will take to complete an enforcement action. Moreover, we believe there is a trend in increasing numbers of civil lawsuits and criminal proceedings before federal judges and, as a result, we believe that the risk of delays in our patent enforcement actions will have a greater effect on our business in the future unless this trend changes.

Any reductions in the funding of the USPTO could have an adverse impact on the cost of processing pending patent applications and the value of those pending patent applications.

The assets of our operating subsidiaries consist of patent portfolios, including pending patent applications before the USPTO. The value of our patent portfolios is dependent upon the issuance of patents in a timely manner, and any reductions in the funding of the USPTO could negatively impact the value of our assets. Further, reductions in funding from Congress could result in higher patent application filing and maintenance fees charged by the USPTO, causing an unexpected increase in our expenses.

Competition is intense in the industries in which our subsidiaries do business and as a result, we may not be able to grow or maintain our market share for our technologies and patents.

We expect to encounter competition in the area of patent portfolio investments and enforcement as the number of companies entering this market is increasing. This includes competitors seeking to invest in the same or similar patents and technologies that we may seek to invest in. Entities including RPX, AST, Intellectual Ventures, Wi-LAN, Conversant, Round Rock Research LLC, IPvalue Management Inc., Vringo Inc., VirnetX and Pendrell Corporation compete in acquiring rights to patents, and we expect more entities to enter the market. As new technological advances occur, many of our patented

technologies may become obsolete before they are completely monetized. If we are unable to replace obsolete technologies with more technologically advanced patented technologies, then this obsolescence could have a negative effect on our ability to generate future revenues.

Our licensing business also competes with venture capital firms and various industry leaders for patent licensing opportunities. Many of these competitors may have more financial and human resources than we do. As we become more successful, we may find more companies entering the market for similar technology opportunities, which may reduce our market share in one or more technology industries that we currently rely upon to generate future revenue.

Our patented technologies face uncertain market value.

Our operating subsidiaries have invested in patents and technologies that may be in the early stages of adoption in the commercial and consumer markets. Demand for some of these technologies is untested and is subject to fluctuation based upon the rate at which our licensees will adopt our patents and technologies in their products and services.

Further, significant judgment is required in connection with estimates of the recoverability of the carrying value of our intangible patent assets, including estimates of market values, estimates of the amount and timing of future cash flows, and estimates of other factors that are used to determine the fair value and recoverability of the respective patent asset values. Developments with respect to ongoing patent litigation, patent challenges and re-exams, legislative and judicial decisions and other factors outside of our control, may unfavorably impact the validity, applicability, and enforceability of our patent assets, and therefore, negatively impact the future value of our patent portfolios. If certain of these unfavorable events occur, our estimates or related projections may change materially in future periods, and future intangible asset impairment tests may result in material charges to earnings.

As patent enforcement litigation becomes more prevalent, it may become more difficult for us to voluntarily license our patents.

We believe that the more prevalent patent enforcement actions become, the more difficult it will be for us to voluntarily license our patents. As a result, we may need to increase the number of our patent enforcement actions to cause infringing companies to license the patent or pay damages for lost royalties. This may increase the risks associated with an investment in our company.

Patent litigation trials and scheduled trial dates are subject to routine delay, and any such delays could adversely impact our business, results of operations and financial condition.

Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to the existence of possible future revenue opportunities for us. Patent litigation schedules in general, and in particular trial dates, are subject to routine adjustment, and in most cases delay, as courts adjust their calendars or respond to requests from one or more parties. Trial dates often are rescheduled by the court for various reasons that are often unrelated to the underlying patent assets and typically for reasons that are beyond our control. As a result, to the extent such events are an indicator of possible future revenue opportunities for us, or other outcome determinative events, they may and often do change which can result in delay of the expected scheduled event. Any such delay could be significant and could affect the corresponding future revenue opportunities, thus adversely impacting our business, results of operations and financial condition.

The markets served by our operating subsidiaries are subject to rapid technological change, and if our operating subsidiaries are unable to develop and invest in new technologies and patents, our ability to generate revenues could be substantially impaired.

The markets served by our operating subsidiaries and their licensees frequently undergo transitions in which products rapidly incorporate new features and performance standards on an industry-wide basis. Products for communications applications and high-speed computing applications, as well as other applications covered by our operating subsidiaries’ intellectual property, are based on continually evolving industry standards. In addition, the communications industry is intensely competitive and has been impacted by price erosion, rapid technological change, short product life cycles, cyclical market patterns and increasing foreign and domestic competition. Our ability to compete in the future will depend on our ability to identify and ensure compliance with evolving industry standards. This will require our continued efforts and success in acquiring new patent portfolios with licensing and enforcement opportunities. While we expect for the foreseeable future to have sufficient liquidity and capital resources to maintain the level of patent portfolio investments necessary to keep pace with these technological advances, various factors may require us to have greater liquidity and capital resources than we currently

expect. If we are unable to invest in new patented technologies and patent portfolios, or to identify and ensure compliance with evolving industry standards, our ability to generate revenues could be substantially impaired and our business and financial condition could be materially harmed.

Uncertainty in global economic conditions could negatively affect our business, results of operations and financial condition.

Our revenue-generating opportunities depend on the use of our patented technologies by existing and prospective licensees, the overall demand for the products and services of our licensees, and on the overall economic and financial health of our licensees. Although economic conditions appear to be improving, recent uncertainties in global economic conditions have resulted in the tightening of the credit markets, a low level of liquidity in many financial markets, and extreme volatility in the credit, equity and fixed income markets. If economic conditions do not continue to improve, or if they further deteriorate, many of our licensees’ customers, which may rely on credit financing, may delay or reduce their purchases of our licensees’ products and services. In addition, the use or adoption of our patented technologies is often based on current and forecasted demand for our licensees’ products and services in the marketplace and may require companies to make significant initial commitments of capital and other resources. If negative conditions in the global credit markets delay or prevent our licensees’ and their customers’ access to credit, overall consumer spending on the products and services of our licensees may decrease and the adoption or use of our patented technologies may slow, respectively. Further, if the markets in which our licensees’ participate do not continue to improve, or deteriorate further, this could negatively impact our licensees’ long-term sales and revenue generation, margins and operating expenses, which could in turn have an adverse effect on our business, results of operations and financial condition.

In addition, we have significant patent-related intangible assets recorded on our consolidated balance sheets. We will continue to evaluate the recoverability of the carrying amount of our patent-related intangible assets on an ongoing basis, and we may incur substantial impairment charges, which would adversely affect our consolidated financial results. There can be no assurance that the outcome of such reviews in the future will not result in substantial impairment charges. Impairment assessment inherently involves judgment as to assumptions about expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact our assumptions as to prices, costs, holding periods or other factors that may result in changes in our estimates of future cash flows. Although we believe the assumptions we used in testing for impairment are reasonable, significant changes in any one of our assumptions could produce a significantly different result.

Risks Related to Our Common Stock

The availability of shares for sale in the future could reduce the market price of our common stock.

In the future, we may issue securities to raise cash for operations and patent portfolio investments. We may also pay for interests in additional subsidiary companies by using shares of our common stock or a combination of cash and shares of our common stock. We may also issue securities convertible into our common stock. Any of these events may dilute stockholders’ ownership interests in our company and have an adverse impact on the price of our common stock.

In addition, sales of a substantial amount of our common stock in the public market, or the perception that these sales may occur, could reduce the market price of our common stock. This could also impair our ability to raise additional capital through the sale of our securities.

Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of our company that might otherwise result in our stockholders receiving a premium over the market price of their shares.

Provisions of Delaware law and our certificate of incorporation and bylaws could make the acquisition of our company by means of a tender offer, proxy contest or otherwise, and the removal of incumbent officers and directors, more difficult. These provisions include:


•	Section 203 of the Delaware General Corporation Law, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, until three years after that party became a 15%-or-greater stockholder;


•	amendment of our bylaws by the stockholders requires a two-thirds approval of the outstanding shares;


•	the authorization in our certificate of incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover;


•	provisions in our bylaws eliminating stockholders’ rights to call a special meeting of stockholders, which could make it more difficult for stockholders to wage a proxy contest for control of our board of directors or to vote to repeal any of the anti-takeover provisions contained in our certificate of incorporation and bylaws; and


•	the division of our board of directors into three classes with staggered terms for each class, which could make it more difficult for an outsider to gain control of our board of directors.

Together, these provisions may make the removal of management more difficult and may discourage transactions that could otherwise involve payment of a premium over prevailing market prices for our common stock.

We may fail to meet market expectations because of fluctuations in quarterly operating results, which could cause the price of our common stock to decline.

Our reported revenues and operating results have fluctuated in the past and may continue to fluctuate significantly from quarter to quarter in the future. It is possible that in future periods, revenues could fall below the expectations of securities analysts or investors, which could cause the market price of our common stock to decline. The following are among the factors that could cause our operating results to fluctuate significantly from period to period:


•	the dollar amount of agreements executed in each period, which is primarily driven by the nature and characteristics of the technology being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed in each period and the periods of infringement contemplated by the respective payments;


•	fluctuations in the total number of agreements executed;


•	fluctuations in the sales results or other royalty-per-unit activities of our licensees that impact the calculation of license fees due;


•	the timing of the receipt of periodic license fee payments and/or reports from licensees;


•	fluctuations in the net number of active licensees period to period;


•	costs related to investments, alliances, licenses and other efforts to expand our operations;


•	the timing of payments under the terms of any customer or license agreements into which our operating subsidiaries may enter;


•	expenses related to, and the timing and results of, patent filings and other enforcement proceedings relating to intellectual property rights, as more fully described in this section; and


•	new litigation or developments in current litigation and the unpredictability of litigation results or settlements or appeals.

Technology company stock prices are especially volatile, and this volatility may depress the price of our common stock.

The stock market has experienced significant price and volume fluctuations, and the market prices of technology companies have been highly volatile. We believe that various factors may cause the market price of our common stock to fluctuate, perhaps substantially, including, among others, the following:


•	announcements of developments in our patent enforcement actions;


•	developments or disputes concerning our patents;


•	our or our competitors’ technological innovations;


•	developments in relationships with licensees;


•	variations in our quarterly operating results;


•	our failure to meet or exceed securities analysts’ expectations of our financial results;


•	a change in financial estimates or securities analysts’ recommendations;


•	changes in management’s or securities analysts’ estimates of our financial performance;


•	changes in market valuations of similar companies;


•	concerns about sovereign debt of the United States and the European Union;


•	announcements by us or our competitors of significant contracts, investments, strategic partnerships, joint ventures, capital commitments, new technologies, or patents; and


•	failure to complete significant transactions.

For example, the NASDAQ-100 Technology Sector Index (NDXT) had a range of $1,942.62 - $2,953.37 during the 52-weeks ended December 31, 2016 and the NASDAQ Composite Index (IXIC) had a range of $4,209.76 - $5,512.37 over the same period. Over the same period, our common stock fluctuated within a range of $2.82 - $7.68.

The recent financial crisis affecting the banking system and financial markets and the uncertainty in global economic conditions have resulted in a tightening in the credit markets, a low level of liquidity in many financial markets, and extreme volatility in the credit, equity and fixed income markets. As noted above, our stock price, like many others, has fluctuated significantly in recent periods and if investors have concerns that our business, operating results and financial condition will be negatively impacted by global economic conditions, our stock price could continue to fluctuate significantly in future periods.

In addition, we believe that fluctuations in our stock price during applicable periods can also be impacted by court rulings and/or other developments in our patent licensing and enforcement actions. Court rulings in patent enforcement actions are often difficult to understand, even when favorable or neutral to the value of our patents and our overall business, and we believe that investors in the market may overreact, causing fluctuations in our stock prices that may not accurately reflect the impact of court rulings on our business operations and assets.

In the past, companies that have experienced volatility in the market price of their stock have been the objects of securities class action litigation. If our common stock was the object of securities class action litigation, it could result in substantial costs and a diversion of management’s attention and resources, which could materially harm our business and financial results.

We do not currently intend to pay dividends on our common stock in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

On February 23, 2016, our board of directors eliminated our dividend policy that provided for the discretionary payment of a total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter, effective as of February 23, 2016. As a result, we do not anticipate paying any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which our stockholders have purchased their shares.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our principal executive, corporate and administrative offices are located in Newport Beach, California, where we lease approximately 17,758 square feet of office space, under a lease agreement that expires in December 2019. Our primary operating subsidiary, Acacia Research Group, LLC, and its subsidiaries, are headquartered in Dallas, Texas, where we lease approximately 1,810 square feet of office space, under a lease agreement that expires in April 2017. Certain of our operating subsidiaries also maintain additional leased office space in Munich, Germany. We believe that our facilities are adequate, suitable and of sufficient capacity to support our immediate needs.

ITEM 3. LEGAL PROCEEDINGS

In the ordinary course of business, we are the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our patent enforcement activities. We believe that any liability arising from these actions will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. Certain of our operating subsidiaries are parties to ongoing patent enforcement related litigation, alleging infringement by third-parties of certain of the patented technologies owned or controlled by our operating subsidiaries.

In connection with any of our patent enforcement actions, it is possible that a defendant may claim and/or a court may rule that we have violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by us or our operating subsidiaries, could materially harm our operating results and our financial position.

ITEM 4. MINE SAFETY DISCLOSURES

None.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

General

Our common stock trades on The NASDAQ Global Select Market under the symbol “ACTG.”

Price Range of Common Stock

The high and low sales prices for our common stock as reported by The NASDAQ Global Select Market for the periods indicated are shown in the table below. Such prices are inter-dealer prices without retail markups, markdowns or commissions and may not necessarily represent actual transactions.



	2016				2015
	Fourth Quarter	Third Quarter	Second Quarter	First Quarter	Fourth Quarter	Third Quarter	Second Quarter	First Quarter

High	$7.68	$7.25	$5.64	$4.30	$9.97	$10.63	$12.51	$17.22
Low	$5.55	$4.20	$3.75	$2.82	$3.82	$7.88	$8.61	$10.18

Dividend Policy

On April 23, 2013, we announced that our Board of Directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, we paid quarterly cash dividends totaling $25.4 million and $25.0 million during 2015 and 2014, respectively. On February 23, 2016, our Board of Directors terminated the company’s dividend policy effective immediately. Our Board of Directors terminated the dividend policy due to a number of factors, including our financial performance, our available cash resources, our cash requirements and alternative uses of capital that our Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

The current policy of our Board of Directors is to retain earnings, if any, to provide for our growth and the growth of our operating subsidiaries. Consequently, we do not expect to pay any cash dividends in the foreseeable future. Further, there can be no assurance that our proposed operations will generate revenues and cash flow needed to declare any future cash dividends or that we will have legally available funds to pay future dividends.

Holders of Common Stock

On March 6, 2017, there were approximately 68 owners of record of our common stock. The majority of the outstanding shares of our common stock are held by a nominee holder on behalf of an indeterminable number of ultimate beneficial owners.

Stock Price Performance Graph

The following stock price performance graph shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act.

The Stock Performance Graph depicted below compares the yearly change in our cumulative total stockholder return for the last five fiscal years with the cumulative total return of The NASDAQ Stock Market (U.S.) Composite Index and the NASDAQ-100 Technology Sector Index.



	2012	2013	2014	2015	2016

Acacia Research Corporation common stock	$70	$40	$46	$12	$18
Nasdaq Composite Index (IXIC)	$116	$160	$182	$192	$207
NASDAQ-100 Technology Sector Index (NDXT)	$107	$147	$182	$178	$221

The graph covers the period from December 31, 2011 to December 31, 2016. Cumulative total returns are calculated assuming that $100 was invested on December 31, 2011, in our common stock, in the NASDAQ Composite Index, and in the NASDAQ-100 Technology Sector Index, and that all dividends, if any, were reinvested. Stockholder returns over the indicated period should not be considered indicative of future stock prices or stockholder returns.

ITEM 6. SELECTED FINANCIAL DATA

The consolidated selected balance sheet data as of December 31, 2016 and 2015 and the consolidated selected statements of operations data for the years ended December 31, 2016, 2015 and 2014 set forth below have been derived from our audited consolidated financial statements included elsewhere herein, and should be read in conjunction with those financial statements (including notes thereto). The consolidated selected balance sheet data as of December 31, 2014, 2013 and 2012 and the consolidated selected statements of operations data for the years ended December 31, 2013 and 2012 have been derived from audited consolidated financial statements not included herein, but which were previously filed with the SEC.

Consolidated Statements of Operations Data

(In thousands, except share and per share data)



	For the Years Ended December 31,
	2016			2015			2014			2013			2012

Revenues	$	152,699		$	125,037		$	130,876		$	130,556		$	250,727
Inventor royalties and contingent legal fees expense	49,204			34,631			44,233			54,508			50,679
Litigation and licensing expenses - patents	27,858			39,373			37,614			39,335			21,591
Amortization of patents	34,208			53,067			53,745			49,039			39,019
General and administrative expenses (excluding non-cash stock compensation expense)	23,857			27,128			30,439			31,335			28,426
Non-cash stock compensation expense (included in G&A in the statements of operations)	9,062			11,048			18,115			27,894			25,657
Research, consulting and other expenses - business development	3,079			3,391			3,840			3,251			4,943
Impairment of patent-related intangible assets	42,340			74,731			3,497			4,619			—
Impairment of goodwill	—			30,149			—			—			—
Other	500			4,141			1,548			3,506			—
Operating income (loss)	$	(37,409	)	$	(152,622	)	$	(62,155	)	$	(82,931	)	$	80,412

Income (loss) from continuing operations before (provision for) benefit from income taxes	$	(36,611	)	$	(152,678	)	$	(62,750	)	$	(80,800	)	$	81,349
(Provision for) benefit from income taxes	(18,188		)	(4,800		)	(3,912		)	21,958			(22,060		)
Net income (loss) from continuing operations including noncontrolling interests in operating subsidiaries	$	(54,799	)	$	(157,478	)	$	(66,662	)	$	(58,842	)	$	59,289

Net income (loss) attributable to Acacia Research Corporation	$	(54,067	)	$	(160,036	)	$	(66,029	)	$	(56,434	)	$	59,453

Diluted income (loss) per common share	$	(1.08	)	$	(3.25	)	$	(1.37	)	$	(1.18	)	$	1.21

Cash dividends declared per common share	$	—		$	0.50		$	0.50		$	0.375		$	—

Consolidated Balance Sheet Data (In thousands)



	At December 31,
	2016		2015		2014		2013		2012

Cash and cash equivalents, restricted cash and investments	$	158,495	$	145,948	$	193,024	$	256,702	$	311,279
Patents, net of accumulated amortization	86,319		162,642		286,636		288,432		313,529
Total assets	296,003		347,901		536,348		593,393		668,717
Total liabilities	28,560		33,746		47,300		31,195		50,239
Noncontrolling interests in operating subsidiaries	1,854		3,944		5,491		6,488		6,976
Acacia Research Corporation stockholders’ equity	265,589		310,211		483,557		555,710		611,502

Factors Affecting Comparability:


•	Net deferred tax liabilities resulting from an acquisition in January 2012 created an additional source of income to utilize against the majority of our existing consolidated net deferred tax assets. In addition, we estimated that certain of our other

foreign tax credit and state tax related deferred tax assets were more likely than not realizable in future periods. Accordingly, the valuation allowance on the majority of our net deferred tax assets was released, resulting in a financial statement income tax benefit of $10.7 million during the year ended December 31, 2012. At December 31, 2013, we recorded a partial valuation allowance for certain tax attribute carryforwards and other deferred tax assets totaling $7.6 million, due to uncertainty regarding future realization. We recorded a full valuation allowance for net deferred tax assets generated during fiscal year 2016, 2015 and 2014, due to uncertainty regarding future realization.

•

For the years ended December 31, 2016, 2015, 2014, 2013 and 2012, we paid patent related investment costs totaling $1.2 million, $19.5 million, $42.7 million, $25.1 million and $178.3 million (excluding business combinations of $150.0 million), respectively. Patent related investment costs are amortized using the straight-line method over the estimated economic useful life of the underlying patents.

•

For the years ended December 31, 2016, 2015, 2014 and 2013 we recognized patent impairment charges totaling $42.3 million, $74.7 million, $3.5 million and $4.6 million, respectively. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse legal outcomes and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.


•	We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company's stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors including the risks we discuss in Item 1A, “Risk Factors,” and elsewhere herein.

General

Our operating subsidiaries invest in, license and enforce patented technologies. Our operating subsidiaries partner with inventors and patent owners, applying our legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Our operating subsidiaries generate revenues and related cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries control or own. Our operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. We are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.

We are a leader in licensing patented technologies and have established a proven track record of licensing success with over 1,530 license agreements executed to date, across 192 patent portfolio licensing and enforcement programs. Currently, on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries. To date, we have generated gross licensing revenue of approximately $1.4 billion, and have returned more than $726 million to our patent partners.

The patent portfolio investment, development, licensing and enforcement business conducted by our operating subsidiaries is described more fully in Item 1. “Business,” of this annual report.

Executive Overview

Our operating activities during the periods presented have been principally focused on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent licensing and enforcement programs. In addition, we and our operating subsidiaries may from time to time evaluate, leveraging our intellectual property expertise, other business opportunities. In some cases, these opportunities will compliment, and / or supplement our primary licensing and enforcement business.

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents and inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then we may not be able to identify new technology-based opportunities for sustainable revenue and /or revenue growth.

affect the market availability of suitable patent portfolios for acquisition. These industry trends have continued, and as a result, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business. We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our revenues will decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

As a result of the foregoing, our operating subsidiaries may from time to time evaluate other business opportunities which compliment, or supplement, our primary licensing and enforcement business and leverage our intellectual property expertise. For example, in August 2016, we announced the formation of a strategic partnership with Veritone, Inc. (“Veritone”), a leading cloud-based Artificial Intelligence (“AI”) technology company that is pioneering next generation search and analytics through their proprietary Cognitive Media Platform™. Under the partnership, we expect to leverage our intellectual property expertise to assist Veritone with building its patent portfolio and executing upon its overall intellectual property strategy. In order to enhance Veritone’s leadership position in the field of machine learning and AI, we provided $20 million in funding to Veritone in the form of two $10 million loans, each convertible upon the occurrence of certain events into Veritone equity. Additionally, upon the occurrence of certain events and the achievement of certain milestones by Veritone, we may invest up to an additional $30 million in Veritone, for a total investment of up to $50 million. Our Board of Directors unanimously approved the investment, and believes that this partnership with Veritone will be synergistic with our business strategies.

Operating activities during the periods presented included the following:



	2016		2015		2014

Revenues (in thousands)	$	152,699	$	125,037	$	130,876
New agreements executed	39		63		88
Licensing and enforcement programs generating revenues - during the respective period	28		30		46
Licensing and enforcement programs with initial revenues	7		4		15
New patent portfolios	2		3		6
Year end cash, cash equivalents, short-term investments and restricted cash balance	$	158,495	$	145,948	$	193,024

We measure and assess the performance and growth of the patent licensing and enforcement businesses conducted by our operating subsidiaries based on consolidated revenues (including other operating income) recognized across all of our patent licensing and enforcement programs on a trailing twelve-month basis. Trailing twelve-month revenues during the periods presented were as follows (in thousands, except percentage change values):



As of Date:	Trailing Twelve -Month Revenues		% Change

December 31, 2016	$	152,699	(9	)%
September 30, 2016	168,227		44	%
June 30, 2016	116,563		1	%
March 31, 2016	115,548		(8	)%
December 31, 2015	125,037		(4	)%
December 31, 2014	130,876		—

Our revenues historically have fluctuated period to period, and can vary significantly, based on a number of factors including the following:


•	the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;


•	the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments;


•	fluctuations in the total number of agreements executed each period;


•	the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;


•	the relative maturity of licensing programs during the applicable periods;


•	other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors; and


•	historically, based on the merits and strength of our operating subsidiary’s patent infringement claims and other factors, many prospective licensees have elected to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as those patent infringement cases approached a court determined trial date.

Our management does not attempt to manage for smooth sequential periodic growth in revenues period to period, and therefore, periodic results can be uneven. Unlike most operating businesses and industries, licensing revenues not generated in a current period are not necessarily foregone but, depending on whether negotiations, litigation or both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be pushed into subsequent fiscal periods.

Summary of Results of Operations - For Fiscal Years 2016, 2015 and 2014

(In thousands, except percentage change values)



	Fiscal Year									% Change
	2016			2015			2014			2016 vs. 2015		2015 vs. 2014

Revenues	$	152,699		$	125,037		$	130,876		22	%	(4	)%
Inventor royalties and contingent legal fees	49,204			34,631			44,233			42	%	(22	)%
Litigation and licensing expenses - patents	27,858			39,373			37,614			(29	)%	5	%
Amortization expense	34,208			53,067			53,745			(36	)%	(1	)%
Impairment of patent-related intangible assets	42,340			74,731			3,497			(43	)%	*
Impairment of goodwill	—			30,149			—			(100	)%	100	%
Other operating costs and expenses⁽¹⁾	36,498			45,708			53,942			(20	)%	(15	)%
Operating loss	(37,409		)	(152,622		)	(62,155		)	(75	)%	146	%
Provision for income taxes	(18,188		)	(4,800		)	(3,912		)	279	%	23	%
Net (income) loss attributable to noncontrolling interests⁽²⁾	732			(2,558		)	633			(129	)%	*
Net loss attributable to Acacia Research Corporation	(54,067		)	(160,036		)	(66,029		)	(66	)%	142	%

____________________________________

* Percentage change in excess of 300%

⁽¹⁾ Includes non-cash stock compensation charges of $9.1 million, $11.0 million and $18.1 million in fiscal years 2016, 2015 and 2014, respectively, included in General and administrative expense in the consolidated statements of operations.

⁽²⁾ Refer to Note 1 to the notes to consolidated financial statements included elsewhere in this annual report for additional information.

Overview - Fiscal year 2016 compared with Fiscal Year 2015


•	Revenues increased $27.7 million, or 22% to $152.7 million for fiscal year 2016, as compared to fiscal year 2015, due to an increase in average revenue per agreement, which was partially offset by a decrease in the number of agreements executed.


•	Inventor royalties and contingent legal fees, on a combined basis, increased $14.6 million, or 42%, due primarily to the 22% increase in revenues in fiscal year 2016, and a 4% increase in average contingent legal fee rates for the portfolios generating revenues in fiscal year 2016, as compared to the portfolios generating revenues in fiscal year 2015.


•	Litigation and licensing expenses-patents decreased $11.5 million, or 29%, to $27.9 million, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with patent trials and ongoing licensing and enforcement programs.


•	Amortization expense decreased $18.9 million, or 36%, to $34.2 million, due to a decrease in scheduled amortization on existing patent portfolios resulting from various patent portfolio impairment charges previously recorded in the fourth quarter of 2015 and second quarter of 2016.

•

Impairment of patent-related intangible asset charges decreased $32.4 million, or 43%, to $42.3 million. Impairment charges reflect the impact of reductions in expected estimated future net cash flows for certain patent portfolios and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

•

In the fourth quarter of fiscal 2015, we performed an impairment analysis of goodwill. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in the Company's stock price and adverse litigation outcomes occurring in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.


•	General and administrative expenses decreased $5.3 million, or 14%, to $32.9 million, due primarily to a net decrease in personnel costs in connection with the net reduction in headcount during 2016 and 2015 and a net decrease in non-cash stock compensation expense.


•	Fiscal year 2016 and 2015 operating expenses included expenses for court ordered attorney fees totaling $500,000 and $4.1 million, respectively.

•

Tax expense for the periods presented reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss (2015 only)and foreign tax credit related tax assets generated during the periods. As such, no tax benefit was recognized for net operating loss and foreign tax credit related tax benefits generated during the applicable periods presented.

Overview - Fiscal year 2015 compared with Fiscal Year 2014


•	Revenues decreased $5.8 million, or 4% to $125.0 million for fiscal year 2015, as compared to fiscal year 2014.


•	Inventor royalties and contingent legal fees, on a combined basis, decreased $9.6 million, or 22%, due primarily to certain patent portfolios generating revenue in 2015 with a higher amount of cost recoveries and lower contingent fee rates, as compared to the portfolios generating revenues in fiscal year 2014.


•	Litigation and licensing expenses-patents increased $1.8 million, or 5%, to $39.4 million, due primarily to a net increase in litigation support and third-party technical consulting expenses associated with trials occurring in 2015 and scheduled to occur in 2016, and ongoing and new licensing and enforcement programs commenced during fiscal year 2015.

•

Impairment of patent-related intangible asset charges increased $71.2 million, or +300%, to $74.7 million, reflecting the impact of reductions in expected estimated future net cash flows for certain patent portfolios and certain patent portfolios that management determined it would no longer allocate resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

•


•	General and administrative expenses decreased $10.4 million, or 21%, to $38.2 million, due primarily to a net decrease in personnel costs in connection with the net reduction in headcount during 2014 and 2015, a decrease in variable performance-based compensation costs, and a net decrease in non-cash stock compensation expense.


•	Fiscal year 2015 operating expenses included expenses for court ordered attorney fees totaling $4.1 million. Fiscal year 2014 operating expenses included an expense accrual for court ordered attorney fees related to matters initiated in 2010 and 2011 totaling $1.5 million.


•	Tax expense for the periods presented reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss and foreign

tax credit related tax assets generated during the periods. As such, no tax benefit was recognized for net operating loss and foreign tax credit related tax benefits generated during the periods presented.

Revenues for the periods presented included fees from the following licensing and enforcement programs:



•	360 Degree View Technology⁽²⁾	•	Mobile Computer Synchronization technology⁽²⁾⁽³⁾
•	3G & 4G Cellular Air Interface and Infrastructure technology⁽²⁾⁽³⁾	•	Multi-Display Content Delivery and Data Aggregation technology⁽³⁾
•	4G Wireless technology^(1)(2)(3)	•	Oil and Gas Drilling technology⁽¹⁾
•	Audio Communications Fraud Detection technology^(1)(2)(3)	•	Oil and Gas Production technology ⁽²⁾⁽³⁾
•	Automotive Safety, Navigation and Diagnostics technology⁽²⁾⁽³⁾	•	Online Auction Guarantee technology^(1)(2)(3)
•	Bone Wedge technology⁽¹⁾⁽²⁾	•	Online Gaming technology⁽³⁾
•	Broadband Communications technology^(1)(2)(3)	•	Optical Networking technology^(1)(2)(3)
•	Cardiology and Vascular Device technology^(1)(2)(3)	•	Optimized Microprocessor Operation technology⁽²⁾⁽³⁾
•	Computer Aided Design Tools technology⁽³⁾	•	Radio Frequency Modulation technology⁽³⁾
•	Computer-Aided Design technology⁽³⁾	•	Reflective and Radiant Barrier Insulation technology^(1)(2)(3)
•	Core Fiber Optic Network Architectures technology⁽³⁾	•	Semiconductor 3D Die Stacking technology⁽¹⁾
•	Diamond and Gemstone Grading technology⁽¹⁾	•	Semiconductor Memory Circuit and Manufacturing Processes technology⁽¹⁾
•	DisplayPort and MIPI DSI technology⁽¹⁾⁽²⁾	•	Semiconductor Packaging technology⁽³⁾
•	Distributed Data Management & Synchronization technology⁽³⁾	•	Semiconductor Testing technology⁽²⁾
•	DMT® technology⁽³⁾	•	Shared Memory for Multimedia Processing⁽¹⁾⁽²⁾
•	DRAM and Flash Memory technology⁽¹⁾	•	Software Activation technology⁽³⁾
•	Electronic Access Control technology⁽²⁾⁽³⁾	•	Software Technology⁽³⁾
•	Electronic spreadsheet, data analysis and software development technology⁽¹⁾	•	Speech codes used in wireless and wireline systems technology^(1)(2)(3)
•	Enhanced Mobile Communications technology⁽²⁾⁽³⁾	•	Spinning and Jousting Toy Game technology ⁽²⁾⁽³⁾
•	Flash Memory technology⁽¹⁾	•	Super Resolutions Microscopy technology^(1)(2)(3)
•	Gas Modulation Control Systems technology^(1)(2)(3)	•	Surgical Access technology⁽²⁾
•	High Speed Circuit Interconnect and Display Control technology^(1)(2)(3)	•	Suture Anchors technology⁽²⁾⁽³⁾
•	Improved Lighting technology⁽²⁾⁽³⁾	•	Telematics technology^(1)(2)(3)
•	Innovative Display technology⁽²⁾⁽³⁾	•	Unicondylar Knee Replacement technology⁽²⁾
•	Intercarrier SMS technology⁽²⁾⁽³⁾	•	Variable Data Printing technology⁽¹⁾
•	Interstitial and Pop-Up Internet Advertising technology^(1)(2)(3)	•	Video Analytics for Security technology⁽²⁾⁽³⁾
•	Knee Replacement technology⁽¹⁾	•	Voice-Over-IP technology⁽²⁾⁽³⁾
•	Lighting Ballast technology⁽¹⁾	•	Wireless Data Synchronization & Data Transfer technology⁽²⁾⁽³⁾
•	Location Based Services technology⁽²⁾⁽³⁾	•	Wireless Infrastructure and User Equipment technology^(1)(2)(3)
•	Messaging technology⁽²⁾⁽³⁾	•	Wireless Location Based Services technology⁽²⁾⁽³⁾
•	Microprocessor and Memory technology^(1)(2)(3)	•	Wireless Monitoring technology⁽²⁾⁽³⁾

______________________________________



⁽¹⁾	Licensing and enforcement program generating revenue in 2016.
⁽²⁾	Licensing and enforcement program generating revenue in 2015.
⁽³⁾	Licensing and enforcement program generating revenue in 2014.

Revenues from one or more of our patents or patent portfolios may be significant in a specific reporting period, and may be significant to our licensing and enforcement business as a whole.

Patent Licensing and Enforcement

Patent Litigation Trial Dates and Related Trials. As of the date of this report, our operating subsidiaries have in excess of 6 pending patent infringement cases with a scheduled trial date in the next six months. Patent infringement trials are components of our overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities for us. Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods, the trials may occur according to the court’s scheduling calendar at a specific point in time. A court may change previously scheduled trial dates. In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent assets and typically for reasons that are beyond our control. While scheduled trial dates provide an indication of the timing of possible future revenue generating opportunities for us, the trials themselves and the immediately

preceding periods represent the possible future revenue generating opportunities. These future opportunities can result in varying outcomes. In fact, it is difficult to predict the outcome of patent enforcement litigation at the trial level and outcomes can be unfavorable. It can be difficult to understand complex patented technologies, and as a result, this may lead to a higher rate of unfavorable litigation outcomes. For example, in the fourth quarter of 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., AT&T Mobility LLC, Cellco Partnership, and Sprint Spectrum L.P., lead case 6:12-cv-00022 pending in the Eastern District of Texas. The jury returned a verdict that the asserted claims of U.S. Patent No. 6,870,808 were invalid and non-infringed. Moreover, in the event of a favorable outcome, there is a higher rate of successful appeals in patent enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased costs and a potential for delayed or foregone revenue opportunities in the event of modification or reversal of favorable outcomes. Although we diligently pursue enforcement litigation, we cannot predict with reliability the decisions made by juries and trial courts. Please refer to Item 1A. "Risk Factors" for additional information regarding trials, patent litigation and related risks.

Litigation and Licensing Expense. We expect patent-related legal expenses to continue to fluctuate from period to period based on the factors summarized herein, in connection with future trial dates, international enforcement, strategic patent portfolio prosecution and our current and future patent portfolio investment, prosecution, licensing and enforcement activities. The pursuit of enforcement actions in connection with our licensing and enforcement programs can involve certain risks and uncertainties, including the following:

•

Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs could increase our operating costs and decrease our profit generating opportunities;


•	Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;

•

New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions. For instance, the United States House of Representatives passed a bill that would require non-practicing entities that bring patent infringement lawsuits to pay legal costs of the defendants, if the lawsuits are unsuccessful and certain standards are not met;


•	Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position; and


•	The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e. markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios.

Investments in Patent Portfolios

In fiscal year 2016 we acquired control of 2 additional patent portfolios, compared to 3 new patent portfolios, and 6 new patent portfolios in fiscal years 2015 and 2014, respectively. In fiscal year 2016, we acquired a portfolio from our patent partner Renesas Electronics of Japan, comprised of 24 U.S. and 12 foreign patents covering technologies such as semiconductor chips for power management, system-on-chip architecture in microprocessors and packaging technology in memory and semiconductors. In addition, we acquired a portfolio containing 29 U.S. and 31 foreign patents covering circuits used in DRAM and Flash Memory. Patent portfolio investment costs paid in fiscal year 2016 totaled $1.2 million, compared to $19.5 million and $42.7 million in fiscal years 2015 and 2014, respectively.

Neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment in patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If our operating subsidiaries are unable to

maintain those relationships and to continue to identify and grow new relationships, then we may not be able to identify new technology-based opportunities for sustainable revenue and / or revenue growth.

Our current or future relationships may not provide the volume or quality of technologies necessary to sustain our licensing and enforcement business. In some cases, universities and other technology sources compete against us as they seek to develop and commercialize technologies. Universities may receive financing for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies employed by potential partners may reduce the number of technology sources and potential clients to whom we can market its solutions. If we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology, such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain our licensing and enforcement business.

For example, during fiscal year 2016 and 2015, we obtained control of only 2 and 3, respectively, new patent portfolios, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. This decrease in our patent portfolio intake reflects in part our strategic decision in 2013 to shift the focus of our operating business to serving a smaller number of customers, each having higher quality patent portfolios. As a result, our gross number of patent portfolio acquisitions has decreased significantly. This decrease in our patent portfolio intake also reflects in part industry trends impacting our ability to acquire patent portfolios. For example, legislative and legal changes have increased the complexity of patent enforcement actions and may significantly affect the market availability of suitable patent portfolios for acquisition. These industry trends have continued, and as a result, our recent and future patent portfolio intake has been and may continue to be negatively impacted, resulting in further decreases in future revenue generating opportunities, and continued negative adverse impacts on the sustainability of our licensing and enforcement business We continue to experience significant adverse challenges with respect to our patent intake efforts, and if these adverse challenges continue, our revenues will decline and we will be unable to profitably sustain our licensing and enforcement business going forward.

Critical Accounting Policies

Our consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America. In preparing these financial statements, we make assumptions, judgments and estimates that can have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions, judgments and estimates and make changes accordingly.

We believe that, of the significant accounting policies discussed in Note 2 to our notes to consolidated financial statements, the following accounting policies require our most difficult, subjective or complex judgments:


•	revenue recognition;


•	stock-based compensation expense;


•	valuation of long-lived and intangible assets including goodwill; and


•	accounting for income taxes.

We discuss below the critical accounting assumptions, judgments and estimates associated with these policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. For further information on our critical accounting policies, refer to Note 2 to the notes to consolidated financial statements included herein.

Revenue Recognition

As described below, significant management judgment must be made and used in connection with the revenue recognized in any accounting period. Material differences may result in the amount and timing of revenue recognized or deferred for any period, if management made different judgments.

Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been performed pursuant to the terms of the agreement, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.

We make estimates and judgments when determining whether the collectibility of fees receivable from licensees is reasonably assured. We assess the collectibility of fees receivable based on a number of factors, including past transaction

history and the credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash for transactions where collectibility may have been an issue. Management’s estimates regarding collectibility impact the actual revenues recognized each period and the timing of the recognition of revenues. Our assumptions and judgments regarding future collectibility could differ from actual events and thus materially impact our financial position and results of operations.

In general, our revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by our operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by our operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, our operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on our operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

Depending on the complexity of the underlying revenue arrangement and related terms and conditions, significant judgments, assumptions and estimates may be required to determine when substantial delivery of contract elements has occurred, whether any significant ongoing obligations exist subsequent to contract execution, whether amounts due are collectible and the appropriate period or periods in which, or during which, the completion of the earnings process occurs. Depending on the magnitude of specific revenue arrangements, if different judgments, assumptions and estimates are made regarding contracts executed in any specific period, our periodic financial results may be materially affected.

Our operating subsidiaries are responsible for the licensing and enforcement of their respective patented technologies and pursue third-parties that are utilizing their intellectual property without a license or who have under-reported the amount of royalties owed under a license agreement. As a result of these activities, from time to time, our operating subsidiaries may recognize revenues in a current period that relate to infringements by licensees that occurred in prior periods. These recoveries may cause revenues to be higher than expected during a particular reporting period and may not occur in subsequent periods. Differences between amounts initially recognized and amounts subsequently audited or reported as an adjustment to those amounts, are recognized in the period such adjustment is determined as a change in accounting estimate.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by our operating subsidiaries. Inventor royalties, noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties, noncontrolling interests and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

For fiscal years 2016, 2015 and 2014, the majority of our revenue agreements provided for the payment to us of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents. Pursuant to the terms of these agreements, our operating subsidiaries have no further obligation with respect to the grant of the non-exclusive licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on our operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. The agreements provided for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement. As such, the earnings process was determined to be complete and revenue was recognized upon the execution of the agreements, when all other revenue recognition criteria were met. Historically, term license agreements have not been a material component of our operating revenues, with the majority of license agreements being paid-up, perpetual license agreements.

Stock-based Compensation Expense

Stock-based compensation payments to employees and non-employee directors are recognized as expense in the statements of operations. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award (determined using a Black-Scholes option pricing model for stock options and intrinsic value on the date of grant for nonvested restricted stock), and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity award). Determining the fair value of stock-based awards at the grant date requires significant estimates and judgments, including estimating the market price volatility of our common stock, future employee stock option exercise behavior and requisite service periods.

Stock-based compensation expense for awards with service and / or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated pre-vesting forfeiture rate. As such, we are required to estimate pre-vesting option forfeitures at the time of grant and reflect the impact of estimated pre-vesting option forfeitures on compensation expense recognized. Estimates of pre-vesting forfeitures must be periodically revised in subsequent periods if actual forfeitures differ from those estimates. We consider several factors in connection with our estimate of pre-vesting forfeitures, including types of awards, employee class, performance criteria, historical pre-vesting forfeiture data and other considerations. The estimation of stock awards that will ultimately vest requires judgment, and to the extent that actual results differ from our estimates, such amounts will be recorded as cumulative adjustments in the period the estimates are revised. If actual results differ significantly from these estimates, stock-based compensation expense and our results of operations could be materially impacted. Refer to Notes 2 and 11 to our notes to consolidated financial statements included elsewhere herein.

During the year ended December 31, 2016, the Company granted 138,000 shares of restricted stock and 200,000 stock options (with weighted-average exercise price of $5.75 per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the award, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of December 31, 2016, 138,000 shares of restricted stock and 200,000 stock options with performance-based vesting conditions remain unvested. As of December 31, 2016, recognized expense for awards with performance-based vesting conditions totaled $197,000 and unrecognized expense for awards with performance-based vesting conditions totaled $683,000.

During the year ended December 31, 2016, the Company also granted 2,250,000 stock options with market-based vesting conditions, with a weighted-average exercise price of $5.75 per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the award, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the four-year performance period. The stock options vest in equal installments of 25% upon the Company's achievement of 30-day average share prices ranging from $7.00 to $10.00. As of December 31, 2016 1,687,500 options with market-based vesting conditions remain unvested. As of December 31, 2016, unrecognized expense for options with market-based vesting conditions totaled $2.4 million which is expected to be recognized over an estimated 1 year period.

The effect of a market-based vesting condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate of .92%; expected volatility of 55%; and expected dividend yield of 0%. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Valuation of Long-lived and Intangible Assets Including Goodwill

Patent Portfolio and Goodwill Impairment Testing. Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, in our case our patent portfolios, are to be tested for impairment before goodwill.

Patent Portfolio Impairment Testing. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not

be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows.

We performed an impairment analysis for our patents as of December 31, 2015, utilizing the assistance of a third-party valuation specialist, resulting in $74.7 million of patent portfolio impairment charges, for the following reasons:

•

In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the applicable patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to impairment charges on the portfolio in the fourth quarter of 2015.

•

Management considered the impact of the fourth quarter 2015 adverse trial outcomes on our estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for certain portfolios were reduced in part, in connection with our assessment of probabilities of realization given the recent adverse trial outcomes.

•

Patent impairment charges include the carrying value of other patent portfolios for which, in the fourth quarter of 2015, we experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios we intend to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off of any remaining carrying value in the fourth quarter of 2015.

Further, for the fiscal year ended December 31, 2016, we recorded $42.3 million of patent portfolio impairment charges, primarily comprised of the write-off of the remaining carrying value of our Adaptix portfolio. The impairment charges were recorded in the period due to adverse litigation outcomes, a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date. Estimated fair value was determined based on estimates of future cash flows and estimates of probabilities of realization given adverse litigation outcomes and resource allocation decisions.

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at our single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the Company's stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for the Company's overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

We consider our market capitalization and other valuation techniques, as applicable, when estimating fair value for goodwill impairment testing purposes. When conducting annual and interim goodwill impairment assessments, we initially perform a qualitative evaluation (considering factors described above as applicable) of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, we apply a two-step impairment. The two-step impairment test first compares the estimated fair value of our single reporting unit to its carrying or book value. If the estimated fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and there is no requirement to perform further testing. If the carrying value of the reporting unit exceeds its estimated fair value, we are required to perform step-two of the impairment analysis to determine the estimated implied fair value of the reporting unit’s goodwill, and if the carrying value of the reporting unit’s goodwill exceeds its estimated implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statements of operations.

In connection with our annual goodwill impairment testing for 2015, we identified several qualitative factors triggering an impairment test at December 31, 2015, as follows;

•

Adverse legal outcomes and changes in legal factors. In December 2015, we announced that our subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patent in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Consistent gradual decline in the Company’s stock price: Historically, our stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, our stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in our stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of our company, as reflected in our lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization due to changes in our management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios we intend to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to our decision to no longer allocate resources to those programs. In addition, we made changes in estimates regarding the best and highest use of certain patent portfolios, resulting in reductions in estimated future cash flows.

At December 31, 2015, we utilized the following methods and assumptions in our annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:

•

At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in our stock price was sustained. We also considered the impact of the December 2015 adverse trial outcomes on our stock price and related estimates of fair value for remaining portfolio opportunities. Based on our assessment of these factors, we determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

We conducted the first step of the goodwill impairment test for our single reporting unit as of December 31, 2015. We utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying our stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for our single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of our reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of our reporting unit did not exceed the amounts assigned to our reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

Accounting for Income Taxes

As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves the estimating of our actual current tax exposure together with assessing temporary differences resulting from differing treatment of items. These differences result in deferred

tax assets and liabilities, which are included within our consolidated balance sheets. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not likely, we must establish a valuation allowance. To the extent we establish a valuation allowance or increase this allowance in a period, we must include an expense within the tax provision in the consolidated statements of operations.

Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and our valuation allowance. Due to uncertainties related to our ability to utilize certain deferred tax assets in future periods, we have recorded a full valuation allowance against our net deferred tax assets as of December 31, 2016 and 2015. These assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.

In assessing the need for a valuation allowance, management has considered both the positive and negative evidence available, including but not limited to, estimates of future taxable income and related probabilities, estimates surrounding the character of future income and the timing of realization, consideration of the period over which our deferred tax assets may be recoverable, our recent history of net income and prior history of losses, projected future outcomes, industry and market trends and the nature of existing deferred tax assets. In management’s estimate, any positive indicators, including forecasts of potential future profitability of our businesses, are outweighed by the uncertainties surrounding our estimates and judgments of potential future taxable income, primarily due to uncertainties surrounding the timing of realization of future taxable income and the character of such income in particular future periods (i.e. foreign or domestic). In the event that actual results differ from these estimates or we adjust these estimates should we believe we would be able to realize these deferred tax assets in the future, an adjustment to the valuation allowance would increase income in the period such determination was made.

For example, a similar analysis was performed in the first quarter of 2012, resulting in the release of the valuation allowance on the majority of our net deferred tax assets and a related tax benefit of $10.7 million recognized in the first quarter of 2012. In 2016, 2015 and 2014, based on management’s assessment, a full valuation allowance was recorded against the company’s net deferred tax assets generated during the periods and the balances as of the end of each of the periods, due to uncertainty regarding future realization of such tax assets pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if we determine that the company will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is recorded.

Any changes in the judgments, assumptions and estimates associated with our analysis of the need for a valuation allowance in any future periods could materially impact our financial position and results of operations in the periods in which those determinations are made.

Consolidated Results of Operations

Comparison of the Results of Operations for Fiscal Years 2016, 2015 and 2014

Revenues



							2016 vs. 2015				2015 vs. 2014
	2016		2015		2014		$ Change		% Change		$ Change			% Change
	(in thousands, except percentage change values and number of agreements)
Revenues	$	152,699	$	125,037	$	130,876	$	27,662	22	%	$	(5,839	)	(4	)%
New revenue agreements executed	39		63		88
Average revenue per agreement	$	3,915	$	1,985	$	1,487

A reconciliation of the change in revenues (based on average revenue per agreement) for the periods presented, in relation to the revenues reported for the comparable prior year period, is as follows:



	2016 vs. 2015			2015 vs. 2014
	(in thousands)
Decrease in number of agreements executed	$	(47,633	)	$	(37,181	)
Increase in average revenue per agreement executed	75,295			31,342
Total	$	27,662		$	(5,839	)

Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. For the periods presented herein, the majority of the revenue agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Net Loss



										2016 vs. 2015				2015 vs. 2014
	2016			2015			2014			$ Change		% Change		$ Change			% Change
	(in thousands, except percentages)
Net loss attributable to Acacia Research Corporation	$	(54,067	)	$	(160,036	)	$	(66,029	)	$	105,969	(66	)%	$	(94,007	)	142	%

A reconciliation of the change in net loss for the periods presented is as follows:



	2016 vs. 2015			%		2015 vs. 2014			%
	(in thousands, except percentage values)
Increase (decrease) in revenues	$	27,662		26	%	$	(5,839	)	6	%
(Increase) decrease in inventor royalties and contingent legal fees combined	(14,573		)	(14	)%	9,602			(10	)%
Decrease in general and administrative expenses	5,257			5	%	10,378			(11	)%
(Increase) decrease in litigation and licensing expenses	11,515			11	%	(1,759		)	2	%
Decrease in patent amortization expenses	18,859			18	%	678			(1	)%
(Increase) decrease in impairment of patent-related intangible assets	32,391			31	%	(71,234		)	76	%
(Increase) decrease in impairment for goodwill	30,149			28	%	(30,149		)	32	%
Change in provision for income taxes	(13,388		)	(13	)%	(888		)	1	%
Other	8,097			8	%	(4,796		)	5	%
Net change in net loss	$	105,969		100	%	$	(94,007	)	100	%

Cost of Revenues



							2016 vs. 2015					2015 vs. 2014
	2016		2015		2014		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
Inventor royalties	$	22,730	$	18,462	$	20,670	$	4,268		23	%	$	(2,208	)	(11	)%
Contingent legal fees	26,474		16,169		23,563		10,305			64	%	(7,394		)	(31	)%
Litigation and licensing expenses - patents	27,858		39,373		37,614		(11,515		)	(29	)%	1,759			5	%
Amortization of patents	34,208		53,067		53,745		(18,859		)	(36	)%	(678		)	(1	)%

Inventor Royalties and Contingent Legal Fees Expense. The economic terms of patent partnering agreements, operating agreements and contingent legal fee arrangements, associated with the patent portfolios owned or controlled by our operating subsidiaries, if any, including royalty obligations, if any, royalty rates, contingent fee rates and other terms and conditions, vary across the patent portfolios owned or controlled by our operating subsidiaries. In certain instances, we have invested in certain patent portfolios without future inventor royalty obligations. These costs fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms, conditions and obligations generating revenues each period.

A summary of the main drivers of the change in inventor royalties expense and contingent legal fees expense, in relation to the change in total revenues, for the comparable periods presented, is as follows:



	2016 vs. 2015			% of Prior Period Balance		2015 vs. 2014			% of Prior Period Balance
Inventor Royalties:	(in thousands, except percentage change values)
Increase (decrease) in inventor royalty rates	$	11,518		62	%	$	(3,995	)	(20	)%
Increase (decrease) in total revenues	4,729			26	%	(1,214		)	(6	)%
Decrease (increase) in revenues without inventor royalty obligations	(11,979		)	(65	)%	3,001			15	%
Total change - inventor royalties expense	$	4,268		23	%	$	(2,208	)	(11	)%



	2016 vs. 2015			% of Prior Period Balance		2015 vs. 2014			% of Prior Period Balance
Contingent Legal Fees:	(in thousands, except percentage change values)
Increase (decrease) in contingent legal fee rates	$	6,850		43	%	$	(6,400	)	(27	)%
Increase (decrease) in total revenues	3,719			23	%	(1,096		)	(4	)%
Decrease (increase) in revenues without contingent legal fee obligations	(264		)	(2	)%	102			—	%
Total change - contingent legal fees	$	10,305		64	%	$	(7,394	)	(31	)%

Litigation and Licensing Expenses - Patents. Litigation and licensing expenses-patents include patent-related litigation, enforcement and prosecution costs incurred by external patent attorneys engaged on an hourly basis and the out-of-pocket expenses incurred by law firms engaged on a contingent fee basis. Litigation and licensing expenses-patents also includes licensing and enforcement related third-party patent research, development, prosecution, re-exam and inter partes reviews, consulting, and other costs incurred in connection with the licensing and enforcement of patent portfolios. Litigation and licensing expenses-patents fluctuate from period to period based on patent enforcement and prosecution activity associated with ongoing licensing and enforcement programs and the timing of the commencement of new licensing and enforcement programs in each period.

Fiscal year 2016 litigation and licensing expenses-patents decreased, as compared to fiscal year 2015, due primarily to a net decrease in litigation support and third-party technical consulting expenses associated with patent trials and ongoing licensing and enforcement programs.

Fiscal year 2015 litigation and licensing expenses-patents increased, as compared to fiscal year 2014, due primarily to a net increase in litigation support and third-party technical consulting expenses associated with trials occurring in 2015 and scheduled to occur in 2016, and ongoing and new licensing and enforcement programs commenced during fiscal year 2015.

We expect patent-related legal expenses to continue to fluctuate period to period as we incur increased costs related to upcoming scheduled and/or anticipated trial dates, international enforcement activities and strategic patent portfolio prosecution activities over the next several fiscal quarters, as we continue to focus on our investments in these areas.

Amortization of Patents. The change in amortization expense for the comparable periods presented was due to the following:



	2016 vs. 2015			2015 vs. 2014
	(in thousands)
Amortization of patent portfolio investments made since the end of the prior year, not partially or fully recovered	$	—		$	402
Scheduled amortization related to patent portfolios owned or controlled as of the end of the prior year	(18,704		)	2,489
Accelerated amortization related to recovery of upfront advances	225			(1,247		)
Patent portfolio dispositions	(380		)	(2,322		)
Total change in patent amortization expense	$	(18,859	)	$	(678	)

Impairment Charges



							2016 vs. 2015					2015 vs. 2014
	2016		2015		2014		$ Change			% Change		$ Change		% Change
	(in thousands, except percentages)
Impairment of patent-related intangible assets	$	42,340	$	74,731	$	3,497	$	(32,391	)	(43	)%	$	71,234	2,037	%
Impairment of goodwill	—		30,149		—		(30,149		)	(100	)%	30,149		100	%

Patent Impairment Charges

2016 versus 2015. Patent portfolio impairment charges totaled $42.3 million and $74.7 million in fiscal years 2016 and 2015, respectively. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse litigation outcomes and certain patent portfolios that management determined it would no longer allocate licensing and enforcement resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date.

2015 versus 2014. Patent portfolio impairment charges totaled $74.7 million and $3.5 million in fiscal years 2015 and 2014, respectively. The impairment charges for the periods presented reflect the impact of reductions in expected estimated future net cash flows for certain portfolios due to adverse litigation outcomes and industry factors and certain patent portfolios that management determined it would no longer allocate licensing and enforcement resources to in future periods. The impairment charges consisted of the excess of the asset’s carrying value over its estimated fair value as of the applicable measurement date. Refer to Critical Accounting Policies elsewhere herein for additional information.

Impairment of Goodwill

We conducted an annual goodwill impairment test as of December 31, 2015. Based upon the difference between the implied fair value of goodwill and the historical carrying value of goodwill, due primarily to the sustained decline in our stock price and adverse litigation outcomes in the fourth quarter of 2015, we recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015. Refer to Critical Accounting Policies elsewhere herein for additional information.

Operating Expenses



							2016 vs. 2015					2015 vs. 2014
	2016		2015		2014		$ Change			% Change		$ Change			% Change
	(in thousands, except percentages)
General and administrative	$	23,857	$	27,128	$	30,439	$	(3,271	)	(12	)%	$	(3,311	)	(11	)%
Non-cash stock compensation	9,062		11,048		18,115		(1,986		)	(18	)%	(7,067		)	(39	)%
Total general and administrative expenses	$	32,919	$	38,176	$	48,554	$	(5,257	)	(14	)%	$	(10,378	)	(21	)%

Research, consulting and other expenses - business development	3,079		3,391		3,840		(312		)	(9	)%	(449		)	(12	)%

General and Administrative Expenses. General and administrative expenses include employee compensation and related personnel costs, including variable performance based compensation and non-cash stock compensation expenses, office and facilities costs, legal and accounting professional fees, public relations, marketing, stock administration, state taxes based on gross receipts and other corporate costs. A summary of the main drivers of the change in general and administrative expenses for the periods presented, is as follows (in thousands):



	2016 vs. 2015			2015 vs. 2014
	(in thousands)
Net change in personnel costs	$	(5,841	)	$	(1,264	)
Variable performance-based compensation costs	1,839			(1,631		)
Corporate, general and administrative costs	1,594			(985		)
Non-cash stock compensation expense ⁽¹⁾	(1,986		)	(7,067		)
Employee severance costs	(863		)	569
Total change in general and administrative expenses	$	(5,257	)	$	(10,378	)

_________________________________________________________________

(1) - Refer to Note 11 in the accompany consolidated financial statements

Non-cash stock compensation expense decreased due primarily to a decrease in the average grant date fair value for the shares expensed in the respective periods. The decrease was partially offset by an increase in fiscal year 2016 for non-cash stock compensation expense related to the grant of options with market-based vesting conditions with graded vesting features, resulting in higher non-cash stock compensation expense during the earlier stages of the applicable service period.

Research, Consulting and Other Expenses - Business Development. Research, consulting and other expenses include third-party business development related research, development, consulting, and other costs incurred in connection with business development activities. These costs fluctuate period to period based on business development related activities in each period.

Other Operating Expenses

Fiscal year 2016, 2015 and 2014 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $500,000, $4.1 million and $1.5 million, respectively.

Income Taxes



	2016			2015			2014
Provision for income taxes (in thousands)	$	(18,188	)	$	(4,800	)	$	(3,912	)
Effective tax rate	50		%	3		%	6		%

Our effective tax rates for fiscal year 2016, 2015 and 2014, were primarily comprised of foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions and other state taxes, and the impact of full valuation allowances recorded for net operating loss (2015 and 2014) and foreign tax credit related tax assets generated in those periods due to uncertainty regarding future realization. Our effective tax rate for fiscal year 2014 also included the reversal of a net deferred tax liability at the beginning of the year totaling $1.7 million. Foreign taxes withheld related to revenue agreements executed with third-party licensees domiciled in certain foreign jurisdictions for fiscal year 2016, 2015 and 2014 totaled $17.9 million, $4.4 million and $5.2 million, respectively.

Recent Developments

On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia Research Corporation, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of equity interests in AIP to certain members of management and our Board of Directors as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the equity value of AIP increases beyond the value at issuance. The equity interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the

adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones, subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement.

We own substantially all of the equity in AIP and at all times will control AIP. Although AIP currently holds no material assets, we from time to time may contribute to AIP certain assets or securities related to portfolio companies in which we hold an interest. Units may be awarded as one-time, discretionary grants to recipients.

Inflation

Inflation has not had a significant impact on us or any of our subsidiaries in the current or prior periods.

Liquidity and Capital Resources

General

Our primary sources of liquidity are cash, cash equivalents and short-term investments on hand generated from our operating activities. Our management believes that our cash and cash equivalent balances, investments, and anticipated cash flow from operations will be sufficient to meet our cash requirements through at least March 2018 and for the foreseeable future.

We may, however, encounter unforeseen difficulties that may deplete our capital resources more rapidly than anticipated, including those set forth under Item 1A, “Risk Factors”, above. Any efforts to seek additional funding could be made through issuances of equity or debt, or other external financing. However, additional funding may not be available on favorable terms, if at all. The capital and credit markets have experienced extreme volatility and disruption since 2007 and the volatility and impact of the disruption has continued into 2016. At times during this period, the volatility and disruption has reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and credit capacity for certain issuers, and there can be no assurance that the commercial paper markets will be a reliable source of short-term financing for us. If we fail to obtain additional funding when needed, we may not be able to execute our business plans and our business, conducted by our operating subsidiaries, may suffer.

Certain of our operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material.

Cash, Cash Equivalents and Investments

Our consolidated cash and cash equivalents and investments on hand, excluding restricted cash balances, totaled $147.0 million at December 31, 2016, compared to $135.2 million at December 31, 2015. The net change in cash and cash equivalents for the periods presented was comprised of the following (in thousands):



	2016			2015			2014

Net cash provided by (used in):
Operating activities	$	34,061		$	(9,949	)	$	4,184
Investing activities	(40,630		)	39,307			29,297
Financing activities	(1,114		)	(28,601		)	(25,700		)
	$	(7,683	)	$	757		$	7,781

Cash Flows from Operating Activities. Cash receipts from licensees totaled $160.2 million, $111.0 million and $117.0 million in fiscal years 2016, 2015 and 2014, respectively. The fluctuations in cash receipts for the periods presented primarily reflects the corresponding fluctuations in revenues recognized during the same periods, as described above, and the related timing of payments received from licensees. Cash outflows from operations totaled $126.1 million, $120.9 million and $112.9 million in fiscal years 2016, 2015 and 2014, respectively. The fluctuations in cash outflows for the periods presented reflects

the fluctuations in revenue-related inventor royalties and contingent legal fees and other operating costs and expenses during the same periods, as discussed above, and the impact of the timing of payments to inventors, attorneys and other vendors.

Restricted Cash. In March 2015, an operating subsidiary of ours entered into a Guarantee with a bank in connection with enforcing a ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. The Guarantee is secured by a cash deposit (classified as restricted cash in the accompanying balances sheets) at the contracting bank, totaling $11.5 million and $10.7 million at December 31, 2016 and 2015, respectively. See below for additional information.

Cash Flows from Investing Activities. Cash flows from investing activities and related changes were comprised of the following for the periods presented (in thousands):



	2016			2015			2014

Patent portfolio investment costs	$	(1,225	)	$	(19,504	)	$	(42,746	)
Advances to Investee⁽¹⁾	(20,000		)	—			—
Net sale (purchase) of available-for-sale investments	(19,401		)	58,819			72,152
Other	(4		)	(8		)	(109		)
Net cash provided by (used in) investing activities	$	(40,630	)	$	39,307		$	29,297

_________________________________________________________________

(1) - Refer to Note 8 in the accompany consolidated financial statements

Strategic Partnership. In August 2016, we formed a strategic partnership with Veritone pursuant to which we expect to leverage our expertise in intellectual property licensing and enforcement to assist Veritone with building its patent portfolio and execute upon its overall intellectual property strategy. As a part of this strategic partnership, we entered into an Investment Agreement with Veritone that provides for us to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, we entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permits Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum. On August 15, 2016, we funded the initial $10 million loan (the “First Loan”), which originally had a one-year term. On November 25, 2016, we funded the second $10 million loan (the “Second Loan”), which matures on November 25, 2017. In addition, upon the funding of the Second Loan, the maturity date of the First Loan was automatically extend to November 25, 2017. Veritone’s obligations under the Veritone Loans are secured by substantially all of Veritone’s assets pursuant to a security agreement that we entered into with Veritone dated August 15, 2016.

In addition, commencing on the earlier of Veritone’s consummation of a private round of financing of at least $10 million (a “Next Equity Financing”) and the maturity date of the Veritone Loans, we have the right, under certain circumstances, to convert all or a portion of the principal and accrued interest of the Veritone Loans into shares of Veritone’s Series B Preferred Stock or, if Veritone consummates a Next Equity Financing, into shares of Veritone capital stock issued in such financing, at various conversion rates, with the exact conversion rate to depend upon (i) whether Veritone consummates a Next Equity Financing, (ii) the price per share in such Next Equity Financing and (iii) whether or not Acacia elects to convert all of the outstanding principal and accrued interest under the Veritone Loans. If Veritone consummates a qualified public offering of its common stock, any outstanding principal and accrued interest under the Veritone Loans will automatically convert into shares of Veritone common stock at the applicable conversion rate.

In conjunction with the First Loan, Veritone issued us a four-year $700,000 warrant to purchase shares of Veritone’s common stock at various exercise prices, with the actual exercise price to be determined by the type and/or valuation of Veritone’s future equity financings, if any. The actual number of shares to be purchased upon exercise of the warrant is determined by dividing the warrant value by the applicable exercise price. In conjunction with the funding of the Second Loan, Veritone issued to us two additional four-year $700,000 warrants to purchase shares of Veritone’s common stock with similar terms.

In addition, pursuant to the Investment Agreement, Veritone issued us a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or payments under the Veritone Loans, worth of shares of Veritone’s common stock at various exercise prices, with the actual exercise price per share to be determined by the amount of principal and accrued interest under the Veritone Loans converted into shares of Veritone common stock. Acacia may exercise the Primary Warrant at any time during its five-year term after the earlier of August 15, 2017 or the completion of a public offering of common stock by Veritone with gross proceeds to Veritone of at least $15.0 million. Upon the consummation of a public offering as described

above, and subject to the satisfaction of certain other conditions, Veritone has the right to elect that we exercise the Primary Warrant, and upon such election, we agree to exercise the Primary Warrant in full.

Immediately following our exercise of the Primary Warrant in full, Veritone has the obligation to issue to us an additional 10% Warrant that provides for the issuance of additional shares of Veritone common stock, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of shares vesting on the anniversary of the issuance date of the 10% Warrant.

Cash Flows from Financing Activities. Cash flows from financing activities and related changes included the following for the periods presented (in thousands):



	2016			2015			2014

Dividends paid to stockholders	$	—		$	(25,434	)	$	(25,039	)
Distributions to noncontrolling interests - Acacia IP Fund	(1,358		)	(4,105		)	(867		)
Proceeds from the exercise of stock options	326			938			206
Repurchases of common stock	(82		)	—			—
Net cash provided by financing activities	$	(1,114	)	$	(28,601	)	$	(25,700	)

Dividends to Stockholders. In April 2013, our Board of Directors approved the adoption of a cash dividend policy that called for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, we paid quarterly cash dividends totaling $25.4 million and $25.0 million in 2015 and 2014, respectively.

On February 23, 2016, we announced that our Board of Directors terminated the dividend policy effective immediately. Our Board of Directors terminated the dividend policy due to a number of factors, including our financial performance, our available cash resources, our cash requirements and alternative uses of capital that our Board of Directors concluded would represent an opportunity to generate a greater return on investment for us and our stockholders.

Working Capital

The primary components of working capital are cash and cash equivalents, restricted cash, short-term investments, accounts receivable, prepaid expenses, accounts payable, accrued expenses, and royalties and contingent legal fees payable. Working capital at December 31, 2016 was $160.3 million, compared to $150.7 million at December 31, 2015.

Consolidated accounts receivable from licensees decreased to $26.8 million at December 31, 2016, compared to $33.5 million at December 31, 2015. Accounts receivable balances fluctuate based on the timing, magnitude and payment terms associated with revenue agreements executed during the year, and the timing of cash receipts on accounts receivable balances recorded in previous periods. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016. Two licensees individually represented approximately 72% and 21%, respectively, of accounts receivable at December 31, 2015.

Accounts payable and accrued expenses decreased to $14.3 million at December 31, 2016, from $17.3 million at December 31, 2015, due primarily to the related timing of payments to vendors in the ordinary course.

Consolidated royalties and contingent legal fees payable decreased to $13.9 million at December 31, 2016, compared to $14.9 million at December 31, 2015. Royalties and contingent legal fees payable balances fluctuate based on the magnitude and timing of the execution of related license agreements, the timing of cash receipts for the related license agreements, and the timing of payment of current and prior period royalties and contingent legal fees payable to inventor and outside attorneys, respectively.

The majority of accounts receivable from licensees at December 31, 2016 were collected or scheduled to be collected in the first quarter of 2017, in accordance with the terms of the related underlying license agreements. The majority of royalties and contingent legal fees payable are scheduled to be paid in the first and second quarter of 2017 in accordance with the underlying contractual arrangements.

Off-Balance Sheet Arrangements

We have not entered into off-balance sheet financing arrangements, other than operating leases.

Contractual Obligations

We have no significant commitments for capital expenditures in 2017. Other than our restricted cash of $11.5 million as of December 31, 2016, we have no committed lines of credit or other committed funding or long-term debt. The following table lists our material known future cash commitments as of December 31, 2016, and any material known commitments arising from events subsequent to year end:



	Payments Due by Period (In thousands)
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years

Operating leases, net of guaranteed sublease income	$	3,987	$	1,279	$	2,692	$	16	$	—
Investment Agreement - Primary Warrant Put Right, contingent obligation ⁽¹⁾	30,000		—		30,000		—		—
Total contractual obligations	$	33,987	$	1,279	$	32,692	$	16	$	—

___________________________________________________

^{(1) - Refer to description of Strategic Partnership - Veritone, above}

Standby Letter of Credit and Guarantee Arrangement. In March 2015, an operating subsidiary of ours entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).

Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by our operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.

The Guarantee is secured by a cash deposit at the contracting bank totaling $11.5 million and $10.7 million at December 31, 2016 and 2015, respectively, which is classified as restricted cash in the accompanying balance sheet. The Guarantee expires on April 10, 2016, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the statement of operations.

Uncertain Tax Positions. At December 31, 2016, we had total unrecognized tax benefits of approximately $1.7 million, including a recorded noncurrent liability of $85,000 related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2016 and 2015. If recognized, approximately $1.4 million would impact our effective tax rate. We do not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2016 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period.

Recent Accounting Pronouncements

Refer to Note 2 to our notes to consolidated financial statements included elsewhere herein.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The primary objective of our investment activities is to preserve principal while concurrently maximizing the income we receive from our investments without significantly increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity markets, with respect to market risk, may cause the principal amount or market value of the investments to fluctuate. For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.

At December 31, 2016, our short-term investments were comprised of AAA rated money market funds that invest in first-tier only securities, which primarily include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying consolidated balance sheets), and direct investments in highly liquid, AAA, U.S. government securities (included in short term investments in the accompanying consolidated balance sheets). Short-term investment balances were zero at December 31, 2015.

In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate. Accordingly, a 100 basis point increase in interest rates or a 10% decline in the value of the United States equity markets would not be expected to have a material impact on the value of such money market funds. Investments in U.S. government fixed income securities are subject to interest rate risk and will decline in value if interest rates increase. However, due to the relatively short duration of our investment portfolio, an immediate 10% change in interest rates would have no material impact on our financial condition, results of operations or cash flows. Declines in interest rates over time will, however, reduce our interest income.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and related financial information required to be filed hereunder are indexed under Item 15 of this report and are incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures. Based on the evaluation of our disclosure controls and procedures (as defined in the Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act) required by Exchange Act Rules 13a-15(b) or 15d-15(b), our principal executive officer and our principal financial officer have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were not effective as a result of the material weakness in our internal control over financial reporting discussed below.

Changes in internal controls. There were no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, except as described below.

Material Weakness. As reported in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016 filed with the SEC on November 14, 2016 (“Third Quarter 2016 10-Q”), we identified a material weakness in our internal control over financial reporting relating to the sufficiency of company resources with accounting technical knowledge and expertise related to the accounting and disclosure of infrequent, unusual, or complex accounting matters. Specifically, an internal control failure occurred that allowed for misapplication of Accounting Standards Codification (“ASC”) 718-10,

“Compensation - Stock Compensation,” in connection with the accounting for stock options with market-based vesting conditions, granted during the third quarter of 2016, which impacted stock based compensation expense recorded in the third quarter of 2016. We properly reflected the non-cash stock compensation expense in our consolidated financial statements included in our Third Quarter 2016 10-Q. We did not grant any equity-based awards with market-based vesting conditions prior to the third quarter of 2016. We were not required to restate or change our consolidated financial statements for any prior annual or interim period. Our management concluded that this deficiency constitutes a material weakness in our internal control over financial reporting. We developed a remediation plan for this material weakness, which we describe below.

Inherent Limitations on Effectiveness of Controls. Our management, including our chief executive officer and chief financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

Management’s Annual Report on Internal Control Over Financial Reporting. Our management, including our principal executive officer and principal financial officer, is responsible for establishing and maintaining adequate internal control over financial reporting. Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on its evaluation, our management has concluded that our internal control over financial reporting was not effective as of December 31, 2016, due to the material weakness in our internal control over financial reporting discussed herein. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

Grant Thornton LLP, our independent registered public accounting firm, audited the effectiveness of our internal control over financial reporting as of December 31, 2016, as stated in their report which appears in Item 15(a) of this Annual Report on Form 10-K.

Remediation Plan. In connection with our evaluation of disclosure controls and procedures in connection with the filing of our Third Quarter 2016 10-Q, we disclosed that we were developing a plan to address the material weakness and enhance our control procedures related to infrequent, unusual, or complex accounting matters, and anticipated implementation of this remediation plan in the fourth quarter of 2016. We developed and implemented the remediation plan to address the internal control deficiency that led to the material weakness in the fourth quarter of 2016. The remediation plan includes the following elements:


•	The revised procedures apply to all material new, infrequent, unusual or complex transactions.

•

Implemented specific revised review procedures for material new, infrequent, unusual or complex transactions, including the specific assessment of whether the accounting for material new, infrequent, unusual or complex transactions should be conducted internally or outsourced to technical subject matter specialists, and enhanced review procedures involving both our chief financial officer and corporate controller with respect to the review and assessment of such transactions, designed to enhance our overall assessment and controls; and


•	Strengthening our material new, infrequent, unusual or complex transaction controls with improved documentation standards and technical oversight.

Our enhanced review procedures and documentation standards were in place and operating during the fourth quarter of 2016. However, due to the short period of time and limited use of this new control as contemplated by the applicable Public Company Accounting Oversight Board standards, we are unable to conclude in this report as to the operating effectiveness of our enhanced review procedures and documentation standards as of December 31, 2016. Our goal is to remediate this material weakness as contemplated by the standards by the end of the first quarter of 2017, subject to there being sufficient opportunities to conclude, through testing, that the enhanced control is operating effectively.

ITEM 9B. OTHER INFORMATION

None

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Except as provided below, in accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2017 annual meeting of stockholders to be filed with the SEC no later than April 30, 2017.

Code of Conduct.

We have adopted a Code of Conduct that applies to all employees, including our chief executive officer, chief financial and accounting officer, president and any persons performing similar functions. Our Code of Conduct is provided on our internet website at www.acaciaresearch.com.

ITEM 11. EXECUTIVE COMPENSATION

In accordance with General Instruction G(3) to Form 10-K, the information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2017 annual meeting of stockholders to be filed with the SEC no later than April 30, 2017.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

In accordance with General Instruction G(3) to Form 10-K, certain information required by this Item is incorporated herein by reference to our definitive proxy statement for our 2017 annual meeting of stockholders to be filed with the SEC no later than April 30, 2017.

Equity Compensation Plan Information

The following table provides information with respect to shares of our common stock issuable under our equity compensation plans as of December 31, 2016:



Plan Category	(a) Number of securities to be issued upon exercise of outstanding options	(b) Weighted-average exercise price of outstanding options		(c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

Equity compensation plans approved by security holders
2002 Acacia Technologies Stock Incentive Plan⁽¹⁾	15,000	$	13.38	—
2013 Acacia Research Stock Incentive Plan⁽²⁾	2,021,000	3.45		—
2016 Acacia Research Stock Incentive Plan⁽³⁾	3,560,000	5.74		1,754,000
Subtotal	5,596,000	4.93		1,754,000

____________________


(1)	The 2002 Stock Plan expired in December 2012. Column (a) excludes 32,000 in nonvested restricted stock units outstanding at December 31, 2016. Refer to Note 11 to our notes to consolidated financial statements included elsewhere herein.

(2)

The initial share reserve under the 2013 Acacia Research Stock Incentive Plan, or the 2013 Plan, was 4,750,000 shares of our common stock. Column (a) excludes 395,000 in nonvested restricted stock awards and restricted stock units outstanding at December 31, 2016. Refer to Note 11 to our notes to consolidated financial statements included elsewhere herein. In June 2016, 625,390 shares of common stock available for issuance under the 2013 Stock Plan were transferred into the 2016 Stock Plan.

(3)

The initial share reserve under the 2016 Stock Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under the 2013 Plan. No new additional shares will be added to the 2016 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2016 Plan). Refer to Note 11 to our notes to consolidated financial statements included elsewhere herein.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES



(a)	The following documents are filed as part of this report.



(1) Financial Statements		Page

Acacia Research Corporation Consolidated Financial Statements
Reports of Independent Registered Public Accounting Firm		F- 1
Consolidated Balance Sheets as of December 31, 2016 and 2015		F- 4
Consolidated Statements of Operations for the Years Ended December 31, 2016, 2015 and 2014		F- 5
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2016, 2015 and 2014		F- 6
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2016, 2015 and 2014		F- 7
Consolidated Statements of Cash Flows for the Years Ended December 31, 2016, 2015 and 2014		F- 8
Notes to Consolidated Financial Statements		F- 9

(2) Financial Statement Schedules

Financial statement schedules are omitted because they are not applicable or the required information is shown in the Financial Statements or the Notes thereto.

(3) Exhibits

Refer to Item 15(b) below.



(b)	Exhibits. The following exhibits are either filed herewith or incorporated herein by reference:



Exhibit Number	Description

2.1	Agreement and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.(15)
3.1	Amended and Restated Certificate of Incorporation (1)
3.2	Amended and Restated Bylaws (21)
4.1	Tax Benefits Preservation Plan, dated as of March 16, 2016, by and between Acacia Research Corporation and Computershare Inc., as Rights Agent, which includes the form of Certificate of Designation of Series A Cumulative Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Terms as Exhibit C (24)
10.1*	Acacia Research Corporation 1996 Stock Option Plan, as amended (2)
10.2*	Form of Option Agreement constituting the Acacia Research Corporation 1996 Executive Stock Bonus Plan (3)
10.3*	2002 Acacia Technologies Stock Incentive Plan (4)
10.4*	2007 Acacia Technologies Stock Incentive Plan (5)
10.5*	Form of Acacia Technologies Stock Option Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.6*	Form of Acacia Technologies Stock Issuance Agreement under the 2002 Acacia Technologies Stock Incentive Plan (6)



10.7*	Form of Acacia Technologies Stock Issuance Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.8	Office Space Lease dated January 28, 2002, between Acacia Research Corporation and The Irvine Company (7)
10.9	Form of Indemnification Agreement (8)
10.10	Third Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (9)
10.11*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Edward Treska (20)
10.12	Fourth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.13	Fifth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.15*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Robert L. Harris (20)
10.16*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Clayton J. Haynes (20)
10.17*	Acacia Research Corporation Amended and Restated Executive Severance Policy (12)
10.18	Sixth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (14)
10.19	Form of Purchase Agreement (16)
10.20*	2013 Acacia Research Corporation Stock Incentive Plan (18)
10.21*	Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan (19)
10.22*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Matthew Vella (20)
10.23*	2016 Acacia Research Corporation Stock Incentive Plan (22)
10.24*	Form of Stock Option Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan
10.25*	Form of Stock Issuance Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan
10.26*	Director Service Agreement, dated February 29, 2016, by and between Acacia Research Corporation and Robert L. Harris (23)
18.1	Preferability Letter dated February 25, 2010 from Grant Thornton LLP, independent registered public accounting firm, regarding change in accounting principle (13)
21.1	List of Subsidiaries
23.1	Consent of Independent Registered Public Accounting Firm
24.1	Power of Attorney (included in the signature page hereto).
31.1†	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2†	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

___________________________


*	The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.

†

The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Acacia Research Corporation under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language contained in any filing.


(1)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on June 5, 2008 (File No. 000-26068).


(2)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 20, 2000 (File No. 000-26068).


(3)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 26, 1996 (File No. 000-26068).


(4)	Incorporated by reference to Annex E to the Proxy Statement/Prospectus which formed part of Acacia Research Corporation’s Registration Statement on Form S-4 (File No. 333-87654) which became effective on November 8, 2002.


(5)	Incorporated by reference to Acacia Research Corporation’s Registration Statement on Form S-8 (File No. 333-144754) which became effective on July 20, 2007.


(6)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2007, filed on November 2, 2007 (File No. 000-26068).


(7)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10‑K for the year ended December 31, 2001, filed on March 27, 2002 (File No. 000‑26068).


(8)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed on July 30, 2012 (File No. 000-26068).


(9)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed on May 10, 2006 (File No. 000‑26068).


(10)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, filed on March 14, 2008 (File No. 000-26068).


(11)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on April 2, 2008 (File No. 000-26068).


(12)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No. 000-26068).


(13)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2009, filed on February 26, 2010, as amended on March 1, 2010 (File No. 000-26068)


(14)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 28, 2011, as amended on March 24, 2011 (File No. 000-26068).


(15)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material has been separately filed with the Securities and Exchange Commission.


(16)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).


(17)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 28, 2013 (File No. 000-26068).


(18)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).


(19)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on May 22, 2013 (File No. 000-26068).


(20)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on November 9, 2015 (File No. 000-26068).


(21)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 28, 2016 (File No. 000-37721).


(22)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on August 9, 2016 (File No. 001-37721).


(23)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 4, 2016 (File No. 000-26068).


(24)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 21, 2016 (File No. 000-26068).

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



			ACACIA RESEARCH CORPORATION

Dated:	March 10, 2017	By:	/s/ Marvin Key
			Marvin Key
			Interim Chief Executive Officer (Authorized Signatory)

POWER OF ATTORNEY

We, the undersigned directors and officers of Acacia Research Corporation, do hereby constitute and appoint Marvin Key and Clayton J. Haynes, and each of them, as our true and lawful attorneys-in-fact and agents with power of substitution, to do any and all acts and things in our name and behalf in our capacities as directors and officers and to execute any and all instruments for us and in our names in the capacities indicated below, which said attorney-in-fact and agent may deem necessary or advisable to enable said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the Securities and Exchange Commission, in connection with this Annual Report on Form 10-K, including specifically but without limitation, power and authority to sign for us or any of us in our names in the capacities indicated below, any and all amendments hereto; and we do hereby ratify and confirm all that said attorney-in-fact and agent, shall do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and the capacities and on the dates indicated.



Signature		Title	Date

/s/	Marvin Key	Interim Chief Executive Officer	March 10, 2017
	Marvin Key	(Principal Executive Officer)

/s/	Clayton J. Haynes	Chief Financial Officer and Treasurer	March 10, 2017
	Clayton J. Haynes	(Principal Financial and Accounting Officer)

/s/	Fred A. de Boom	Director	March 10, 2017
	Fred A. de Boom

/s/	Edward W. Frykman	Director	March 10, 2017
	Edward W. Frykman

/s/	G. Louis Graziadio, III	Executive Chairman and Director	March 10, 2017
	G. Louis Graziadio, III

/s/	William S. Anderson	Director	March 10, 2017
	William S. Anderson

/s/	Frank E. Walsh, III	Director	March 10, 2017
	Frank E. Walsh, III

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

We have audited the accompanying consolidated balance sheets of Acacia Research Corporation (the “Company”) as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive loss, shareholders’ equity, and cash flows for each of the three years in the period ended December 31, 2016. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Acacia Research Corporation as of December 31, 2016 and 2015, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2016, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 10, 2017, expressed an adverse opinion.

/s/ GRANT THORNTON LLP

Irvine, California

March 10, 2017

F- 1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Acacia Research Corporation

We have audited the internal control over financial reporting of Acacia Research Corporation (the “Company”) as of December 31, 2016, based on criteria established in the 2013 Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting (“Management’s Report”). Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A material weakness is a deficiency, or combination of control deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment.

The matter involving internal controls and procedures that management considered to be a material weakness involves the sufficiency of company resources with accounting technical knowledge and expertise related to the accounting and disclosure of infrequent, unusual, or complex accounting matters. Specifically, a control failure occurred that allowed for misapplication of Accounting Standards Codification 718-10, “Compensation - Stock Compensation,” in connection with the accounting for stock options with market-based vesting conditions, granted during the third quarter of 2016, which impacted stock-based compensation expense for the third quarter of 2016.

In our opinion, because of the effect of the material weakness described above on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2016, based on criteria established in the 2013 Internal Control-Integrated Framework issued by COSO.

F- 2

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements of the Company as of and for the year ended December 31, 2016. The material weakness identified above was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2016 consolidated financial statements, and this report does not affect our report dated March 10, 2017, which expressed an unqualified opinion on those financial statements.

/s/ GRANT THORNTON LLP

Irvine, California

March 10, 2017

F- 3

ACACIA RESEARCH CORPORATION

CONSOLIDATED BALANCE SHEETS

As of December 31, 2016 and 2015

(In thousands, except share and per share information)



	2016			2015
ASSETS
Current assets:
Cash and cash equivalents	$	127,540		$	135,223
Restricted cash	11,512			10,725
Short-term investments	19,443			—
Accounts receivable	26,750			33,500
Deferred income tax	—			210
Prepaid expenses and other current assets	3,245			4,219
Total current assets	188,490			183,877
Loan receivable and accrued interest (Note 8)	18,616			—
Investment in warrants (Note 8)	1,960			—
Property and equipment, net	127			272
Patents, net of accumulated amortization	86,319			162,642
Other assets	491			1,110
	$	296,003		$	347,901
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$	14,283		$	17,347
Accrued patent investment costs	—			1,000
Royalties and contingent legal fees payable	13,908			14,878
Total current liabilities	28,191			33,225
Deferred income taxes	—			210
Other liabilities	369			311
Total liabilities	28,560			33,746
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	—			—
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,476,042 shares issued and outstanding as of December 31, 2016 and 50,651,239 shares issued and outstanding as of December 31, 2015	50			51
Treasury stock, at cost, 1,729,408 shares as of December 31, 2016 and 2015	(34,640		)	(34,640		)
Additional paid-in capital	642,453			633,146
Accumulated comprehensive loss	(76		)	(215		)
Accumulated deficit	(342,198		)	(288,131		)
Total Acacia Research Corporation stockholders’ equity	265,589			310,211
Noncontrolling interests in operating subsidiaries	1,854			3,944
Total stockholders’ equity	267,443			314,155
	$	296,003		$	347,901

The accompanying notes are an integral part of these consolidated financial statements.

F- 4

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2016, 2015 and 2014

(In thousands, except share and per share information)



	2016			2015			2014

Revenues	$	152,699		$	125,037		$	130,876
Operating costs and expenses:
Cost of revenues:
Inventor royalties	22,730			18,462			20,670
Contingent legal fees	26,474			16,169			23,563
Litigation and licensing expenses - patents	27,858			39,373			37,614
Amortization of patents	34,208			53,067			53,745
General and administrative expenses (including non-cash stock compensation expense of $9,062 in 2016, $11,048 in 2015 and $18,115 in 2014)	32,919			38,176			48,554
Research, consulting and other expenses - business development	3,079			3,391			3,840
Impairment of patent-related intangible assets	42,340			74,731			3,497
Impairment of goodwill	—			30,149			—
Other	500			4,141			1,548

Total operating costs and expenses	190,108			277,659			193,031

Operating loss	(37,409		)	(152,622		)	(62,155		)

Total other income (expense)	798			(56		)	(595		)

Loss from operations before provision for income taxes	(36,611		)	(152,678		)	(62,750		)
Provision for income taxes	(18,188		)	(4,800		)	(3,912		)
Net loss including noncontrolling interests in operating subsidiaries	(54,799		)	(157,478		)	(66,662		)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	732			(2,558		)	633
Net loss attributable to Acacia Research Corporation	$	(54,067	)	$	(160,036	)	$	(66,029	)

Net loss attributable to common stockholders - basic and diluted	$	(54,067	)	$	(160,730	)	$	(66,755	)

Basic and diluted loss per common share	$	(1.08	)	$	(3.25	)	$	(1.37	)

Weighted-average number of shares outstanding, basic and diluted	50,075,847			49,505,817			48,658,088

Cash dividends declared per common share	$	—		$	0.50		$	0.50

The accompanying notes are an integral part of these consolidated financial statements.

F- 5

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

For the Years Ended December 31, 2016, 2015 and 2014

(In thousands)



	2016			2015			2014
Net loss including noncontrolling interests in operating subsidiaries	$	(54,799	)	$	(157,478	)	$	(66,662	)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term investments, net of tax of $0	40			(356		)	(1,488		)
Unrealized gain (loss) on foreign currency translation, net of tax of $0	77			(123		)	(128		)
Add: reclassification adjustment for losses included in net loss	22			617			2,210
Total other comprehensive loss	(54,660		)	(157,340		)	(66,068		)
Comprehensive income (loss) attributable to noncontrolling interests	732			(2,558		)	633
Comprehensive loss attributable to Acacia Research Corporation	$	(53,928	)	$	(159,898	)	$	(65,435	)

The accompanying notes are an integral part of these consolidated financial statements.

F- 6

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Years Ended December 31, 2016, 2015 and 2014

(In thousands, except share information)



	Common Shares		Common Stock			Treasury Stock			Additional Paid-in Capital			Accumulated Comprehensive Loss			Accumulated Deficit			Noncontrolling Interests in Operating Subsidiaries			Total

Balance at December 31, 2013	49,385,057		$	49		$	(34,640	)	$	653,314		$	(947	)	$	(62,066	)	$	6,488		$	562,198
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(66,029		)	—			(66,029		)
Dividends paid to stockholders	—		—			—			(25,039		)	—			—			—			(25,039		)
Stock options exercised	44,506		—			—			206			—			—			—			206
Compensation expense for share-based awards, net of forfeitures	635,819		1			—			18,114			—			—			—			18,115
Net loss attributable to noncontrolling interests in operating subsidiaries	—		—			—			—			—			—			(633		)	(633		)
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(364		)	(364		)
Unrealized loss on foreign currency translation	—		—			—			—			(99		)	—			—			(99		)
Unrealized gain on short-term investments	—		—			—			—			693			—			—			693
Balance at December 31, 2014	50,065,382		50			(34,640		)	646,595			(353		)	(128,095		)	5,491			489,048
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(160,036		)	—			(160,036		)
Dividends paid to stockholders	—		—			—			(25,434		)	—			—			—			(25,434		)
Stock options exercised	135,000		—			—			938			—			—			—			938
Compensation expense for share-based awards, net of forfeitures	450,857		1			—			11,047			—			—			—			11,048
Net income attributable to noncontrolling interests in operating subsidiaries	—		—			—			—			—			—			2,558			2,558
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(4,105		)	(4,105		)
Unrealized loss on foreign currency translation	—		—			—			—			(123		)	—			—			(123		)
Unrealized gain on short-term investments	—		—			—			—			261			—			—			261
Balance at December 31, 2015	50,651,239		51			(34,640		)	633,146			(215		)	(288,131		)	3,944			314,155
Net loss attributable to Acacia Research Corporation	—		—			—			—			—			(54,067		)	—			(54,067		)
Stock options exercised	100,992		—			—			326			—			—			—			326
Compensation expense for share-based awards, net of forfeitures	(262,660	)	(1		)	—			9,063			—			—			—			9,062
Repurchase of restricted common stock	(13,529	)							(82		)										(82		)
Net loss attributable to noncontrolling interests in operating subsidiaries	—		—			—			—			—			—			(732		)	(732		)
Distributions to noncontrolling interests in operating subsidiary	—		—			—			—			—			—			(1,358		)	(1,358		)
Unrealized gain on foreign currency translation	—		—			—			—			40			—			—			40
Unrealized gain on short-term investments	—		—			—			—			99			—			—			99
Balance at December 31, 2016	50,476,042		$	50		$	(34,640	)	$	642,453		$	(76	)	$	(342,198	)	$	1,854		$	267,443

The accompanying notes are an integral part of these consolidated financial statements.

F- 7

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2016, 2015 and 2014

(In thousands)



	2016			2015			2014

Cash flows from operating activities:
Net loss including noncontrolling interests in operating subsidiaries	$	(54,799	)	$	(157,478	)	$	(66,662	)
Adjustments to reconcile net loss including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:
Depreciation and amortization	34,355			53,289			54,049
Non-cash stock compensation	9,062			11,048			18,115
Deferred income taxes	—			—			(1,736		)
Impairment of patent-related intangible assets	42,340			74,731			3,497
Impairment of goodwill	—			30,149			—
Other	(477		)	(109		)	(28		)
Changes in assets and liabilities:
Restricted cash	(787		)	(10,725		)	—
Accounts receivable	6,750			(13,332		)	(13,827		)
Prepaid expenses and other assets	1,593			(619		)	3,154
Accounts payable and accrued expenses / patent costs	(3,006		)	2,570			3,718
Royalties and contingent legal fees payable	(970		)	527			3,904

Net cash provided by (used in) operating activities	34,061			(9,949		)	4,184

Cash flows from investing activities:
Patent portfolio investment costs	(1,225		)	(19,504		)	(42,746		)
Advances to Investee (Note 8)	(20,000		)	—			—
Purchases of property and equipment	(4		)	(8		)	(109		)
Purchases of short-term investments	(62,633		)	(23,296		)	(109,963		)
Sales and maturities of short-term investments	43,232			82,115			182,115

Net cash provided by (used in) investing activities	(40,630		)	39,307			29,297

Cash flows from financing activities:
Dividends paid to stockholders	—			(25,434		)	(25,039		)
Distributions to noncontrolling interests in operating subsidiary	(1,358		)	(4,105		)	(867		)
Proceeds from the exercise of stock options	326			938			206
Repurchases of restricted common stock	(82		)	—			—

Net cash used in financing activities	(1,114		)	(28,601		)	(25,700		)

Increase (decrease) in cash and cash equivalents	(7,683		)	757			7,781

Cash and cash equivalents, beginning	135,223			134,466			126,685

Cash and cash equivalents, ending	$	127,540		$	135,223		$	134,466

Supplemental schedule of noncash investing activities:
Patent portfolio investment costs included in accrued expenses / costs	$	—		$	1,000		$	16,700

The accompanying notes are an integral part of these consolidated financial statements.

F- 8

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If Acacia's operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and / or revenue growth.

During fiscal 2016 Acacia obtained control of 2 new patent portfolios. Further, in fiscal year 2015, Acacia obtained control of 3 new patent portfolios, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End. The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Principles of Consolidation. The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 12 to these consolidated financial statements.

F- 9

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.

For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues. Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net

F- 10

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 12 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:



●	Level 1 -	Observable Inputs: Quoted prices in active markets for identical investments;
●	Level 2 -	Pricing Models with Significant Observable Inputs: Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and
●	Level 3 -	Unobservable Inputs: Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.

Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents. Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Investments in Marketable Securities. Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2016, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in total other income (expense).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks. Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with

F- 11

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016. Two licensees individually represented approximately 72% and 21%, respectively, of accounts receivable at December 31, 2015.

For 2016, 2015 and 2014, 79%, 49% and 43%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Property and Equipment. Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:



Furniture and fixtures	3 to 5 years
Computer hardware and software	3 to 5 years
Leasehold improvements	2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents. Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Acacia's goodwill balance of $30.1 million was fully written-off as of December 31, 2015. Refer to Note 7 for additional information.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not

F- 12

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments. The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.

Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and / or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 11 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

The fair value of stock options granted during the year ended December 31, 2016 was estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:



	Weighted-Average Assumptions

Risk-free interest rate	1.1%
Term	3.06
Volatility	53%
Dividend yield	—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the year ended December 31, 2016. Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

F- 13

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Income Taxes. Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting. Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates. The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, the allocation of loans to investees between the loans receivable and common stock purchase warrants received, and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share. The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of

F- 14

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:



	2016			2015			2014
Numerator (in thousands):
Basic and Diluted
Net loss	$	(54,067	)	$	(160,036	)	$	(66,029	)
Total dividends declared / paid	—			(25,434		)	(25,039		)
Dividends attributable to common stockholders	—			24,740			24,313
Net loss attributable to common stockholders – basic and diluted	$	(54,067	)	$	(160,730	)	$	(66,755	)

Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted	50,075,847			49,505,817			48,658,088

Basic and diluted net loss per common share	$	(1.08	)	$	(3.25	)	$	(1.37	)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share	3,682,532			71,468			27,760

Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted. In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

F- 15

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In June 2016, the FASB issued guidance on the measurement and recognition of credit losses on most financial assets. For trade receivables, loans, and held-to-maturity debt securities, the current probable loss recognition methodology is being replaced by an expected credit loss model. For available-for-sale debt securities, the recognition model on credit losses is generally unchanged, except the losses will be presented as an adjustable allowance. The guidance will be applied retrospectively with the cumulative effect recognized as of the date of adoption. The guidance will become effective at the beginning of our first quarter of fiscal 2021 but can be adopted as early as the beginning of our first quarter of fiscal 2020. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Recently Adopted. In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The adoption of this standard effective December 31, 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In June 2014, the FASB issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The adoption of this standard effective January 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In August 2016, the FASB issued amended guidance to clarify guidance on the classification of certain cash receipts and cash payments. Additionally, the guidance requires that the statement of cash flows reflect changes in restricted cash in addition to cash and cash equivalents. Amended guidance includes clarification on debt prepayment and extinguishment costs, contingent consideration in business combinations, proceeds from insurance claims, and premium payments on company-owned life insurance. Refer to the consolidated statement of cash flows elsewhere herein for separate presentation of changes in restricted cash.

3. SHORT-TERM INVESTMENTS

Short-term marketable securities for the periods presented were comprised of the following (in thousands):



	December 31, 2016
Security Type	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
U.S. government fixed income securities	$	19,403	$	40	$	—	$	19,443

Short-term investments at December 31, 2016 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2017. There were no short-term investments at December 31, 2015.

U.S. government fixed income securities. The Company has the ability to hold these securities until maturity, currently has no intent to sell, there is no requirement to sell and the Company believes that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. However, the Company cannot provide any assurance that its portfolio of short-term marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.

For the year ended December 31, 2016, proceeds from the sale of short-term marketable securities classified as available-for-sale were $43,232,000 and gross realized gains were $1,000. For the year ended December 31, 2015, proceeds from the sale of short-term marketable securities were $82,115,000 and gross realized losses were $617,000. For the year ended December 31, 2014, proceeds from the sale of short-term marketable securities were $182,115,000 and gross realized losses were $2,188,000. Gross realized gains are recorded in the statements of operations in other income (expense).

F- 16

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

4. PROPERTY AND EQUIPMENT

Property and equipment consists of the following at December 31, 2016 and 2015 (in thousands):



	2016			2015

Furniture and fixtures	$	733		$	739
Computer hardware and software	603			649
Leasehold improvements	131			145
	1,467			1,533
Less: accumulated depreciation and amortization	(1,340		)	(1,261		)
	$	127		$	272

Depreciation expense was $147,000, $222,000 and $304,000 for the years ended December 31, 2016, 2015 and 2014, respectively. In 2016 and 2015, the Company retired $68,000 and $30,000, respectively, of items held in furniture and equipment and recorded a $3,000 and $14,000, respectively, loss on disposal.

5. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2016 and 2015 (in thousands):



	2016		2015

Payroll and other employee benefits	$	1,593	$	576
Accrued vacation	533		701
Accrued legal expenses - patent	6,564		10,135
Foreign taxes payable ⁽¹⁾	3,150		3,960
Accrued consulting and other professional fees	1,967		1,592
Other accrued liabilities	476		383
	$	14,283	$	17,347

⁽¹⁾ - Included in "Accounts payable and accrued expenses / patent costs" line item on the consolidated statement of cash flows included elsewhere herein.

6. PATENTS

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to seven years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2016 and 2015 are as follows (in thousands):



	2016			2015

Gross carrying amount - patents	$	444,362		$	444,137
Accumulated amortization - patents⁽¹⁾	(358,043		)	(281,495		)
Patents, net	$	86,319		$	162,642

⁽¹⁾ Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 5 years. Scheduled annual aggregate amortization expense is estimated to be $22,333,000 in 2017, $21,256,000 in 2018, $19,150,000 in 2019, $6,707,000 in 2020, $5,421,000 in 2021 and $11,452,000 thereafter.

For the years ended December 31, 2016, 2015 and 2014, Acacia paid patent investment costs totaling $1,225,000, $19,504,000 and $42,746,000, respectively. The patents have initial estimated economic useful lives ranging from two to ten years. Included in net additions to capitalized patent costs during the year ended December 31, 2015 and 2014 are accrued

F- 17

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

patent investment costs totaling $1,000,000 and $16,700,000, respectively, which are amortized over the estimated economic useful life of the related patents.

During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2016 and 2014, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled $225,000 and $1,247,000, respectively. For the year ended December 31, 2015, there was no accelerated amortization expense.

For the years ended December 31, 2015 and 2014, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $380,000 and $2,702,000, respectively. For the year ended December 31, 2016, there were no terminations or sales of patent portfolios.

Acacia recorded impairment of patent-related intangible asset charges totaling $42,340,000, $74,731,000 and $3,497,000 for the years ended December 31, 2016, 2015 and 2014, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles.

In December 2015, Acacia's subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to partial impairment charges on the portfolio in the fourth quarter of 2015. Patent impairment charges included the impairment of the remaining carrying value for the Adapitx portfolio in the second quarter of 2016. In addition, for the year ended December 31, 2015 analysis, management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes. Additionally, patent impairment charges include the carrying value of other patent portfolios for which, in 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.

The impairment charges for the periods presented consisted of the excess of the asset’s carrying value over its estimated fair value.

For the years ended December 31, 2016, 2015 and 2014, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):



	2016		2015		2014

Capitalized patent costs	$	—	$	500	$	3,000
Accumulated amortization	—		120		298
Sales proceeds	—		750		3,500

7. GOODWILL IMPAIRMENT CHARGES

Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill. Refer to Note 6 for additional information regarding patent impairment charges for the year ended December 31, 2015.

F- 18

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:


•	significant consistent gradual decline in the Company's stock price for a sustained period;


•	significant underperformance relative to expected historical or projected future operating results;


•	significant changes in the manner of use of assets or the strategy for the Company's overall business;


•	significant negative industry or economic trends; and


•	significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:

•

Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.

•

Significant consistent gradual decline in the Company’s stock price: Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.

•

Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.

At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:

•

At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.

•

The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.


•	Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.

F- 19

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

•

The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

8. LOAN RECEIVABLE AND INVESTMENT IN WARRANTS

On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provides for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permits Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the consolidated statement of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”), which initially had a one-year term. On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”), which has a one-year term. In addition, upon the funding of the Second Loan, the maturity date of the First Loan was automatically extend to the maturity date of the Second Loan. As a result, both the First Loan and the Second Loan are due and payable on November 25, 2017. Veritone’s obligations under the Veritone Loans are secured by substantially all of Veritone’s assets pursuant to a security agreement that Acacia entered into with Veritone dated August 15, 2016.

In addition, commencing on the earlier of Veritone’s consummation of a private round of financing of at least $10 million (a “Next Equity Financing”) and the maturity date of the Veritone Loans, Acacia has the right, under certain circumstances, to convert all or a portion of the principal and accrued interest of the Veritone Loans into shares of Veritone’s Series B Preferred Stock or, if Veritone consummates a Next Equity Financing, into shares of Veritone capital stock issued in such financing, at various conversion rates, with the exact conversion rate to depend upon (i) whether Veritone consummates a Next Equity Financing, (ii) the price per share in such Next Equity Financing and (iii) whether or not Acacia elects to convert all of the outstanding principal and accrued interest under the Veritone Loans. If Veritone consummates a qualified public offering of its common stock, any outstanding principal and accrued interest under the Veritone Loans will automatically convert into shares of Veritone’s common stock at the applicable conversion rate.

In conjunction with the First Loan, Veritone issued Acacia a four-year $700,000 warrant to purchase shares of Veritone’s common stock at various exercise prices, with the actual exercise price to be determined by the type and/or valuation of Veritone’s future equity financings, if any. The actual number of shares to be purchased upon exercise of the warrant is determined by dividing the warrant value by the applicable exercise price. Upon funding of the Second Loan, Veritone issued to Acacia two additional four-year $700,000 warrants to purchase shares of Veritone’s common stock with similar terms.

In addition, pursuant to the Investment Agreement, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at various exercise prices, with the actual exercise price per share to be determined by the amount of principal and accrued interest under the Veritone Loans converted into shares of Veritone common stock. Acacia may exercise the Primary Warrant at any time during its five year term after the earlier of August 15, 2017 or the completion of a public offering with gross proceeds to Veritone of at least $15.0 million. Immediately subsequent to such a public offering, Veritone has the right to elect that Acacia exercise the Primary Warrant, and upon such election, Acacia agrees to exercise the Primary Warrant in full, provided that the then current fair market value of Veritone common stock is equal to or greater than the exercise price per share of the Primary Warrant. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone has the obligation to issue to Acacia an additional 10% Warrant that provides for the issuance of additional shares of Veritone common stock, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of shares vesting on the anniversary of the issuance date of the 10% Warrant.

Our Investment Agreement, as described above, represents a variable interest in Veritone for which Acacia is not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. As of December 31, 2016, the Veritone Loans are not considered in-substance common stock and the common stock purchase warrants are unexercised, and therefore, the equity method of accounting is not applied. In addition, the Veritone Loans do not meet the criteria for classification as a debt security. As such, the Veritone Loans and the related common stock purchase warrants described above are accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the

F- 20

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

transaction, with the $20 million amount of the Veritone Loans allocated to (1) the Veritone Loans, which are accounted for as long-term loan receivables and (2) the common stock purchase warrants. The estimated relative fair value allocation of the $20 million investment to the Veritone Loans and the related common stock purchase warrants was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone's equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Veritone Loans. A summary of assumptions used in connection with estimating the relative fair values were as follows:



Valuation Technique	Significant Unobservable Inputs	Range of Inputs
Monte Carlo simulation model	Volatility	40	%	-	50%
	Marketability discount	7%
	Funding scenario probabilities	25	%	-	75%
	Recovery	100%

The Veritone Loans and warrants are reflected in the accompanying consolidated financial statements as follows (in thousands):



	As of and For the Year Ended December 31, 2016
Face value of loan receivable	$	20,000
Unamortized loan discount	(1,384		)
Carrying value of loan receivable	18,616
Investment in warrants (initial loan discount)	1,960
Total	$	20,576

Interest receivable	$	286
Accretion of loan discount	576
Interest income	$	862

The loan discount, representing the difference between the face amount of the Veritone Loans and the relative fair value allocated to the Veritone Loans, is accreted over the expected life of the loans, using the effective interest method, with the related interest amounts reflected in Other Income in the consolidated statement of operations. Acacia will re-evaluate its variable interest in Veritone and related accounting conclusions and disclosure requirements each reporting period. The effective yield for the First Loan and Second Loan was 20% and 9%, respectively.

Management performs a review of the Veritone Loans on a quarterly basis to assess the need for allowances for uncollectibility, based on current trends and other factors affecting collectibility, and to determine if any impairment has occurred. A loan receivable is considered impaired when it is probable that amounts related to the loan receivable will not be collected according to the contractual terms of the agreement. As of December 31, 2016, no allowances for uncollectibility have been recorded. An allowance for uncollectibility would be reflected as a charge to earnings in the consolidated statement of operations.

Acacia reflects its investment in warrants at relative value, which now represents cost, on a nonrecurring basis when they are deemed to be other-than-temporarily impaired. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections. An impairment charge is recorded when the cost of the investment exceeds its fair value and this condition is determined to be other-than-temporary. For the year ended December 31, 2016, no impairment charges have been recorded.

F- 21

9. STOCKHOLDERS’ EQUITY

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 and $25,039,000 in 2015 and 2014, respectively. On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

Tax Benefits Preservation Plan. On March 15, 2016, Acacia's Board of Directors announced that it unanimously approved the adoption of a Tax Benefits Preservation Plan (the “Plan"). The purpose of the Plan is to protect the Company's ability to utilize potential tax assets, such as net operating loss carryforwards (“NOLs") and tax credits to offset potential future taxable income.

The Plan is designed to reduce the likelihood that the Company will experience an ownership change by discouraging any (i) person or group from acquiring beneficial ownership of 4.9% or more of the Company's outstanding common stock and (ii) any existing shareholders who, as of the time of the first public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company's then-outstanding shares of the Company's common stock from acquiring additional shares of the Company's common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.

In connection with the adoption of the Plan, Acacia's Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company's common stock to shareholders of record at the close of business on March 16, 2016.

Approval of 2016 Acacia Research Corporation Stock Incentive Plan. On April 26, 2016, Acacia’s Board of Directors adopted the 2016 Acacia Research Corporation Stock Incentive Plan, or the Plan, which was approved by the stockholders in June 2016. The Plan will expire on the 10th anniversary of the date of its approval by shareholders, except with respect to awards then outstanding, and no further awards may be granted thereafter.

Summary of the Plan

•

Shares Available. The number of shares of our common stock initially reserved for issuance under the Plan shall be 4,500,000 shares plus any shares remaining available for issuance under our 2013 Acacia Research Corporation Stock Incentive Plan, or the 2013 Plan, as of the effective date of the Plan. As of the approval date of the Plan, 625,390 shares of our common stock were available for grant under the 2013 Plan.

•

Eligibility. Options, restricted stock units and direct stock awards may be granted under the Plan. Options may be either “incentive stock options,” as defined in Section 422 of the Internal Revenue Code of 1986, as amended, or the Code, or non-qualified stock options. Awards may be granted under the Plan to any employee, non-employee member of the Board of Directors, consultant or advisor who provides services to us or our subsidiaries, except for incentive stock options which may be granted only to our employees.

•

Administration. Generally, the Plan will be administered by either the entire Acacia Board of Directors or a committee of the Board of Directors, which shall consist of at least two members of the Board, each of whom must qualify as a “non-employee director” under Rule 16b-3 under the Exchange Act, an “outside director” under Section 162(m) of the Code and an “independent director” under the Nasdaq Listing Rules.

•

Discretionary Option Awards. The Plan administrator may grant either non-qualified stock options or incentive stock options. A stock option entitles the recipient to purchase a specified number of shares of our common stock at a fixed price subject to terms and conditions set by the Plan administrator, including conditions for exercise that must be satisfied, which typically will be based on continued provision of services. The exercise price of stock options granted under the Plan cannot be less than 100% of the fair market value of our common stock on the date the option is granted.

F- 22

•

Direct Stock Awards. Direct stock awards may be issued under the Stock Issuance Program (as defined in the Plan) either alone or in addition to other awards granted under the Plan. The Plan administrator determines the terms and conditions of direct stock awards, including the number of shares of common stock granted, and the conditions for vesting that must be satisfied, if any, which typically will be based on continued provision of services but may include a performance-based component. Unless otherwise provided in the award agreement, the holder of a restricted direct stock award will have the rights of a stockholder from the date of grant of the award, including the right to vote the shares of common stock and the right to receive distributions on the shares.

•

Discretionary Restricted Stock Unit Awards. The Plan provides that the Plan administrator may grant restricted stock units to Plan participants. A restricted stock unit entitles the recipient to receive upon settlement thereof a specified number of shares of our common stock subject to terms and conditions set by the Plan administrator. The restricted stock units will vest as prescribed by the Plan administrator. The Plan permits payment of the purchase price of restricted stock units, if any, to be made by cash or cash equivalents, shares of our common stock previously acquired by the underlying optionee, cancellation of indebtedness, waiver of compensation due for services rendered or to be rendered, any other form of legal consideration determined by the Plan administrator, or any combination of the foregoing.

•

Termination of Employment. The Plan administrator will determine and set forth in the award agreement whether any awards will continue to be exercisable, and the terms of such exercise, on and after the date the participant ceases to be employed by, or to otherwise provide services to, us, whether by reason of death, disability, voluntary or involuntary termination of employment or service, or otherwise, but in no event shall any unvested awards vest after the date the participant ceases to be employed by, or otherwise provide services to, us.

10. INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):



	2016		2015		2014

Current:
Federal	$	—	$	—	$	—
State taxes	262		379		289
Foreign taxes	17,926		4,421		5,359
Total current	18,188		4,800		5,648
Deferred:
Federal	—		—		(1,867		)
State taxes	—		—		131
Total deferred	—		—		(1,736		)
Provision for income taxes	$	18,188	$	4,800	$	3,912

F- 23

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2016 and 2015 (in thousands):



	2016			2015

Deferred tax assets:
Net operating loss and capital loss carryforwards and credits	$	83,323		$	71,494
Stock compensation	2,416			1,385
Fixed assets and intangibles	14,343			1,359
Basis of investments in affiliates	2,195			499
Accrued liabilities and other	422			442
State taxes	90			81
Total deferred tax assets	102,789			75,260
Valuation allowance	(102,627		)	(75,179		)
Total deferred tax assets, net of valuation allowance	162			81

Deferred tax liabilities:
Fixed assets and intangibles	—			—
Other	(162		)	(81		)
Total deferred tax liabilities	(162		)	(81		)

Net deferred tax assets (liabilities)	$	—		$	—

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:



	2016		2015		2014

Statutory federal tax rate - (benefit) expense	(35	)%	(35	)%	(35	)%
State income and foreign taxes, net of federal tax effect	50	%	3	%	9	%
Foreign tax credit	(49	)%	(3	)%	(8	)%
Noncontrolling interests in operating subsidiaries	1	%	(1	)%	—	%
Goodwill	—	%	7	%	—	%
Nondeductible permanent items	—	%	—	%	1	%
Expired capital loss carryforwards	—	%	1	%	—	%
Valuation allowance	83	%	31	%	39	%
	50	%	3	%	6	%

For the fiscal years ended December 31, 2016 and 2015, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.

At December 31, 2016, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $147,770,000 and $32,821,000, expiring between 2025 and 2035, and 2017 and 2036, respectively, for which $0 and $441,000 of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, $1,928,000 and $37,771,000 of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled $3,423,000 at December 31, 2015, expiring between 2017 and 2020.

F- 24

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

At December 31, 2016, approximately $29,318,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2016, Acacia had approximately $52,224,000 of foreign tax credits, expiring between 2017 and 2026, of which $20,313,000 has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling $1,735,000 from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were (33)%, (28)% and (33)%, for fiscal years 2016, 2015 and 2014, respectively.

The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the years ended December 31, 2016, 2015 and 2014, the Company incurred approximately $1,319,000, $1,917,000 and $2,713,000, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,319,000, $1,917,000 and $2,713,000, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2001. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2016 and 2015, the Company had total unrecognized tax benefits of approximately $1,355,000 and $2,127,000, including a recorded noncurrent liability of $85,000, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2016. At December 31, 2016, if recognized, approximately $1,355,000, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2016 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

11. STOCK-BASED INCENTIVE PLANS

The 2002 Acacia Technologies Stock Incentive Plan (“2002 Plan”), the 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in December 2002, May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws,

F- 25

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•

Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•

Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•

Automatic Option Grant Program. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date, provided that such individual has served as a non-employee director for at least 6 months. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the restricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The number of shares of common stock available for issuance under the 2002 Plan automatically increased on the first trading day of January each calendar year during the term of the Plan by an amount equal to three percent (3%) of the total number of shares of common stock outstanding on the last trading day in December of the immediately preceding calendar year, not to exceed 500,000 shares. The aggregate number of shares of common stock available for issuance under the 2002 Plan could not exceed 20,000,000 shares. At December 31, 2016, there were no shares available for grant under the 2002 Plan.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan.

On April 26, 2016, Acacia’s Board of Directors adopted the 2016 Plan which was approved by the stockholders in June 2016. The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At December 31, 2016, there were 1,754,000 shares available for grant under the 2016 Plan.

F- 26

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval.

The following table summarizes stock-based award grant activity for the Plans for the years ended December 31, 2016 and 2015:



	2016			2015
	Shares	Aggregate fair value (in thousands)		Shares	Aggregate fair value (in thousands)

Restricted stock awards with time-based service conditions	—	$	—	894,000	$	11,470
Restricted stock unit awards with time-based service conditions	—	—		28,000	468
Restricted stock awards with performance-based vesting conditions	138,000	431		—	—
Stock options with time-based service vesting conditions	3,434,000	5,704		—	—
Stock options with market-based vesting conditions	2,250,000	5,530		—	—
Stock options with performance-based vesting conditions	200,000	487		—	—
Total incentive awards granted	6,022,000	$	12,152	922,000	$	11,938

During the year ended December 31, 2016, the Company granted restricted stock awards and stock options (with weighted-average exercise price of $5.75 per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of December 31, 2016, 138,000 shares of restricted stock and 200,000 stock options with performance-based vesting conditions remain unvested. As of December 31, 2016, unrecognized expense for awards with performance-based vesting conditions totaled $683,000.

During the year ended December 31, 2016, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of $5.75 per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of 25% upon the Company's achievement of 30-day average share prices ranging from $7.00 to $10.00. As of December 31, 2016, 1,687,500 options with market-based vesting conditions remain unvested. As of December 31, 2016, unrecognized expense for options with market-based vesting conditions totaled $2.4 million which is expected to be recognized over an estimated 1 year period.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2016:



			Weighted-Average
	Options		Exercise Price		Remaining Contractual Term	Aggregate Intrinsic Value

Outstanding at December 31, 2015	15,000		$	13.38
Granted	5,884,000		$	4.82
Exercised	(101,000	)	$	3.22
Expired/forfeited	(202,000	)	$	3.12
Outstanding at December 31, 2016	5,596,000		$	4.93	6.7 years	$	8,865,000
Vested	1,113,000		$	5.03	6.5 years	$	1,743,000
Exercisable at December 31, 2016	1,113,000		$	5.03	6.5 years	$	1,743,000

The aggregate intrinsic value of options exercised during the years ended December 31, 2016, 2015 and 2014 was $344,000, $751,000, and $518,000, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2016 was $2,074,000. The aggregate fair value of options granted during the year ended December 31, 2016 was

F- 27

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

$11,721,000.The aggregate fair value of options vested during the year ended December 31, 2016 was $2,342,000. No options were granted or vested during the years ended December 31, 2015 and 2014. As of December 31, 2016, the total unrecognized compensation expense related to nonvested stock option awards was $6,842,000, which is expected to be recognized over a weighted-average term of approximately 2 years.

The following table summarizes nonvested restricted share activity for the year ended December 31, 2016:



	Nonvested Restricted Shares		Weighted Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2015	829,000		$	14.41
Granted	138,000		$	3.12
Vested	(342,000	)	$	15.33
Canceled	(292,000	)	$	14.28
Nonvested restricted stock at December 31, 2016	333,000		$	8.90

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2016, 2015 and 2014 was $3.12, $12.83, and $14.41, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2016, 2015 and 2014 was $5,243,000, $11,494,000 and $21,490,000, respectively. As of December 31, 2016, the total unrecognized compensation expense related to nonvested restricted stock awards was $1,873,000, which is expected to be recognized over a weighted-average period of approximately 1 year.

The following table summarizes restricted stock unit activity for the year ended December 31, 2016:



	Restricted Stock Units		Weighted Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2015	35,000		$	15.78
Vested	(21,000	)	$	15.43
Nonvested restricted stock units outstanding at December 31, 2016	14,000		$	16.27
Vested restricted stock units outstanding at December 31, 2016	80,000		$	20.99

The weighted-average grant date fair value of restricted stock units granted during the years ended December 31, 2015 and 2014 was $16.72 and $14.33, respectively. There were no restricted units granted during the year ended December 31, 2016. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2016, 2015 and 2014 was $324,000, $480,000 and $460,000, respectively. As of December 31, 2016, the total unrecognized compensation expense related to restricted stock unit awards was $162,000, which is expected to be recognized over a weighted-average period of approximately 1 year.

Compensation expense for the periods presented was comprised of the following:



	2016		2015		2014

Restricted stock awards with time-based service conditions	$	—	$	10,575	$	17,631
Restricted stock unit awards with time-based service conditions	4,391		473		484
Restricted stock awards with performance-based vesting conditions	197		—		—
Stock options with time-based service vesting conditions	1,316		—		—
Stock options with market-based vesting conditions	3,158		—		—
Stock options with performance-based vesting conditions	—		—		—
Total compensation expense	$	9,062	$	11,048	$	18,115

As of December 31, 2016, there are 7,445,000 shares of common stock reserved for issuance under the Plans.

F- 28

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

12. COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2017 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):



Years ending December 31,
2017	$	1,279
2018	1,323
2019	1,369
2020	16
Total minimum lease payments	$	3,987

Rent expense for the years ended December 31, 2016, 2015 and 2014 approximated $1,795,000, $1,926,000 and $1,523,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by Acacia’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor royalties, payments to noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows.

Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position. Fiscal year 2016, 2015 and 2014 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $500,000, $4,141,000 and $1,548,000, respectively.

F- 29

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2016.

Bank Guarantee

In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).

Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by the operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.

The Guarantee is secured by a cash deposit at the contracting bank, which is classified as restricted cash in the accompanying balance sheets, totaling $11,512,000 and $10,725,000 of December 31, 2016 and 2015, respectively. Changes in the balance are primarily a result of additional court rulings granting injunctions with respect to additional defendants, and foreign currency exchange rate fluctuations and the related impact on the underlying collateral, which is denominated in U.S. dollars. The Guarantee expires on April 10, 2017, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the consolidated statement of operations.

F- 30

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund is authorized to raise up to $250,000,000. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. Refer to Note 2 to these notes to consolidated financial statements for information regarding the consolidation of majority-owned subsidiaries and the presentation of related noncontrolling interests. At December 31, 2016 and 2015, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):



	2016		2015
Cash and other assets	$	1,118	$	7,740
Patents, net of accumulated amortization	—		147
Investments - noncurrent	2,933		5,829
Total assets	$	4,051	$	13,716

Accrued expenses and contributions	$	2,394	$	7,436
Net assets	$	1,657	$	6,280



	2016			2015
Revenues	$	16		$	18
Operating expenses	572			1,617
Loss from operations	(556		)	(1,599		)
Net gain (loss) in equity method investments	(1,013		)	6,922
Net income (loss)	$	(1,569	)	$	5,323

13. RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

14. SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for state income taxes totaled $223,000, $211,000 and $172,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Foreign taxes withheld totaled $14,776,000, $4,421,000 and $5,159,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Refer to Note 5 for accrued foreign taxes payable.

Refer to Note 6 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 8 for information regarding noncash investing activity related to the investment in Veritone, Inc. for the periods presented.

F- 31

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

15. QUARTERLY FINANCIAL DATA (unaudited)

The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2016. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.



	Quarter Ended
	Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,			Mar. 31,			Jun. 30,			Sept. 30,			Dec. 31,
	2016			2016			2016			2016			2015			2015			2015			2015
	(Unaudited, in thousands, except share and per share information)
Revenues	$	24,721		$	41,351		$	64,658		$	21,969		$	34,210		$	40,336		$	12,994		$	37,497
Operating costs and expenses:
Cost of revenues:
Inventor royalties	1,573			—			17,844			3,313			9,325			1,265			116			7,756
Contingent legal fees	4,109			10,418			7,709			4,238			4,784			5,512			1,972			3,901
Litigation and licensing expenses - patents	7,723			7,324			7,348			5,463			8,675			9,012			10,345			11,341
Amortization of patents	10,760			10,759			6,467			6,222			13,038			13,228			13,688			13,113
General and administrative expenses (including non-cash stock compensation expense)	7,994			7,535			8,334			9,056			10,575			9,587			9,442			8,572
Research, consulting and other expenses - business development	522			1,334			666			557			997			732			802			860
Impairment of patent-related intangible assets	—			40,165			—			2,175			—			—			—			74,731
Impairment of goodwill	—			—			—			—			—			—			—			30,149
Other	1,742			(1,242		)	—			—			426			—			3,465			250
Total operating costs and expenses	34,423			76,293			48,368			31,024			47,820			39,336			39,830			150,673
Operating income (loss)	(9,702		)	(34,942		)	16,290			(9,055		)	(13,610		)	1,000			(26,836		)	(113,176		)
Total other income (expense)	(3		)	(52		)	261			592			228			(104		)	(180		)	—
Income (loss) before (provision for) benefit from income taxes	(9,705		)	(34,994		)	16,551			(8,463		)	(13,382		)	896			(27,016		)	(113,176		)
Provision for income taxes	(192		)	(5,927		)	(9,655		)	(2,414		)	(170		)	(119		)	(337		)	(4,174		)
Net income (loss) including noncontrolling interests	(9,897		)	(40,921		)	6,896			(10,877		)	(13,552		)	777			(27,353		)	(117,350		)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(68		)	348			186			266			422			(4,463		)	43			1,440
Net income (loss) attributable to Acacia Research Corporation	$	(9,965	)	$	(40,573	)	$	7,082		$	(10,611	)	$	(13,130	)	$	(3,686	)	$	(27,310	)	$	(115,910	)
Net loss per common share attributable to Acacia Research Corporation:
Basic and diluted income (loss) per share	$	(0.20	)	$	(0.81	)	$	0.14		$	(0.21	)	$	(0.27	)	$	(0.08	)	$	(0.55	)	$	(2.33	)
Weighted-average number of shares outstanding, basic	49,925,550			50,015,869			50,124,302			50,237,784			49,212,207			49,423,472			49,630,369			49,749,941
Weighted-average number of shares outstanding, diluted	49,925,550			50,015,869			50,618,757			50,237,784			49,212,207			49,423,472			49,630,369			49,749,941

F- 32

ACACIA RESEARCH CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

16. SUBSEQUENT EVENTS

On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of equity interests in AIP to certain members of management and Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the equity value of AIP increases beyond the value at issuance. The equity interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones, subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement.

Acacia owns substantially all of the equity in AIP and at all times will control AIP. Although AIP currently holds no material assets, Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients.

EXHIBIT INDEX



Exhibit Number	Description

2.1	Agreement and Plan of Merger, dated November 22, 2011, by and among Acacia Research Group LLC, Apollo Patent Corp., Adaptix, Inc., and Baker Communications Fund II (QP), L.P., solely in its capacity as representative for the shareholders of Adaptix, Inc.(15)
3.1	Amended and Restated Certificate of Incorporation (1)
3.2	Amended and Restated Bylaws (21)
4.1	Tax Benefits Preservation Plan, dated as of March 16, 2016, by and between Acacia Research Corporation and Computershare Inc., as Rights Agent, which includes the form of Certificate of Designation of Series A Cumulative Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Terms as Exhibit C (24)
10.1*	Acacia Research Corporation 1996 Stock Option Plan, as amended (2)
10.2*	Form of Option Agreement constituting the Acacia Research Corporation 1996 Executive Stock Bonus Plan (3)
10.3*	2002 Acacia Technologies Stock Incentive Plan (4)
10.4*	2007 Acacia Technologies Stock Incentive Plan (5)
10.5*	Form of Acacia Technologies Stock Option Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.6*	Form of Acacia Technologies Stock Issuance Agreement under the 2002 Acacia Technologies Stock Incentive Plan (6)
10.7*	Form of Acacia Technologies Stock Issuance Agreement under the 2007 Acacia Technologies Stock Incentive Plan (6)
10.8	Office Space Lease dated January 28, 2002, between Acacia Research Corporation and The Irvine Company (7)
10.9	Form of Indemnification Agreement (8)
10.10	Third Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (9)
10.11*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Edward Treska (20)
10.12	Fourth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.13	Fifth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (10)
10.15*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Robert L. Harris (20)
10.16*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Clayton J. Haynes (20)

F- 33



10.17*	Acacia Research Corporation Amended and Restated Executive Severance Policy (12)
10.18	Sixth Amendment to Lease dated January 28, 2002 between Acacia Research Corporation and the Irvine Company (14)
10.19	Form of Purchase Agreement (16)
10.20*	2013 Acacia Research Corporation Stock Incentive Plan (18)
10.21*	Form of Stock Issuance Agreement under the 2013 Acacia Research Corporation Stock Incentive Plan (19)
10.22*	Employment Agreement, dated September 22, 2015, by and between Acacia Research Group LLC and Matthew Vella (20)
10.23*	2016 Acacia Research Corporation Stock Incentive Plan (22)
10.24*	Form of Stock Option Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan
10.25*	Form of Stock Issuance Agreement under the 2016 Acacia Research Corporation Stock Incentive Plan
10.26	Director Service Agreement, dated February 29, 2016, by and between Acacia Research Corporation and Robert L. Harris (23)
18.1	Preferability Letter dated February 25, 2010 from Grant Thornton LLP, independent registered public accounting firm, regarding change in accounting principle (13)
21.1	List of Subsidiaries
23.1	Consent of Independent Registered Public Accounting Firm
24.1	Power of Attorney (included in the signature page hereto).
31.1†	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2†	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
32.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350
101	Interactive Date Files Pursuant to Rule 405 of Regulation S-T.

___________________________


*	The referenced exhibit is a management contract, compensatory plan or arrangement required to be filed as an exhibit to this Annual Report on Form 10-K pursuant to Item 15(c) of Form 10-K.

†


(1)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on June 5, 2008 (File No. 000-26068).


(2)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 20, 2000 (File No. 000-26068).


(3)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 26, 1996 (File No. 000-26068).


(4)	Incorporated by reference to Annex E to the Proxy Statement/Prospectus which formed part of Acacia Research Corporation’s Registration Statement on Form S-4 (File No. 333-87654) which became effective on November 8, 2002.


(5)	Incorporated by reference to Acacia Research Corporation’s Registration Statement on Form S-8 (File No. 333-144754) which became effective on July 20, 2007.


(6)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended September 30, 2007, filed on November 2, 2007 (File No. 000-26068).


(7)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10‑K for the year ended December 31, 2001, filed on March 27, 2002 (File No. 000‑26068).


(8)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended June 30, 2012, filed on July 30, 2012 (File No. 000-26068).


(9)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q for the period ended March 31, 2006, filed on May 10, 2006 (File No. 000‑26068).


(10)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2007, filed on March 14, 2008 (File No. 000-26068).


(11)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on April 2, 2008 (File No. 000-26068).


(12)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008, filed on February 26, 2009 (File No. 000-26068).


(13)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2009, filed on February 26, 2010, as amended on March 1, 2010 (File No. 000-26068)


(14)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2010, filed on February 28, 2011, as amended on March 24, 2011 (File No. 000-26068).


(15)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K/A filed on January 19, 2012 (File No. 000-26068). Portions of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24-b-2 of the Securities Exchange Act of 1934, as amended. The omitted material has been separately filed with the Securities and Exchange Commission.


(16)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on February 16, 2012 (File No. 000-26068).


(17)	Incorporated by reference to Acacia Research Corporation’s Annual Report on Form 10-K for the year ended December 31, 2012, filed on February 28, 2013 (File No. 000-26068).


(18)	Incorporated by reference to Appendix A to Acacia Research Corporation’s Definitive Proxy Statement on Schedule 14A filed on April 24, 2013 (File No. 000-26068).


(19)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on May 22, 2013 (File No. 000-26068).


(20)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on November 9, 2015 (File No. 000-26068).


(21)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 28, 2016 (File No. 000-37721).


(22)	Incorporated by reference to Acacia Research Corporation’s Quarterly Report on Form 10-Q filed on August 9, 2016 (File No. 001-37721).


(23)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 4, 2016 (File No. 000-26068).


(24)	Incorporated by reference to Acacia Research Corporation’s Current Report on Form 8-K filed on March 21, 2016 (File No. 000-26068).

EX-10.24 2 actgex1024123116.htm EXHIBIT 10.24 Exhibit

ACACIA RESEARCH CORPORATION

STOCK OPTION AGREEMENT

r e c i t a l s:

A. The Board has adopted the 2016 Acacia Research Corporation Stock Incentive Plan (the “Plan”) (i) to enhance the Corporation’s ability to attract and retain the services of qualified employees, officers, directors, consultants and other service providers upon whose judgment, initiative and efforts the successful conduct and development of the Corporation’s business largely depends, and (ii) to provide additional incentives to such persons or entities to devote their utmost effort and skill to the advancement and betterment of the Corporation, by providing them an opportunity to participate in the ownership of the Corporation and thereby have an interest in the success and increased value of the Corporation.

B. Optionee is to render valuable services to the Corporation (or a Parent or Subsidiary), and this Stock Option Agreement (the “Agreement”) is executed pursuant to, and is intended to carry out the purposes of, the Plan in connection with the Corporation's grant of an option to Optionee.

C. All capitalized terms but not defined in this Agreement shall have the meanings assigned to them in the Appendix attached to the Plan.

NOW, THEREFORE, it is hereby agreed as follows:

GRANT OF OPTION. The Corporation hereby grants to Optionee, as of the date of grant of the options (the “Grant Date”) as specified in the Notice of Grant of Stock Option (the “Grant Notice”), an option to purchase up to the number of shares of Common Stock subject to the option as specified in the Grant Notice (the “Option Shares”) specified in the Grant Notice. The Option Shares shall be purchasable from time to time during the option term specified in Paragraph 2 hereof at the exercise price per Option Share as specified in the Grant Notice (the “Exercise Price”).

OPTION TERM. This option shall have a maximum term of seven (7) years² measured from the Grant Date and shall accordingly expire at the close of business on the expiration date specified in the Grant Notice (the “Expiration Date”), unless sooner terminated in accordance with Paragraph 5 or 6 hereof.

LIMITED TRANSFERABILITY. This option shall be neither transferable nor assignable by Optionee other than by will or by the laws of descent and distribution following Optionee's death and may be exercised, during Optionee's lifetime, only by Optionee. However, if this option is designated a Non-Statutory Option in the Grant Notice, then this option may be assigned in whole or in part during Optionee's lifetime to one or more members of the Optionee's Immediate Family or to a trust established for the exclusive benefit of Optionee or one or more members of the Optionee's Immediate Family or to the Optionee's former spouse, to the extent such assignment is in connection with Optionee's estate plan or pursuant to a domestic relations order. The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment. Notwithstanding the

foregoing, the Optionee may also designate one or more persons as the beneficiary or beneficiaries of this option and this option shall, in accordance with such designation,

²NTD: Option to expire on date set forth in grant notice. Cannot exceed 10 years.

automatically be transferred to such beneficiary or beneficiaries upon the Optionee's death while holding this option. Such beneficiary or beneficiaries shall take the transferred option subject to all the terms and conditions of this Agreement, including (without limitation) the limited time period during which the option may be exercised following the Optionee's death.

DATES OF EXERCISE. This option shall become exercisable for the Option Shares in one or more installments as specified in the Grant Notice. As the option becomes exercisable for such installments, those installments shall accumulate, and the option shall remain exercisable for the accumulated installments until the Expiration Date or sooner termination of the option term under Paragraph 5 or 6 hereof.

CESSATION OF SERVICE. The option term specified in Paragraph 2 hereof shall terminate (and this option shall cease to be outstanding) prior to the Expiration Date should any of the following provisions become applicable:

•

Should Optionee cease to remain in Service for any reason (other than death, Permanent Disability, Voluntary Termination, which shall mean Optionee terminates employment voluntarily, or Misconduct) while this option is outstanding, then Optionee shall have a period of six (6) months (commencing with the date of such cessation of Service) during which to exercise this option, but in no event shall this option be exercisable at any time after the Expiration Date.


•	Should Optionee voluntarily terminate Service while this option is outstanding, then Optionee shall have a period of three (3) months (commencing with the date of such Voluntary Termination) during which to exercise this option, but in no event shall this option be exercisable at any time after the Expiration Date.

•

Should Optionee die while this option is outstanding, then the personal representative of Optionee's estate or the person or persons to whom the option is transferred pursuant to Optionee's will or in accordance with the laws of descent and distribution or any person or trust to whom all or a portion of this option is transferred in accordance with Paragraph 3 hereof or the designated beneficiary or beneficiaries of this option shall have the right to exercise this option. Such right shall lapse, and this option shall cease to be outstanding, upon the earlier of (i) the expiration of the twelve (12)-month period measured from the date of Optionee's death or (ii) the Expiration Date.


•	Should Optionee cease Service by reason of Permanent Disability while this option is outstanding, then Optionee shall have a period of twelve (12) months (commencing with the date of such cessation of Service) during which to exercise this option. In no event shall this option be exercisable at any time after the Expiration Date.

During the limited period of post-Service exercisability, this option may not be exercised in the aggregate for more than the number of vested Option Shares for which the option is exercisable at the time of Optionee's cessation of Service. Upon the expiration of such limited exercise period or (if earlier) upon the Expiration Date, this option shall

terminate and cease to be outstanding for any vested Option Shares for which the option has not been exercised. However, this option shall, immediately upon Optionee's cessation of Service for any reason, terminate and cease to be outstanding with respect to any Option Shares for which this option is not otherwise at that time exercisable.

Should Optionee's Service be terminated for Misconduct, then this option shall terminate immediately and cease to remain outstanding.

CHANGE IN CONTROL/HOSTILE TAKE-OVER

Unless otherwise determined by the Plan Administrator in the event of a Change in Control/Hostile Take-Over, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) may assume or continue this option or may substitute similar stock awards for this option (including but not limited to, awards to acquire the same consideration paid to the stockholders of the Corporation pursuant to the Change in Control/Hostile Take-Over), and any reacquisition or repurchase rights held by the Corporation in respect of Common Stock issued pursuant to this option may be assigned by the Corporation to the successor of the Corporation (or the successor’s parent company, if any), in connection with such Change in Control/Hostile Take-Over. A surviving corporation or acquiring corporation (or its parent) may choose to assume or continue only a portion of this option or substitute a similar stock award for only a portion of this option, or may choose not to assume this option. The terms of any assumption, continuation or substitution will be set by the Board. If either (x) Optionee’s employment with the Corporation is terminated by the Corporation without Cause (which termination shall be effective as of the date specified by the Corporation in a written notice to Optionee), other than due to death or Permanent Disability, or in the event Optionee terminates his or her employment with Good Reason, in either case within twelve months following a Change in Control/Hostile Take-Over, or (y) Optionee voluntarily terminates his or her employment on his or her own initiative after the twelfth month but no later than the thirteenth month following a Change in Control/Hostile Take-Over, in either case of (x) or (y), then the vesting of this option will be accelerated in full and the time when this option may be exercised will be accelerated in full. Such vesting acceleration will occur on the date of termination of Optionee’s Service.

In the event of a Change in Control/Hostile Take-Over in which the surviving corporation or acquiring corporation (or its parent company) does not assume or continue this option or substitute similar stock awards for this option, then if this option has not been assumed, continued or substituted, the vesting of this option will be accelerated in full to a date prior to the effective time of such Change in Control/Hostile Take-Over (contingent upon the effectiveness of the Change in Control/Hostile Take-Over) as the Board will determine (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Change in Control/Hostile Take-Over), and this option will terminate if not exercised (if applicable) at or prior to the effective time of the Change in Control/Hostile Take-Over, and any reacquisition or repurchase rights held by the Corporation with respect to this option will lapse (contingent upon the effectiveness of the Change in Control/Hostile Take-Over).

Notwithstanding the foregoing, in the event this option will terminate if not exercised prior to the effective time of a Change in Control/Hostile Take-Over, the Board may provide, in its sole discretion, that Optionee may not exercise this option but instead

will receive a payment, in such form as may be determined by the Board, equal in value to the excess, if any, of (i) the value of the property Optionee would have received upon the exercise of this option immediately prior to the effective time of the Change in Control/Hostile Take-Over (including, at the discretion of the Board, any unvested portion of this option), over (ii) any exercise price payable by Optionee in connection with such exercise. For clarity, this payment may be zero if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Common Stock in connection with the Change in Control/Hostile Take-Over is delayed as a result of escrows, earn outs, holdbacks or any other contingencies.

The portion of any Incentive Option accelerated in connection with a Change in Control or Hostile Take-Over shall remain exercisable as an Incentive Option only to the extent the applicable One Hundred Thousand Dollar ($100,000) limitation is not exceeded. To the extent such dollar limitation is exceeded, the accelerated portion of such option shall be exercisable as a Non-Statutory Option under the Federal tax laws.

ADJUSTMENT IN OPTION SHARES. Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation's receipt of consideration, appropriate adjustments shall be made to the number and/or class of securities and the Exercise Price in effect under this option. Such adjustments to this option are to be effected in a manner which shall preclude the enlargement or dilution of rights and benefits under this option. The adjustments determined by the Plan Administrator shall be final, binding and conclusive

STOCKHOLDER RIGHTS. The holder of this option shall not have any stockholder rights with respect to the Option Shares until such person shall have exercised the option, paid the Exercise Price and become a holder of record of the purchased shares.

MANNER OF EXERCISING OPTION.

In order to exercise this option with respect to all or any part of the Option Shares for which this option is at the time exercisable, Optionee (or any other person or persons exercising the option) must take the following actions:

Execute and deliver to the Corporation a Preclearance to Exercise Options Form, attached hereto as Schedule I, for the Option Shares for which the option is exercised.

Pay the aggregate Exercise Price for the purchased shares in one or more of the following forms:


•	cash or check made payable to the Corporation;


•	the surrender of shares of Common Stock owned by Optionee (provided that shares acquired pursuant to the exercise of options granted by the Corporation must have been held by Optionee for the requisite period necessary to avoid a charge to the Corporation’s earnings for financial reporting purposes), which surrendered shares shall be valued at Fair Market Value as of the date of such exercise;


•	the cancellation of indebtedness of the Corporation to Optionee;


•	provided that a public market for the Common Stock exists, a “same day sale” commitment from Optionee and an NASD Dealer whereby Optionee irrevocably elects to exercise this option and to sell a portion of the shares so purchased to pay for the Exercise Price and whereby the NASD Dealer irrevocably commits upon receipt of such shares to forward the Exercise Price directly to the Corporation;


•	the waiver of compensation due or accrued for services rendered or to be rendered during a vesting period; or


•	any combination of the foregoing methods of payment or any other consideration or method of payment as shall be permitted by applicable law.

Except to the extent the sale and remittance procedure is utilized in connection with the option exercise, payment of the Exercise Price must accompany the Notice of Exercise delivered to the Corporation in connection with the option exercise.

Furnish to the Corporation appropriate documentation that the person or persons exercising the option (if other than Optionee) have the right to exercise this option.

Make appropriate arrangements with the Corporation (or Parent or Subsidiary employing or retaining Optionee) for the satisfaction of all Federal, state and local income and employment tax withholding requirements applicable to the option exercise.

As soon as practical after the Exercise Date, the Corporation shall issue to or on behalf of Optionee (or any other person or persons exercising this option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto. To the extent any such Option Shares are unvested, the certificates for those Option Shares shall be endorsed with an appropriate legend evidencing the Corporation's repurchase rights and may be held in escrow with the Corporation until such shares vest.

In no event may this option be exercised for any fractional shares.

NO IMPAIRMENT OF RIGHTS. This Agreement shall not in any way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise make changes in its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. In addition, this Agreement shall not in any way be construed or interpreted so as to affect adversely or otherwise impair the rights of the Corporation (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to terminate Optionee's Service at any time for any reason, with or without cause.

COMPLIANCE WITH LAWS AND REGULATIONS. The exercise of this option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Corporation and Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any Stock Exchange on which the Common Stock may be listed for trading at the time of such exercise and issuance.

The inability of the Corporation to obtain approval from any regulatory body having authority deemed by the Corporation to be necessary to the lawful issuance and sale of any Common Stock pursuant to this option shall relieve the Corporation of any liability with respect to

the non-issuance or sale of the Common Stock as to which such approval shall not have been obtained. The Corporation, however, shall use its best efforts to obtain all such approvals.

SUCCESSORS AND ASSIGNS. Except to the extent otherwise provided in Paragraphs 3 and 6 hereof, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and Optionee, Optionee's assigns and the legal representatives, heirs and legatees of Optionee's estate.

NOTICES. Any notice required to be given or delivered to the Corporation under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal corporate offices. Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the address indicated below Optionee's signature line on the Grant Notice. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.

CONSTRUCTION. This Agreement and the option evidenced hereby are made and granted pursuant to the Plan and are in all respects limited by and subject to the terms of the Plan. All decisions of the Plan Administrator with respect to any question or issue arising under the Plan or this Agreement shall be conclusive and binding on all persons having an interest in this option.

GOVERNING LAW. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Delaware without resort to that State's conflict-of-laws rules.

EXCESS SHARES. If the Option Shares covered by this Agreement exceed, as of the Grant Date, the number of shares of Common Stock which may without stockholder approval be issued under the Plan, then this option shall be void with respect to those excess shares, unless stockholder approval of an amendment sufficiently increasing the number of shares of Common Stock issuable under the Plan is obtained in accordance with the provisions of the Plan.

ADDITIONAL TERMS APPLICABLE TO AN INCENTIVE OPTION. In the event this option is designated an Incentive Option in the Grant Notice, the option is intended to be an incentive stock option as described in Code Section 422, but the Corporation does not represent or warrant that the option qualifies as such. Optionee should consult with his or her own tax advisors regarding the tax effects of this option and the requirements necessary to obtain favorable income tax treatment under Code Section 422, including, but not limited to, holding period requirements with respect to the Option Shares after exercise of this option. In addition, the following terms and conditions shall also apply to the grant:

This option shall cease to qualify for favorable tax treatment as an Incentive Option if (and to the extent) this option is exercised for one or more Option Shares: (A) more than three (3) months after the date Optionee ceases to be an Employee for any reason other than death or Permanent Disability or (B) more than twelve (12) months after the date Optionee ceases to be an Employee by reason of Permanent Disability.

No installment under this option shall qualify for favorable tax treatment as an Incentive Option if (and to the extent) the aggregate Fair Market Value (determined at the Grant Date) of the Common Stock for which such installment first becomes exercisable hereunder would, when added to the aggregate value (determined as of the respective date or dates of grant) of the Common Stock or other securities for which this option or any other Incentive Options granted to

Optionee prior to the Grant Date (whether under the Plan or any other option plan of the Corporation or any Parent or Subsidiary) first become exercisable during the same calendar year, exceed One Hundred Thousand Dollars ($100,000) in the aggregate. Should such One Hundred Thousand Dollar ($100,000) limitation be exceeded in any calendar year, this option shall nevertheless become exercisable for the excess shares in such calendar year as a Non-Statutory Option.

Should the exercisability of this option be accelerated upon a Change in Control, then this option shall qualify for favorable tax treatment as an Incentive Option only to the extent the aggregate Fair Market Value (determined at the Grant Date) of the Common Stock for which this option first becomes exercisable in the calendar year in which the Change in Control occurs does not, when added to the aggregate value (determined as of the respective date or dates of grant) of the Common Stock or other securities for which this option or one or more other Incentive Options granted to Optionee prior to the Grant Date (whether under the Plan or any other option plan of the Corporation or any Parent or Subsidiary) first become exercisable during the same calendar year, exceed One Hundred Thousand Dollars ($100,000) in the aggregate. Should the applicable One Hundred Thousand Dollar ($100,000) limitation be exceeded in the calendar year of such Change in Control, the option may nevertheless be exercised for the excess shares in such calendar year as a Non-Statutory Option.

Should Optionee hold, in addition to this option, one or more other options to purchase Common Stock which become exercisable for the first time in the same calendar year as this option, then the foregoing limitations on the exercisability of such options as Incentive Options shall be applied on the basis of the order in which such options are granted.

SCHEDULE I

PRECLEARANCE TO EXERCISE OPTIONS

I,_______________________, hereby notify Acacia Research Corporation (the “Corporation”) that I elect to purchase ____________ shares (the “Exercised Shares”) of the Corporation’s Common Stock (“Common Stock”) at the option exercise price of ________per share (the “Exercise Price”) pursuant to that certain option granted to me under the Acacia Research Corporation 2016 Stock Incentive Plan on ____________, 20__(the “Option”).

Type of Option

_______ Incentive Option (ISO) _______Non-Statutory Option (Non-Qual)

Type of Transaction


____	Cash Exercise (Purchase of the option shares with the intent to hold the shares for sale at a future date). NOTE: If you choose to do a cash exercise, you may not sell the acquired share without subsequent approval during a period when the trading window is open. Please refer to the Acacia Insider Trading Policy.


____	Cashless Exercise (Same-day purchase of the option shares and immediate sale of all the shares on the open market.)


____	Sell-to-Cover Exercise (Purchase of the option shares and immediate sale of less than all the shares). NOTE: If you choose to do a Sell-to-Cover exercise, you may not sell the remaining shares without subsequent approval during a period when the trading window is open. Please refer to the Acacia Insider Trading policy.

Concurrently with the delivery of this Notice of Exercise to the Corporation, I shall pay, or cause to be paid to the Corporation the Exercise Price for the Exercised Shares in accordance with the provisions of my agreement with the Corporation (or other documents) evidencing the Option and shall deliver whatever additional documents may be required by such agreement as a condition for exercise.

I hereby certify as of the date above that:


•	I have previously received and am familiar with the Corporation’s Insider Trading Policy;


•	I have complied with all procedures established by the Corporation’s Insider Trading Policy in connection with the transaction described above; and


•	To my knowledge, I am not in possession of any material nonpublic information about the Corporation and/or its affiliated companies.

I acknowledge that I have ten (10) business days from the date of approval, or until the window closes, whichever is shorter, in which to complete the trade I have requested. I also acknowledge that I will notify ________ by email as soon as I have given my broker any exercise instructions.

_______________________ __________________________________

Date Signature

APPROVED:

_________________________________

Date:_____________________________

EX-10.25 3 actgex1025123116.htm EXHIBIT 10.25 Exhibit

ACACIA RESEARCH CORPORATION

2016 ACACIA RESEARCH CORPORATION STOCK INCENTIVE PLAN

STOCK ISSUANCE AGREEMENT

THIS AGREEMENT is made this [date] day of [month], 201_, by and between Acacia Research Corporation, a Delaware corporation, and [namename], a Participant in the Corporation’s 2016 Acacia Research Corporation Stock Incentive Plan (the “Plan”).

All capitalized terms in this Agreement shall have the meaning assigned to them in this Agreement, in the attached Appendix or, if such term is not defined in this Agreement or the Appendix, such term shall have the meaning assigned to it under the Plan.


A.	GRANT OF SHARES

1.Grant. Participant is hereby granted _____ shares of Common Stock (the “Shares”) pursuant to the provisions of the Stock Issuance Program.

2.Consideration. With respect to the par value of the Shares, such Shares are granted in consideration for past services provided by the Participant to the Corporation. The consideration for the remaining value of the Shares is provided and for the services Participant shall provide to the Corporation over the vesting period provided in Paragraph C.2.

3.Other Documents. Participant shall deliver a duly executed blank Assignment Separate from Certificate (in the form attached hereto as Exhibit I) with respect to the Shares.

4.Stockholder Rights. Until such time as the Unvested Shares are forfeited pursuant to Paragraph C.1., Participant (or any successor in interest) shall have all the rights of a stockholder (including voting, dividend and liquidation rights) with respect to the Shares, subject, however, to the transfer restrictions of this Agreement.

5.Escrow. The Corporation shall have the right to hold the Shares in escrow until those shares have vested in accordance with Paragraph C.2.

6.Compliance with Law. Under no circumstances shall shares of Common Stock or other assets be issued or delivered to Participant pursuant to the provisions of this Agreement unless, in the opinion of counsel for the Corporation or its successors, there shall have been compliance with all applicable requirements of applicable securities laws, all applicable listing requirements of any stock exchange (or the Nasdaq National Market, if applicable) on which the Common Stock is at the time listed for trading and all other requirements of law or of any regulatory bodies having jurisdiction over such issuance and delivery.


B.	TRANSFER RESTRICTIONS

1.Restriction on Transfer. Except for any Permitted Transfer, Participant shall not transfer, assign, encumber or otherwise dispose of any of the Shares which are Unvested Shares.

2.Restrictive Legend. The stock certificate for the Shares shall be endorsed with the following restrictive legend:

“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE UNVESTED AND SUBJECT TO FORFEITURE TO THE CORPORATION IN CERTAIN CIRCUMSTANCES AND ACCORDINGLY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE CORPORATION AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). A COPY OF SUCH AGREEMENT IS MAINTAINED AT THE CORPORATION’S PRINCIPAL CORPORATE OFFICES.”

3.Transferee Obligations. Each person (other than the Corporation) to whom the Shares are transferred by means of a Permitted Transfer must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Corporation that such person is bound by the provisions of this Agreement and that the transferred shares are subject to the forfeiture provisions to the same extent such shares would be so subject if retained by Participant.


C.	FORFEITURE OF SHARES.

1.Forfeiture of Shares. On the date Participant ceases for any reason to remain in Service, all of the Shares in which Participant is not, at the time of his or her termination of Service, vested in accordance with Paragraph C.2. of this Agreement (such shares to be hereinafter referred to as the “Unvested Shares”) shall be forfeited, shall become the property of the Corporation and the Participant shall no longer have any right to or ownership of such Shares. The certificates representing the forfeited Unvested Shares shall be delivered to the Corporation as soon as possible after the termination of Service.

2.Termination of Forfeiture. One-sixth of the Shares shall vest and the forfeiture shall lapse on each six month anniversary of your first day of employment, so that on the third year anniversary of your first day of employment, the forfeiture shall have lapsed as to all of the Shares and there will be no Unvested Shares. This vesting is subject to Participant's continuous service from the first day of employment through each vesting date.

3.Recapitalization. Any new, substituted or additional securities or other property (including cash paid other than as a regular cash dividend) which is by reason of any Recapitalization distributed with respect to the Shares shall be immediately subject to forfeiture pursuant to this Paragraph C and any escrow requirements hereunder, but only to the extent the Shares are at the time covered by such forfeiture or escrow requirements. Appropriate adjustments to reflect such distribution shall be made to the number, kind, type and/or class of securities subject to this Agreement in order to reflect the effect of any such Recapitalization upon the Corporation’s capital structure.

4.Change in Control./Hostile Take-Over. All of the Shares shall become fully vested and any Forfeiture Provision shall terminate in full, immediately prior to and contingent upon a Change in Control or Hostile Take-Over.


D.	TAX PROVISIONS.

1. Tax Consequences. Participant has reviewed with Participant’s own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on such advisors and not on any statements or representations of the Corporation or any of its agents. Participant understands that Participant (and not the Corporation) shall be responsible for any tax liability that may arise as a result of the transactions contemplated by this Agreement. Participant understands that Section 83 of the Code, taxes as ordinary income the difference between the purchase price for the Shares and the Fair Market Value of the Shares as of the date any restrictions on the Shares lapse. In this context, “restriction” includes forfeiture provision pursuant to Paragraph C.1. with respect to the Unvested Shares. Participant understands that Participant may elect to be taxed at the time the Shares are granted rather than when and as the forfeiture provision lapses by filing an election under Section 83(b) of the Code with the IRS within thirty (30) days from the date of grant. Participant acknowledges that it is Participant’s sole responsibility, and not the Corporation’s, to file a timely election under code section 83(b), even if Participant requests the Corporation or its representatives to make this filing on his or her behalf.

2.Withholding Obligations. At the time the Shares subject to this Agreement are granted, or at any time thereafter as requested by the Corporation, Participant hereby authorizes withholding from payroll and any other amounts payable to Participant, including these Shares, and otherwise agrees to make adequate provision for, any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Corporation or any Parent or Subsidiary, if any, which arise in connection with the grant of the Shares.

The Corporation, in its sole discretion, and in compliance with any applicable legal conditions or restrictions, may withhold from fully vested Shares otherwise deliverable to Participant upon the vesting of the Unvested Shares a number of whole Shares having a Fair Market Value, as determined by the Corporation as of the date of vesting, not in excess of the amount of tax required to be withheld by law (or such lower amount as may be necessary to avoid adverse financial accounting treatment). Any adverse consequences to Participant arising in connection with such share withholding procedure shall be the Participant’s sole responsibility.

Unless the tax withholding obligations of the Corporation or any Parent or Subsidiary are satisfied, the Corporation shall have no obligation to issue a certificate for such Shares or release such Shares from any escrow provided for herein.


E.	GENERAL PROVISIONS

1.Assignment. The Corporation may assign its rights under this Agreement, including, but not limited to the forfeiture provision of Paragraph C.1., to any person or entity selected by the Board, including (without limitation) one or more stockholders of the Corporation.

2.Employment At Will . Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining Participant) or of Participant, which rights are hereby expressly reserved by each, to terminate Participant’s Service at any time for any reason, with or without cause.

3.Notices. Any notice required to be given under this Agreement shall be in writing and shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, registered or certified, postage prepaid and properly addressed to the party entitled to such notice at the address indicated below such party’s signature line on this Agreement or at such other address as such party may designate by ten (10) days advance written notice under this paragraph to all other parties to this Agreement.

4.No Waiver. The failure of the Corporation in any instance to enforce the forfeiture provision or any other term of this Agreement shall not constitute a waiver of any other forfeiture provision or other term that may subsequently arise under the provisions of this Agreement or any other agreement between the Corporation and Participant. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature.

5.Cancellation of Shares. If the Shares subject to this Agreement are forfeited, then from and after such time, the person from whom such Shares are forfeited shall no longer have any rights as a holder of such Shares. Such shares shall be deemed forfeited in accordance with the applicable provisions hereof, and the Corporation shall be deemed the owner and holder of such shares, whether or not the certificates therefor have been delivered as required by this Agreement.

6.Participant Undertaking. Participant hereby agrees to take whatever additional action and execute whatever additional documents the Corporation may deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on either Participant or the Shares pursuant to the provisions of this Agreement.

7.Agreement is Entire Contract. This Agreement constitutes the entire contract between the parties hereto with regard to the subject matter hereof. This Agreement is made pursuant to the provisions of the Plan and shall in all respects be construed in conformity with the terms of the Plan. In the event of a conflict between the Plan and this Agreement, the terms of the Plan shall govern.

8.Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of California without regard to the conflict-of-laws rules thereof or of any other jurisdiction.

9.Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.

10.Successors and Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and upon Participant, Participant’s assigns and the legal representatives, heirs and legatees of Participant’s estate, whether or not any such person shall have become a party to this Agreement and have agreed in writing to join herein and be bound by the terms hereof.

11.Representations. Participant agrees upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Corporation to carry out the purposes or intent of this Agreement.

12.

Participant acknowledges and agrees that Participant has reviewed the Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing and accepting the award and fully understands all provisions of the Agreement.

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year first indicated above.

ACACIA RESEARCH CORPORATION

By:_________________________________

Title:________________________________

Address:_____________________________

_____________________________

PARTICIPANT

By:________________________________

Name:________________________________

Address:______________________________

______________________________

SPOUSAL ACKNOWLEDGMENT

The undersigned spouse of the Participant has read and hereby approves the foregoing Stock Issuance Agreement. In consideration of the Corporation’s granting the Participant the right to acquire the Shares in accordance with the terms of such Agreement, the undersigned hereby agrees to be irrevocably bound by all the terms of such Agreement, including (without limitation) the forfeiture to the Corporation (or its assigns) any Shares in which the Participant is not vested at the time of his or her termination of Service.

PARTICIPANT'S SPOUSE

By:________________________________

Name:________________________________

Address:______________________________

______________________________

EXHIBIT I

ASSIGNMENT SEPARATE FROM CERTIFICATE

FOR VALUE RECEIVED _______________________ hereby sell(s), assign(s) and transfer(s) unto Acacia Research Corporation (the “Corporation”), _____________________ (________) shares of the Common Stock of the Corporation standing in his or her name on the books of the Corporation represented by Certificate No. ______________ herewith and do(es) hereby irrevocably constitute and appoint ______________________________ Attorney to transfer the said stock on the books of the Corporation with full power of substitution in the premises.

Dated: _________________, _____.

Signature ________________________________

Instruction: Please do not fill in any blanks other than the signature line. Please sign exactly as you would like your name to appear on the issued stock certificate. The purpose of this assignment is to enable the Corporation to enforce the forfeiture provision without requiring additional signatures on the part of Participant.

APPENDIX

The following definitions shall be in effect under the Agreement:

A.Agreement shall mean this Stock Issuance Agreement.

B.Owner shall mean Participant and all subsequent holders of the Shares who derive their chain of ownership through a Permitted Transfer from Participant.

C.Participant shall mean the person to whom the Shares are issued under the Stock Issuance Program.

D.Permitted Transfer shall mean (i) a gratuitous transfer of the Shares, provided and only if Participant obtains the Corporation’s prior written consent to such transfer, (ii) a transfer of title to the Shares effected pursuant to Participant’s will or the laws of inheritance following Participant’s death or (iii) a transfer to the Corporation in pledge as security for any purchase-money indebtedness incurred by Participant in connection with the acquisition of the Shares.

E.Plan shall mean the Corporation’s 2013 Acacia Research Corporation Stock Incentive Plan.

F.Shares shall have the meaning assigned to such term in Paragraph A.1.

G.Recapitalization shall mean any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the Corporation’s outstanding Common Stock as a class without the Corporation’s receipt of consideration.

H.Service shall mean the Participant’s performance of services for the Corporation (or any Parent or Subsidiary) in the capacity of an employee, subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance, a non-employee member of the board of directors or an independent consultant. Service shall not be deemed to cease during a period of military leave, sick leave or other personal leave approved by the Corporation; provided, however, that except to the extent otherwise required by law, no Service credit shall be given for purposes of the vesting of the Unvested Shares hereunder for any period the Participant is on a leave of absence.

I.Stock Issuance Program shall mean the Stock Issuance Program under the Plan.

J.Unvested Shares shall have the meaning assigned to such term in Paragraph C.1.

EX-21.1 4 actgex211123116.htm EXHIBIT 21.1 Exhibit

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT

The following is a listing of the significant subsidiaries of Acacia Research Corporation:



	Jurisdiction of Incorporation

Acacia Global Acquisition LLC and subsidiaries	Delaware

Acacia Research Group, LLC, formerly Acacia Patent Acquisition, LLC and subsidiaries	Delaware

Acacia Global Acquisition LLC and Acacia Research Group, LLC, wholly own multiple consolidated operating subsidiaries, that are included in Acacia Research Corporation's consolidated financial statements included elsewhere herein, each of which are separate and distinct legal entities, and all of which are in the patent acquisition, development, licensing and enforcement business. All of the operating subsidiaries wholly owned by Acacia Global Acquisition LLC and Acacia Research Group, LLC operate in the United States.

EX-23.1 5 actgex231123116.htm EXHIBIT 23.1 Exhibit

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 10, 2017, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Acacia Research Corporation on Form 10-K for the year ended December 31, 2016. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Acacia Research Corporation on Forms S-3 (File No. 333-122452, File No. 333-157623, File No. 333-173045, File No. 333-180858) and on Forms S-8 (File No. 333-102181, File No. 333-109352, File No. 333-119811, File No. 333-127583, File No. 333-131463, File No. 333-140280, File No. 333-144754, File No. 333-149849, File No. 333-157626, File No. 333-165110, File No. 333-172538, File No. 333-179010, File No. 333-189135).

/s/ GRANT THORNTON LLP

Irvine, California

March 10, 2017

EX-31.1 6 actgex311123116.htm EXHIBIT 31.1 Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Marvin Key, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 10, 2017	/s/ Marvin Key
		Marvin Key Interim Chief Executive Officer (Principal Executive Officer)

EX-31.2 7 actgex312123116.htm EXHIBIT 31.2 Exhibit

EXHIBIT 31.2

CERTIFICATION

I, Clayton J. Haynes, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Acacia Research Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and


5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Dated:	March 10, 2017	/s/ Clayton J. Haynes
		Clayton J. Haynes Chief Financial Officer (Principal Financial Officer)

EX-32.1 8 actgex321123116.htm EXHIBIT 32.1 Exhibit

EXHIBIT 32.1

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2016, as filed with the Securities and Exchange Commission on March 10, 2017 (the “Report”), I, Marvin Key, Interim Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Marvin Key
		Marvin Key
		Interim Chief Executive Officer
		March 10, 2017

This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

EX-32.2 9 actgex322123116.htm EXHIBIT 32.2 Exhibit

EXHIBIT 32.2

CERTIFICATION

In connection with the Annual Report of Acacia Research Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2016, as filed with the Securities and Exchange Commission on March 10, 2017 (the “Report”), I, Clayton J. Haynes, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



	By:	/s/ Clayton J. Haynes
		Clayton J. Haynes
		Chief Financial Officer
		March 10, 2017

EX-101.INS 10 actg-20161231.xml XBRL INSTANCE DOCUMENT 0000934549 2016-01-01 2016-12-31 0000934549 2017-03-06 0000934549 2016-06-30 0000934549 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0000934549 2015-01-01 2015-12-31 0000934549 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee1Member 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee2Member 2015-01-01 2015-12-31 0000934549 2015-12-31 0000934549 2016-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000934549 us-gaap:CommonStockMember 2016-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0000934549 us-gaap:TreasuryStockMember 2013-12-31 0000934549 us-gaap:TreasuryStockMember 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000934549 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000934549 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000934549 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2013-12-31 0000934549 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2015-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0000934549 us-gaap:RetainedEarningsMember 2015-12-31 0000934549 us-gaap:CommonStockMember 2015-12-31 0000934549 us-gaap:TreasuryStockMember 2016-12-31 0000934549 2013-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0000934549 us-gaap:CommonStockMember 2014-12-31 0000934549 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000934549 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000934549 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000934549 us-gaap:TreasuryStockMember 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-12-31 0000934549 us-gaap:CommonStockMember 2013-12-31 0000934549 us-gaap:RetainedEarningsMember 2014-12-31 0000934549 us-gaap:NoncontrollingInterestMember 2016-12-31 0000934549 us-gaap:RetainedEarningsMember 2013-12-31 0000934549 us-gaap:RetainedEarningsMember 2016-12-31 0000934549 2013-01-01 2013-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee3Member 2016-01-01 2016-12-31 0000934549 us-gaap:MinimumMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2015-01-01 2015-12-31 0000934549 us-gaap:MaximumMember 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee2Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2016-01-01 2016-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee2Member 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee1Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2015-01-01 2015-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:Licensee3Member 2015-01-01 2015-12-31 0000934549 us-gaap:AccountsReceivableMember actg:Licensee4Member 2016-01-01 2016-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2014-01-01 2014-12-31 0000934549 us-gaap:RevenueRightsGrantedMember actg:LicenseesInForeignJurisdictionsMember 2016-01-01 2016-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000934549 actg:ComputerHardwareAndSoftwareMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000934549 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000934549 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000934549 us-gaap:PatentsMember 2015-12-31 0000934549 us-gaap:PatentsMember 2016-12-31 0000934549 us-gaap:PatentsMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0000934549 us-gaap:PatentsMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0000934549 2015-01-02 0000934549 2016-02-29 0000934549 2016-08-15 0000934549 actg:FirstLoanMember 2016-01-01 2016-12-31 0000934549 2016-09-30 0000934549 actg:SecondLoanMemberMember 2016-01-01 2016-12-31 0000934549 actg:A2016PlanMember 2016-04-26 0000934549 actg:A2013StockPlanMember 2016-04-26 0000934549 us-gaap:InternalRevenueServiceIRSMember actg:CapitalLossCarryforwardRelatedToBusinessAcquisitionMember 2016-12-31 0000934549 us-gaap:DomesticCountryMember 2016-12-31 0000934549 us-gaap:StateAndLocalJurisdictionMember 2016-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0000934549 actg:A10OrMoreMember actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2016-01-01 2016-12-31 0000934549 us-gaap:RestrictedStockMember 2015-01-01 2015-12-31 0000934549 actg:A2002StockPlanMember 2016-01-01 2016-12-31 0000934549 us-gaap:RestrictedStockMember 2016-01-01 2016-12-31 0000934549 us-gaap:RestrictedStockMember 2016-12-31 0000934549 us-gaap:EmployeeStockOptionMember 2016-12-31 0000934549 actg:MarketBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 us-gaap:RestrictedStockMember 2014-01-01 2014-12-31 0000934549 us-gaap:StockOptionMember 2016-12-31 0000934549 actg:StockIssuanceProgramMember 2016-01-01 2016-12-31 0000934549 actg:NonstatutoryOptionsMember actg:DiscretionaryOptionGrantProgramMember 2016-01-01 2016-12-31 0000934549 actg:PerformanceBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 actg:LessThan10Member actg:IncentiveStockOptionsMember actg:DiscretionaryOptionGrantProgramMember 2016-01-01 2016-12-31 0000934549 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0000934549 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-12-31 0000934549 actg:A2016PlanMember 2016-12-31 0000934549 actg:A2013PlanMember 2016-12-31 0000934549 actg:A2002StockPlanMember 2016-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithperformancebasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:RestrictedstockunitawardswithperformancebasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:StockoptionswithmarketbasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2016-01-01 2016-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:RestrictedstockawardswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:StockoptionswithtimebasedvestingconditionsMember 2014-01-01 2014-12-31 0000934549 actg:RestrictedstockunitawardswithtimebasedvestingconditionsMember 2015-01-01 2015-12-31 0000934549 actg:TimeBasedVestingConditionsMember 2016-01-01 2016-12-31 0000934549 actg:TimeBasedVestingConditionsMember 2015-01-01 2015-12-31 0000934549 actg:MarketBasedVestingConditionsMember 2015-01-01 2015-12-31 0000934549 actg:PerformanceBasedVestingConditionsMember 2015-01-01 2015-12-31 0000934549 actg:A2007PlanMember 2016-12-31 0000934549 2016-07-01 2016-09-30 0000934549 2015-10-01 2015-12-31 0000934549 2015-04-01 2015-06-30 0000934549 2015-07-01 2015-09-30 0000934549 2015-01-01 2015-03-31 0000934549 2016-01-01 2016-03-31 0000934549 2016-04-01 2016-06-30 0000934549 2016-10-01 2016-12-31 iso4217:USD xbrli:shares actg:patents xbrli:shares xbrli:pure iso4217:USD 10000000 1247000 0 225000 2702000 380000 0 7436000 2394000 10135000 6564000 16700000 1000000 1000000 0 298000 120000 0 P10Y P2Y 0.049 3423000 7740000 1118000 172000 211000 223000 0.125 649000 603000 23563000 4784000 5512000 1972000 3901000 16169000 4109000 10418000 7709000 4238000 26474000 71494000 83323000 0 0 0 0 1359000 14343000 24313000 24740000 0 0.00 0.01 0.00 0.00 0.07 0.00 -0.33 -0.28 2400000 P1Y 683000 344300000 252000000 1 14100000 700000 52224000 5159000 4421000 14776000 20313000 3960000 3150000 1599000 556000 5323000 -1569000 6922000 -1013000 -1617000 -572000 3904000 527000 -970000 5829000 2933000 0 1960000 P3M 37614000 8675000 9012000 10345000 11341000 39373000 7723000 7324000 7348000 5463000 27858000 10.00 7.00 50000000 6280000 1657000 1928000 37771000 25 6 3 2 147770000 32821000 0.10 250000000 16700000 1000000 0 3000000 500000 0 281495000 358043000 444137000 444362000 162642000 162642000 86319000 86319000 147000 0 P45D P30D 15000000 3840000 997000 732000 802000 860000 3391000 522000 1334000 666000 557000 3079000 -18000 -16000 14878000 13908000 700000 20000000 10000000 0.03 80000 35000 14000 11938000 12152000 138000 200000 20000000 500000 2074000 0 11470000 431000 0 28000000 0 14.33 16.72 0.00 15.78 16.27 -21000 460000 480000 324000 15.43 20.99 922000000 6022000000 0 0 0 11721000 5530000 487000 5704000 468000 0 1735000 13716000 4051000 20576000 -1384000 85000 1687500 50000000 false --12-31 FY 2016 2016-12-31 10-K 0000934549 50466611 Yes Large Accelerated Filer 216379000 ACACIA RESEARCH CORP No No 2017-12-31

17347000

14283000

33500000

26750000

576000

1592000

1967000

701000

533000

1261000

1340000

-215000

-76000

P5Y

633146000

642453000

2713000

1917000

1319000

53745000

13038000

13228000

13688000

13113000

53067000

10760000

10759000

6467000

6222000

34208000

27760

71468

3682532

347901000

296003000

183877000

188490000

19443000

19403000

2188000

617000

1000

40000

126685000

134466000

135223000

127540000

7781000

757000

-7683000

7445000

0.500

0.000

0.50

0.001

100000000

50651239

50476042

49385057

50065382

50651239

50476042

51000

50000

-65435000

-159898000

-53928000

-66068000

-157340000

-54660000

0.22

0.43

0.72

0.21

0.24

0.20

0.16

0.49

0.39

0.22

0.16

0.15

0.26

0.23

0.11

0.79

5359000

4421000

17926000

5648000

4800000

18188000

289000

379000

262000

-1867000

-1736000

81000

162000

131000

75260000

102789000

499000

2195000

210000

81000

162000

441000

81000

90000

1385000

2416000

442000

422000

75179000

102627000

210000

81000

162000

304000

222000

147000

54049000

53289000

34355000

-1.37

-0.27

-0.08

-0.55

-2.33

-3.25

-0.20

-0.81

0.14

-0.21

-1.08

0.06

0.03

0.50

-0.35

0.39

0.31

0.83

0.00

-0.01

0.01

0.00

0.09

0.03

0.50

-0.08

-0.03

-0.49

576000

1593000

6842000

1873000

162000

P2Y

P1Y

0.50

0.40

0.07

0.75

0.25

P7Y

P1Y

P10Y

P1Y

11452000

22333000

5421000

6707000

19150000

21256000

-99000

-123000

40000

739000

733000

14000

3000

48554000

10575000

9587000

9442000

8572000

38176000

7994000

7535000

8334000

9056000

32919000

30100000

30149000

3497000

74731000

40165000

2175000

42340000

-62750000

-13382000

896000

-27016000

-113176000

-152678000

-9705000

-34994000

16551000

-8463000

-36611000

3912000

170000

119000

337000

4174000

4800000

192000

5927000

9655000

2414000

18188000

3718000

2570000

-3006000

-13827000

-13332000

6750000

3154000

-619000

1593000

-10725000

-787000

862000

286000

1523000

1926000

1795000

145000

131000

33746000

28560000

347901000

296003000

33225000

28191000

130876000

125037000

152699000

0.0115

18616000

3944000

1854000

-364000

-4105000

-1358000

-25700000

-28601000

-1114000

29297000

39307000

-40630000

4184000

-9949000

34061000

-66029000

-13130000

-3686000

-27310000

-115910000

-160036000

-9965000

-40573000

7082000

-10611000

-54067000

-633000

-422000

4463000

-43000

-1440000

2558000

68000

-348000

-186000

-266000

-732000

-66755000

-160730000

-54067000

193031000

47820000

39336000

39830000

150673000

277659000

34423000

76293000

48368000

31024000

190108000

-62155000

-13610000

1000000

-26836000

-113176000

-152622000

-9702000

-34942000

16290000

-9055000

-37409000

3987000

1279000

16000

1369000

1323000

29318000

383000

476000

1110000

491000

-128000

-123000

77000

-2210000

-617000

-22000

-1488000

-356000

40000

1548000

426000

3465000

250000

4141000

1742000

-1242000

500000

311000

369000

-595000

228000

-104000

-180000

-56000

-3000

-52000

261000

592000

798000

-28000

-109000

-477000

82000

25039000

25434000

109963000

23296000

62633000

42746000

19504000

1225000

20000000

109000

8000

4000

867000

4105000

1358000

0.001

10000000

4219000

3245000

182115000

82115000

43232000

182115000

82115000

43232000

3500000

750000

206000

938000

326000

-66662000

-13552000

777000

-27353000

-117350000

-157478000

-9897000

-40921000

6896000

-10877000

-54799000

30000

68000

1533000

1467000

272000

127000

0.2

0.09

10725000

11512000

-288131000

-342198000

34210000

40336000

12994000

37497000

24721000

41351000

64658000

21969000

20670000

9325000

1265000

116000

7756000

18462000

1573000

17844000

3313000

22730000

18115000

17631000

484000

18114000

1000

11048000

10575000

473000

11047000

1000

9062000

197000

4391000

3158000

1316000

9063000

-1000

292000

14.28

894000000

138000

138000000

14.41

12.83

3.12

829000

333000

14.41

8.90

342000

21490000

11494000

5243000

15.33

0.01

0.53

4500000

4750000

1754000

625390

1113000

5.03

518000

751000

344000

-202000

3.12

5884000

2250000000

200000000

3434000000

8865000

15000

5596000

13.38

4.93

1743000

1113000

5.03

3.22

4.82

5.75

4.29

16.72

3.16

0.25

P3Y22D

1743000

P6Y6M

P6Y8M

P6Y6M

2342000

1.10

1.00

0.85

1.00

19443000

635819

450857

-262660

44506

135000

101000

100992

-25039000

206000

938000

326000

-13529

310211000

265589000

562198000

-947000

653314000

49000

6488000

-62066000

-34640000

489048000

-353000

646595000

50000

5491000

-128095000

-34640000

314155000

-215000

633146000

51000

3944000

-288131000

-34640000

267443000

-76000

642453000

50000

1854000

-342198000

-34640000

0.06

1729408

34640000

693000

261000

99000

2127000

1355000

-1736000

49212207

49423472

49630369

49749941

49925550

50015869

50618757

50237784

48658088

49212207

49423472

49630369

49749941

49505817

49925550

50015869

50124302

50237784

50075847

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Liabilities.</font><font style="font-family:inherit;font-size:10pt;"> The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cost of Revenues</font><font style="font-family:inherit;font-size:10pt;">.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill. </font><font style="font-family:inherit;font-size:10pt;">Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Acacia's goodwill balance of $30.1 million was fully written-off as of December 31, 2015. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventor Royalties and Contingent Legal Expenses. </font><font style="font-family:inherit;font-size:10pt;">Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> for additional information.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;">, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and other assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net of accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments - noncurrent</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,933</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,829</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,051</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,716</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses and contributions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,436</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,280</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:81.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,617</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss from operations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,599</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net gain (loss) in equity method investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,922</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,569</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">12</font><font style="font-family:inherit;font-size:10pt;"> to these consolidated financial statements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized patent costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales proceeds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Patents.</font><font style="font-family:inherit;font-size:10pt;">  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">ten</font><font style="font-family:inherit;font-size:10pt;"> years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amounts and accumulated amortization related to investments in intangible assets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross carrying amount - patents                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization - patents</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">                                                                         </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(358,043</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281,495</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,319</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,642</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:44%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:top;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:60px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 to 5 years (Lesser of lease term or useful life of improvement)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements - Recently Adopted. </font><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The adoption of this standard effective December 31, 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014, the FASB issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The adoption of this standard effective January 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued amended guidance to clarify guidance on the classification of certain cash receipts and cash payments. Additionally, the guidance requires that the statement of cash flows reflect changes in restricted cash in addition to cash and cash equivalents. Amended guidance includes clarification on debt prepayment and extinguishment costs, contingent consideration in business combinations, proceeds from insurance claims, and premium payments on company-owned life insurance. Refer to the consolidated statement of cash flows elsewhere herein for separate presentation of changes in restricted cash.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock-based award grant activity for the Plans for the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and 2015:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">894,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,470</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,434,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total incentive awards granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,022,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">922,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,938</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Treasury Stock</font><font style="font-family:inherit;font-size:10pt;">. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash and Cash Equivalents</font><font style="font-family:inherit;font-size:10pt;">.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risks.  </font><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">26%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">24%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues recognized during the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually represented approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">72%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">79%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">49%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">43%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LOAN RECEIVABLE AND INVESTMENT IN WARRANTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"></font><font style="font-family:inherit;font-size:10pt;">On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provides for Acacia to invest up to </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;"> in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permits Veritone to borrow up to </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> through two </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> advances, each bearing interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">6.0%</font><font style="font-family:inherit;font-size:10pt;"> per annum (included in Other Income (Expense) in the consolidated statement of operations). On August 15, 2016, Acacia funded the initial </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the “First Loan”), which initially had a one-year term.   On November 25, 2016, Acacia funded the second </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> loan (the “Second Loan”), which has a one-year term. In addition, upon the funding of the Second Loan, the maturity date of the First Loan was automatically extend to the maturity date of the Second Loan. As a result, both the First Loan and the Second Loan are due and payable on November 25, 2017. Veritone’s obligations under the Veritone Loans are secured by substantially all of Veritone’s assets pursuant to a security agreement that Acacia entered into with Veritone dated August 15, 2016.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, commencing on the earlier of Veritone’s consummation of a private round of financing of at least </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> (a “Next Equity Financing”) and the maturity date of the Veritone Loans, Acacia has the right, under certain circumstances, to convert all or a portion of the principal and accrued interest of the Veritone Loans into shares of Veritone’s Series B Preferred Stock or, if Veritone consummates a Next Equity Financing, into shares of Veritone capital stock issued in such financing, at various conversion rates, with the exact conversion rate to depend upon (i) whether Veritone consummates a Next Equity Financing, (ii) the price per share in such Next Equity Financing and (iii) whether or not Acacia elects to convert all of the outstanding principal and accrued interest under the Veritone Loans.  If Veritone consummates a qualified public offering of its common stock, any outstanding principal and accrued interest under the Veritone Loans will automatically convert into shares of Veritone’s common stock at the applicable conversion rate.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with the First Loan, Veritone issued Acacia a four-year </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;"> warrant to purchase shares of Veritone’s common stock at various exercise prices, with the actual exercise price to be determined by the type and/or valuation of Veritone’s future equity financings, if any.  The actual number of shares to be purchased upon exercise of the warrant is determined by dividing the warrant value by the applicable exercise price. Upon funding of the Second Loan, Veritone issued to Acacia two additional four-year </font><font style="font-family:inherit;font-size:10pt;">$700,000</font><font style="font-family:inherit;font-size:10pt;"> warrants to purchase shares of Veritone’s common stock with similar terms.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, pursuant to the Investment Agreement, Veritone issued Acacia a five-year Primary Warrant to purchase up to </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;">, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at various exercise prices, with the actual exercise price per share to be determined by the amount of principal and accrued interest under the Veritone Loans converted into shares of Veritone common stock.  Acacia may exercise the Primary Warrant at any time during its five year term after the earlier of August 15, 2017 or the completion of a public offering with gross proceeds to Veritone of at least </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">.  Immediately subsequent to such a public offering, Veritone has the right to elect that Acacia exercise the Primary Warrant, and upon such election, Acacia agrees to exercise the Primary Warrant in full, provided that the then current fair market value of Veritone common stock is equal to or greater than the exercise price per share of the Primary Warrant. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone has the obligation to issue to Acacia an additional 10% Warrant that provides for the issuance of additional shares of Veritone common stock, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of shares vesting on the anniversary of the issuance date of the 10% Warrant. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Investment Agreement, as described above, represents a variable interest in Veritone for which Acacia is not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. As of December 31, 2016, the Veritone Loans are not considered in-substance common stock and the common stock purchase warrants are unexercised, and therefore, the equity method of accounting is not applied. In addition, the Veritone Loans do not meet the criteria for classification as a debt security. As such, the Veritone Loans and the related common stock purchase warrants described above are accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the transaction, with the </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> amount of the Veritone Loans allocated to (1) the Veritone Loans, which are accounted for as long-term loan receivables and (2) the common stock purchase warrants. The estimated relative fair value allocation of the </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> investment to the Veritone Loans and the related common stock purchase warrants was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone's equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Veritone Loans. A summary of assumptions used in connection with estimating the relative fair values were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.5%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Range of Inputs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Monte Carlo simulation model</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketability discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Funding scenario probabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recovery</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Veritone Loans and warrants are reflected in the accompanying consolidated financial statements as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:64.0625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and For the Year Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face value of loan receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized loan discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,384</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying value of loan receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment in warrants (initial loan discount)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,960</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,576</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion of loan discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">576</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The loan discount, representing the difference between the face amount of the Veritone Loans and the relative fair value allocated to the Veritone Loans, is accreted over the expected life of the loans, using the effective interest method, with the related interest amounts reflected in Other Income in the consolidated statement of operations. Acacia will re-evaluate its variable interest in Veritone and related accounting conclusions and disclosure requirements each reporting period. The effective yield for the First Loan and Second Loan was </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">9%</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management performs a review of the Veritone Loans on a quarterly basis to assess the need for allowances for uncollectibility, based on current trends and other factors affecting collectibility, and to determine if any impairment has occurred. A loan receivable is considered impaired when it is probable that amounts related to the loan receivable will not be collected according to the contractual terms of the agreement. As of December 31, 2016, no allowances for uncollectibility have been recorded. An allowance for uncollectibility would be reflected as a charge to earnings in the consolidated statement of operations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCK-BASED INCENTIVE PLANS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2002 Acacia Technologies Stock Incentive Plan (“2002 Plan”), the 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in December 2002, May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Plans provide for the following separate programs:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Discretionary Option Grant Program</font><font style="font-family:inherit;font-size:10pt;">. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of those shares on the grant date (not less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">110%</font><font style="font-family:inherit;font-size:10pt;"> of fair market value if such employee actually or constructively owns more than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10%</font><font style="font-family:inherit;font-size:10pt;"> of Acacia’s voting stock or the voting stock of any of its subsidiaries).</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:60px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stock Issuance Program</font><font style="font-family:inherit;font-size:10pt;">. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:60px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Automatic Option Grant Program</font><font style="font-family:inherit;font-size:10pt;">. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date, provided that such individual has served as a non-employee director for at least 6 months. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the restricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of shares of common stock available for issuance under the 2002 Plan automatically increased on the first trading day of January each calendar year during the term of the Plan by an amount equal to three percent (</font><font style="font-family:inherit;font-size:10pt;">3%</font><font style="font-family:inherit;font-size:10pt;">) of the total number of shares of common stock outstanding on the last trading day in December of the immediately preceding calendar year, not to exceed </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;"> shares. The aggregate number of shares of common stock available for issuance under the 2002 Plan could not exceed </font><font style="font-family:inherit;font-size:10pt;">20,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> shares available for grant under the 2002 Plan.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was </font><font style="font-family:inherit;font-size:10pt;">4,750,000</font><font style="font-family:inherit;font-size:10pt;"> shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, </font><font style="font-family:inherit;font-size:10pt;">625,390</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 26, 2016, Acacia’s Board of Directors adopted the 2016 Plan which was approved by the stockholders in June 2016. The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was </font><font style="font-family:inherit;font-size:10pt;">4,500,000</font><font style="font-family:inherit;font-size:10pt;"> shares plus </font><font style="font-family:inherit;font-size:10pt;">625,390</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">1,754,000</font><font style="font-family:inherit;font-size:10pt;"> shares available for grant under the 2016 Plan.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval.  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock-based award grant activity for the Plans for the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and 2015:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate fair value (in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">894,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,470</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,434,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,704</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,250,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">487</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total incentive awards granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,022,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">922,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,938</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company granted restricted stock awards and stock options (with weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.75</font><font style="font-family:inherit;font-size:10pt;"> per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">138,000</font><font style="font-family:inherit;font-size:10pt;"> shares of restricted stock and </font><font style="font-family:inherit;font-size:10pt;">200,000</font><font style="font-family:inherit;font-size:10pt;"> stock options with performance-based vesting conditions remain unvested. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, unrecognized expense for awards with performance-based vesting conditions totaled </font><font style="font-family:inherit;font-size:10pt;">$683,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$5.75</font><font style="font-family:inherit;font-size:10pt;"> per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> upon the Company's achievement of 30-day average share prices ranging from </font><font style="font-family:inherit;font-size:10pt;">$7.00</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,687,500</font><font style="font-family:inherit;font-size:10pt;"> options with market-based vesting conditions remain unvested. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, unrecognized expense for options with market-based vesting conditions totaled </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> which is expected to be recognized over an estimated </font><font style="font-family:inherit;font-size:10pt;">1 year</font><font style="font-family:inherit;font-size:10pt;"> period.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the Plans for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Contractual Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,884,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,596,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,865,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,113,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,113,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate intrinsic value of options exercised during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$344,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$751,000</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$518,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2016 was </font><font style="font-family:inherit;font-size:10pt;">$2,074,000</font><font style="font-family:inherit;font-size:10pt;">. The aggregate fair value of options granted during the year ended December 31, 2016 was </font><font style="font-family:inherit;font-size:10pt;">$11,721,000</font><font style="font-family:inherit;font-size:10pt;">.The aggregate fair value of options vested during the year ended December 31, 2016 was </font><font style="font-family:inherit;font-size:10pt;">$2,342,000</font><font style="font-family:inherit;font-size:10pt;">.  No options were granted or vested during the years ended December 31, 2015 and 2014. As of December 31, 2016, the total unrecognized compensation expense related to nonvested stock option awards was </font><font style="font-family:inherit;font-size:10pt;">$6,842,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average term of approximately </font><font style="font-family:inherit;font-size:10pt;">2 years</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes nonvested restricted share activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonvested</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(342,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(292,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant date fair value of nonvested restricted stock granted during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$3.12</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$12.83</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$14.41</font><font style="font-family:inherit;font-size:10pt;">, respectively. The aggregate fair value of restricted stock that vested during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5,243,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11,494,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21,490,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the total unrecognized compensation expense related to nonvested restricted stock awards was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,873,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average period of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1 year</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average grant date fair value of restricted stock units granted during the years ended December 31, 2015 and 2014 was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16.72</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$14.33</font><font style="font-family:inherit;font-size:10pt;">, respectively.  There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> restricted units granted during the year ended December 31, 2016. The aggregate fair value of restricted stock units that vested during the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$324,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$480,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$460,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the total unrecognized compensation expense related to restricted stock unit awards was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$162,000</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average period of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1 year</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense for the periods presented was comprised of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.60975609756098%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,391</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,062</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, there are </font><font style="font-family:inherit;font-size:10pt;">7,445,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock reserved for issuance under the Plans.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income (Loss) Per Share.  </font><font style="font-family:inherit;font-size:10pt;">The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.” </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,039</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,313</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,658,088</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,682,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of assumptions used in connection with estimating the relative fair values were as follows:</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.5%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Valuation Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Significant Unobservable Inputs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Range of Inputs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Monte Carlo simulation model</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketability discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Funding scenario probabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recovery</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL IMPAIRMENT CHARGES</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill. Refer to Note 6 for additional information regarding patent impairment charges for the year ended December 31, 2015.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill Impairment Testing - December 31, 2015.</font><font style="font-family:inherit;font-size:10pt;"> At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;">. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant consistent gradual decline in the Company's stock price for a sustained period;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant underperformance relative to expected historical or projected future operating results;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant changes in the manner of use of assets or the strategy for the Company's overall business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant negative industry or economic trends; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adverse legal outcomes and changes in legal factors.</font><font style="font-family:inherit;font-size:10pt;"> In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Significant consistent gradual decline in the Company’s stock price: </font><font style="font-family:inherit;font-size:10pt;">Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from </font><font style="font-family:inherit;font-size:10pt;">$16.72</font><font style="font-family:inherit;font-size:10pt;"> as of January 2, 2015, to </font><font style="font-family:inherit;font-size:10pt;">$4.29</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to </font><font style="font-family:inherit;font-size:10pt;">$3.16</font><font style="font-family:inherit;font-size:10pt;"> as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Changes in Company Management and Resource Allocations.</font><font style="font-family:inherit;font-size:10pt;"> In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist: </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of </font><font style="font-family:inherit;font-size:10pt;">$252 million</font><font style="font-family:inherit;font-size:10pt;"> was below its carrying value of </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;"> as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:66px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling </font><font style="font-family:inherit;font-size:10pt;">$30.1 million</font><font style="font-family:inherit;font-size:10pt;"> in the fourth quarter of 2015.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,926</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,359</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,385</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,260</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and 2015, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately </font><font style="font-family:inherit;font-size:10pt;">$147,770,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$32,821,000</font><font style="font-family:inherit;font-size:10pt;">, expiring between 2025 and 2035, and 2017 and 2036, respectively, for which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$441,000</font><font style="font-family:inherit;font-size:10pt;"> of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, </font><font style="font-family:inherit;font-size:10pt;">$1,928,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$37,771,000</font><font style="font-family:inherit;font-size:10pt;"> of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled </font><font style="font-family:inherit;font-size:10pt;">$3,423,000</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2015, expiring between 2017 and 2020.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">$29,318,000</font><font style="font-family:inherit;font-size:10pt;"> of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately </font><font style="font-family:inherit;font-size:10pt;">$14,100,000</font><font style="font-family:inherit;font-size:10pt;">, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, Acacia had approximately </font><font style="font-family:inherit;font-size:10pt;">$52,224,000</font><font style="font-family:inherit;font-size:10pt;"> of foreign tax credits, expiring between 2017 and 2026, of which </font><font style="font-family:inherit;font-size:10pt;">$20,313,000</font><font style="font-family:inherit;font-size:10pt;"> has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">      </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling </font><font style="font-family:inherit;font-size:10pt;">$1,735,000</font><font style="font-family:inherit;font-size:10pt;"> from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were </font><font style="font-family:inherit;font-size:10pt;">(33)%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">(28)%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">(33)%</font><font style="font-family:inherit;font-size:10pt;">, for fiscal years 2016, 2015 and 2014, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the years ended December 31, 2016, 2015 and 2014, the Company incurred approximately </font><font style="font-family:inherit;font-size:10pt;">$1,319,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,917,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,713,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which </font><font style="font-family:inherit;font-size:10pt;">$1,319,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,917,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,713,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2001. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;"> and 2015, the Company had total unrecognized tax benefits of approximately </font><font style="font-family:inherit;font-size:10pt;">$1,355,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,127,000</font><font style="font-family:inherit;font-size:10pt;">, including a recorded noncurrent liability of </font><font style="font-family:inherit;font-size:10pt;">$85,000</font><font style="font-family:inherit;font-size:10pt;">, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. At December 31, 2016, if recognized, approximately </font><font style="font-family:inherit;font-size:10pt;">$1,355,000</font><font style="font-family:inherit;font-size:10pt;">, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2016 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">seven years</font><font style="font-family:inherit;font-size:10pt;">. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross carrying amount - patents                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444,137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization - patents</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">                                                                         </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(358,043</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281,495</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, net                                                                             </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,319</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,642</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> (1)</sup></font><font style="font-family:inherit;font-size:8pt;"> Includes patent impairment charges for the applicable periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5 years</font><font style="font-family:inherit;font-size:10pt;">. Scheduled annual aggregate amortization expense is estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$22,333,000</font><font style="font-family:inherit;font-size:10pt;"> in 2017, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21,256,000</font><font style="font-family:inherit;font-size:10pt;"> in 2018, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19,150,000</font><font style="font-family:inherit;font-size:10pt;"> in 2019, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6,707,000</font><font style="font-family:inherit;font-size:10pt;"> in 2020, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5,421,000</font><font style="font-family:inherit;font-size:10pt;"> in 2021 and </font><font style="font-family:inherit;font-size:10pt;">$11,452,000</font><font style="font-family:inherit;font-size:10pt;"> thereafter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, Acacia paid patent investment costs totaling </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,225,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$19,504,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$42,746,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. The patents have initial estimated economic useful lives ranging from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">ten years</font><font style="font-family:inherit;font-size:10pt;">. Included in net additions to capitalized patent costs during the year ended December 31, 2015 and 2014 are accrued patent investment costs totaling </font><font style="font-family:inherit;font-size:10pt;">$1,000,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$16,700,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, which are amortized over the estimated economic useful life of the related patents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2016 and 2014, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$225,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1,247,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the year ended December 31, 2015, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> accelerated amortization expense. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended December 31, 2015 and 2014, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling </font><font style="font-family:inherit;font-size:10pt;">$380,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,702,000</font><font style="font-family:inherit;font-size:10pt;">, respectively. For the year ended December 31, 2016, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> terminations or sales of patent portfolios. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia recorded impairment of patent-related intangible asset charges totaling $</font><font style="font-family:inherit;font-size:10pt;">42,340,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$74,731,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3,497,000</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2015, Acacia's subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to partial impairment charges on the portfolio in the fourth quarter of 2015. Patent impairment charges included the impairment of the remaining carrying value for the Adapitx portfolio in the second quarter of 2016. In addition, for the year ended December 31, 2015 analysis, management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes. Additionally, patent impairment charges include the carrying value of other patent portfolios for which, in 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The impairment charges for the periods presented consisted of the excess of the asset’s carrying value over its estimated fair value. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized patent costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">298</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales proceeds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments in Marketable Securities.  </font><font style="font-family:inherit;font-size:10pt;">Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2016, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in total other income (expense).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Impairment of Marketable Securities. </font><font style="font-family:inherit;font-size:10pt;">Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.   </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term marketable securities for the periods presented were comprised of the following (in thousands):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:92.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Security Type</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. government fixed income securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,403</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,443</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements - Not Yet Adopted. </font><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue.  Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services.  The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted.  The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued guidance on the measurement and recognition of credit losses on most financial assets. For trade receivables, loans, and held-to-maturity debt securities, the current probable loss recognition methodology is being replaced by an expected credit loss model. For available-for-sale debt securities, the recognition model on credit losses is generally unchanged, except the losses will be presented as an adjustable allowance. The guidance will be applied retrospectively with the cumulative effect recognized as of the date of adoption. The guidance will become effective at the beginning of our first quarter of fiscal 2021 but can be adopted as early as the beginning of our first quarter of fiscal 2020. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROPERTY AND EQUIPMENT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment consists of the following at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">733</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:  accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,340</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$147,000</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$222,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$304,000</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. In 2016 and 2015, the Company retired </font><font style="font-family:inherit;font-size:10pt;">$68,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$30,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, of items held in furniture and equipment and recorded a </font><font style="font-family:inherit;font-size:10pt;">$3,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$14,000</font><font style="font-family:inherit;font-size:10pt;">, respectively, loss on disposal.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment consists of the following at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">733</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">603</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">649</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,533</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:  accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,340</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUARTERLY FINANCIAL DATA (unaudited)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,723</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">General and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,056</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research, consulting and other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,742</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,242</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">250</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,423</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,368</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,024</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,820</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,336</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,830</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150,673</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,702</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,290</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,055</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,836</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(180</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,705</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,994</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,551</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,463</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,382</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(192</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,927</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,655</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,414</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(337</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,174</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,897</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,921</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,877</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,552</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(117,350</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">348</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,463</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,965</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,573</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,082</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,611</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,130</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,686</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,310</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(115,910</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,124,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, diluted </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,618,757</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Veritone Loans and warrants are reflected in the accompanying consolidated financial statements as follows (in thousands):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:64.0625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">As of and For the Year Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face value of loan receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unamortized loan discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,384</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Carrying value of loan receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,616</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment in warrants (initial loan discount)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,960</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,576</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">286</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion of loan discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">576</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">862</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands): </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,926</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,421</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,359</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,867</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes                                                      </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">December 31, 2016 and 2015</font><font style="font-family:inherit;font-size:10pt;"> (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss and capital loss carryforwards and credits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,323</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,494</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,385</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,343</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basis of investments in affiliates</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">422</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102,789</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,260</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102,627</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75,179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax assets, net of valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed assets and intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total deferred tax liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets (liabilities)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Numerator (in thousands):</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basic and Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total dividends declared / paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,434</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,039</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividends attributable to common stockholders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,313</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(160,730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Denominator:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50,075,847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,505,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,658,088</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted net loss per common share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,682,532</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,468</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statutory federal tax rate - (benefit) expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income and foreign taxes, net of federal tax effect</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax credit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible permanent items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired capital loss carryforwards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:70.703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years ending December 31,</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,369</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,987</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes nonvested restricted share activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nonvested</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(342,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(292,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation expense for the periods presented was comprised of the following:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.60975609756098%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,631</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock unit awards with time-based service conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,391</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with time-based service vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with market-based vesting conditions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options with performance-based vesting conditions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total compensation expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,062</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="33" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Mar. 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Jun. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Sept. 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dec. 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="31" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Unaudited, in thousands, except share and per share information)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,721</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,658</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,210</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,336</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,994</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating costs and expenses:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cost of revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Inventor royalties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,844</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,756</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent legal fees</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,512</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,972</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Litigation and licensing expenses - patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,723</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,324</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,463</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,675</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,012</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,345</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,341</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,467</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,222</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">General and administrative expenses (including non-cash stock compensation expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,994</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,056</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,575</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research, consulting and other expenses - business development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">732</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">860</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of patent-related intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,165</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">74,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment of goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,742</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,242</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,465</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">250</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating costs and expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,423</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">76,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,368</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,024</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,820</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,336</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,830</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">150,673</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,702</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,290</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,055</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,836</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total other income (expense)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">261</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(180</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income (loss) before (provision for) benefit from income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,705</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34,994</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,551</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,463</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,382</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,016</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(113,176</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(192</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,927</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,655</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,414</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(119</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(337</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,174</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) including noncontrolling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,897</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,921</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,896</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,877</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,552</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,353</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(117,350</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (income) loss attributable to noncontrolling interests in operating subsidiaries</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">348</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">422</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,463</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to Acacia Research Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,965</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40,573</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,082</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,611</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,130</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,686</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27,310</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(115,910</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per common share attributable to Acacia Research Corporation:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted income (loss) per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.81</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.27</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,124,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average number of shares outstanding, diluted </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,925,550</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,015,869</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,618,757</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,237,784</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,212,207</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,423,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:4px double #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,630,369</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49,749,941</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Average Grant Date Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nonvested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested restricted stock units outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes stock option activity for the Plans for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Remaining</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Contractual Term</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Aggregate</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-align:center;">Intrinsic Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,884,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(101,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired/forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(202,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,596,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.93</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,865,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,113,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,113,000</font></div></td><td style="vertical-align:bottom;border-bottom:4px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of stock options granted during the year ended December 31, 2016 was estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:69.53125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:36%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average Assumptions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.06</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Volatility</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—%</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SUBSEQUENT EVENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of equity interests in AIP to certain members of management and Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the equity value of AIP increases beyond the value at issuance. The equity interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones, subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement.<br clear="none"/> <br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acacia owns substantially all of the equity in AIP and at all times will control AIP. Although AIP currently holds no material assets, Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients.</font></div></div>

EX-101.SCH 11 actg-20161231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Accounts Payable and Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Commitments and Contingencies Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Consolidated Balance Sheets Parentheticals link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1002001 - Statement - Consolidated Statements of Operations Parentheticals link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1004001 - Statement - Consolidated Statements of Stockholders' Equity Parentheticals link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Goodwill Impairment Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Goodwill Impairment Charges Details (Details) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Goodwill Impairment Charges (Notes) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Goodwill Impairment Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Income Taxes Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Income Taxes Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Income Taxes Provision for Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Loan Receivable and Investment in Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Loan Receivable and Investment in Warrants (Notes) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Loan Receivable and Investment in Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Patents link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Patents Cost and Accumulated Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Patents (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Patents Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Patents (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Property and Equipment Summary of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Quarterly Financial Data link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Quarterly Financial Data (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Quarterly Financial Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Retirement Savings Plan and Executive Severance Policy link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Short-term Investments link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Short-term Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Short-term Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Stock-Based Incentive Plans link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Stock-Based Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2416404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2416405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) link:presentationLink link:calculationLink link:definitionLink 2416406 - Disclosure - Stock-Based Incentive Plans Schedule of Grants by Type (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Stock-Based Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Stockholders' Equity Repurchases of Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Subsequent Events (Notes) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Subsequent Events (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - Summary of Significant Accounting Policies Impact of revision (Details) link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 actg-20161231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 actg-20161231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 actg-20161231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accounts Payable and Accrued Liabilities, Current [Abstract] Payroll and other employee benefits Employee-related Liabilities, Current Accrued vacation Accrued Vacation Accrued legal expenses - patent Accrued Legal Expenses - Patent Accrued Legal Expenses - Patent Accrual for court ordered attorneys fees Accrual for court ordered attorneys fees Accrual for court ordered attorneys fees Foreign taxes payable Foreign taxes payable Amounts due to foreign jurisdictions for income taxes. Accrued consulting and other professional fees Accrued Professional Fees, Current Other accrued liabilities Other Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Patents [Abstract] Patents [Abstract] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Patents [Member] Patents [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Patents [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Gross carrying amount - patents Patents, Gross Patents, Gross Accumulated amortization - patents Patents, Accumulated Amortization Patents, Accumulated Amortization Patents, net Patents, net of accumulated amortization Carrying value for patents, net of accumulated amortization. Patents, useful life Finite-Lived Intangible Asset, Useful Life Patents, weighted average useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Payments to acquire intangible assets Payments to Acquire Intangible Assets Acquired Finite Lived Intangible Asset, Useful Life Acquired Finite Lived Intangible Asset, Useful Life Acquired Finite Lived Intangible Asset, Useful Life Accrued patent acquisition related payments Accrued Patent Acquisition Related Payments Accrued Patent Acquisition Related Payments Accelerated amortization expense Accelerated amortization expense Accelerated amortization expense Accelerated amortization expense (termination) Accelerated amortization expense (termination/sale) Accelerated amortization expense (termination/sale) Impairment of Patent-Related Intangible Assets Impairment of Intangible Assets, Finite-lived Impairment of Intangible Assets (Excluding Goodwill) Impairment of Intangible Assets (Excluding Goodwill) Accounting Policies [Abstract] Concentration Risk [Table] Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Name of Major Customer [Domain] Customer [Domain] Licensee 1 [Member] Licensee 1 [Member] Licensee 1 [Member] Licensee 2 [Member] Licensee 2 [Member] Licensee 2 [Member] Licensee 3 [Member] Licensee 3 [Member] Licensee 3 [Member] Licensee 4 [Member] Licensee 4 [Member] Licensee 4 [Member] Licensees in foreign jurisdictions [Member] Licensees in foreign jurisdictions [Member] Licensees in foreign jurisdictions [Member] Concentration Risk by Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue, Rights Granted [Member] Revenue, Rights Granted [Member] Accounts Receivable [Member] Accounts Receivable [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration risk, percentage Concentration Risk, Percentage Disclosure of Grants in Period by Type [Abstract] Disclosure of Grants in Period by Type [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Time Based Vesting Conditions [Member] Time Based Vesting Conditions [Member] Time Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Market Based Vesting Conditions [Member] Performance Based Vesting Conditions [Member] Performance Based Vesting Conditions [Member] Performance Based Vesting Conditions Restricted Stock [Member] Restricted Stock [Member] Equity Option [Member] Equity Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Employee Service Share-based Compensation, Awards with Performance Based Conditions, Compensation Cost Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized Market Based Vesting Conditions, price Market Based Vesting Conditions, price Market Based Vesting Conditions, price Unvested Shares with Market Based Vesting Conditions Unvested Shares with Market Based Vesting Conditions Unvested Shares with Market Based Vesting Conditions Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] DESCRIPTION OF BUSINESS [Abstract] DESCRIPTION OF BUSINESS [Abstract] Description of Business Business Description and Basis of Presentation [Text Block] 2017 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Five After Year Five Finite-Lived Intangible Assets, Amortization Expense, after Year Five Stockholders' Equity Note [Abstract] Treasury stock, shares acquired Treasury Stock, Shares, Acquired Treasury stock acquired, average price paid per share Treasury Stock Acquired, Average Cost Per Share Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Investments, All Other Investments [Abstract] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Share-based Compensation [Abstract] Ownership of Voting Interests [Axis] Ownership of Voting Interests [Axis] Ownership of Voting Interests [Axis] Ownership of Voting Interests [Domain] Ownership of Voting Interests [Domain] [Domain] for Ownership of Voting Interests [Axis] Less than 10% [Member] Less than 10% [Member] Less than 10% [Member] 10% or More [Member] 10% or More [Member] 10% or More [Member] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2007 Plan [Member] 2007 Plan [Member] 2007 Plan [Member] 2016 Plan [Member] 2016 Plan [Member] 2016 Plan [Member] Discretionary Option Grant Program [Member] Discretionary Option Grant Program [Member] Discretionary Option Grant Program [Member] Stock Issuance Program [Member] Stock Issuance Program [Member] Stock Issuance Program [Member] 2002 Stock Plan [Member] 2002 Stock Plan [Member] 2002 Stock Plan [Member] 2013 Plan [Member] 2013 Plan [Member] 2013 Plan [Member] 2013 Stock Plan [Member] 2013 Stock Plan [Member] 2013 Stock Plan [Member] Award Type [Domain] Restricted stock awards with time based vesting conditions [Member] Restricted stock awards with time based vesting conditions [Member] Restricted stock awards with time based vesting conditions [Member] Nonstatutory Options [Member] Nonstatutory Options [Member] Nonstatutory Options [Member] Incentive Stock Options [Member] Incentive Stock Options [Member] Incentive Stock Options [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Restricted stock unit awards with time-based vesting conditions [Member] Restricted stock unit awards with time-based vesting conditions [Member] Restricted stock unit awards with time-based vesting conditions [Member] Restricted stock unit awards with performance based vesting conditions [Member] Restricted stock unit awards with performance based vesting conditions [Member] Restricted stock unit awards with performance based vesting conditions [Member] Stock options with time-based vesting conditions [Member] Stock options with time-based vesting conditions [Member] Stock options with time-based vesting conditions [Member] Stock options with market-based vesting conditions [Member] Stock options with market-based vesting conditions [Member] Stock options with market-based vesting conditions [Member] Stock options with performance-based vesting conditions [Member] Stock options with performance-based vesting conditions [Member] Stock options with performance-based vesting conditions [Member] Share-based Compensation Arrangement by Share-based Payment Award Non-cash stock compensation Share-based Compensation Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value Percentage of fair market value on grant date, minimum exercise price Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Increase in number of shares available, percentage of outstanding shares on last trading day of prior December Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase By Percentage Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase By Percentage Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance Ownership percent of voting stock Ownership Percent of Voting Stock Ownership Percent of Voting Stock Aggregate shares available for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares available for grant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Aggregate intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Weighted average grant date fair value of restricted stock granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Aggregate fair value of restricted stock vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Total unrecognized compensation expense for nonvested awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period over which unrecognized compensation expense will be recognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Number of shares of common stock reserved for issuance Common Stock, Capital Shares Reserved for Future Issuance Commitments and Contingencies Disclosure [Abstract] Rent expense Operating Leases, Rent Expense Other Other Cost and Expense, Operating Partners' capital, authorized Partners Capital, Authorized Authorized amount of capital to be raised by the fund. Cash and other assets, IP Fund Cash and other assets, IP Fund Cash and other assets, IP Fund Patents, net of accumulated amortization, IP Fund Patents, net of accumulated amortization, IP Fund Patents, net of accumulated amortization, IP Fund Investments, IP Fund Investments, IP Fund Investments, IP Fund Total assets, IP Fund Total assets, IP Fund Total assets, IP Fund Accrued expenses and contributions, IP Fund Accrued expenses and contributions, IP Fund Accrued expenses and contributions, IP Fund Net assets, IP Fund Net Assets, Fund Related Fund net assets Revenues, IP Fund Revenues, IP Fund Revenues, IP Fund IP Fund, Operating expenses IP Fund, Operating expenses IP Fund, Operating expenses IP Fund, Gain from Operations IP Fund, Gain from Operations IP Fund, Gain from Operations IP Fund, Net Loss in Equity Method Investment IP Fund, Net Loss in Equity Method Investment IP Fund, Net Loss in Equity Method Investment IP Fund, Net Loss IP Fund, Net Loss IP Fund, Net Loss Line of Credit Facility, Commitment Fee Percentage Line of Credit Facility, Commitment Fee Percentage Property, Plant and Equipment [Abstract] Schedule of Property and Equipment [Table] Property, Plant and Equipment [Table] Property and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Property and Equipment [Line Items] Property, Plant and Equipment [Line Items] Furniture and fixtures Furniture and Fixtures, Gross Computer hardware and software Computer Hardware and Software Computer Hardware and Software Leasehold improvements Leasehold Improvements, Gross Property and equipment, gross Property, Plant and Equipment, Gross Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, net Property, Plant and Equipment, Net Schedule of Treasury Stock by Class Class of Treasury Stock [Table Text Block] Short-term Investments [Abstract] Short-Term Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Year: Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2017 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2018 Operating Leases, Future Minimum Payments, Due in Two Years 2019 Operating Leases, Future Minimum Payments, Due in Three Years 2020 Operating Leases, Future Minimum Payments, Due in Four Years 2021 Operating Leases, Future Minimum Payments, Due in Five Years Total minimum lease payments Operating Leases, Future Minimum Payments Due Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Patents [Line Items] Finite-Lived Intangible Assets [Line Items] Patent cost, disposals Patent cost, disposals Patent cost, disposals Accumulated amortization, disposals Accumulated amortization, disposals Accumulated amortization, disposals Proceeds from Sale of Intangible Assets Proceeds from Sale of Intangible Assets Nonvested at December 31, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Canceled Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Nonvested at December 31, 2016 Nonvested, weighted average grant date fair value at December 31, 2015 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted, weighted average grant date fair value Vested, weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Canceled, weighted average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Nonvested, weighted average grant date fair value at December 31, 2016 Subsequent Events [Abstract] Net income (loss) attributable to Acacia Research Corporation Net Income (Loss) Attributable to Parent Net Loss Available to Common Stockholders, Basic and Diluted Net Income (Loss) Available to Common Stockholders, Basic Weighted-average number of shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Basic Basic and diluted loss per common share Earnings Per Share, Basic Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] ASSETS Assets [Abstract] EX-101.PRE 15 actg-20161231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 16 acaciaresearchcorp04.jpg begin 644 acaciaresearchcorp04.jpg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businessmodeloptionsv4a04.jpg begin 644 businessmodeloptionsv4a04.jpg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�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end GRAPHIC 18 stockperfgraphv2.jpg begin 644 stockperfgraphv2.jpg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end XML 19 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1

Document and Entity Information Document - USD ($)
12 Months Ended

Dec. 31, 2016

Mar. 06, 2017

Jun. 30, 2016

Entity Information [Line Items]

Entity Registrant Name ACACIA RESEARCH CORP

Entity Central Index Key 0000934549

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Document Type 10-K

Document Period End Date Dec. 31, 2016

Document Fiscal Year Focus 2016

Document Fiscal Period Focus FY

Amendment Flag false

Entity Common Stock, Shares Outstanding 50,466,611

Entity Well-known Seasoned Issuer No

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Public Float $ 216,379,000

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_EntityInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 20 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Balance Sheets - USD ($)
$ in Thousands

Dec. 31, 2016

Dec. 31, 2015

Current assets:

Cash and cash equivalents $ 127,540 $ 135,223

Restricted cash 11,512 10,725

Short-term investments 19,443 0

Accounts receivable 26,750 33,500

Deferred income tax 0 210

Prepaid expenses and other current assets 3,245 4,219

Total current assets 188,490 183,877

Loan receivable and accrued interest 18,616 0

Investment warrants 1,960 0

Property and equipment, net of accumulated depreciation and amortization 127 272

Patents, net of accumulated amortization 86,319 162,642

Other assets 491 1,110

Total assets 296,003 347,901

Current liabilities:

Accounts payable and accrued expenses 14,283 17,347

Accrued patent investment costs 0 1,000

Royalties and contingent legal fees payable 13,908 14,878

Total current liabilities 28,191 33,225

Deferred income taxes 0 210

Other liabilities 369 311

Total liabilities 28,560 33,746

Commitments and contingencies (Note 12)

Stockholders' equity:

Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding 0 0

Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,476,042 shares issued and outstanding as of December 31, 2016 and 50,651,239 shares issued and outstanding as of December 31, 2015 50 51

Treasury stock, at cost, 1,729,408 shares as of December 31, 2016 and 2015 (34,640) (34,640)

Additional paid-in capital 642,453 633,146

Accumulated comprehensive loss (76) (215)

Accumulated deficit (342,198) (288,131)

Total Acacia Research Corporation stockholders’ equity 265,589 310,211

Noncontrolling interests in operating subsidiaries 1,854 3,944

Total stockholders’ equity 267,443 314,155

Total liabilities and stockholders' equity $ 296,003 $ 347,901

X

- Definition
Accrued Patent Acquisition Related Payments, Current
+ References
No definition available.
+ Details

Name: actg_AccruedPatentAcquisitionRelatedPaymentsCurrent

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Investment warrants
+ References
No definition available.
+ Details

Name: actg_Investmentwarrants

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_RoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestmentsAndReceivablesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_OtherLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(g))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 21 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Balance Sheets Parentheticals - $ / shares

Dec. 31, 2016

Dec. 31, 2015

Preferred stock, shares authorized 10,000,000 10,000,000

Preferred stock, par value per share $ 0.001 $ 0.001

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value per share $ 0.001 $ 0.001

Common stock, shares authorized 100,000,000 100,000,000

Common stock, shares issued 50,476,042 50,651,239

Common stock, shares outstanding 50,476,042 50,651,239

Treasury stock, shares 1,729,408 1,729,408

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 22 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Income Statement [Abstract]

Revenues $ 152,699 $ 125,037 $ 130,876

Cost of revenues:

Inventor royalties 22,730 18,462 20,670

Contingent legal fees 26,474 16,169 23,563

Litigation and licensing expenses - patents 27,858 39,373 37,614

Amortization of patents 34,208 53,067 53,745

General and administrative expenses (including non-cash stock compensation expense of $9,062 in 2016, $11,048 in 2015 and $18,115 in 2014) 32,919 38,176 48,554

Research, consulting and other expenses - business development 3,079 3,391 3,840

Impairment of Patent-Related Intangible Assets 42,340 74,731 3,497

Impairment of Goodwill 0 30,149 0

Other 500 4,141 1,548

Total operating costs and expenses 190,108 277,659 193,031

Operating loss (37,409) (152,622) (62,155)

Total other income (expense) 798 (56) (595)

Loss from operations before provision for income taxes (36,611) (152,678) (62,750)

Provision for income taxes (18,188) (4,800) (3,912)

Net loss including noncontrolling interests in operating subsidiaries (54,799) (157,478) (66,662)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries 732 (2,558) 633

Net loss attributable to Acacia Research Corporation (54,067) (160,036) (66,029)

Net Loss Available to Common Stockholders, Basic and Diluted $ (54,067) $ (160,730) $ (66,755)

Earnings Per Share, Basic and Diluted $ (1.08) $ (3.25) $ (1.37)

Weighted Average Number of Shares Outstanding, Basic and Diluted 50,075,847 49,505,817 48,658,088

Common Stock, Dividends, Per Share, Cash Paid $ 0.000 $ 0.500 $ 0.500

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate dividends paid during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareCashPaid

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfRevenueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_LicensesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 23 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Statements of Operations Parentheticals - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Non-cash stock compensation $ 9,062 $ 11,048 $ 18,115

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 24 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Statement of Comprehensive Income [Abstract]

Net income (loss) including noncontrolling interests in operating subsidiaries $ (54,799) $ (157,478) $ (66,662)

Other comprehensive income (loss):

Unrealized loss on short-term investments 40 (356) (1,488)

Unrealized gain on foreign currency translation 77 (123) (128)

Add: reclassification adjustment for losses included in net income 22 617 2,210

Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (54,660) (157,340) (66,068)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (732) 2,558 (633)

Comprehensive income $ (53,928) $ (159,898) $ (65,435)

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32157-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 25 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands

Total

Common Stock [Member]

Treasury Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Other Comprehensive Income (Loss) [Member]

Accumulated Deficit [Member]

Noncontrolling Interests [Member]

Balance at Dec. 31, 2013 $ 562,198 $ 49 $ (34,640) $ 653,314 $ (947) $ (62,066) $ 6,488

Common stock, shares outstanding at Dec. 31, 2013 49,385,057

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (66,029) (66,029)

Payments of Dividends (25,039) (25,039)

Stock Issued During Period, Value, New Issues (25,039)

Stock options exercised, shares 44,506

Proceeds from Stock Options Exercised 206

Stock options exercised, value 206 206

Stock issued during period, shares, share-based compensation, net of forfeitures 635,819

Non-cash stock compensation 18,115 $ 1 18,114

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (633) (633)

Payments to Noncontrolling Interests 867

Foreign Currency Transaction Gain (Loss), Unrealized (99) (99)

Unrealized Gain (Loss) on Investments 693 693

Distributions to noncontrolling interests in operating subsidiary (364) (364)

Payments for Repurchase of Common Stock 0

Balance at Dec. 31, 2014 489,048 $ 50 (34,640) 646,595 (353) (128,095) 5,491

Common stock, shares outstanding at Dec. 31, 2014 50,065,382

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation (160,036) (160,036)

Payments of Dividends (25,434) (25,434)

Stock options exercised, shares 135,000

Proceeds from Stock Options Exercised 938

Stock options exercised, value 938 938

Stock issued during period, shares, share-based compensation, net of forfeitures 450,857

Non-cash stock compensation 11,048 $ 1 11,047

Net (income) loss attributable to noncontrolling interests in operating subsidiaries 2,558 2,558

Payments to Noncontrolling Interests 4,105

Foreign Currency Transaction Gain (Loss), Unrealized (123) (123)

Unrealized Gain (Loss) on Investments 261 261

Distributions to noncontrolling interests in operating subsidiary (4,105) (4,105)

Payments for Repurchase of Common Stock 0

Balance at Dec. 31, 2015 $ 314,155 $ 51 (34,640) 633,146 (215) (288,131) 3,944

Common stock, shares outstanding at Dec. 31, 2015 50,651,239 50,651,239

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income (loss) attributable to Acacia Research Corporation $ (54,067) (54,067)

Payments of Dividends $ 0

Stock Repurchased During Period, Shares (13,529)

Stock options exercised, shares 101,000 100,992

Proceeds from Stock Options Exercised $ 326

Stock options exercised, value 326

Stock issued during period, shares, share-based compensation, net of forfeitures (262,660)

Non-cash stock compensation 9,062 $ (1) 9,063

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (732) (732)

Payments to Noncontrolling Interests 1,358

Foreign Currency Transaction Gain (Loss), Unrealized 40

Unrealized Gain (Loss) on Investments 99

Distributions to noncontrolling interests in operating subsidiary (1,358)

Payments for Repurchase of Common Stock (82)

Balance at Dec. 31, 2016 $ 267,443 $ 50 $ (34,640) $ 642,453 $ (76) $ (342,198) $ 1,854

Common stock, shares outstanding at Dec. 31, 2016 50,476,042 50,476,042

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64836518&loc=d3e30690-110894

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64836518&loc=d3e30700-110894

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossUnrealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_StockRepurchasedDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments, not including unrealized gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, held at each balance sheet date and included in earnings for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 26 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1

Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Cash flows from operating activities:

Net income (loss) including noncontrolling interests in operating subsidiaries $ (54,799) $ (157,478) $ (66,662)

Adjustments to reconcile net income (loss) including noncontrolling interests in operating subsidiaries to net cash provided by (used in) operating activities:

Depreciation and amortization 34,355 53,289 54,049

Non-cash stock compensation 9,062 11,048 18,115

Provision for deferred income taxes 0 0 (1,736)

Impairment of Patent-Related Intangible Assets 42,340 74,731 3,497

Impairment of Goodwill 0 30,149 0

Other (477) (109) (28)

Changes in assets and liabilities:

Increase (Decrease) in Restricted Cash (787) (10,725) 0

Accounts receivable 6,750 (13,332) (13,827)

Prepaid expenses and other assets 1,593 (619) 3,154

Accounts payable and accrued expenses / costs (3,006) 2,570 3,718

Royalties and contingent legal fees payable (970) 527 3,904

Net cash provided by (used in) operating activities 34,061 (9,949) 4,184

Cash flows from investing activities:

Purchase of property and equipment (4) (8) (109)

Purchase of available-for-sale investments (62,633) (23,296) (109,963)

Sale of available-for-sale investments 43,232 82,115 182,115

Patent acquisition costs (1,225) (19,504) (42,746)

Payments to Acquire Investments (20,000) 0 0

Net cash provided by (used in) investing activities (40,630) 39,307 29,297

Cash flows from financing activities:

Payments of Dividends 0 (25,434) (25,039)

Distributions to noncontrolling interests in operating subsidiary (1,358) (4,105) (867)

Proceeds from the exercise of stock options 326 938 206

Repurchases of common stock (82) 0 0

Net cash provided by (used in) financing activities (1,114) (28,601) (25,700)

Increase in cash and cash equivalents (7,683) 757 7,781

Cash and cash equivalents, beginning 135,223 134,466 126,685

Cash and cash equivalents, ending 127,540 135,223 134,466

Patent acquisition costs included in accrued expenses $ 0 $ 1,000 $ 16,700

X

- Definition
Increase (decrease) in royalties and contingent legal fees payable
+ References
No definition available.
+ Details

Name: actg_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Patent Acquisition Costs Included in Accrued Expenses
+ References
No definition available.
+ Details

Name: actg_PatentAcquisitionCostsIncludedInAccruedExpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_IncreaseDecreaseInRestrictedCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingActivitiesCashFlowStatement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562
+ Details

Name: us-gaap_PaymentsToAcquireAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e32123-109318
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 27 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1

Description of Business
12 Months Ended

Dec. 31, 2016

DESCRIPTION OF BUSINESS [Abstract]

Description of Business
DESCRIPTION OF BUSINESS

Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries.

Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions.

Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.

Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If Acacia's operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and / or revenue growth.

During fiscal 2016 Acacia obtained control of 2 new patent portfolios. Further, in fiscal year 2015, Acacia obtained control of 3 new patent portfolios, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively.

Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

X

- Definition
DESCRIPTION OF BUSINESS [Abstract]
+ References
No definition available.
+ Details

Name: actg_DescriptionOfBusinessAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 12 to these consolidated financial statements.

Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.
For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 12 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

●
Level 1 -
Observable Inputs:  Quoted prices in active markets for identical investments;

●
Level 2 -
Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and

●
Level 3 -
Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.
Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Investments in Marketable Securities.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2016, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in total other income (expense).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016. Two licensees individually represented approximately 72% and 21%, respectively, of accounts receivable at December 31, 2015.

For 2016, 2015 and 2014, 79%, 49% and 43%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.

Property and Equipment.  Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Acacia's goodwill balance of $30.1 million was fully written-off as of December 31, 2015. Refer to Note 7 for additional information.

Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note 7 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and / or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 11 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

The fair value of stock options granted during the year ended December 31, 2016 was estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

Weighted-Average Assumptions

Risk-free interest rate
1.1%
Term
3.06
Volatility
53%
Dividend yield
—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the year ended December 31, 2016.  Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, the allocation of loans to investees between the loans receivable and common stock purchase warrants received, and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2016

2015

2014
Numerator (in thousands):

Basic and Diluted

Net loss

$
(54,067
)

$
(160,036
)

$
(66,029
)
Total dividends declared / paid

—

(25,434
)

(25,039
)
Dividends attributable to common stockholders

—

24,740

24,313

Net loss attributable to common stockholders – basic and diluted

$
(54,067
)

$
(160,730
)

$
(66,755
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

50,075,847

49,505,817

48,658,088

Basic and diluted net loss per common share

$
(1.08
)

$
(3.25
)

$
(1.37
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

3,682,532

71,468

27,760


Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.

Recent Accounting Pronouncements - Not Yet Adopted. In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In June 2016, the FASB issued guidance on the measurement and recognition of credit losses on most financial assets. For trade receivables, loans, and held-to-maturity debt securities, the current probable loss recognition methodology is being replaced by an expected credit loss model. For available-for-sale debt securities, the recognition model on credit losses is generally unchanged, except the losses will be presented as an adjustable allowance. The guidance will be applied retrospectively with the cumulative effect recognized as of the date of adoption. The guidance will become effective at the beginning of our first quarter of fiscal 2021 but can be adopted as early as the beginning of our first quarter of fiscal 2020. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently Adopted Accounting Pronouncements - Recently Adopted. In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The adoption of this standard effective December 31, 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In June 2014, the FASB issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The adoption of this standard effective January 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In August 2016, the FASB issued amended guidance to clarify guidance on the classification of certain cash receipts and cash payments. Additionally, the guidance requires that the statement of cash flows reflect changes in restricted cash in addition to cash and cash equivalents. Amended guidance includes clarification on debt prepayment and extinguishment costs, contingent consideration in business combinations, proceeds from insurance claims, and premium payments on company-owned life insurance. Refer to the consolidated statement of cash flows elsewhere herein for separate presentation of changes in restricted cash.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18854-107790
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1

Short-term Investments
12 Months Ended

Dec. 31, 2016

Short-term Investments [Abstract]

Short-Term Investments
SHORT-TERM INVESTMENTS

Short-term marketable securities for the periods presented were comprised of the following (in thousands):

December 31, 2016
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
19,403

$
40

$
—

$
19,443

Short-term investments at December 31, 2016 were comprised of investments in highly liquid, AAA, U.S. government fixed income securities with maturity dates in 2017. There were no short-term investments at December 31, 2015.

U.S. government fixed income securities. The Company has the ability to hold these securities until maturity, currently has no intent to sell, there is no requirement to sell and the Company believes that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. However, the Company cannot provide any assurance that its portfolio of short-term marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.

For the year ended December 31, 2016, proceeds from the sale of short-term marketable securities classified as available-for-sale were $43,232,000 and gross realized gains were $1,000. For the year ended December 31, 2015, proceeds from the sale of short-term marketable securities were $82,115,000 and gross realized losses were $617,000. For the year ended December 31, 2014, proceeds from the sale of short-term marketable securities were $182,115,000 and gross realized losses were $2,188,000. Gross realized gains are recorded in the statements of operations in other income (expense).

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Debt Security
-URI http://asc.fasb.org/extlink&oid=6509901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27290-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Equity Security
-URI http://asc.fasb.org/extlink&oid=6511694

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27405-111563
+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1

Property and Equipment
12 Months Ended

Dec. 31, 2016

Property, Plant and Equipment [Abstract]

Property and Equipment
PROPERTY AND EQUIPMENT

Property and equipment consists of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Furniture and fixtures

$
733

$
739

Computer hardware and software

603

649

Leasehold improvements

131

145

1,467

1,533

Less:  accumulated depreciation and amortization

(1,340
)

(1,261
)

$
127

$
272

Depreciation expense was $147,000, $222,000 and $304,000 for the years ended December 31, 2016, 2015 and 2014, respectively. In 2016 and 2015, the Company retired $68,000 and $30,000, respectively, of items held in furniture and equipment and recorded a $3,000 and $14,000, respectively, loss on disposal.

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13-14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64827811&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64862545&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accounts Payable and Accrued Expenses
12 Months Ended

Dec. 31, 2016

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consist of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Payroll and other employee benefits

$
1,593

$
576

Accrued vacation

533

701

Accrued legal expenses - patent

6,564

10,135

Foreign taxes payable ⁽¹⁾

3,150

3,960

Accrued consulting and other professional fees

1,967

1,592

Other accrued liabilities

476

383

$
14,283

$
17,347

⁽¹⁾ - Included in "Accounts payable and accrued expenses / patent costs" line item on the consolidated statement of cash flows included elsewhere herein.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1

Patents
12 Months Ended

Dec. 31, 2016

Patents [Abstract]

Patents

Acacia’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from one to seven years. For all periods presented, all of Acacia’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2016 and 2015 are as follows (in thousands):

2016

2015

Gross carrying amount - patents

$
444,362

$
444,137

Accumulated amortization - patents⁽¹⁾

(358,043
)

(281,495
)
Patents, net

$
86,319

$
162,642

⁽¹⁾ Includes patent impairment charges for the applicable periods.

The weighted-average remaining estimated economic useful life of Acacia’s patents and patent rights is 5 years. Scheduled annual aggregate amortization expense is estimated to be $22,333,000 in 2017, $21,256,000 in 2018, $19,150,000 in 2019, $6,707,000 in 2020, $5,421,000 in 2021 and $11,452,000 thereafter.

For the years ended December 31, 2016, 2015 and 2014, Acacia paid patent investment costs totaling $1,225,000, $19,504,000 and $42,746,000, respectively. The patents have initial estimated economic useful lives ranging from two to ten years. Included in net additions to capitalized patent costs during the year ended December 31, 2015 and 2014 are accrued patent investment costs totaling $1,000,000 and $16,700,000, respectively, which are amortized over the estimated economic useful life of the related patents.

During the periods presented, certain operating subsidiaries recovered up-front patent portfolio advances from applicable net licensing proceeds prior to the scheduled amortization of such up-front patent portfolio advances, resulting in the acceleration of amortization expense for the applicable patent-related assets. For the years ended December 31, 2016 and 2014, accelerated amortization expense related to the recovery of up-front patent portfolio advances totaled $225,000 and $1,247,000, respectively. For the year ended December 31, 2015, there was no accelerated amortization expense.

For the years ended December 31, 2015 and 2014, pursuant to the terms of the respective inventor agreements, certain Acacia operating subsidiaries elected to terminate or sell their rights to patent portfolios, resulting in the acceleration of amortization expense for the patent-related assets totaling $380,000 and $2,702,000, respectively. For the year ended December 31, 2016, there were no terminations or sales of patent portfolios.

Acacia recorded impairment of patent-related intangible asset charges totaling $42,340,000, $74,731,000 and $3,497,000 for the years ended December 31, 2016, 2015 and 2014, respectively. The impairment charges related to impairments of patent portfolios due to a reduction in expected estimated future net cash flows and certain patent portfolios that management determined it would no longer allocate future resources to in connection with the licensing and enforcement of such portfolios, due primarily to adverse litigation outcomes, potential prior art related complexities and/or the overall determination that future resources would be allocated to other licensing and enforcement programs with higher potential return profiles.

In December 2015, Acacia's subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, Inc., and others. The jury returned a verdict that the asserted claims of the patent at issue were invalid and non-infringed. The Adaptix trial loss resulted in a reduction in estimated cash flows for the Adaptix portfolio expected to be realized from future licensing and enforcement activities, leading to partial impairment charges on the portfolio in the fourth quarter of 2015. Patent impairment charges included the impairment of the remaining carrying value for the Adapitx portfolio in the second quarter of 2016. In addition, for the year ended December 31, 2015 analysis, management considered the impact of the fourth quarter 2015 adverse trial outcomes on its estimates of future cash flows that could be realized from future licensing and enforcement activities for other patent portfolios. Estimates of future cash flows for these portfolios were reduced in part in connection with the Company's assessment of probabilities of realization given the recent adverse trial outcomes. Additionally, patent impairment charges include the carrying value of other patent portfolios for which, in 2015, the Company experienced adverse litigation or trial outcomes, leading to a reduction in or elimination of expected future cash flows. In addition, headcount reductions and internal staff optimization efforts led to changes with respect to which patent portfolios the Company intends to allocate licensing and enforcement resources to in future periods. As such, certain portfolio programs were selected for termination due to a decision to no longer pursue or allocate resources, resulting in a write-off any remaining carrying value in the fourth quarter of 2015.

The impairment charges for the periods presented consisted of the excess of the asset’s carrying value over its estimated fair value.

For the years ended December 31, 2016, 2015 and 2014, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):

2016

2015

2014

Capitalized patent costs

$
—

$
500

$
3,000

Accumulated amortization

—

120

298

Sales proceeds

—

750

3,500

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill Impairment Charges (Notes)
12 Months Ended

Dec. 31, 2016

Goodwill and Patent Impairment Charges [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]
GOODWILL IMPAIRMENT CHARGES
Pursuant to applicable accounting standards, if goodwill and another asset group of a reporting unit are tested for impairment at the same time, the other asset group, the Company's patent portfolios, are to be tested for impairment before goodwill. Refer to Note 6 for additional information regarding patent impairment charges for the year ended December 31, 2015.
Goodwill Impairment Testing - December 31, 2015. At December 31, 2015, prior to the completion of the annual goodwill impairment test, the goodwill balance totaled $30.1 million. Goodwill is tested for impairment at the Company's single reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Factors considered important, which could trigger an impairment review, include the following:
•
significant consistent gradual decline in the Company's stock price for a sustained period;
•
significant underperformance relative to expected historical or projected future operating results;
•
significant changes in the manner of use of assets or the strategy for the Company's overall business;
•
significant negative industry or economic trends; and
•
significant adverse changes in legal factors or in the business climate, including adverse regulatory actions or assessments.

     In connection with Acacia's annual goodwill impairment testing for 2015, the Company identified several qualitative factors triggering an impairment test at December 31, 2015, as follows:
•
Adverse legal outcomes and changes in legal factors. In December 2015, Acacia announced that its subsidiary Adaptix, Inc. received a jury verdict in its case against Alcatel Lucent USA, et al., deciding that the claims of the applicable patents in suit were invalid and non-infringed. This adverse legal outcome and others in the fourth quarter of 2015 resulted in changes in estimates of realization related to litigation outcomes in future periods for certain patent portfolios.
•
Significant consistent gradual decline in the Company’s stock price: Historically, the Company's stock price has been volatile, and the volatility continued during fiscal 2015, declining from $16.72 as of January 2, 2015, to $4.29 as of December 31, 2015, a 74% decline. In addition, subsequent to December 31, 2015, the Company's stock price volatility has continued, trending downward to $3.16 as of February 29, 2016. In the fourth quarter of 2015, given the continued decline in stock price up through December 31, 2015, and the impact of the December 2015 adverse trial outcomes noted above, the gradual consistent decline in the Company's stock price was deemed to be sustained, and hence indicative of a reduction in the estimated fair value of the Company, as reflected in its lower overall market capitalization.
•
Changes in Company Management and Resource Allocations. In connection with certain resource allocation changes within the organization given a change in management in the fourth quarter of 2015, headcount reductions and internal staff optimization efforts occurred, which led to changes with respect to estimates of which patent portfolios the Company intends to continue to allocate licensing and enforcement resources to in future periods. As such, certain patent portfolio programs were selected for termination due to a decision to no longer allocate resources. In addition, changes in estimates regarding the best and highest use of certain patent portfolios were made, resulting in reductions in estimated future cash flows.
At December 31, 2015, the Company utilized the following methods and assumptions in its annual goodwill impairment testing, which was prepared with the assistance of a third-party valuation specialist:
•
At December 31, 2015, the initial qualitative assessment included consideration of the factors described above, resulting in a conclusion that as of December 31, 2015, the consistent gradual decline in the Company’s stock price was sustained. The Company also considered the impact of the December 2015 adverse trial outcomes on the Company's stock price and related estimates of fair value for remaining portfolio opportunities. Based on the Company's assessment of these factors, the Company determined that it was more likely than not that goodwill was impaired, constituting a triggering event requiring a goodwill impairment test as of December 31, 2015.
•
The Company conducted the first step of the goodwill impairment test for its single reporting unit as of December 31, 2015. The Company utilized the market capitalization plus cost synergies approach to estimate the fair value of the Company. The estimated market capitalization was determined by multiplying the Company's stock price and the common shares outstanding as of December 31, 2015. Management also considered a control premium in its estimate of fair value for the Company's single reporting unit. The cost synergies were estimated based on the cost savings which could be achieved if the Company was acquired by a competitor in the same operating business.
•
Based on the analysis utilizing the market capitalization plus cost synergies approach, the estimated fair value of the reporting unit of $252 million was below its carrying value of $344.3 million as of December 31, 2015, and therefore, goodwill was determined to be more likely than not, impaired.
•
The purpose of step 2 of the analysis was to determine the estimated fair value of the assets and liabilities of the Company's reporting unit, in order to determine the implied fair value of goodwill for the reporting unit. The excess, if any, of the fair value of a reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. Based upon the analysis performed, the fair value of the Company's single reporting unit did not exceed the amounts assigned to its reporting unit assets and liabilities, resulting in a difference between the implied fair value of goodwill of zero and the historical carrying value of goodwill. As a result, the Company recognized a goodwill impairment charge totaling $30.1 million in the fourth quarter of 2015.

X

- Definition
Goodwill and Patent Impairment Charges [Abstract]
+ References
No definition available.
+ Details

Name: actg_GoodwillandPatentImpairmentChargesAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1

Loan Receivable and Investment in Warrants (Notes)
12 Months Ended

Dec. 31, 2016

Investments, All Other Investments [Abstract]

Investments and Other Noncurrent Assets [Text Block]
LOAN RECEIVABLE AND INVESTMENT IN WARRANTS

On August 15, 2016, Acacia entered into an Investment Agreement with Veritone, Inc. (“Veritone”), which provides for Acacia to invest up to $50 million in Veritone, consisting of both debt and equity components. Pursuant to the Investment Agreement, on August 15, 2016, Acacia entered into a secured convertible promissory note with Veritone (the “Veritone Loans”), which permits Veritone to borrow up to $20 million through two $10 million advances, each bearing interest at the rate of 6.0% per annum (included in Other Income (Expense) in the consolidated statement of operations). On August 15, 2016, Acacia funded the initial $10 million loan (the “First Loan”), which initially had a one-year term.   On November 25, 2016, Acacia funded the second $10 million loan (the “Second Loan”), which has a one-year term. In addition, upon the funding of the Second Loan, the maturity date of the First Loan was automatically extend to the maturity date of the Second Loan. As a result, both the First Loan and the Second Loan are due and payable on November 25, 2017. Veritone’s obligations under the Veritone Loans are secured by substantially all of Veritone’s assets pursuant to a security agreement that Acacia entered into with Veritone dated August 15, 2016.
In addition, commencing on the earlier of Veritone’s consummation of a private round of financing of at least $10 million (a “Next Equity Financing”) and the maturity date of the Veritone Loans, Acacia has the right, under certain circumstances, to convert all or a portion of the principal and accrued interest of the Veritone Loans into shares of Veritone’s Series B Preferred Stock or, if Veritone consummates a Next Equity Financing, into shares of Veritone capital stock issued in such financing, at various conversion rates, with the exact conversion rate to depend upon (i) whether Veritone consummates a Next Equity Financing, (ii) the price per share in such Next Equity Financing and (iii) whether or not Acacia elects to convert all of the outstanding principal and accrued interest under the Veritone Loans. If Veritone consummates a qualified public offering of its common stock, any outstanding principal and accrued interest under the Veritone Loans will automatically convert into shares of Veritone’s common stock at the applicable conversion rate.
In conjunction with the First Loan, Veritone issued Acacia a four-year $700,000 warrant to purchase shares of Veritone’s common stock at various exercise prices, with the actual exercise price to be determined by the type and/or valuation of Veritone’s future equity financings, if any. The actual number of shares to be purchased upon exercise of the warrant is determined by dividing the warrant value by the applicable exercise price. Upon funding of the Second Loan, Veritone issued to Acacia two additional four-year $700,000 warrants to purchase shares of Veritone’s common stock with similar terms.
In addition, pursuant to the Investment Agreement, Veritone issued Acacia a five-year Primary Warrant to purchase up to $50 million, less all converted amounts or amounts repaid under the Veritone Loans, worth of shares of Veritone’s common stock at various exercise prices, with the actual exercise price per share to be determined by the amount of principal and accrued interest under the Veritone Loans converted into shares of Veritone common stock. Acacia may exercise the Primary Warrant at any time during its five year term after the earlier of August 15, 2017 or the completion of a public offering with gross proceeds to Veritone of at least $15.0 million. Immediately subsequent to such a public offering, Veritone has the right to elect that Acacia exercise the Primary Warrant, and upon such election, Acacia agrees to exercise the Primary Warrant in full, provided that the then current fair market value of Veritone common stock is equal to or greater than the exercise price per share of the Primary Warrant. Immediately following Acacia’s exercise of the Primary Warrant in full, Veritone has the obligation to issue to Acacia an additional 10% Warrant that provides for the issuance of additional shares of Veritone common stock, with 50% of the shares underlying the 10% Warrant vesting as of the issuance date of the 10% Warrant, and the remaining 50% of shares vesting on the anniversary of the issuance date of the 10% Warrant.
Our Investment Agreement, as described above, represents a variable interest in Veritone for which Acacia is not the primary beneficiary, primarily due to a lack of a controlling interest in Veritone. As of December 31, 2016, the Veritone Loans are not considered in-substance common stock and the common stock purchase warrants are unexercised, and therefore, the equity method of accounting is not applied. In addition, the Veritone Loans do not meet the criteria for classification as a debt security. As such, the Veritone Loans and the related common stock purchase warrants described above are accounted for as separate units of account based on the relative estimated fair values of the separate units as of the effective date of the transaction, with the $20 million amount of the Veritone Loans allocated to (1) the Veritone Loans, which are accounted for as long-term loan receivables and (2) the common stock purchase warrants. The estimated relative fair value allocation of the $20 million investment to the Veritone Loans and the related common stock purchase warrants was determined using a Monte Carlo simulation model. Key inputs to the model included the estimated value of Veritone's equity on the effective date of the transactions, related volatility of equity assumptions, discounts for lack of marketability, assumptions related to liquidity scenarios, and assumptions related to recovery scenarios on the Veritone Loans. A summary of assumptions used in connection with estimating the relative fair values were as follows:
Valuation Technique

Significant Unobservable Inputs

Range of Inputs
Monte Carlo simulation model

Volatility

40
%
-
50%

Marketability discount

7%

Funding scenario probabilities

25
%
-
75%

Recovery

100%

The Veritone Loans and warrants are reflected in the accompanying consolidated financial statements as follows (in thousands):

As of and For the Year Ended December 31, 2016
Face value of loan receivable

$
20,000

Unamortized loan discount

(1,384
)
Carrying value of loan receivable

18,616

Investment in warrants (initial loan discount)

1,960

Total

$
20,576

Interest receivable

$
286

Accretion of loan discount

576

Interest income

$
862

The loan discount, representing the difference between the face amount of the Veritone Loans and the relative fair value allocated to the Veritone Loans, is accreted over the expected life of the loans, using the effective interest method, with the related interest amounts reflected in Other Income in the consolidated statement of operations. Acacia will re-evaluate its variable interest in Veritone and related accounting conclusions and disclosure requirements each reporting period. The effective yield for the First Loan and Second Loan was 20% and 9%, respectively.

Management performs a review of the Veritone Loans on a quarterly basis to assess the need for allowances for uncollectibility, based on current trends and other factors affecting collectibility, and to determine if any impairment has occurred. A loan receivable is considered impaired when it is probable that amounts related to the loan receivable will not be collected according to the contractual terms of the agreement. As of December 31, 2016, no allowances for uncollectibility have been recorded. An allowance for uncollectibility would be reflected as a charge to earnings in the consolidated statement of operations.

X

- Definition
The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).
+ References
No definition available.
+ Details

Name: us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stockholders' Equity
12 Months Ended

Dec. 31, 2016

Stockholders' Equity Note [Abstract]

Stockholders' Equity
STOCKHOLDERS’ EQUITY

Cash Dividends. On April 23, 2013, Acacia announced that its Board of Directors approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the policy, the Company paid four quarterly cash dividends totaling $25,434,000 and $25,039,000 in 2015 and 2014, respectively. On February 25, 2016, Acacia announced that its Board of Directors terminated the company’s dividend policy effective February 23, 2016. The Board of Directors terminated the dividend policy due to a number of factors, including the Company’s financial performance and its available cash resources, the Company’s cash requirements and alternative uses of capital that the Board of Directors concluded would represent an opportunity to generate a greater return on investment for the Company and its stockholders.

Tax Benefits Preservation Plan. On March 15, 2016, Acacia's Board of Directors announced that it unanimously approved the adoption of a Tax Benefits Preservation Plan (the “Plan"). The purpose of the Plan is to protect the Company's ability to utilize potential tax assets, such as net operating loss carryforwards (“NOLs") and tax credits to offset potential future taxable income.

The Plan is designed to reduce the likelihood that the Company will experience an ownership change by discouraging any (i) person or group from acquiring beneficial ownership of 4.9% or more of the Company's outstanding common stock and (ii) any existing shareholders who, as of the time of the first public announcement of the adoption of the Plan, beneficially own more than 4.9% of the Company's then-outstanding shares of the Company's common stock from acquiring additional shares of the Company's common stock (subject to certain exceptions). There is no guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.

In connection with the adoption of the Plan, Acacia's Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company's common stock to shareholders of record at the close of business on March 16, 2016.

Approval of 2016 Acacia Research Corporation Stock Incentive Plan. On April 26, 2016, Acacia’s Board of Directors adopted the 2016 Acacia Research Corporation Stock Incentive Plan, or the Plan, which was approved by the stockholders in June 2016. The Plan will expire on the 10th anniversary of the date of its approval by shareholders, except with respect to awards then outstanding, and no further awards may be granted thereafter.

Summary of the Plan

•
Shares Available. The number of shares of our common stock initially reserved for issuance under the Plan shall be 4,500,000 shares plus any shares remaining available for issuance under our 2013 Acacia Research Corporation Stock Incentive Plan, or the 2013 Plan, as of the effective date of the Plan. As of the approval date of the Plan, 625,390 shares of our common stock were available for grant under the 2013 Plan.

•
Eligibility. Options, restricted stock units and direct stock awards may be granted under the Plan. Options may be either “incentive stock options,” as defined in Section 422 of the Internal Revenue Code of 1986, as amended, or the Code, or non-qualified stock options. Awards may be granted under the Plan to any employee, non-employee member of the Board of Directors, consultant or advisor who provides services to us or our subsidiaries, except for incentive stock options which may be granted only to our employees.

•
Administration. Generally, the Plan will be administered by either the entire Acacia Board of Directors or a committee of the Board of Directors, which shall consist of at least two members of the Board, each of whom must qualify as a “non-employee director” under Rule 16b-3 under the Exchange Act, an “outside director” under Section 162(m) of the Code and an “independent director” under the Nasdaq Listing Rules.

•
Discretionary Option Awards. The Plan administrator may grant either non-qualified stock options or incentive stock options. A stock option entitles the recipient to purchase a specified number of shares of our common stock at a fixed price subject to terms and conditions set by the Plan administrator, including conditions for exercise that must be satisfied, which typically will be based on continued provision of services. The exercise price of stock options granted under the Plan cannot be less than 100% of the fair market value of our common stock on the date the option is granted.

•
Direct Stock Awards. Direct stock awards may be issued under the Stock Issuance Program (as defined in the Plan) either alone or in addition to other awards granted under the Plan. The Plan administrator determines the terms and conditions of direct stock awards, including the number of shares of common stock granted, and the conditions for vesting that must be satisfied, if any, which typically will be based on continued provision of services but may include a performance-based component. Unless otherwise provided in the award agreement, the holder of a restricted direct stock award will have the rights of a stockholder from the date of grant of the award, including the right to vote the shares of common stock and the right to receive distributions on the shares.

•
Discretionary Restricted Stock Unit Awards. The Plan provides that the Plan administrator may grant restricted stock units to Plan participants. A restricted stock unit entitles the recipient to receive upon settlement thereof a specified number of shares of our common stock subject to terms and conditions set by the Plan administrator. The restricted stock units will vest as prescribed by the Plan administrator. The Plan permits payment of the purchase price of restricted stock units, if any, to be made by cash or cash equivalents, shares of our common stock previously acquired by the underlying optionee, cancellation of indebtedness, waiver of compensation due for services rendered or to be rendered, any other form of legal consideration determined by the Plan administrator, or any combination of the foregoing.

•
Termination of Employment.  The Plan administrator will determine and set forth in the award agreement whether any awards will continue to be exercisable, and the terms of such exercise, on and after the date the participant ceases to be employed by, or to otherwise provide services to, us, whether by reason of death, disability, voluntary or involuntary termination of employment or service, or otherwise, but in no event shall any unvested awards vest after the date the participant ceases to be employed by, or otherwise provide services to, us.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes
12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Income Taxes
INCOME TAXES

Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2016

2015

2014

Current:

Federal

$
—

$
—

$
—

State taxes

262

379

289

Foreign taxes

17,926

4,421

5,359

Total current

18,188

4,800

5,648

Deferred:

Federal

—

—

(1,867
)
State taxes

—

—

131

Total deferred

—

—

(1,736
)
Provision for income taxes

$
18,188

$
4,800

$
3,912

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
83,323

$
71,494

Stock compensation

2,416

1,385

Fixed assets and intangibles

14,343

1,359

Basis of investments in affiliates

2,195

499

Accrued liabilities and other

422

442

State taxes

90

81

Total deferred tax assets

102,789

75,260

Valuation allowance

(102,627
)

(75,179
)
Total deferred tax assets, net of valuation allowance

162

81

Deferred tax liabilities:

Fixed assets and intangibles

—

—

Other

(162
)

(81
)
Total deferred tax liabilities

(162
)

(81
)

Net deferred tax assets (liabilities)

$
—

$
—

A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2016

2015

2014

Statutory federal tax rate - (benefit) expense

(35
)%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

50
%

3
%

9
%
Foreign tax credit

(49
)%

(3
)%

(8
)%
Noncontrolling interests in operating subsidiaries

1
%

(1
)%

—
%
Goodwill

—
%

7
%

—
%
Nondeductible permanent items

—
%

—
%

1
%
Expired capital loss carryforwards

—
%

1
%

—
%
Valuation allowance

83
%

31
%

39
%

50
%

3
%

6
%

For the fiscal years ended December 31, 2016 and 2015, the Company recorded full valuation allowances against its net deferred tax assets due to uncertainty regarding future realization pursuant to guidance set forth in ASC 740, “Income Taxes.” In future periods, if the Company determines it will more likely than not be able to realize certain of these amounts, the applicable portion of the benefit from the release of the valuation allowance will generally be recognized in the statement of operations in the period the determination is made.

At December 31, 2016, Acacia had U.S. federal and state income tax net operating loss carryforwards (“NOLs”) totaling approximately $147,770,000 and $32,821,000, expiring between 2025 and 2035, and 2017 and 2036, respectively, for which $0 and $441,000 of federal and state net operating losses are included as a deferred tax asset related to the tax benefits of stock option deductions and which will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return. In addition, $1,928,000 and $37,771,000 of federal and state net operating losses are not included as a deferred tax asset and will be credited to additional paid-in capital when realized as a reduction of taxes payable on Acacia’s tax return as they relate to unrecognized excess tax benefits (see additional information regarding the ordering of windfall tax benefits and use of the “with-and-without” approach below). Capital loss carryovers totaled $3,423,000 at December 31, 2015, expiring between 2017 and 2020.

At December 31, 2016, approximately $29,318,000 of the U.S. federal NOLs, acquired in connection with the acquisition of ADAPTIX, Inc. in 2012, are subject to an annual utilization limitation of approximately $14,100,000, pursuant to the “change in ownership” provisions under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).

As of December 31, 2016, Acacia had approximately $52,224,000 of foreign tax credits, expiring between 2017 and 2026, of which $20,313,000 has been utilized for financial statement purposes. Future realization of the credits as a reduction of taxes payable on Acacia’s tax return will result in an income tax benefit recognizable through additional paid in capital since the entire amount of the credits have been utilized for financial statement purposes under the “with-and-without approach.” In general, foreign taxes withheld may be claimed as a deduction on future U.S. corporate income tax returns, or as a credit against future U.S. income tax liabilities, subject to certain limitations.

Tax expense for the periods presented, primarily reflects foreign taxes withheld on revenue agreements with licensees in foreign jurisdictions, a benefit totaling $1,735,000 from the reversal of the net deferred tax liability that existed at the beginning of the year (2014 only) and other state taxes. Excluding the impact of the change in valuation allowance, annual effective tax rates were (33)%, (28)% and (33)%, for fiscal years 2016, 2015 and 2014, respectively.

The Company has elected to utilize the “with-and-without approach” regarding ordering of windfall tax benefits to determine whether the windfall tax benefit has reduced taxes payable. Under this approach, the windfall tax benefits would be recognized in additional paid in capital only if an incremental tax benefit is realized after considering all other tax benefits presently available to the Company. The deductions related to the exercise and vesting of equity-based incentive awards during the periods presented are, in general, available to offset taxable income on Acacia’s consolidated tax returns. Accordingly, the excess tax benefit related to the exercise and vesting of equity-based incentive awards for the periods presented was credited to additional paid-in capital, not taxes payable. For the years ended December 31, 2016, 2015 and 2014, the Company incurred approximately $1,319,000, $1,917,000 and $2,713,000, respectively, of net short falls from the exercise and vesting of equity-based incentive awards, of which $1,319,000, $1,917,000 and $2,713,000, respectively, was recorded against its additional paid-in capital, subject to a full valuation allowance, with no impact to the income statement.

Acacia is subject to taxation in the U.S. and in various state jurisdictions and incurs foreign tax withholdings on revenue agreements with licensees in certain foreign jurisdictions. With no material exceptions, Acacia is no longer subject to U.S. federal or state examinations by tax authorities for years before 2001. The California Franchise Tax Board is auditing the 2011 and 2012 California combined income tax returns. The audit is in process and no findings or adjustments have been proposed.

At December 31, 2016 and 2015, the Company had total unrecognized tax benefits of approximately $1,355,000 and $2,127,000, including a recorded noncurrent liability of $85,000, related to unrecognized tax benefits primarily associated with state taxes. No interest and penalties have been recorded for the unrecognized tax benefits as of December 31, 2016. At December 31, 2016, if recognized, approximately $1,355,000, net of valuation analysis, would impact the Company’s effective tax rate. The Company does not expect that the liability for unrecognized tax benefits will change significantly within the next 12 months. The change in total unrecognized tax benefits as of December 31, 2016 was due to a lapse of the applicable statute of limitations related to an unrecognized benefit originating in a prior period.

Acacia recognizes interest and penalties with respect to unrecognized tax benefits in income tax expense. Acacia has identified no uncertain tax position for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within 12 months.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans
12 Months Ended

Dec. 31, 2016

Share-based Compensation [Abstract]

Stock-based Incentive Plans
STOCK-BASED INCENTIVE PLANS

The 2002 Acacia Technologies Stock Incentive Plan (“2002 Plan”), the 2013 Acacia Research Corporation Stock Incentive Plan (“2013 Plan”) and the 2016 Acacia Research Corporation Stock Incentive Plan (“2016 Plan”) (collectively, the “Plans”) were approved by the stockholders of Acacia in December 2002, May 2013 and June 2016, respectively. All Plans allow grants of stock options, stock awards and performance shares with respect to Acacia common stock to eligible individuals, which generally includes directors, officers, employees and consultants. Except as noted below, the terms and provisions of the Plans are identical in all material respects.

Acacia’s compensation committee administers the discretionary option grant and stock issuance programs. The compensation committee determines which eligible individuals are to receive option grants or stock issuances under those programs, the time or times when the grants or issuances are to be made, the number of shares subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of Acacia’s common stock on the date of grant. Options generally begin to be exercisable six months to one year after grant and generally expire seven to ten years after grant. Stock options with time-based vesting generally vest over two to three years and restricted shares with time based vesting generally vest in full after two to three years (generally representing the requisite service period). The Plans terminate no later than the tenth anniversary of the approval of the incentive plans by Acacia’s stockholders.

The Plans provide for the following separate programs:

•
Discretionary Option Grant Program. Under the discretionary option grant program, Acacia’s compensation committee may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Acacia or its subsidiaries (including employees, non-employee board members and consultants) at an exercise price not less than 85% of the fair market value of those shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of those shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Acacia’s voting stock or the voting stock of any of its subsidiaries).

•
Stock Issuance Program. Under the stock issuance program, eligible individuals may be issued shares of common stock directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares shall not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. The eligible individuals shall have full stockholder rights with respect to any shares of Common Stock issued to them under the Stock Issuance Program, whether or not their interest in those shares is vested. Accordingly, the eligible individuals shall have the right to vote such shares and to receive any regular cash dividends paid on such shares.

•
Automatic Option Grant Program. Each non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual retainer by the grant date fair value of Acacia’s common stock on the grant date, provided that such individual has served as a non-employee director for at least 6 months. In addition, each new non-employee director will receive restricted stock units or stock options for the number of shares determined by dividing the annual board of directors retainer by the grant date fair value of Acacia’s common stock on the commencement date. Restricted stock units and stock options vest in a series of twelve quarterly installments over the three year period following the grant date, subject to immediate acceleration upon a change in control. Acacia will deliver the restricted shares corresponding to the vested restricted stock units within thirty (30) days after the first to occur of the following events: (i) the fifth (5th) anniversary of the grant date; or (ii) termination of the non-employee director’s service as a member of the Company’s Board of Directors. The non-employee directors do not have any rights, benefits or entitlements with respect to any shares unless and until the shares have been delivered.

The number of shares of common stock available for issuance under the 2002 Plan automatically increased on the first trading day of January each calendar year during the term of the Plan by an amount equal to three percent (3%) of the total number of shares of common stock outstanding on the last trading day in December of the immediately preceding calendar year, not to exceed 500,000 shares. The aggregate number of shares of common stock available for issuance under the 2002 Plan could not exceed 20,000,000 shares. At December 31, 2016, there were no shares available for grant under the 2002 Plan.

The number of shares of Common Stock initially reserved for issuance under the 2013 Plan was 4,750,000 shares. No new additional shares will be added to the 2013 Plan without security holder approval (except for shares subject to outstanding awards that are forfeited or otherwise returned to the 2013 Plan). The stock issuable under the 2013 Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market. In June 2016, 625,390 shares of common stock available for issuance under the 2013 Plan were transferred into the 2016 Plan.

On April 26, 2016, Acacia’s Board of Directors adopted the 2016 Plan which was approved by the stockholders in June 2016. The number of shares of Common Stock initially reserved for issuance under the 2016 Plan was 4,500,000 shares plus 625,390 shares of common stock available for issuance under the 2013 Plan, as of the effective date of the Plan. At December 31, 2016, there were 1,754,000 shares available for grant under the 2016 Plan.

Upon the exercise of stock options, the granting of restricted stock, or the delivery of shares pursuant to vested restricted stock units, it is Acacia’s policy to issue new shares of common stock. Acacia’s board of directors may amend or modify the Plans at any time, subject to any required stockholder approval.

The following table summarizes stock-based award grant activity for the Plans for the years ended December 31, 2016 and 2015:

2016

2015

Shares

Aggregate fair value (in thousands)

Shares

Aggregate fair value (in thousands)

Restricted stock awards with time-based service conditions

—

$
—

894,000

$
11,470

Restricted stock unit awards with time-based service conditions

—

—

28,000

468

Restricted stock awards with performance-based vesting conditions

138,000

431

—

—

Stock options with time-based service vesting conditions

3,434,000

5,704

—

—

Stock options with market-based vesting conditions

2,250,000

5,530

—

—

Stock options with performance-based vesting conditions

200,000

487

—

—

Total incentive awards granted

6,022,000

$
12,152

922,000

$
11,938

During the year ended December 31, 2016, the Company granted restricted stock awards and stock options (with weighted-average exercise price of $5.75 per share) with performance-based vesting conditions. The awards vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant. Under the terms of the awards, the number of restricted shares or stock options that will actually vest is based on the extent to which the Company achieves the specified performance targets during the performance period. As of December 31, 2016, 138,000 shares of restricted stock and 200,000 stock options with performance-based vesting conditions remain unvested. As of December 31, 2016, unrecognized expense for awards with performance-based vesting conditions totaled $683,000.

During the year ended December 31, 2016, the Company granted stock options with market-based vesting conditions, with a weighted-average exercise price of $5.75 per share. The options with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. Under the terms of the awards, the number of stock options that will actually vest is based on the extent to which the Company achieves the specified market conditions during the four-year performance period. The stock options vest in equal installments of 25% upon the Company's achievement of 30-day average share prices ranging from $7.00 to $10.00. As of December 31, 2016, 1,687,500 options with market-based vesting conditions remain unvested. As of December 31, 2016, unrecognized expense for options with market-based vesting conditions totaled $2.4 million which is expected to be recognized over an estimated 1 year period.

The following table summarizes stock option activity for the Plans for the year ended December 31, 2016:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value

Outstanding at December 31, 2015

15,000

$
13.38

Granted

5,884,000

$
4.82

Exercised

(101,000
)

$
3.22

Expired/forfeited

(202,000
)

$
3.12

Outstanding at December 31, 2016

5,596,000

$
4.93

6.7 years

$
8,865,000

Vested

1,113,000

$
5.03

6.5 years

$
1,743,000

Exercisable at December 31, 2016

1,113,000

$
5.03

6.5 years

$
1,743,000

The aggregate intrinsic value of options exercised during the years ended December 31, 2016, 2015 and 2014 was $344,000, $751,000, and $518,000, respectively. The aggregate intrinsic value of options vested during the year ended December 31, 2016 was $2,074,000. The aggregate fair value of options granted during the year ended December 31, 2016 was $11,721,000.The aggregate fair value of options vested during the year ended December 31, 2016 was $2,342,000.  No options were granted or vested during the years ended December 31, 2015 and 2014. As of December 31, 2016, the total unrecognized compensation expense related to nonvested stock option awards was $6,842,000, which is expected to be recognized over a weighted-average term of approximately 2 years.

The following table summarizes nonvested restricted share activity for the year ended December 31, 2016:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2015

829,000

$
14.41

Granted

138,000

$
3.12

Vested

(342,000
)

$
15.33

Canceled

(292,000
)

$
14.28

Nonvested restricted stock at December 31, 2016

333,000

$
8.90

The weighted-average grant date fair value of nonvested restricted stock granted during the years ended December 31, 2016, 2015 and 2014 was $3.12, $12.83, and $14.41, respectively. The aggregate fair value of restricted stock that vested during the years ended December 31, 2016, 2015 and 2014 was $5,243,000, $11,494,000 and $21,490,000, respectively. As of December 31, 2016, the total unrecognized compensation expense related to nonvested restricted stock awards was $1,873,000, which is expected to be recognized over a weighted-average period of approximately 1 year.

The following table summarizes restricted stock unit activity for the year ended December 31, 2016:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2015

35,000

$
15.78

Vested

(21,000
)

$
15.43

Nonvested restricted stock units outstanding at December 31, 2016

14,000

$
16.27

Vested restricted stock units outstanding at December 31, 2016

80,000

$
20.99

The weighted-average grant date fair value of restricted stock units granted during the years ended December 31, 2015 and 2014 was $16.72 and $14.33, respectively. There were no restricted units granted during the year ended December 31, 2016. The aggregate fair value of restricted stock units that vested during the years ended December 31, 2016, 2015 and 2014 was $324,000, $480,000 and $460,000, respectively. As of December 31, 2016, the total unrecognized compensation expense related to restricted stock unit awards was $162,000, which is expected to be recognized over a weighted-average period of approximately 1 year.

Compensation expense for the periods presented was comprised of the following:

2016

2015

2014

Restricted stock awards with time-based service conditions

$
—

$
10,575

$
17,631

Restricted stock unit awards with time-based service conditions

4,391

473

484

Restricted stock awards with performance-based vesting conditions

197

—

—

Stock options with time-based service vesting conditions

1,316

—

—

Stock options with market-based vesting conditions

3,158

—

—

Stock options with performance-based vesting conditions

—

—

—

Total compensation expense

$
9,062

$
11,048

$
18,115

As of December 31, 2016, there are 7,445,000 shares of common stock reserved for issuance under the Plans.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1

Commitments and Contingencies
12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
COMMITMENTS AND CONTINGENCIES

Operating Leases

Acacia leases certain office space under various operating lease agreements expiring at various dates from 2017 through 2020. Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2017
$
1,279

2018
1,323

2019
1,369

2020
16

Total minimum lease payments
$
3,987

Rent expense for the years ended December 31, 2016, 2015 and 2014 approximated $1,795,000, $1,926,000 and $1,523,000, respectively. Rental payments are expensed in the statements of operations in the period to which they relate. Scheduled rent increases are amortized on a straight-line basis over the lease term.

Inventor Royalties and Contingent Legal Expenses

In connection with the investment in certain patents and patent rights, certain of Acacia’s operating subsidiaries executed related agreements which grant to the former owners of the respective patents or patent rights, the right to receive inventor royalties based on future net revenues (as defined in the respective agreements) generated as a result of licensing and otherwise enforcing the respective patents or patent portfolios.

Acacia’s operating subsidiaries may retain the services of law firms that specialize in patent licensing and enforcement and patent law in connection with their licensing and enforcement activities. These law firms may be retained on a contingent fee basis whereby such law firms are paid on a scaled percentage of any negotiated fees, settlements or judgments awarded based on how and when the fees, settlements or judgments are obtained.

The economic terms of the inventor agreements, operating agreements and contingent legal fee arrangements associated with the patent portfolios owned or controlled by Acacia’s operating subsidiaries, if any, including royalty rates, contingent fee rates and other terms, vary across the patent portfolios owned or controlled by such operating subsidiaries. Inventor royalties, payments to noncontrolling interests and contingent legal fees expenses fluctuate period to period, based on the amount of revenues recognized each period, the terms and conditions of revenue agreements executed each period and the mix of specific patent portfolios with varying economic terms and obligations generating revenues each period. Inventor royalties and contingent legal fees expenses will continue to fluctuate and may continue to vary significantly period to period, based primarily on these factors.

Patent Enforcement and Other Litigation

Acacia is subject to claims, counterclaims and legal actions that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and legal actions, if any, will not have a material effect on Acacia’s consolidated financial position, results of operations or cash flows.

Certain of Acacia’s operating subsidiaries are often required to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia’s operating subsidiaries’ patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating subsidiaries or award attorney’s fees and/or expenses to a defendant(s), which could be material, and if required to be paid by Acacia or its operating subsidiaries, could materially harm the Company’s operating results and financial position. Fiscal year 2016, 2015 and 2014 operating expenses included expenses for court ordered attorney fees and settlement and contingency accruals totaling $500,000, $4,141,000 and $1,548,000, respectively.

Guarantees and Indemnifications

Certain of Acacia’s operating subsidiaries have made guarantees and indemnities under which they may be required to make payments to a guaranteed or indemnified party, in relation to certain transactions, including revenue transactions in the ordinary course of business. In connection with certain facility leases, Acacia and certain of its operating subsidiaries have indemnified lessors for certain claims arising from the facilities or the leases. Acacia indemnifies its directors and officers to the maximum extent permitted under the laws of the State of Delaware. However, Acacia has a directors and officers insurance policy that may reduce its exposure in certain circumstances and may enable it to recover a portion of future amounts that may be payable, if any. The duration of the guarantees and indemnities varies and, in many cases is indefinite but subject to statute of limitations. The majority of guarantees and indemnities do not provide any limitations of the maximum potential future payments that Acacia could be obligated to make. To date, Acacia has made no payments related to these guarantees and indemnities. Acacia estimates the fair value of its indemnification obligations to be insignificant based on this history and therefore, have not recorded any liability for these guarantees and indemnities in the accompanying consolidated balance sheets. Additionally, no events or transactions have occurred that would result in a material liability at December 31, 2016.

Bank Guarantee
In March 2015, an operating subsidiary of Acacia entered into a standby letter of credit and guarantee arrangement (“Guarantee”) with a bank for purposes of enforcing a court ruling in a German patent court granting an injunction against the defendants in the related patent infringement case. An injunction is an equitable remedy in the form of a court order that compels the defendant(s) to cease marketing, offering for sale or importing applicable infringing products into applicable jurisdiction(s).
Under German law, in order to enforce the injunction granted by the court, a Guarantee is required to be furnished by the operating subsidiary, the plaintiff in the case, for potential payment to the defendants of any applicable claims which may be incurred by the defendants as a result of the enforcement of the injunction, only in the event that the aforementioned court ruling is subsequently successfully appealed by the defendants or otherwise amended. The Guarantee is required to be issued unlimited with respect to time, until appropriately extinguished in accordance with German law. The Guarantee will be extinguished when a relevant extinguishment order by the court having jurisdiction takes effect, typically occurring when the related infringement case has been settled or a final non-appealable decision has been issued by the court.
The Guarantee is secured by a cash deposit at the contracting bank, which is classified as restricted cash in the accompanying balance sheets, totaling $11,512,000 and $10,725,000 of December 31, 2016 and 2015, respectively. Changes in the balance are primarily a result of additional court rulings granting injunctions with respect to additional defendants, and foreign currency exchange rate fluctuations and the related impact on the underlying collateral, which is denominated in U.S. dollars. The Guarantee expires on April 10, 2017, however, it is automatically extended without amendment for a period of one (1) year from the present or any future expiration date, unless at least 30 days prior to any expiration date, the Guarantee is extinguished in accordance with German law. The Guarantee facility fee is 1.15% per year, and the related expense is included in the consolidated statement of operations.

Other

In August 2010, a wholly owned subsidiary of Acacia became the general partner of the Acacia IP Fund, which was formed in August 2010. The Acacia IP Fund is authorized to raise up to $250,000,000. The Acacia IP Fund invests in, licenses and enforces intellectual property consisting primarily of patents, patent rights, and patented technologies. Refer to Note 2 to these notes to consolidated financial statements for information regarding the consolidation of majority-owned subsidiaries and the presentation of related noncontrolling interests. At December 31, 2016 and 2015, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):

2016

2015
Cash and other assets

$
1,118

$
7,740

Patents, net of accumulated amortization

—

147

Investments - noncurrent

2,933

5,829

Total assets

$
4,051

$
13,716

Accrued expenses and contributions

$
2,394

$
7,436

Net assets

$
1,657

$
6,280

2016

2015
Revenues

$
16

$
18

Operating expenses

572

1,617

Loss from operations

(556
)

(1,599
)
Net gain (loss) in equity method investments

(1,013
)

6,922

Net income (loss)

$
(1,569
)

$
5,323

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73718637&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1

Retirement Savings Plan and Executive Severance Policy
12 Months Ended

Dec. 31, 2016

RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]

Retirement Savings Plan and Executive Severance Policy
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY

Retirement Savings Plan.  Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented.

Executive Severance Policy.  Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

X

- Definition
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
+ References
No definition available.
+ Details

Name: actg_RetirementSavingsPlanAndExecutiveSeverancePolicyAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 80
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e2410-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39675-114964

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963
+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1

Supplemental Cash Flow Information
12 Months Ended

Dec. 31, 2015

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information
SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for state income taxes totaled $223,000, $211,000 and $172,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Foreign taxes withheld totaled $14,776,000, $4,421,000 and $5,159,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Refer to Note 5 for accrued foreign taxes payable.

Refer to Note 6 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 8 for information regarding noncash investing activity related to the investment in Veritone, Inc. for the periods presented.

X

- Definition
The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586
+ Details

Name: us-gaap_CashFlowSupplementalDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1

Quarterly Financial Data
12 Months Ended

Dec. 31, 2016

Quarterly Financial Data [Abstract]

Quarterly Financial Data
QUARTERLY FINANCIAL DATA (unaudited)
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2016. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2016

2016

2016

2016

2015

2015

2015

2015

(Unaudited, in thousands, except share and per share information)
Revenues

$
24,721

$
41,351

$
64,658

$
21,969

$
34,210

$
40,336

$
12,994

$
37,497

Operating costs and expenses:

Cost of revenues:

Inventor royalties

1,573

—

17,844

3,313

9,325

1,265

116

7,756

Contingent legal fees

4,109

10,418

7,709

4,238

4,784

5,512

1,972

3,901

Litigation and licensing expenses - patents

7,723

7,324

7,348

5,463

8,675

9,012

10,345

11,341

Amortization of patents

10,760

10,759

6,467

6,222

13,038

13,228

13,688

13,113

General and administrative expenses (including non-cash stock compensation expense)

7,994

7,535

8,334

9,056

10,575

9,587

9,442

8,572

Research, consulting and other expenses - business development

522

1,334

666

557

997

732

802

860

Impairment of patent-related intangible assets

—

40,165

—

2,175

—

—

—

74,731

Impairment of goodwill

—

—

—

—

—

—

—

30,149

Other

1,742

(1,242
)

—

—

426

—

3,465

250

Total operating costs and expenses

34,423

76,293

48,368

31,024

47,820

39,336

39,830

150,673

Operating income (loss)

(9,702
)

(34,942
)

16,290

(9,055
)

(13,610
)

1,000

(26,836
)

(113,176
)
Total other income (expense)

(3
)

(52
)

261

592

228

(104
)

(180
)

—

Income (loss) before (provision for) benefit from income taxes

(9,705
)

(34,994
)

16,551

(8,463
)

(13,382
)

896

(27,016
)

(113,176
)
Provision for income taxes

(192
)

(5,927
)

(9,655
)

(2,414
)

(170
)

(119
)

(337
)

(4,174
)
Net income (loss) including noncontrolling interests

(9,897
)

(40,921
)

6,896

(10,877
)

(13,552
)

777

(27,353
)

(117,350
)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries

(68
)

348

186

266

422

(4,463
)

43

1,440

Net income (loss) attributable to Acacia Research Corporation

$
(9,965
)

$
(40,573
)

$
7,082

$
(10,611
)

$
(13,130
)

$
(3,686
)

$
(27,310
)

$
(115,910
)
Net loss per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.20
)

$
(0.81
)

$
0.14

$
(0.21
)

$
(0.27
)

$
(0.08
)

$
(0.55
)

$
(2.33
)
Weighted-average number of shares outstanding, basic

49,925,550

50,015,869

50,124,302

50,237,784

49,212,207

49,423,472

49,630,369

49,749,941

Weighted-average number of shares outstanding, diluted

49,925,550

50,015,869

50,618,757

50,237,784

49,212,207

49,423,472

49,630,369

49,749,941

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialDataAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305
+ Details

Name: us-gaap_QuarterlyFinancialInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1

Subsequent Events (Notes)
12 Months Ended

Dec. 31, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]
SUBSEQUENT EVENTS

On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of equity interests in AIP to certain members of management and Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the equity value of AIP increases beyond the value at issuance. The equity interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones, subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement.

Acacia owns substantially all of the equity in AIP and at all times will control AIP. Although AIP currently holds no material assets, Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Fiscal Period
Accounting Principles and Fiscal Year End.  The consolidated financial statements and accompanying notes are prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America.

Consolidation, Subsidiaries or Other Investments, Consolidated Entities
Principles of Consolidation.  The accompanying consolidated financial statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany transactions and balances have been eliminated in consolidation.

Net income (loss) attributable to noncontrolling interest
Noncontrolling interests in Acacia’s majority-owned and controlled operating subsidiaries (“noncontrolling interests”) are separately presented as a component of stockholders’ equity. Consolidated net income or (loss) is adjusted to include the net (income) or loss attributed to noncontrolling interests in the consolidated statements of operations. Refer to the accompanying consolidated statements of stockholders’ equity for total noncontrolling interests.

A wholly owned subsidiary of Acacia is the general partner of the Acacia Intellectual Property Fund, L.P. (the “Acacia IP Fund”), which was formed in August 2010. The Acacia IP Fund is included in the Company’s consolidated financial statements since 2010, as Acacia’s wholly owned subsidiary, as the general partner, has the ability to control the operations and activities of the Acacia IP Fund. Refer to Note 12 to these consolidated financial statements.

Revenue Recognition
Revenue Recognition.  Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectibility of amounts is reasonably assured.

In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by Acacia’s operating subsidiaries. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled by Acacia’s operating subsidiaries, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, Acacia’s operating subsidiaries have no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on Acacia’s operating subsidiaries’ part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectibility is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met.
For the periods presented herein, the majority of the revenue agreements executed by the Company provided for the payment of one-time, paid-up license fees in consideration for the grant of certain intellectual property rights for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending until the expiration of the underlying patents.

Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.

Certain of the Company’s revenue arrangements provide for the calculation of fees based on a licensee’s actual quarterly sales or actual per unit activity, applied to a contractual royalty rate. Licensees that pay fees on a quarterly basis generally report actual quarterly sales or actual per unit activity information and related quarterly fees due within 30 days to 45 days after the end of the quarter in which such sales or activity takes place. The amount of fees due under these revenue arrangements each quarter cannot be reasonably estimated by management. Consequently, Acacia’s operating subsidiaries recognize revenue from these revenue arrangements on a three-month lag basis, in the quarter following the quarter of sales or per unit activity, provided amounts are fixed or determinable and collectibility is reasonably assured. The lag method described above allows for the receipt of licensee royalty reports prior to the recognition of revenue.

Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.

Acacia assesses the collectibility of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectibility becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.

Cost of Revenues

Cost of Revenues.  Cost of revenues include the costs and expenses incurred in connection with Acacia’s patent licensing and enforcement activities, including inventor royalties paid to original patent owners, contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment costs. These costs are included under the caption “Cost of revenues” in the accompanying consolidated statements of operations.

Inventor Royalties and Contingent Legal Expenses
Inventor Royalties and Contingent Legal Expenses. Inventor royalties are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of the underlying inventor agreements, upfront advances paid to patent owners by Acacia’s operating subsidiaries are recoverable from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense is included in amortization expense in the consolidated statements of operations. Any unamortized upfront advances recovered from net revenues are expensed in the period recovered, and included in amortization expense in the consolidated statements of operations. Refer to Note 12 for additional information.

Contingent legal fees are expensed in the consolidated statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal fees are paid; however, Acacia’s operating subsidiaries may be liable for certain out of pocket legal costs incurred pursuant to the underlying legal services agreement.

Fair Value Measurements
Fair Value Measurements. U.S. generally accepted accounting principles define fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established to measure fair value is defined as follows:

●
Level 1 -
Observable Inputs:  Quoted prices in active markets for identical investments;

●
Level 2 -
Pricing Models with Significant Observable Inputs:  Other significant observable inputs, including quoted prices for similar investments, interest rates, credit risk, etc.; and

●
Level 3 -
Unobservable Inputs:  Significant unobservable inputs, including the entity’s own assumptions in determining the fair value of investments.
Whenever possible, the Company is required to use observable market inputs (Level 1 - quoted market prices) when measuring fair value. Acacia has not elected the fair value option for recording non-financial assets and liabilities, and therefore no fair value measurements are performed on a recurring basis.

Cash and Cash Equivalents

Cash and Cash Equivalents.  Acacia considers all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia’s cash equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations, and fully collateralized repurchase agreements. Acacia’s cash equivalents are measured at fair value using quoted prices that represent Level 1 inputs.

Marketable Securities
Investments in Marketable Securities.  Investments in securities with original maturities of greater than three months and less than one year and other investments representing amounts that are available for current operations are classified as short-term investments, unless there are indications that such investments may not be readily sold in the short term. The fair values of these investments approximate their carrying values. As of December 31, 2015, the balance of short term investments was zero. At December 31, 2016, all of Acacia’s short-term investments were classified as available-for-sale, which are reported at fair value on a recurring basis using significant observable inputs (Level 1), with related unrealized gains and losses in the value of such securities recorded as a separate component of other comprehensive income (loss) in stockholders’ equity until realized. Realized and unrealized gains and losses are recorded based on the specific identification method. Interest on all securities is included in total other income (expense).

Impairment of Marketable Securities. Acacia evaluates its investments in marketable securities for potential impairment, employing a systematic methodology on a quarterly basis that considers available quantitative and qualitative evidence. If the cost or carrying value of an investment exceeds its estimated fair value, the Company evaluates, among other factors, general market conditions, credit quality of instrument issuers, the duration and extent to which the fair value is less than cost, and the Company’s intent and ability to hold, or plans or ability to sell. Fair value is estimated based on publicly available market information or other estimates determined by management. Investments are considered to be impaired when a decline in fair value is estimated to be other-than-temporary. Acacia reviews impairments associated with its investments in marketable securities and determines the classification of any impairment as temporary or other-than-temporary. An impairment is deemed other-than-temporary unless (a) Acacia has the ability and intent to hold an investment for a period of time sufficient for recovery of its carrying amount and (b) positive evidence indicating that the investment’s carrying amount is recoverable within a reasonable period of time outweighs any evidence to the contrary. All available evidence, both positive and negative, is considered to determine whether, based on the weight of such evidence, the carrying amount of the investment is recoverable within a reasonable period of time. For investments classified as available-for-sale, unrealized losses that are other-than-temporary are recognized in the consolidated statements of operations.

Concentrations of Credit Risk

Concentration of Credit Risks.  Financial instruments that potentially subject Acacia to concentrations of credit risk are cash equivalents, investments and accounts receivable. Acacia places its cash equivalents and investments primarily in highly rated money market funds and investment grade marketable securities. Cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not experienced any significant losses on its deposits of cash and cash equivalents.

Three licensees individually accounted for 26%, 23% and 11%, respectively, of revenues recognized during the year ended December 31, 2016. Three licensees individually accounted for 24%, 20% and 16%, respectively, of revenues recognized during the year ended December 31, 2015. Two licensees individually accounted for 22% and 22%, respectively, of revenues recognized during the year ended December 31, 2014. Four licensees individually represented approximately 39%, 22%, 16% and 15%, respectively, of accounts receivable at December 31, 2016. Two licensees individually represented approximately 72% and 21%, respectively, of accounts receivable at December 31, 2015.

For 2016, 2015 and 2014, 79%, 49% and 43%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.

Acacia performs credit evaluations of its licensees with significant receivable balances, if any, and has not experienced any significant credit losses. Accounts receivable are recorded at the executed contract amount and generally do not bear interest. Collateral is not required. An allowance for doubtful accounts may be established to reflect the Company’s best estimate of probable losses inherent in the accounts receivable balance, and is reflected as a contra-asset account on the balance sheet and a charge to operating expenses in the statement of operations for the applicable period. The allowance is determined based on known troubled accounts, historical experience, and other currently available evidence. There was no allowance for doubtful accounts established for the periods presented.


Furniture and Equipment
Property and Equipment.  Property and equipment are recorded at cost. Major additions and improvements that materially extend useful lives of property and equipment are capitalized. Maintenance and repairs are charged against the results of operations as incurred. When these assets are sold or otherwise disposed of, the asset and related depreciation are relieved, and any gain or loss is included in the consolidated statements of operations for the period of sale or disposal. Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Rental payments on operating leases are charged to expense in the consolidated statements of operations on a straight-line basis over the lease term.

Patents
Patents.  Patents include the cost of patents or patent rights (hereinafter, collectively “patents”) acquired from third-parties or obtained in connection with business combinations. Patent costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio.

Goodwill
Goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis (December 31) and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. Acacia considers its market capitalization and the carrying value of its assets and liabilities, including goodwill, when performing its goodwill impairment test. When conducting its annual goodwill impairment assessment, the Company initially performs a qualitative evaluation of whether it is more likely than not that goodwill is impaired. If it is determined by a qualitative evaluation that it is more likely than not that goodwill is impaired, the Company then applies a two-step impairment test. The two-step impairment test first compares the fair value of the Company’s reporting unit to its carrying or book value. If the fair value of the reporting unit exceeds its carrying value, goodwill is not impaired and the Company is not required to perform further testing. If the carrying value of the reporting unit exceeds its fair value, the Company determines the implied fair value of the reporting unit’s goodwill and if the carrying value of the reporting unit’s goodwill exceeds its implied fair value, then an impairment loss equal to the difference is recorded in the consolidated statement of operations. Acacia's goodwill balance of $30.1 million was fully written-off as of December 31, 2015. Refer to Note 7 for additional information.

Impairment of Long-Lived Assets
Impairment of Long-lived Assets. Acacia reviews long-lived assets and intangible assets for potential impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than the carrying amount of the asset, an impairment loss is recorded equal to the excess of the asset’s carrying value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques, including a discounted value of estimated future cash flows. Refer to Note 7 for additional information.

Fair value is generally estimated using the “Income Approach,” focusing on the estimated future net income-producing capability of the patent portfolios over the estimated remaining economic useful life. Estimates of future after-tax cash flows are converted to present value through “discounting,” including an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market share data. Estimated cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio’s licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology coverage and other pertinent information that could impact future net cash flows.

Fair Value of Financial Instruments
Fair Value of Financial Instruments.  The carrying value of cash and cash equivalents, investments, accounts receivables, and accounts payable approximates their fair values due to their short-term maturities.

Contingent liabilities [Policy Text Block]
Contingent Liabilities. The Company, from time to time, is involved in certain legal proceedings. Based upon consultation with outside counsel handling its defense in these matters and the Company’s analysis of potential outcomes, if the Company determines that a loss arising from such matters is probable and can be reasonably estimated, an estimate of the contingent liability is recorded in its consolidated financial statements. If only a range of estimated loss can be determined, an amount within the range that, based on estimates, assumptions and judgments, reflects the most likely outcome, is recorded as a contingent liability in the consolidated financial statements. In situations where none of the estimates within the estimated range is a better estimate of probable loss than any other amount, the Company records the low end of the range. Any such accrual would be charged to expense in the appropriate period. Litigation expenses for these types of contingencies are recognized in the period in which the litigation services were provided.

Stock-based Compensation
Stock-Based Compensation. The compensation cost for all stock-based awards is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee’s requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model. Stock-based compensation expense for awards with service and / or performance conditions that affect vesting is recorded only for those awards expected to vest using an estimated forfeiture rate. Refer to Note 11 to these notes to consolidated financial statements for information on stock-based awards granted for the periods presented.

The fair value of stock options granted during the year ended December 31, 2016 was estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

Weighted-Average Assumptions

Risk-free interest rate
1.1%
Term
3.06
Volatility
53%
Dividend yield
—%

Due to a lack of sufficient historical stock option exercise experience, the Company utilized the simplified method for estimating the expected term for stock options granted during the year ended December 31, 2016.  Expected volatility is based on the historical volatility of the Company’s stock for the length of time corresponding to the expected term of the option. The risk-free interest rate is based on the U.S. treasury yield curve on the grant date for the expected term of the option.

Restricted stock awards and stock option awards with performance-based vesting conditions generally vest based upon the Company achieving specified cash flow performance targets over a one and two-year period from the date of grant.

Performance-based stock options awards with market-based vesting conditions vest based upon the Company achieving specified stock price targets over a four-year period. The effect of a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique. Compensation cost is recognized for an option with a market-based vesting condition provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. The service period for options with a market-based vesting condition is inferred from the application of the Monte Carlo valuation technique. The derived service period represents the duration of the median of the distribution of share price paths on which the market condition is satisfied. The duration is the period of time from the service inception date to the expected date of satisfaction, as determined from the valuation technique. Assumptions utilized in connection with the Monte Carlo valuation technique included: estimated risk-free interest rate; expected volatility; and expected dividend yield. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on expectations regarding dividend payments.

Income Taxes
Income Taxes.  Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in Acacia’s consolidated financial statements or consolidated income tax returns. A valuation allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized, or if it is determined that there is uncertainty regarding future realization of such assets.

Under U.S. generally accepted accounting principles, a tax position is a position in a previously filed tax return or a position expected to be taken in a future tax filing that is reflected in measuring current or deferred income tax assets and liabilities. Tax positions are recognized only when it is more likely than not (likelihood of greater than 50%), based on technical merits, that the position will be sustained upon examination. Tax positions that meet the more likely than not threshold are measured using a probability weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

If a deduction reported on a tax return for an equity-based incentive award exceeds the cumulative compensation cost for those instruments recognized for financial reporting purposes, any resulting realized tax benefit that exceeds the previously calculated deferred tax asset for those instruments is considered an excess tax benefit, and is recognized as additional paid-in capital. If the tax deduction is less than the cumulative book compensation cost, the tax effect of the resulting difference is charged first to APIC, to the extent of the available pool of windfall tax benefits, with any remainder recognized in income tax expense.

Segment Reporting
Segment Reporting.  Acacia uses the management approach, which designates the internal organization that is used by management for making operating decisions and assessing performance as the basis of Acacia’s reportable segments. Acacia’s patent licensing and enforcement business constitutes its single reportable segment.

Use of Estimates
Use of Estimates.  The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, the allocation of loans to investees between the loans receivable and common stock purchase warrants received, and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.

Earnings Per Share
Income (Loss) Per Share.  The Company computes net income (loss) attributable to common stockholders using the two-class method required for capital structures that include participating securities. Under the two-class method, securities that participate in non-forfeitable dividends, such as the Company’s outstanding unvested restricted stock, are considered “participating securities.”

In applying the two-class method, (i) basic net income (loss) per share is computed by dividing net income (loss) (less any dividends paid on participating securities) by the weighted average number of shares of common stock and participating securities outstanding for the period and (ii) diluted earnings per share may include the additional effect of other securities, if dilutive, in which case the dilutive effect of such securities is calculated by applying the two-class method and the treasury stock method to the assumed exercise or vesting of potentially dilutive common shares. The method yielding the more dilutive result is ultimately reported for the applicable period. Potentially dilutive common stock equivalents primarily consist of employee stock options, and restricted stock units for calculations utilizing the two-class method, and also include unvested restricted stock, when utilizing the treasury method.

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2016

2015

2014
Numerator (in thousands):

Basic and Diluted

Net loss

$
(54,067
)

$
(160,036
)

$
(66,029
)
Total dividends declared / paid

—

(25,434
)

(25,039
)
Dividends attributable to common stockholders

—

24,740

24,313

Net loss attributable to common stockholders – basic and diluted

$
(54,067
)

$
(160,730
)

$
(66,755
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

50,075,847

49,505,817

48,658,088

Basic and diluted net loss per common share

$
(1.08
)

$
(3.25
)

$
(1.37
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

3,682,532

71,468

27,760



Treasury Stock [Policy Text Block]
Treasury Stock. Repurchases of the Company’s outstanding common stock are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to additional paid-in capital, and reflected as Treasury Stock on the consolidated balance sheets.


Recently Adopted Accounting Policies
Recent Accounting Pronouncements - Not Yet Adopted. In May 2014, the FASB issued a new accounting standards update addressing revenue from contracts with customers, which clarifies existing accounting literature relating to how and when a company recognizes revenue. Under the standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods and services. The amendments for this standard update are effective for interim and annual reporting periods beginning after December 15, 2016, and are to be applied retrospectively or the cumulative effect as of the date of adoption, with early application not permitted. The Company is currently evaluating the impact and method of adoption the pronouncement will have on its consolidated financial statements and related disclosures.

In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. This update is effective for annual reporting periods beginning after December 31, 2016, including interim periods within those annual periods, and early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In February 2016, the FASB issued an accounting standard update which requires lessees to recognize most leases on the balance sheet. This is expected to increase both reported assets and liabilities. The new lease standard does not substantially change lessor accounting. For public companies, the standard will be effective for the first interim reporting period within annual periods beginning after December 15, 2018, although early adoption is permitted. Lessees and lessors will be required to apply the new standard at the beginning of the earliest period presented in the financial statements in which they first apply the new guidance, using a modified retrospective transition method. The requirements of this standard include a significant increase in required disclosures. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In March 2016, the FASB issued a new standard that changes the accounting for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also allows an employer to repurchase more of an employee’s shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 15, 2016, and interim periods within those years. Early adoption is permitted. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

In June 2016, the FASB issued guidance on the measurement and recognition of credit losses on most financial assets. For trade receivables, loans, and held-to-maturity debt securities, the current probable loss recognition methodology is being replaced by an expected credit loss model. For available-for-sale debt securities, the recognition model on credit losses is generally unchanged, except the losses will be presented as an adjustable allowance. The guidance will be applied retrospectively with the cumulative effect recognized as of the date of adoption. The guidance will become effective at the beginning of our first quarter of fiscal 2021 but can be adopted as early as the beginning of our first quarter of fiscal 2020. Management is currently assessing the impact that adopting this new accounting guidance will have on its financial statements and footnote disclosures.

Recently adopted accounting policies [Policy Text Block]
Recently Adopted Accounting Pronouncements - Recently Adopted. In August 2014, the FASB issued a new accounting standard which requires management to assess an entity’s ability to continue as a going concern every reporting period including interim periods, and to provide related footnote disclosure in certain circumstances. Adoption of this standard is required for annual periods beginning after December 15, 2016 and are to be applied retrospectively or the cumulative effect as of the date of adoption. Early adoption is permitted. The adoption of this standard effective December 31, 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In June 2014, the FASB issued a new accounting standard which requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. Adoption of this standard is required for annual periods beginning after December 15, 2015. Early adoption is permitted. The adoption of this standard effective January 2016 did not have a material impact on the Company's consolidated financial statements and related disclosures.

In August 2016, the FASB issued amended guidance to clarify guidance on the classification of certain cash receipts and cash payments. Additionally, the guidance requires that the statement of cash flows reflect changes in restricted cash in addition to cash and cash equivalents. Amended guidance includes clarification on debt prepayment and extinguishment costs, contingent consideration in business combinations, proceeds from insurance claims, and premium payments on company-owned life insurance. Refer to the consolidated statement of cash flows elsewhere herein for separate presentation of changes in restricted cash.

X

- Definition
Contingent liabilities [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_ContingentliabilitiesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs of revenues recognized during the period.
+ References
No definition available.
+ Details

Name: actg_CostOfRevenuesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Goodwill [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_GoodwillPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Inventor royalties and contingent legal expenses [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_InventorRoyaltiesAndContingentLegalExpensesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Net income (loss) attributable to noncontrolling interest
+ References
No definition available.
+ Details

Name: actg_NetincomelossattributabletononcontrollinginterestPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Recently adopted accounting policies [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_RecentlyAdoptedAccountingPoliciesPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Treasury Stock [Policy Text Block]
+ References
No definition available.
+ Details

Name: actg_TreasuryStockPolicyTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 55
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68064133&loc=d3e61082-112788

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68064133&loc=d3e61044-112788
+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64809438&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.3A-04)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355119-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68079674&loc=d3e5291-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355100-122828

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02(b))
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828
+ Details

Name: us-gaap_FiscalPeriod

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-URI http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64802544&loc=d3e202-110218
+ Details

Name: us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(6))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.M)
-URI http://asc.fasb.org/extlink&oid=65877573&loc=d3e87990-122713

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Readily Determinable Fair Value
-URI http://asc.fasb.org/extlink&oid=65888395

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section S50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6381980&loc=d3e87707-122711

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62652-112803

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_MarketableSecuritiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.B.Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for segment reporting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790
+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The fair value of stock options granted during the year ended December 31, 2016 was estimated using the Black-Scholes option-pricing model, based on the following weighted-average assumptions:

Weighted-Average Assumptions

Risk-free interest rate
1.1%
Term
3.06
Volatility
53%
Dividend yield
—%

Property and Equipment, Useful Lives
Depreciation and amortization is computed on a straight-line basis over the following estimated useful lives of the assets:
Furniture and fixtures
3 to 5 years
Computer hardware and software
3 to 5 years
Leasehold improvements
2 to 5 years (Lesser of lease term or useful life of improvement)

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the weighted-average number of common shares outstanding used in the calculation of basic and diluted income per share:

2016

2015

2014
Numerator (in thousands):

Basic and Diluted

Net loss

$
(54,067
)

$
(160,036
)

$
(66,029
)
Total dividends declared / paid

—

(25,434
)

(25,039
)
Dividends attributable to common stockholders

—

24,740

24,313

Net loss attributable to common stockholders – basic and diluted

$
(54,067
)

$
(160,730
)

$
(66,755
)

Denominator:

Weighted-average shares used in computing net loss per share attributable to common stockholders – basic and diluted

50,075,847

49,505,817

48,658,088

Basic and diluted net loss per common share

$
(1.08
)

$
(3.25
)

$
(1.37
)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted loss per share

3,682,532

71,468

27,760



X

- Definition
Property and Equipment, Useful Lives [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PropertyAndEquipmentUsefulLivesTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1311-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1

Short-term Investments (Tables)
12 Months Ended

Dec. 31, 2016

Short-term Investments [Abstract]

Short-term Investments
Short-term marketable securities for the periods presented were comprised of the following (in thousands):

December 31, 2016
Security Type
Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value
U.S. government fixed income securities
$
19,403

$
40

$
—

$
19,443

X

- Definition
Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26626-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.4)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2,12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MarketableSecuritiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShortTermInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1

Property and Equipment (Tables)
12 Months Ended

Dec. 31, 2016

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment consists of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Furniture and fixtures

$
733

$
739

Computer hardware and software

603

649

Leasehold improvements

131

145

1,467

1,533

Less:  accumulated depreciation and amortization

(1,340
)

(1,261
)

$
127

$
272

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accounts Payable and Accrued Expenses (Tables)
12 Months Ended

Dec. 31, 2016

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accounts Payable and Accrued Expenses / Costs
Accounts payable and accrued expenses consist of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Payroll and other employee benefits

$
1,593

$
576

Accrued vacation

533

701

Accrued legal expenses - patent

6,564

10,135

Foreign taxes payable ⁽¹⁾

3,150

3,960

Accrued consulting and other professional fees

1,967

1,592

Other accrued liabilities

476

383

$
14,283

$
17,347

⁽¹⁾ - Included in "Accounts payable and accrued expenses / patent costs" line item on the consolidated statement of cash flows included elsewhere herein.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1

Patents (Tables)
12 Months Ended

Dec. 31, 2016

Patents [Abstract]

Patents
The gross carrying amounts and accumulated amortization related to investments in intangible assets as of December 31, 2016 and 2015 are as follows (in thousands):

2016

2015

Gross carrying amount - patents

$
444,362

$
444,137

Accumulated amortization - patents⁽¹⁾

(358,043
)

(281,495
)
Patents, net

$
86,319

$
162,642

Patent costs and accumulated amortization related to patent sales and disposals [Table Text Block]
For the years ended December 31, 2016, 2015 and 2014, capitalized patent costs, accumulated amortization, and sales proceeds related to patent-related sales and disposals are as follows (in thousands):

2016

2015

2014

Capitalized patent costs

$
—

$
500

$
3,000

Accumulated amortization

—

120

298

Sales proceeds

—

750

3,500

X

- Definition
Patent costs and accumulated amortization, and sales proceeds and other costs related to patent sales and disposals [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentcostsandaccumulatedamortizationandsalesproceedsandothercostsrelatedtopatentsalesanddisposalsTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_PatentsTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1

Loan Receivable and Investment in Warrants (Tables)
12 Months Ended

Dec. 31, 2016

Investments, All Other Investments [Abstract]

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
A summary of assumptions used in connection with estimating the relative fair values were as follows:
Valuation Technique

Significant Unobservable Inputs

Range of Inputs
Monte Carlo simulation model

Volatility

40
%
-
50%

Marketability discount

7%

Funding scenario probabilities

25
%
-
75%

Recovery

100%

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
The Veritone Loans and warrants are reflected in the accompanying consolidated financial statements as follows (in thousands):

As of and For the Year Ended December 31, 2016
Face value of loan receivable

$
20,000

Unamortized loan discount

(1,384
)
Carrying value of loan receivable

18,616

Investment in warrants (initial loan discount)

1,960

Total

$
20,576

Interest receivable

$
286

Accretion of loan discount

576

Interest income

$
862

X

- Definition
Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258
+ Details

Name: us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAllOtherInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes (Tables)
12 Months Ended

Dec. 31, 2016

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)
Acacia’s provision for income taxes for the fiscal periods presented consisted of the following (in thousands):

2016

2015

2014

Current:

Federal

$
—

$
—

$
—

State taxes

262

379

289

Foreign taxes

17,926

4,421

5,359

Total current

18,188

4,800

5,648

Deferred:

Federal

—

—

(1,867
)
State taxes

—

—

131

Total deferred

—

—

(1,736
)
Provision for income taxes

$
18,188

$
4,800

$
3,912

Schedule of Deferred Tax Assets and Liabilities
The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following at December 31, 2016 and 2015 (in thousands):

2016

2015

Deferred tax assets:

Net operating loss and capital loss carryforwards and credits

$
83,323

$
71,494

Stock compensation

2,416

1,385

Fixed assets and intangibles

14,343

1,359

Basis of investments in affiliates

2,195

499

Accrued liabilities and other

422

442

State taxes

90

81

Total deferred tax assets

102,789

75,260

Valuation allowance

(102,627
)

(75,179
)
Total deferred tax assets, net of valuation allowance

162

81

Deferred tax liabilities:

Fixed assets and intangibles

—

—

Other

(162
)

(81
)
Total deferred tax liabilities

(162
)

(81
)

Net deferred tax assets (liabilities)

$
—

$
—

Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the federal statutory income tax rate and the effective income tax rate is as follows:

2016

2015

2014

Statutory federal tax rate - (benefit) expense

(35
)%

(35
)%

(35
)%
State income and foreign taxes, net of federal tax effect

50
%

3
%

9
%
Foreign tax credit

(49
)%

(3
)%

(8
)%
Noncontrolling interests in operating subsidiaries

1
%

(1
)%

—
%
Goodwill

—
%

7
%

—
%
Nondeductible permanent items

—
%

—
%

1
%
Expired capital loss carryforwards

—
%

1
%

—
%
Valuation allowance

83
%

31
%

39
%

50
%

3
%

6
%

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans (Tables)
12 Months Ended

Dec. 31, 2016

Share-based Compensation [Abstract]

Schedule of Other Share-based Compensation, Activity [Table Text Block]
Compensation expense for the periods presented was comprised of the following:

2016

2015

2014

Restricted stock awards with time-based service conditions

$
—

$
10,575

$
17,631

Restricted stock unit awards with time-based service conditions

4,391

473

484

Restricted stock awards with performance-based vesting conditions

197

—

—

Stock options with time-based service vesting conditions

1,316

—

—

Stock options with market-based vesting conditions

3,158

—

—

Stock options with performance-based vesting conditions

—

—

—

Total compensation expense

$
9,062

$
11,048

$
18,115

Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period [Text Block]
The following table summarizes stock-based award grant activity for the Plans for the years ended December 31, 2016 and 2015:

2016

2015

Shares

Aggregate fair value (in thousands)

Shares

Aggregate fair value (in thousands)

Restricted stock awards with time-based service conditions

—

$
—

894,000

$
11,470

Restricted stock unit awards with time-based service conditions

—

—

28,000

468

Restricted stock awards with performance-based vesting conditions

138,000

431

—

—

Stock options with time-based service vesting conditions

3,434,000

5,704

—

—

Stock options with market-based vesting conditions

2,250,000

5,530

—

—

Stock options with performance-based vesting conditions

200,000

487

—

—

Total incentive awards granted

6,022,000

$
12,152

922,000

$
11,938

Stock Options Activity
The following table summarizes stock option activity for the Plans for the year ended December 31, 2016:

Weighted-Average

Options

Exercise
Price

Remaining
Contractual Term

Aggregate
Intrinsic Value

Outstanding at December 31, 2015

15,000

$
13.38

Granted

5,884,000

$
4.82

Exercised

(101,000
)

$
3.22

Expired/forfeited

(202,000
)

$
3.12

Outstanding at December 31, 2016

5,596,000

$
4.93

6.7 years

$
8,865,000

Vested

1,113,000

$
5.03

6.5 years

$
1,743,000

Exercisable at December 31, 2016

1,113,000

$
5.03

6.5 years

$
1,743,000

Nonvested Restricted Stock Activity
The following table summarizes nonvested restricted share activity for the year ended December 31, 2016:

Nonvested
Restricted Shares

Weighted
Average Grant Date Fair Value

Nonvested restricted stock at December 31, 2015

829,000

$
14.41

Granted

138,000

$
3.12

Vested

(342,000
)

$
15.33

Canceled

(292,000
)

$
14.28

Nonvested restricted stock at December 31, 2016

333,000

$
8.90

Restricted Stock Units Activity
The following table summarizes restricted stock unit activity for the year ended December 31, 2016:

Restricted
Stock Units

Weighted
Average Grant Date Fair Value

Nonvested restricted stock units outstanding at December 31, 2015

35,000

$
15.78

Vested

(21,000
)

$
15.43

Nonvested restricted stock units outstanding at December 31, 2016

14,000

$
16.27

Vested restricted stock units outstanding at December 31, 2016

80,000

$
20.99

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Grants in Period [Text Block]
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardGrantsinPeriodTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in outstanding nonvested shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the changes in other outstanding share-based compensation awards other than stock options or nonvested awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1

Commitments and Contingencies (Tables)
12 Months Ended

Dec. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases
Minimum annual rental commitments for operating leases of continuing operations having initial or remaining noncancellable lease terms in excess of one year are as follows (in thousands):

Years ending December 31,

2017
$
1,279

2018
1,323

2019
1,369

2020
16

Total minimum lease payments
$
3,987

Net assets of IP Fund [Table Text Block]
At December 31, 2016 and 2015, the Acacia IP Fund net assets and net income (loss) were primarily comprised of the following (in thousands):

2016

2015
Cash and other assets

$
1,118

$
7,740

Patents, net of accumulated amortization

—

147

Investments - noncurrent

2,933

5,829

Total assets

$
4,051

$
13,716

Accrued expenses and contributions

$
2,394

$
7,436

Net assets

$
1,657

$
6,280

2016

2015
Revenues

$
16

$
18

Operating expenses

572

1,617

Loss from operations

(556
)

(1,599
)
Net gain (loss) in equity method investments

(1,013
)

6,922

Net income (loss)

$
(1,569
)

$
5,323

X

- Definition
Financial statements of IP Fund [Table Text Block]
+ References
No definition available.
+ Details

Name: actg_NetAssetsOfIpFundTableTextBlock

Namespace Prefix: actg_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1

Quarterly Financial Data (Tables)
12 Months Ended

Dec. 31, 2016

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Quarterly Financial Data
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2016. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.

Quarter Ended

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

Mar. 31,

Jun. 30,

Sept. 30,

Dec. 31,

2016

2016

2016

2016

2015

2015

2015

2015

(Unaudited, in thousands, except share and per share information)
Revenues

$
24,721

$
41,351

$
64,658

$
21,969

$
34,210

$
40,336

$
12,994

$
37,497

Operating costs and expenses:

Cost of revenues:

Inventor royalties

1,573

—

17,844

3,313

9,325

1,265

116

7,756

Contingent legal fees

4,109

10,418

7,709

4,238

4,784

5,512

1,972

3,901

Litigation and licensing expenses - patents

7,723

7,324

7,348

5,463

8,675

9,012

10,345

11,341

Amortization of patents

10,760

10,759

6,467

6,222

13,038

13,228

13,688

13,113

General and administrative expenses (including non-cash stock compensation expense)

7,994

7,535

8,334

9,056

10,575

9,587

9,442

8,572

Research, consulting and other expenses - business development

522

1,334

666

557

997

732

802

860

Impairment of patent-related intangible assets

—

40,165

—

2,175

—

—

—

74,731

Impairment of goodwill

—

—

—

—

—

—

—

30,149

Other

1,742

(1,242
)

—

—

426

—

3,465

250

Total operating costs and expenses

34,423

76,293

48,368

31,024

47,820

39,336

39,830

150,673

Operating income (loss)

(9,702
)

(34,942
)

16,290

(9,055
)

(13,610
)

1,000

(26,836
)

(113,176
)
Total other income (expense)

(3
)

(52
)

261

592

228

(104
)

(180
)

—

Income (loss) before (provision for) benefit from income taxes

(9,705
)

(34,994
)

16,551

(8,463
)

(13,382
)

896

(27,016
)

(113,176
)
Provision for income taxes

(192
)

(5,927
)

(9,655
)

(2,414
)

(170
)

(119
)

(337
)

(4,174
)
Net income (loss) including noncontrolling interests

(9,897
)

(40,921
)

6,896

(10,877
)

(13,552
)

777

(27,353
)

(117,350
)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries

(68
)

348

186

266

422

(4,463
)

43

1,440

Net income (loss) attributable to Acacia Research Corporation

$
(9,965
)

$
(40,573
)

$
7,082

$
(10,611
)

$
(13,130
)

$
(3,686
)

$
(27,310
)

$
(115,910
)
Net loss per common share attributable to Acacia Research Corporation:

Basic and diluted income (loss) per share

$
(0.20
)

$
(0.81
)

$
0.14

$
(0.21
)

$
(0.27
)

$
(0.08
)

$
(0.55
)

$
(2.33
)
Weighted-average number of shares outstanding, basic

49,925,550

50,015,869

50,124,302

50,237,784

49,212,207

49,423,472

49,630,369

49,749,941

Weighted-average number of shares outstanding, diluted

49,925,550

50,015,869

50,618,757

50,237,784

49,212,207

49,423,472

49,630,369

49,749,941

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1280-108306
+ Details

Name: us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1

Description of Business (Details) - patents
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Description of Business [Line Items]

Number of patent portfolios acquired 2 3 6 25

X

- Definition
[Line Items] for Description of Business [Table]
+ References
No definition available.
+ Details

Name: actg_DescriptionOfBusinessLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of patent portfolios acquired
+ References
No definition available.
+ Details

Name: actg_Numberofpatentportfoliosacquired

Namespace Prefix: actg_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

XML 55 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies (Details)
12 Months Ended

Dec. 31, 2016

USD ($)

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1.00%

Fair Value Assumptions, Expected Term 3 years 22 days

Lag time in recognizing revenues from licensee's quarter 3 months

Fair Value Assumptions, Weighted Average Volatility Rate 53.00%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend $ 0

Minimum [Member]

Period after quarter end licensees report activity 30 days

Patents, useful life 1 year

Maximum [Member]

Period after quarter end licensees report activity 45 days

Patents, useful life 10 years

X

- Definition
Lag time in recognizing revenues from licensees' quarter
+ References
No definition available.
+ Details

Name: actg_LagTimeInRecognizingRevenuesFromLicenseesQuarter

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period after quarter end licensees report activity
+ References
No definition available.
+ Details

Name: actg_PeriodAfterQuarterEndLicenseesReportActivity

Namespace Prefix: actg_

Data Type: us-types:durationStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Weighted average expected volatility rate of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies Concentrations (Details)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Licensee 1 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 26.00% 24.00% 22.00%

Licensee 1 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 39.00% 72.00%

Licensee 2 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 23.00% 20.00% 22.00%

Licensee 2 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 22.00% 21.00%

Licensee 3 [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 11.00% 16.00%

Licensee 3 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 16.00%

Licensee 4 [Member] | Accounts Receivable [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 15.00%

Licensees in foreign jurisdictions [Member] | Revenue, Rights Granted [Member]

Concentration Risk [Line Items]

Concentration risk, percentage 79.00% 49.00% 43.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ConcentrationRiskLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64851502&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueRightsGrantedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_Licensee4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=actg_LicenseesInForeignJurisdictionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies Property and Equipment (Details)
12 Months Ended

Dec. 31, 2016

Furniture and Fixtures [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Furniture and Fixtures [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Computer Hardware and Software [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 3

Computer Hardware and Software [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

Leasehold Improvements [Member] | Minimum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 2

Leasehold Improvements [Member] | Maximum [Member]

Property and Equipment [Line Items]

Estimated useful lives, years 5

X

- Definition
Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 35
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223
+ Details

Name: us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=actg_ComputerHardwareAndSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Accounting Policies [Abstract]

Net income (loss) attributable to Acacia Research Corporation $ (10,611) $ 7,082 $ (40,573) $ (9,965) $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (54,067) $ (160,036) $ (66,029)

Payments of Dividends 0 (25,434) (25,039)

Dividends attributable to common stockholders under the two class method 0 24,740 24,313

Net Loss Available to Common Stockholders, Basic and Diluted $ (54,067) $ (160,730) $ (66,755)

Weighted Average Number of Shares Outstanding, Basic and Diluted 50,237,784 50,124,302 50,015,869 49,925,550 49,749,941 49,630,369 49,423,472 49,212,207 50,075,847 49,505,817 48,658,088

Earnings Per Share, Basic and Diluted $ (0.21) $ 0.14 $ (0.81) $ (0.20) $ (2.33) $ (0.55) $ (0.08) $ (0.27) $ (1.08) $ (3.25) $ (1.37)

Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share 3,682,532 71,468 27,760

X

- Definition
Add Back of Dividends attributable to common stockholders under the two class method
+ References
No definition available.
+ Details

Name: actg_Dividendsattributabletocommonstockholdersunderthetwoclassmethod

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 59 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1

Summary of Significant Accounting Policies Impact of revision (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Accounting Policies [Abstract]

Net income (loss) attributable to Acacia Research Corporation $ (10,611) $ 7,082 $ (40,573) $ (9,965) $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (54,067) $ (160,036) $ (66,029)

Net Loss Available to Common Stockholders, Basic and Diluted $ (54,067) $ (160,730) $ (66,755)

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 60 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1

Short-term Investments (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale securities, amortized cost $ 19,403

Available-for-sale securities, gross unrealized gains 40

Available-for-sale securities, gross unrealized losses 0

Available-for-sale securities, fair value $ 19,443

Investment Maturity Date Dec. 31, 2017

Available-for-sale Securities, Gross Realized Losses $ 1 $ 617 $ 2,188

Proceeds from Sale and Maturity of Marketable Securities $ 43,232 $ 82,115 $ 182,115

X

- Definition
The maturity date of the investment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 12
-Sentence Column A
+ Details

Name: invest_InvestmentMaturityDate1

Namespace Prefix: invest_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65884222&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the gross loss realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27357-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26853-111562

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 61 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1

Short-term Investments Marketable Securities (Details)
$ in Thousands
12 Months Ended

Dec. 31, 2016

USD ($)

Schedule of Available-for-sale Securities [Line Items]

Available-for-sale Securities, Amortized Cost Basis $ 19,403

Available-for-sale Securities, Gross Unrealized Gain 40

Available-for-sale Securities, Gross Unrealized Loss 0

Available-for-sale Securities $ 19,443

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65884222&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66010992&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 62 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1

Property and Equipment (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

Depreciation expense $ 147,000 $ 222,000 $ 304,000

Property, Plant and Equipment, Disposals 68,000 30,000

Gain (Loss) on Disposition of Property Plant Equipment $ 3,000 $ 14,000

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisposals

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 63 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1

Property and Equipment Summary of Property and Equipment (Details) - USD ($)
$ in Thousands

Dec. 31, 2016

Dec. 31, 2015

Property and Equipment [Line Items]

Furniture and fixtures $ 733 $ 739

Computer hardware and software 603 649

Leasehold improvements 131 145

Property and equipment, gross 1,467 1,533

Less: accumulated depreciation and amortization (1,340) (1,261)

Property and equipment, net $ 127 $ 272

X

- Definition
Computer Hardware and Software
+ References
No definition available.
+ Details

Name: actg_ComputerHardwareAndSoftware

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_FurnitureAndFixturesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765
+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 64 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands

Dec. 31, 2016

Dec. 31, 2015

Accounts Payable and Accrued Liabilities, Current [Abstract]

Payroll and other employee benefits $ 1,593 $ 576

Accrued vacation 533 701

Accrued legal expenses - patent 6,564 10,135

Foreign taxes payable 3,150 3,960

Accrued consulting and other professional fees 1,967 1,592

Other accrued liabilities 476 383

Accounts payable and accrued expenses $ 14,283 $ 17,347

X

- Definition
Accrued Legal Expenses - Patent
+ References
No definition available.
+ Details

Name: actg_AccruedLegalExpensesPatent

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amounts due to foreign jurisdictions for income taxes.
+ References
No definition available.
+ Details

Name: actg_Foreigntaxespayable

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedProfessionalFeesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 710
-SubTopic 10
-Section 25
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361
+ Details

Name: us-gaap_AccruedVacationCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 65 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1

Patents (Details) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Patents [Line Items]

Patents, net $ 86,319,000 $ 162,642,000 $ 86,319,000 $ 162,642,000

Patents, weighted average useful life 5 years

Payments to acquire intangible assets $ 1,225,000 19,504,000 $ 42,746,000

Accrued patent acquisition related payments 1,000,000 1,000,000 16,700,000

Accelerated amortization expense 225,000 0 1,247,000

Accelerated amortization expense (termination) 0 380,000 2,702,000

Impairment of Patent-Related Intangible Assets 2,175,000 $ 0 $ 40,165,000 $ 0 74,731,000 $ 0 $ 0 $ 0 $ 42,340,000 74,731,000 $ 3,497,000

Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Acquired Finite Lived Intangible Asset, Useful Life 2 years

Maximum [Member]

Patents [Line Items]

Patents, useful life 10 years

Acquired Finite Lived Intangible Asset, Useful Life 10 years

Patents [Member]

Patents [Line Items]

Gross carrying amount - patents 444,362,000 444,137,000 $ 444,362,000 444,137,000

Accumulated amortization - patents 358,043,000 281,495,000 358,043,000 281,495,000

Patents, net $ 86,319,000 $ 162,642,000 $ 86,319,000 $ 162,642,000

Patents [Member] | Minimum [Member]

Patents [Line Items]

Patents, useful life 1 year

Patents [Member] | Maximum [Member]

Patents [Line Items]

Patents, useful life 7 years

X

- Definition
Accelerated amortization expense
+ References
No definition available.
+ Details

Name: actg_AcceleratedAmortizationExpense

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accelerated amortization expense (termination/sale)
+ References
No definition available.
+ Details

Name: actg_Acceleratedamortizationexpenseterminationsale

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accrued Patent Acquisition Related Payments
+ References
No definition available.
+ Details

Name: actg_AccruedPatentAcquisitionRelatedPayments

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Acquired Finite Lived Intangible Asset, Useful Life
+ References
No definition available.
+ Details

Name: actg_AcquiredFiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: actg_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Patents, Accumulated Amortization
+ References
No definition available.
+ Details

Name: actg_PatentsAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Patents, Gross
+ References
No definition available.
+ Details

Name: actg_PatentsGross

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value for patents, net of accumulated amortization.
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortization

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1

Patents Cost and Accumulated Amortization (Details) - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Patents [Line Items]

Patent cost, disposals $ 0 $ 500 $ 3,000

Accumulated amortization, disposals 0 120 298

Proceeds from Sale of Intangible Assets $ 0 $ 750 $ 3,500

X

- Definition
Accumulated amortization, disposals
+ References
No definition available.
+ Details

Name: actg_AccumulatedAmortizationDisposals

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Patent cost, disposals
+ References
No definition available.
+ Details

Name: actg_PatentCostDisposals

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromSaleOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 67 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1

Patents Future Amortization Expense (Details)

Dec. 31, 2016

USD ($)

Patents [Abstract]

2017 $ 22,333,000

2018 21,256,000

2019 19,150,000

2020 6,707,000

2021 5,421,000

After Year Five $ 11,452,000

X

- Definition
Patents [Abstract]
+ References
No definition available.
+ Details

Name: actg_PatentsAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 68 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill Impairment Charges (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Feb. 29, 2016

Jan. 02, 2015

Goodwill and Patent Impairment Charges [Abstract]

Goodwill $ 30,100

Share Price $ 4.29 $ 4.29 $ 3.16 $ 16.72

Estimated Fair Value of the Reporting Unit $ 252,000 $ 252,000

Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach 344,300 344,300

Assets $ 296,003 347,901 $ 296,003 347,901

Impairment of Goodwill $ 0 $ 0 $ 0 $ 0 $ 30,149 $ 0 $ 0 $ 0 $ 0 $ 30,149 $ 0

X

- Definition
Estimated Carrying Value of Reporting Unit, Market Capitalization Plus Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedCarryingValueofReportingUnitMarketCapitalizationPlusCostSynergiesApproach

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Estimated Fair Value of the Reporting Unit, Cost Synergies Approach
+ References
No definition available.
+ Details

Name: actg_EstimatedFairValueoftheReportingUnit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Goodwill and Patent Impairment Charges [Abstract]
+ References
No definition available.
+ Details

Name: actg_GoodwillandPatentImpairmentChargesAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

XML 69 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill Impairment Charges Details (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Goodwill [Line Items]

Goodwill, Impairment Loss $ 0 $ 0 $ 0 $ 0 $ 30,149 $ 0 $ 0 $ 0 $ 0 $ 30,149 $ 0

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 70 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1

Loan Receivable and Investment in Warrants (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Aug. 15, 2016

Dec. 31, 2015

Accounts, Notes, Loans and Financing Receivable [Line Items]

First Loan Warrant $ 700,000

Time-sharing Transactions, Stated Interest Rate for Notes Receivable 6.00%

Maximum Investment in Veritone $ 50,000,000

Secured Promissory Note Advance 10,000,000

1st Loan Warrant Condition: Proceeds from Private Financing $ 10,000,000

Second Loan Warrant 700,000

Veritone Primary Warrant 50,000,000

Primary Warrant Condition: Offering Proceeds 15,000,000

Secured Convertible Promissory Note $ 20,000,000

Unamortized loan discount $ (1,384,000)

Fair Value Inputs, Discount for Lack of Marketability 7.00%

Fair value inputs recovery 100.00%

Loan receivable and accrued interest $ 18,616,000 $ 0

Investment warrants 1,960,000 $ 0

Total Investment, Long Term 20,576,000

Interest Receivable 286,000

Accretion (Amortization) of Discounts and Premiums, Investments 576,000

Interest Income, Other $ 862,000

Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 50.00%

Fair Value Inputs, Probability of Default 75.00%

Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Fair Value Assumptions, Expected Volatility Rate 40.00%

Fair Value Inputs, Probability of Default 25.00%

First Loan [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Receivable with Imputed Interest, Effective Yield (Interest Rate) 20.00%

Second Loan [Member] [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Receivable with Imputed Interest, Effective Yield (Interest Rate) 9.00%

X

- Definition
1st Loan Warrant Condition: Proceeds from Private Financing
+ References
No definition available.
+ Details

Name: actg_A1stLoanWarrantConditionProceedsfromPrivateFinancing

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value inputs recovery
+ References
No definition available.
+ Details

Name: actg_Fairvalueinputsrecovery

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
First Loan Warrant
+ References
No definition available.
+ Details

Name: actg_FirstLoanWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investment warrants
+ References
No definition available.
+ Details

Name: actg_Investmentwarrants

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Maximum Investment in Veritone
+ References
No definition available.
+ Details

Name: actg_MaximumInvestmentinVeritone

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Primary Warrant Condition: Offering Proceeds
+ References
No definition available.
+ Details

Name: actg_PrimaryWarrantConditionOfferingProceeds

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Second Loan Warrant
+ References
No definition available.
+ Details

Name: actg_SecondLoanWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Secured Convertible Promissory Note
+ References
No definition available.
+ Details

Name: actg_SecuredConvertiblePromissoryNote

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Secured Promissory Note Advance
+ References
No definition available.
+ Details

Name: actg_SecuredPromissoryNoteAdvance

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total Investment, Long Term
+ References
No definition available.
+ Details

Name: actg_TotalInvestmentLongTerm

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unamortized loan discount
+ References
No definition available.
+ Details

Name: actg_Unamortizedloandiscount

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Veritone Primary Warrant
+ References
No definition available.
+ Details

Name: actg_VeritonePrimaryWarrant

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsNotesAndLoansReceivableLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustment to the discount rate used to measure fair value for lack of ability to convert business interests into cash quickly.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueInputsDiscountForLackOfMarketability

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of likelihood a loan will not be repaid and instead default, used as an input to measure fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueInputsProbabilityOfDefault

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of interest income earned from interest bearing assets classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_InterestIncomeOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InterestReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestmentsAndReceivablesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Stated interest rate of notes receivable from time-sharing transactions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 978
-SubTopic 310
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68077313&loc=d3e27327-108691
+ Details

Name: us-gaap_TimesharingTransactionsStatedInterestRateForNotesReceivable

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=actg_FirstLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=actg_SecondLoanMemberMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Apr. 26, 2016

Stockholders Equity [Line Items]

Dividends declared, per share $ 0.50

Common stock dividends declared, quarterly $ 0.125

Payments of Dividends $ 0 $ 25,434 $ 25,039

Beneficial Ownership Percentage Limit 4.90%

2013 Stock Plan [Member]

Stockholders Equity [Line Items]

Number of shares available for grant 625,390

X

- Definition
Beneficial Ownership Percentage Limit
+ References
No definition available.
+ Details

Name: actg_BeneficialOwnershipPercentageLimit

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Common stock dividends declared, quarterly
+ References
No definition available.
+ Details

Name: actg_Commonstockdividendsdeclaredquarterly

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
[Line Items] for Stockholders' Equity [Table]
+ References
No definition available.
+ Details

Name: actg_StockholdersEquityLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013StockPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Income Taxes [Line Items]

Operating loss carryforwards, federal $ 147,770,000

Operating loss carryforwards, state 32,821,000

Deferred tax assets, valuation allowance 102,627,000 $ 75,179,000

Federal NOL annual utilization limit 14,100,000

Net operating losses, unrecognized excess tax benefits, federal 1,928,000

Net operating losses, unrecognized excess tax benefits, state 37,771,000

Capital loss carryovers 3,423,000

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits 83,323,000 71,494,000

Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 1,319,000 1,917,000 $ 2,713,000

Foreign tax credits, additional paid in capital benefit 52,224,000

Foreign tax credits utilized for financial statement purposes $ 20,313,000

Tax Benefit From Reversal of the Net Deferred Tax Liability $ 1,735,000

Effective Income Tax Rate Reconciliation, Percent 50.00% 3.00% 6.00%

Effective tax rate excluding valuation allowance (28.00%) (33.00%)

Unrecognized tax benefits $ 1,355,000 $ 2,127,000

unrecognized tax benefits primarily associated with state taxes 85,000

Domestic Tax Authority [Member]

Income Taxes [Line Items]

Net operating losses included in deferred tax assets 0

State and Local Jurisdiction [Member]

Income Taxes [Line Items]

Net operating losses included in deferred tax assets 441,000

Capital Loss Carryforward Related to Business Acquisition [Member] | Internal Revenue Service (IRS) [Member]

Income Taxes [Line Items]

Operating Loss Carryforwards $ 29,318,000

X

- Definition
Capital loss carryovers
+ References
No definition available.
+ Details

Name: actg_Capitallosscarryovers

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Effective tax rate excluding valuation allowance
+ References
No definition available.
+ Details

Name: actg_Effectivetaxrateexcludingvaluationallowance

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Federal NOL Annual Utilization Limit
+ References
No definition available.
+ Details

Name: actg_FederalNolAnnualUtilizationLimit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Foreign tax credits that have not been recorded as a deferred tax asset as the benefit will be credited to additional paid in capital when realized as a reduction of tax payable on the tax return.
+ References
No definition available.
+ Details

Name: actg_ForeignTaxCreditsAdditionalPaidInCapitalBenefit

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Foreign tax credits utilized for financial statement purposes
+ References
No definition available.
+ Details

Name: actg_Foreigntaxcreditsutilizedforfinancialstatementpurposes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
[Line Items] for Income Taxes [Table]
+ References
No definition available.
+ Details

Name: actg_IncomeTaxesLineItems

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Net operating losses, unrecognized excess tax benefits, federal
+ References
No definition available.
+ Details

Name: actg_NetOperatingLossesUnrecognizedExcessTaxBenefitsFederal

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Net operating losses, unrecognized tax benefits, state
+ References
No definition available.
+ Details

Name: actg_NetOperatingLossesUnrecognizedTaxBenefitsState

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Operating loss carryforwards, federal
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsFederal

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Operating loss carryforwards, state
+ References
No definition available.
+ Details

Name: actg_OperatingLossCarryforwardsState

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Tax Benefit From Reversal of the Net Deferred Tax Liability
+ References
No definition available.
+ Details

Name: actg_TaxBenefitFromReversaloftheNetDeferredTaxLiability

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized tax benefits primarily associated with state taxes
+ References
No definition available.
+ Details

Name: actg_UnrecognizedTaxBenefitsPrimarilyAssociatedWithStateTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 740
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65880886&loc=d3e23524-113945

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=SL6600010-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Unrecognized Tax Benefit
-URI http://asc.fasb.org/extlink&oid=6527854
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxCreditCarryforwardAxis=actg_CapitalLossCarryforwardRelatedToBusinessAcquisitionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes Provision for Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Current:

Federal $ 0 $ 0 $ 0

State taxes 262 379 289

Foreign taxes 17,926 4,421 5,359

Total current 18,188 4,800 5,648

Deferred:

Federal 0 0 (1,867)

State taxes 0 0 131

Total deferred 0 0 (1,736)

(Provision) benefit for income taxes $ 2,414 $ 9,655 $ 5,927 $ 192 $ 4,174 $ 337 $ 119 $ 170 $ 18,188 $ 4,800 $ 3,912

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentForeignTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 74 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes Deferred Taxes (Details) - USD ($)
$ in Thousands

Dec. 31, 2016

Dec. 31, 2015

Deferred tax assets:

Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits $ 83,323 $ 71,494

Stock compensation 2,416 1,385

Deferred tax assets intangibles and fixed assets 14,343 1,359

Basis of investments in affiliates 2,195 499

Accrued liabilities and other 422 442

State taxes 90 81

Total deferred tax assets 102,789 75,260

Deferred tax liabilities:

Fixed assets and intangibles 0 0

Other (162) (81)

Deferred Tax Liabilities, Gross (162) (81)

Net deferred tax liabilities 0 0

Less: valuation allowance (102,627) (75,179)

Net deferred taxes $ 162 $ 81

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss and capital loss carryforwards and credits
+ References
No definition available.
+ Details

Name: actg_DeferredTaxAssetOperatingAndCapitalLossCarryforwardsAndCredits

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from tangible and intangible assets.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesFixedAssetsAndIntangibles

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
No definition available.
+ Details

Name: actg_DeferredTaxLiabilitiesNetOfDeferredTaxAssets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Deferred tax assets intangibles and fixed assets
+ References
No definition available.
+ Details

Name: actg_Deferredtaxassetsintangiblesandfixedassets

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(15)(b)(2))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(2))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Liability
-URI http://asc.fasb.org/extlink&oid=6510232

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(26)(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Asset
-URI http://asc.fasb.org/extlink&oid=6510090
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsGrossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the entity's investment in its wholly-owned subsidiaries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319
+ Details

Name: us-gaap_DeferredTaxAssetsInvestmentInSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.
+ References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsStateTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68052875&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 75 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes Income Tax Rate (Details)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Effective income tax rate reconciliation goodwill 0.00% 7.00% 0.00%

Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]

Statutory federal tax rate (35.00%) (35.00%) (35.00%)

State income and foreign taxes, net of federal tax effect 50.00% 3.00% 9.00%

Foreign tax credit (49.00%) (3.00%) (8.00%)

Noncontrolling interests in operating subsidiaries 1.00% (1.00%) 0.00%

Non deductible permanent items 0.00% 0.00% 1.00%

Expired net operating loss carryforwards 0.00% 1.00% 0.00%

Valuation allowance 83.00% 31.00% 39.00%

Total 50.00% 3.00% 6.00%

X

- Definition
Effective income tax rate reconcilation, expired net operating losses
+ References
No definition available.
+ Details

Name: actg_EffectiveIncomeTaxRateReconcilationExpiredNetOperatingLosses

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Effective income tax rate reconciliation goodwill
+ References
No definition available.
+ Details

Name: actg_Effectiveincometaxratereconciliationgoodwill

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 76 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Apr. 26, 2016

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 9,062,000 $ 11,048,000 $ 18,115,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value $ 0.00 $ 16.72 $ 14.33

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value $ 324,000 $ 480,000 $ 460,000

Ownership percent of voting stock 10.00%

Aggregate intrinsic value of options exercised $ 344,000 751,000 518,000

Weighted average grant date fair value of restricted stock granted $ 3.12

Number of shares of common stock reserved for issuance 7,445,000

Restricted stock awards with time based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 0 $ 10,575,000 $ 17,631,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Weighted average grant date fair value of restricted stock granted $ 12.83 $ 14.41

Aggregate fair value of restricted stock vested 5,243,000 $ 11,494,000 $ 21,490,000

Total unrecognized compensation expense for nonvested awards $ 1,873,000

Weighted average period over which unrecognized compensation expense will be recognized 1 year

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Total unrecognized compensation expense for nonvested awards $ 162,000

Weighted average period over which unrecognized compensation expense will be recognized 1 year

Restricted stock unit awards with time-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 4,391,000 473,000 484,000

Restricted stock unit awards with performance based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 197,000 0 0

Stock options with time-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 1,316,000 0 0

Stock options with market-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation 3,158,000 0 0

Stock options with performance-based vesting conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Non-cash stock compensation $ 0 $ 0 $ 0

2007 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 0

2016 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Aggregate shares available for issuance 4,500,000

Number of shares available for grant 1,754,000

Discretionary Option Grant Program [Member] | Nonstatutory Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 85.00%

Stock Issuance Program [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

2002 Stock Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Increase in number of shares available, percentage of outstanding shares on last trading day of prior December 3.00%

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase 500,000

Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance 20,000,000

Number of shares available for grant 0

2013 Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 4,750,000

2013 Stock Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Number of shares available for grant 625,390

Less than 10% [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 100.00%

10% or More [Member] | Discretionary Option Grant Program [Member] | Incentive Stock Options [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Percentage of fair market value on grant date, minimum exercise price 110.00%

X

- Definition
Ownership Percent of Voting Stock
+ References
No definition available.
+ Details

Name: actg_OwnershipPercentOfVotingStock

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase By Percentage
+ References
No definition available.
+ Details

Name: actg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIncreaseByPercentage

Namespace Prefix: actg_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardMaximumNumberofSharesAvailableforIssuance

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesIncrease

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsGrantsinPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Purchase price of common stock expressed as a percentage of its fair value.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockawardswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockunitawardswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_RestrictedstockunitawardswithperformancebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithtimebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithmarketbasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_StockoptionswithperformancebasedvestingconditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2007PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2016PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_DiscretionaryOptionGrantProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_NonstatutoryOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_StockIssuanceProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2002StockPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013PlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=actg_A2013StockPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_LessThan10Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_IncentiveStockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: actg_OwnershipOfVotingInterestsAxis=actg_A10OrMoreMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 77 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans Stock Options (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition 1 year

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 5,884,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 4.82

Outstanding at December 31, 2015 15,000

Exercised (101,000)

Outstanding at December 31, 2016 5,596,000 15,000

Vested 1,113,000

Exercisable at December 31, 2016 1,113,000

Outstanding at December 31, 2015, weighted average exercise price $ 13.38

Exercised, weighted average exercise price 3.22

Outstanding at December 31, 2016, weighted average exercise price 4.93 $ 13.38

Vested, weighted average exercise price 5.03

Exercisable, weighted average exercise price $ 5.03

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 8 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 6 years 6 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $ 1,743,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 6 years 6 months

Outstanding at December 31, 2016, aggregate, intrinsic value $ 8,865,000

Vested, aggregate intrinsic value 2,074,000

Exercisable, aggregate intrinsic value 1,743,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value 11,721,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 2,342,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period (202,000)

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 3.12

Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized $ 683,000

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 25.00%

Unvested Shares with Market Based Vesting Conditions 1,687,500

Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized $ 2,400,000

Performance Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 200,000,000 0

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.75

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 487,000 $ 0

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year

Unrecognized Compensation Expense Options $ 1,873,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 138,000

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years

Unrecognized Compensation Expense Options $ 6,842,000

Equity Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 200,000

Market Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2,250,000,000 0

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 5.75

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 5,530,000 $ 0

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 7.00

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 10.00

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognizedPeriodforRecognition

Namespace Prefix: actg_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithPerformanceCondiditonsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Market Based Vesting Conditions, price
+ References
No definition available.
+ Details

Name: actg_MarketBasedVestingConditionsprice

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number,
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsWithPerformanceConditionsNonvestedNumber

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested During the Period Aggregate Intrinsic Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedDuringthePeriodAggregateIntrinsicValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangmentbySharebasedPaymentAwardOptionsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unvested Shares with Market Based Vesting Conditions
+ References
No definition available.
+ Details

Name: actg_UnvestedShareswithMarketBasedVestingConditions

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=actg_PerformanceBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_MarketBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 78 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans Nonvested Restriced Stock (Details) - $ / shares
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Share-based Compensation Arrangement by Share-based Payment Award

Nonvested at December 31, 2015 829,000

Granted 138,000

Vested (342,000)

Canceled (292,000)

Nonvested at December 31, 2016 333,000 829,000

Nonvested, weighted average grant date fair value at December 31, 2015 $ 14.41

Granted, weighted average grant date fair value 3.12

Vested, weighted average grant date fair value 15.33

Canceled, weighted average grant date fair value 14.28

Nonvested, weighted average grant date fair value at December 31, 2016 $ 8.90 $ 14.41

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award

Granted, weighted average grant date fair value $ 12.83 $ 14.41

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) - $ / shares
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Share-based Compensation Arrangement by Share-based Payment Award

Share-based Awards, Restricted Stock Units, Vested Oustanding 80,000

Share-based Compensation Arrangement Restricted Stock Units, Nonvested 14,000 35,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Nonvested, Weighted Average Grant Date Fair Value $ 16.27 $ 15.78

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period (21,000)

Granted 138,000

Nonvested at December 31, 2016 333,000 829,000

Granted, weighted average grant date fair value $ 3.12

Vested, weighted average grant date fair value 15.43

Nonvested, weighted average grant date fair value at December 31, 2016 8.90 $ 14.41

Vested outstanding, weighted average grant date fair value $ 20.99

X

- Definition
Share-based Awards, Restricted Stock Units, Vested Oustanding
+ References
No definition available.
+ Details

Name: actg_SharebasedAwardsRestrictedStockUnitsVestedOustanding

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement Restricted Stock Units, Nonvested
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementRestrictedStockUnitsNonvested

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Nonvested, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested During Period
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedDuringPeriod

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsVestedinPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Weighted Average Grant Date Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsWeightedAverageGrantDateFairValue

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 80 R62.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock-Based Incentive Plans Schedule of Grants by Type (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 25.00%

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 138,000

Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value $ 0 $ 468,000

Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period 6,022,000,000 922,000,000

Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value $ 12,152,000 $ 11,938,000

Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized $ 683,000

Unvested Shares with Market Based Vesting Conditions 1,687,500

Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized $ 2,400,000

Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition 1 year

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 5,884,000

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 11,721,000

Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 7.00

Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Market Based Vesting Conditions, price $ 10.00

Time Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0 894,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period 0 28,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value $ 0 $ 11,470,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3,434,000,000 0

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 5,704,000 $ 0

Market Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2,250,000,000 0

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 5,530,000 $ 0

Performance Based Vesting Conditions [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 138,000,000 0

Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value $ 431,000 $ 0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 200,000,000 0

Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value $ 487,000 $ 0

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 138,000

Equity Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number, 200,000

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Employee Service Share-based Compensation, Awards with Market Conditions, Compensation Cost Not yet Recognized, Period for Recognition
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithMarketConditionsCompensationCostNotyetRecognizedPeriodforRecognition

Namespace Prefix: actg_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Employee Service Share-based Compensation, Awards with Performance Condiditons, Compensation Cost Not yet Recognized
+ References
No definition available.
+ Details

Name: actg_EmployeeServiceSharebasedCompensationAwardswithPerformanceCondiditonsCompensationCostNotyetRecognized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Market Based Vesting Conditions, price
+ References
No definition available.
+ Details

Name: actg_MarketBasedVestingConditionsprice

Namespace Prefix: actg_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, All Grants, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardAllGrantsFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments With Performance Conditions, Nonvested, Number,
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsWithPerformanceConditionsNonvestedNumber

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Awards, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockAwardsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardRestrictedStockUnitsGrantsinPeriod

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Total Grants During the Period
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangementbySharebasedPaymentAwardTotalGrantsDuringthePeriod

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangment by Share-based Payment Award, Options, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangmentbySharebasedPaymentAwardOptionsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Share-based Compensation Arrangment by Share-based Payment Award, Restricted Stock Units, Granted, Fair Value
+ References
No definition available.
+ Details

Name: actg_SharebasedCompensationArrangmentbySharebasedPaymentAwardRestrictedStockUnitsGrantedFairValue

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unvested Shares with Market Based Vesting Conditions
+ References
No definition available.
+ Details

Name: actg_UnvestedShareswithMarketBasedVestingConditions

Namespace Prefix: actg_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_TimeBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_MarketBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=actg_PerformanceBasedVestingConditionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1

Commitments and Contingencies (Details) - USD ($)
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Rent expense $ 1,795,000 $ 1,926,000 $ 1,523,000

Other $ 0 $ 0 $ (1,242,000) $ 1,742,000 $ 250,000 $ 3,465,000 $ 0 $ 426,000 500,000 4,141,000 $ 1,548,000

Partners' capital, authorized 250,000,000 250,000,000

Cash and other assets, IP Fund 1,118,000 7,740,000 1,118,000 7,740,000

Patents, net of accumulated amortization, IP Fund 0 147,000 0 147,000

Investments, IP Fund 2,933,000 5,829,000 2,933,000 5,829,000

Total assets, IP Fund 4,051,000 13,716,000 4,051,000 13,716,000

Accrued expenses and contributions, IP Fund 2,394,000 7,436,000 2,394,000 7,436,000

Net assets, IP Fund $ 1,657,000 $ 6,280,000 1,657,000 6,280,000

Revenues, IP Fund 16,000 18,000

IP Fund, Operating expenses 572,000 1,617,000

IP Fund, Gain from Operations (556,000) (1,599,000)

IP Fund, Net Loss in Equity Method Investment (1,013,000) 6,922,000

IP Fund, Net Loss $ (1,569,000) $ 5,323,000

Line of Credit Facility, Commitment Fee Percentage 1.15%

X

- Definition
Accrued expenses and contributions, IP Fund
+ References
No definition available.
+ Details

Name: actg_AccruedExpensesAndContributionsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Cash and other assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_CashAndOtherAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
IP Fund, Gain from Operations
+ References
No definition available.
+ Details

Name: actg_IPFundGainfromOperations

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
IP Fund, Net Loss
+ References
No definition available.
+ Details

Name: actg_IPFundNetLoss

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Net Loss in Equity Method Investment
+ References
No definition available.
+ Details

Name: actg_IPFundNetLossinEquityMethodInvestment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
IP Fund, Operating expenses
+ References
No definition available.
+ Details

Name: actg_IPFundOperatingexpenses

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Investments, IP Fund
+ References
No definition available.
+ Details

Name: actg_InvestmentsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fund net assets
+ References
No definition available.
+ Details

Name: actg_NetAssetsFundRelated

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Authorized amount of capital to be raised by the fund.
+ References
No definition available.
+ Details

Name: actg_PartnersCapitalAuthorized

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Patents, net of accumulated amortization, IP Fund
+ References
No definition available.
+ Details

Name: actg_PatentsNetOfAccumulatedAmortizationIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Revenues, IP Fund
+ References
No definition available.
+ Details

Name: actg_RevenuesIPFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total assets, IP Fund
+ References
No definition available.
+ Details

Name: actg_TotalAssetsIpFund

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 82 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1

Commitments and Contingencies Operating Leases (Details)
$ in Thousands

Dec. 31, 2016

USD ($)

Year:

2017 $ 1,279

2018 1,323

2019 1,369

2020 16

Total minimum lease payments $ 3,987

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 83 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1

Supplemental Cash Flow Information (Details) - USD ($)
12 Months Ended

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

Supplemental Cash Flow Information [Abstract]

Cash paid for state income taxes $ 223,000 $ 211,000 $ 172,000

Foreign withholding taxes $ 14,776,000 $ 4,421,000 $ 5,159,000

X

- Definition
Cash paid for state income taxes during the period.
+ References
No definition available.
+ Details

Name: actg_CashPaidForStateIncomeTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Foreign withholding taxes
+ References
No definition available.
+ Details

Name: actg_ForeignWithholdingTaxes

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 84 R66.htm IDEA: XBRL DOCUMENT v3.7.0.1

Quarterly Financial Data (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2014

QUARTERLY FINANCIAL DATA (unaudited) [Abstract]

Revenues $ 21,969 $ 64,658 $ 41,351 $ 24,721 $ 37,497 $ 12,994 $ 40,336 $ 34,210

Inventor royalties 3,313 17,844 0 1,573 7,756 116 1,265 9,325 $ 22,730 $ 18,462 $ 20,670

Contingent legal fees 4,238 7,709 10,418 4,109 3,901 1,972 5,512 4,784 26,474 16,169 23,563

Litigation and licensing expenses - patents 5,463 7,348 7,324 7,723 11,341 10,345 9,012 8,675 27,858 39,373 37,614

Amortization of patents 6,222 6,467 10,759 10,760 13,113 13,688 13,228 13,038 34,208 53,067 53,745

Marketing, general and administrative expenses (including non-cash stock compensation expense) (9,056) (8,334) (7,535) (7,994) (8,572) (9,442) (9,587) (10,575) (32,919) (38,176) (48,554)

Research, consulting and other expenses - business development 557 666 1,334 522 860 802 732 997 3,079 3,391 3,840

Impairment of Patent-Related Intangible Assets 2,175 0 40,165 0 74,731 0 0 0 42,340 74,731 3,497

Impairment of Goodwill 0 0 0 0 30,149 0 0 0 0 30,149 0

Other 0 0 (1,242) 1,742 250 3,465 0 426 500 4,141 1,548

Total operating costs and expenses 31,024 48,368 76,293 34,423 150,673 39,830 39,336 47,820 190,108 277,659 193,031

Operating loss (9,055) 16,290 (34,942) (9,702) (113,176) (26,836) 1,000 (13,610) (37,409) (152,622) (62,155)

Total other income (expense) 592 261 (52) (3) 0 (180) (104) 228 798 (56) (595)

Income (loss) from operations before (provision for) benefit from income taxes (8,463) 16,551 (34,994) (9,705) (113,176) (27,016) 896 (13,382) (36,611) (152,678) (62,750)

(Provision) benefit for income taxes (2,414) (9,655) (5,927) (192) (4,174) (337) (119) (170) (18,188) (4,800) (3,912)

Net loss including noncontrolling interests in operating subsidiaries (10,877) 6,896 (40,921) (9,897) (117,350) (27,353) 777 (13,552) (54,799) (157,478) (66,662)

Net (income) loss attributable to noncontrolling interests in operating subsidiaries (266) (186) (348) 68 (1,440) (43) 4,463 (422) (732) 2,558 (633)

Net loss attributable to Acacia Research Corporation $ (10,611) $ 7,082 $ (40,573) $ (9,965) $ (115,910) $ (27,310) $ (3,686) $ (13,130) $ (54,067) $ (160,036) $ (66,029)

Earnings Per Share, Basic and Diluted $ (0.21) $ 0.14 $ (0.81) $ (0.20) $ (2.33) $ (0.55) $ (0.08) $ (0.27) $ (1.08) $ (3.25) $ (1.37)

Weighted Average Number of Shares Outstanding, Basic and Diluted 50,237,784 50,124,302 50,015,869 49,925,550 49,749,941 49,630,369 49,423,472 49,212,207 50,075,847 49,505,817 48,658,088

Weighted Average Number of Shares Outstanding, Diluted 50,237,784 50,618,757 50,015,869 49,925,550 49,749,941 49,630,369 49,423,472 49,212,207

X

- Definition
Contingent legal fees paid or payable to external counsel.
+ References
No definition available.
+ Details

Name: actg_ContingentLegalFees

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Expenses incurred directly related to litigation and licensing of patents.
+ References
No definition available.
+ Details

Name: actg_LitigationAndLicensingExpensesPatents

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]
+ References
No definition available.
+ Details

Name: actg_QuarterlyFinancialDataUnauditedAbstract

Namespace Prefix: actg_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Expenses incurred directly related to business development research, consulting and other expenses.
+ References
No definition available.
+ Details

Name: actg_ResearchConsultingAndOtherExpensesBusinessDevelopment

Namespace Prefix: actg_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275
+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingCostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_RoyaltyExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 86 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 89 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 139 375 1 false 49 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.acaciaresearch.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Operations Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1002001 - Statement - Consolidated Statements of Operations Parentheticals Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfOperationsParentheticals Consolidated Statements of Operations Parentheticals Statements 5 false false R6.htm 1003000 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.acaciaresearch.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 2101100 - Disclosure - Description of Business Sheet http://www.acaciaresearch.com/role/DescriptionOfBusiness Description of Business Notes 9 false false R10.htm 2102100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 2104100 - Disclosure - Short-term Investments Sheet http://www.acaciaresearch.com/role/ShortTermInvestments Short-term Investments Notes 11 false false R12.htm 2105100 - Disclosure - Property and Equipment Sheet http://www.acaciaresearch.com/role/PropertyAndEquipment Property and Equipment Notes 12 false false R13.htm 2106100 - Disclosure - Accounts Payable and Accrued Expenses Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses Accounts Payable and Accrued Expenses Notes 13 false false R14.htm 2108100 - Disclosure - Patents Sheet http://www.acaciaresearch.com/role/Patents Patents Notes 14 false false R15.htm 2112100 - Disclosure - Goodwill Impairment Charges (Notes) Notes http://www.acaciaresearch.com/role/GoodwillImpairmentChargesNotes Goodwill Impairment Charges (Notes) Notes 15 false false R16.htm 2113100 - Disclosure - Loan Receivable and Investment in Warrants (Notes) Notes http://www.acaciaresearch.com/role/LoanReceivableAndInvestmentInWarrantsNotes Loan Receivable and Investment in Warrants (Notes) Notes 16 false false R17.htm 2114100 - Disclosure - Stockholders' Equity Sheet http://www.acaciaresearch.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 2115100 - Disclosure - Income Taxes Sheet http://www.acaciaresearch.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2116100 - Disclosure - Stock-Based Incentive Plans Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlans Stock-Based Incentive Plans Notes 19 false false R20.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 2118100 - Disclosure - Retirement Savings Plan and Executive Severance Policy Sheet http://www.acaciaresearch.com/role/RetirementSavingsPlanAndExecutiveSeverancePolicy Retirement Savings Plan and Executive Severance Policy Notes 21 false false R22.htm 2119100 - Disclosure - Supplemental Cash Flow Information Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 22 false false R23.htm 2120100 - Disclosure - Quarterly Financial Data Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialData Quarterly Financial Data Notes 23 false false R24.htm 2121100 - Disclosure - Subsequent Events (Notes) Notes http://www.acaciaresearch.com/role/SubsequentEventsNotes Subsequent Events (Notes) Notes 24 false false R25.htm 2202201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 2302302 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 2304301 - Disclosure - Short-term Investments (Tables) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsTables Short-term Investments (Tables) Tables http://www.acaciaresearch.com/role/ShortTermInvestments 27 false false R28.htm 2305301 - Disclosure - Property and Equipment (Tables) Sheet http://www.acaciaresearch.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.acaciaresearch.com/role/PropertyAndEquipment 28 false false R29.htm 2306301 - Disclosure - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables Accounts Payable and Accrued Expenses (Tables) Tables http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpenses 29 false false R30.htm 2308301 - Disclosure - Patents (Tables) Sheet http://www.acaciaresearch.com/role/PatentsTables Patents (Tables) Tables http://www.acaciaresearch.com/role/Patents 30 false false R31.htm 2313301 - Disclosure - Loan Receivable and Investment in Warrants (Tables) Sheet http://www.acaciaresearch.com/role/LoanReceivableAndInvestmentInWarrantsTables Loan Receivable and Investment in Warrants (Tables) Tables http://www.acaciaresearch.com/role/LoanReceivableAndInvestmentInWarrantsNotes 31 false false R32.htm 2315301 - Disclosure - Income Taxes (Tables) Sheet http://www.acaciaresearch.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.acaciaresearch.com/role/IncomeTaxes 32 false false R33.htm 2316301 - Disclosure - Stock-Based Incentive Plans (Tables) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables Stock-Based Incentive Plans (Tables) Tables http://www.acaciaresearch.com/role/StockBasedIncentivePlans 33 false false R34.htm 2317301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.acaciaresearch.com/role/CommitmentsAndContingencies 34 false false R35.htm 2320301 - Disclosure - Quarterly Financial Data (Tables) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables Quarterly Financial Data (Tables) Tables http://www.acaciaresearch.com/role/QuarterlyFinancialData 35 false false R36.htm 2401401 - Disclosure - Description of Business (Details) Sheet http://www.acaciaresearch.com/role/DescriptionOfBusinessDetails Description of Business (Details) Details http://www.acaciaresearch.com/role/DescriptionOfBusiness 36 false false R37.htm 2402403 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables 37 false false R38.htm 2402404 - Disclosure - Summary of Significant Accounting Policies Concentrations (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails Summary of Significant Accounting Policies Concentrations (Details) Details 38 false false R39.htm 2402405 - Disclosure - Summary of Significant Accounting Policies Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies Property and Equipment (Details) Details 39 false false R40.htm 2402406 - Disclosure - Summary of Significant Accounting Policies Earnings per share (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesEarningsPerShareDetails Summary of Significant Accounting Policies Earnings per share (Details) Details 40 false false R41.htm 2402407 - Disclosure - Summary of Significant Accounting Policies Impact of revision (Details) Sheet http://www.acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesImpactOfRevisionDetails Summary of Significant Accounting Policies Impact of revision (Details) Details 41 false false R42.htm 2404402 - Disclosure - Short-term Investments (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsDetails Short-term Investments (Details) Details http://www.acaciaresearch.com/role/ShortTermInvestmentsTables 42 false false R43.htm 2404403 - Disclosure - Short-term Investments Marketable Securities (Details) Sheet http://www.acaciaresearch.com/role/ShortTermInvestmentsMarketableSecuritiesDetails Short-term Investments Marketable Securities (Details) Details 43 false false R44.htm 2405402 - Disclosure - Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://www.acaciaresearch.com/role/PropertyAndEquipmentTables 44 false false R45.htm 2405403 - Disclosure - Property and Equipment Summary of Property and Equipment (Details) Sheet http://www.acaciaresearch.com/role/PropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails Property and Equipment Summary of Property and Equipment (Details) Details 45 false false R46.htm 2406402 - Disclosure - Accounts Payable and Accrued Expenses (Details) Sheet http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesDetails Accounts Payable and Accrued Expenses (Details) Details http://www.acaciaresearch.com/role/AccountsPayableAndAccruedExpensesTables 46 false false R47.htm 2408402 - Disclosure - Patents (Details) Sheet http://www.acaciaresearch.com/role/PatentsDetails Patents (Details) Details http://www.acaciaresearch.com/role/PatentsTables 47 false false R48.htm 2408403 - Disclosure - Patents Cost and Accumulated Amortization (Details) Sheet http://www.acaciaresearch.com/role/PatentsCostAndAccumulatedAmortizationDetails Patents Cost and Accumulated Amortization (Details) Details 48 false false R49.htm 2408404 - Disclosure - Patents Future Amortization Expense (Details) Sheet http://www.acaciaresearch.com/role/PatentsFutureAmortizationExpenseDetails Patents Future Amortization Expense (Details) Details 49 false false R50.htm 2412402 - Disclosure - Goodwill Impairment Charges (Details) Sheet http://www.acaciaresearch.com/role/GoodwillImpairmentChargesDetails Goodwill Impairment Charges (Details) Details http://www.acaciaresearch.com/role/GoodwillImpairmentChargesNotes 50 false false R51.htm 2412403 - Disclosure - Goodwill Impairment Charges Details (Details) Sheet http://www.acaciaresearch.com/role/GoodwillImpairmentChargesDetailsDetails Goodwill Impairment Charges Details (Details) Details 51 false false R52.htm 2413402 - Disclosure - Loan Receivable and Investment in Warrants (Details) Sheet http://www.acaciaresearch.com/role/LoanReceivableAndInvestmentInWarrantsDetails Loan Receivable and Investment in Warrants (Details) Details http://www.acaciaresearch.com/role/LoanReceivableAndInvestmentInWarrantsTables 52 false false R53.htm 2414402 - Disclosure - Stockholders' Equity (Details) Sheet http://www.acaciaresearch.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.acaciaresearch.com/role/StockholdersEquity 53 false false R54.htm 2415402 - Disclosure - Income Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.acaciaresearch.com/role/IncomeTaxesTables 54 false false R55.htm 2415403 - Disclosure - Income Taxes Provision for Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesProvisionForTaxesDetails Income Taxes Provision for Taxes (Details) Details 55 false false R56.htm 2415404 - Disclosure - Income Taxes Deferred Taxes (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesDeferredTaxesDetails Income Taxes Deferred Taxes (Details) Details 56 false false R57.htm 2415405 - Disclosure - Income Taxes Income Tax Rate (Details) Sheet http://www.acaciaresearch.com/role/IncomeTaxesIncomeTaxRateDetails Income Taxes Income Tax Rate (Details) Details 57 false false R58.htm 2416402 - Disclosure - Stock-Based Incentive Plans (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansDetails Stock-Based Incentive Plans (Details) Details http://www.acaciaresearch.com/role/StockBasedIncentivePlansTables 58 false false R59.htm 2416403 - Disclosure - Stock-Based Incentive Plans Stock Options (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansStockOptionsDetails Stock-Based Incentive Plans Stock Options (Details) Details 59 false false R60.htm 2416404 - Disclosure - Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestricedStockDetails Stock-Based Incentive Plans Nonvested Restriced Stock (Details) Details 60 false false R61.htm 2416405 - Disclosure - Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansNonvestedRestrictedStockUnitsDetails Stock-Based Incentive Plans Nonvested Restricted Stock Units (Details) Details 61 false false R62.htm 2416406 - Disclosure - Stock-Based Incentive Plans Schedule of Grants by Type (Details) Sheet http://www.acaciaresearch.com/role/StockBasedIncentivePlansScheduleOfGrantsByTypeDetails Stock-Based Incentive Plans Schedule of Grants by Type (Details) Details 62 false false R63.htm 2417402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.acaciaresearch.com/role/CommitmentsAndContingenciesTables 63 false false R64.htm 2417403 - Disclosure - Commitments and Contingencies Operating Leases (Details) Sheet http://www.acaciaresearch.com/role/CommitmentsAndContingenciesOperatingLeasesDetails Commitments and Contingencies Operating Leases (Details) Details 64 false false R65.htm 2419401 - Disclosure - Supplemental Cash Flow Information (Details) Sheet http://www.acaciaresearch.com/role/SupplementalCashFlowInformationDetails Supplemental Cash Flow Information (Details) Details http://www.acaciaresearch.com/role/SupplementalCashFlowInformation 65 false false R66.htm 2420402 - Disclosure - Quarterly Financial Data (Details) Sheet http://www.acaciaresearch.com/role/QuarterlyFinancialDataDetails Quarterly Financial Data (Details) Details http://www.acaciaresearch.com/role/QuarterlyFinancialDataTables 66 false false All Reports Book All Reports actg-20161231.xml actg-20161231.xsd actg-20161231_cal.xml actg-20161231_def.xml actg-20161231_lab.xml actg-20161231_pre.xml true true ZIP 91 0000934549-17-000006-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000934549-17-000006-xbrl.zip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�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

Document and Entity Information Document - USD ($)	12 Months Ended
Document and Entity Information Document - USD ($)	Dec. 31, 2016	Mar. 06, 2017	Jun. 30, 2016
Entity Information [Line Items]
Entity Registrant Name	ACACIA RESEARCH CORP
Entity Central Index Key	0000934549
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		50,466,611
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 216,379,000

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 127,540	$ 135,223
Restricted cash	11,512	10,725
Short-term investments	19,443	0
Accounts receivable	26,750	33,500
Deferred income tax	0	210
Prepaid expenses and other current assets	3,245	4,219
Total current assets	188,490	183,877
Loan receivable and accrued interest	18,616	0
Investment warrants	1,960	0
Property and equipment, net of accumulated depreciation and amortization	127	272
Patents, net of accumulated amortization	86,319	162,642
Other assets	491	1,110
Total assets	296,003	347,901
Current liabilities:
Accounts payable and accrued expenses	14,283	17,347
Accrued patent investment costs	0	1,000
Royalties and contingent legal fees payable	13,908	14,878
Total current liabilities	28,191	33,225
Deferred income taxes	0	210
Other liabilities	369	311
Total liabilities	28,560	33,746
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, par value $0.001 per share; 100,000,000 shares authorized; 50,476,042 shares issued and outstanding as of December 31, 2016 and 50,651,239 shares issued and outstanding as of December 31, 2015	50	51
Treasury stock, at cost, 1,729,408 shares as of December 31, 2016 and 2015	(34,640)	(34,640)
Additional paid-in capital	642,453	633,146
Accumulated comprehensive loss	(76)	(215)
Accumulated deficit	(342,198)	(288,131)
Total Acacia Research Corporation stockholders’ equity	265,589	310,211
Noncontrolling interests in operating subsidiaries	1,854	3,944
Total stockholders’ equity	267,443	314,155
Total liabilities and stockholders' equity	$ 296,003	$ 347,901

Consolidated Balance Sheets Parentheticals - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	50,476,042	50,651,239
Common stock, shares outstanding	50,476,042	50,651,239
Treasury stock, shares	1,729,408	1,729,408

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
Revenues	$ 152,699	$ 125,037	$ 130,876
Cost of revenues:
Inventor royalties	22,730	18,462	20,670
Contingent legal fees	26,474	16,169	23,563
Litigation and licensing expenses - patents	27,858	39,373	37,614
Amortization of patents	34,208	53,067	53,745
General and administrative expenses (including non-cash stock compensation expense of $9,062 in 2016, $11,048 in 2015 and $18,115 in 2014)	32,919	38,176	48,554
Research, consulting and other expenses - business development	3,079	3,391	3,840
Impairment of Patent-Related Intangible Assets	42,340	74,731	3,497
Impairment of Goodwill	0	30,149	0
Other	500	4,141	1,548
Total operating costs and expenses	190,108	277,659	193,031
Operating loss	(37,409)	(152,622)	(62,155)
Total other income (expense)	798	(56)	(595)
Loss from operations before provision for income taxes	(36,611)	(152,678)	(62,750)
Provision for income taxes	(18,188)	(4,800)	(3,912)
Net loss including noncontrolling interests in operating subsidiaries	(54,799)	(157,478)	(66,662)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	732	(2,558)	633
Net loss attributable to Acacia Research Corporation	(54,067)	(160,036)	(66,029)
Net Loss Available to Common Stockholders, Basic and Diluted	$ (54,067)	$ (160,730)	$ (66,755)
Earnings Per Share, Basic and Diluted	$ (1.08)	$ (3.25)	$ (1.37)
Weighted Average Number of Shares Outstanding, Basic and Diluted	50,075,847	49,505,817	48,658,088
Common Stock, Dividends, Per Share, Cash Paid	$ 0.000	$ 0.500	$ 0.500

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Noncontrolling Interests [Member]
Balance at Dec. 31, 2013	$ 562,198	$ 49	$ (34,640)	$ 653,314	$ (947)	$ (62,066)	$ 6,488
Common stock, shares outstanding at Dec. 31, 2013		49,385,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(66,029)					(66,029)
Payments of Dividends	(25,039)			(25,039)
Stock Issued During Period, Value, New Issues	(25,039)
Stock options exercised, shares		44,506
Proceeds from Stock Options Exercised	206
Stock options exercised, value	206			206
Stock issued during period, shares, share-based compensation, net of forfeitures		635,819
Non-cash stock compensation	18,115	$ 1		18,114
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(633)						(633)
Payments to Noncontrolling Interests	867
Foreign Currency Transaction Gain (Loss), Unrealized	(99)				(99)
Unrealized Gain (Loss) on Investments	693				693
Distributions to noncontrolling interests in operating subsidiary	(364)						(364)
Payments for Repurchase of Common Stock	0
Balance at Dec. 31, 2014	489,048	$ 50	(34,640)	646,595	(353)	(128,095)	5,491
Common stock, shares outstanding at Dec. 31, 2014		50,065,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	(160,036)					(160,036)
Payments of Dividends	(25,434)			(25,434)
Stock options exercised, shares		135,000
Proceeds from Stock Options Exercised	938
Stock options exercised, value	938			938
Stock issued during period, shares, share-based compensation, net of forfeitures		450,857
Non-cash stock compensation	11,048	$ 1		11,047
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	2,558						2,558
Payments to Noncontrolling Interests	4,105
Foreign Currency Transaction Gain (Loss), Unrealized	(123)				(123)
Unrealized Gain (Loss) on Investments	261				261
Distributions to noncontrolling interests in operating subsidiary	(4,105)						(4,105)
Payments for Repurchase of Common Stock	0
Balance at Dec. 31, 2015	$ 314,155	$ 51	(34,640)	633,146	(215)	(288,131)	3,944
Common stock, shares outstanding at Dec. 31, 2015	50,651,239	50,651,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss) attributable to Acacia Research Corporation	$ (54,067)					(54,067)
Payments of Dividends	$ 0
Stock Repurchased During Period, Shares	(13,529)
Stock options exercised, shares	101,000	100,992
Proceeds from Stock Options Exercised	$ 326
Stock options exercised, value				326
Stock issued during period, shares, share-based compensation, net of forfeitures		(262,660)
Non-cash stock compensation	9,062	$ (1)		9,063
Net (income) loss attributable to noncontrolling interests in operating subsidiaries	(732)						(732)
Payments to Noncontrolling Interests	1,358
Foreign Currency Transaction Gain (Loss), Unrealized					40
Unrealized Gain (Loss) on Investments					99
Distributions to noncontrolling interests in operating subsidiary							(1,358)
Payments for Repurchase of Common Stock	(82)
Balance at Dec. 31, 2016	$ 267,443	$ 50	$ (34,640)	$ 642,453	$ (76)	$ (342,198)	$ 1,854
Common stock, shares outstanding at Dec. 31, 2016	50,476,042	50,476,042

Description of Business	12 Months Ended
Description of Business	Dec. 31, 2016
DESCRIPTION OF BUSINESS [Abstract]
Description of Business	DESCRIPTION OF BUSINESS Description of Business. As used herein, “Acacia” and the “Company” refer to Acacia Research Corporation and/or its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All patent investment, prosecution, licensing and enforcement activities are conducted solely by certain of Acacia’s wholly and majority-owned and controlled operating subsidiaries. Acacia’s operating subsidiaries invest in, license and enforce patented technologies. Acacia’s operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. Acacia’s operating subsidiaries generate revenues and related cash flows from the granting of intellectual property rights for the use of patented technologies that its operating subsidiaries control or own. Acacia’s operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. Acacia’s operating subsidiaries are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright. Acacia’s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries. Neither Acacia nor its operating subsidiaries invent new technologies or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own intellectual property through our relationships with inventors, universities, research institutions, technology companies and others. If Acacia's operating subsidiaries are unable to maintain those relationships and to continue to identify and grow new relationships, then they may not be able to identify new technology-based opportunities for sustainable revenue and / or revenue growth. During fiscal 2016 Acacia obtained control of 2 new patent portfolios. Further, in fiscal year 2015, Acacia obtained control of 3 new patent portfolios, compared to 6 new patent portfolios, and 25 new patent portfolios in fiscal years 2014 and 2013, respectively. Acacia was incorporated on January 25, 1993 under the laws of the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.

Retirement Savings Plan and Executive Severance Policy	12 Months Ended
Retirement Savings Plan and Executive Severance Policy	Dec. 31, 2016
RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY [Abstract]
Retirement Savings Plan and Executive Severance Policy	RETIREMENT SAVINGS PLAN AND EXECUTIVE SEVERANCE POLICY Retirement Savings Plan. Acacia has an employee savings and retirement plan under section 401(k) of the Code (the “Plan”). The Plan is a defined contribution plan in which eligible employees may elect to have a percentage of their compensation contributed to the Plan, subject to certain guidelines issued by the Internal Revenue Service. Acacia may contribute to the Plan at the discretion of the board of directors. There were no contributions made by Acacia during the periods presented. Executive Severance Policy. Under Acacia’s Amended Executive Severance Policy, full-time employees with the title of Senior Vice President and higher (“SVP and higher”) are entitled to receive certain benefits upon termination of employment. If employment of an SVP and higher employee is terminated for other than cause or other than on account of death or disability, Acacia will (i) promptly pay to the SVP and higher employee a lump sum amount equal to the aggregate of (a) accrued obligations (i.e., annual base salary through the date of termination to the extent not theretofore paid and any compensation previously deferred (together with any accrued interest or earnings thereon) and any accrued vacation pay, and reimbursable expenses, in each case to the extent not theretofore paid) and (b) three (3) months of base salary for each full year that the SVP and higher employee was employed by the Company (the “Severance Period”), up to a maximum of twelve (12) months (eighteen (18) months for executive officers of Acacia Research Corporation) of base salary, and (ii) provide to the SVP and higher employee, Acacia paid COBRA coverage for the medical and dental benefits selected in the year in which the termination occurs, for the duration of the Severance Period.

Supplemental Cash Flow Information	12 Months Ended
Supplemental Cash Flow Information	Dec. 31, 2015
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	SUPPLEMENTAL CASH FLOW INFORMATION Cash paid for state income taxes totaled $223,000, $211,000 and $172,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Foreign taxes withheld totaled $14,776,000, $4,421,000 and $5,159,000 for the years ended December 31, 2016, 2015 and 2014, respectively. Refer to Note 5 for accrued foreign taxes payable. Refer to Note 6 for information regarding noncash investing activity related to the investment in patent portfolios for the periods presented. Refer to Note 8 for information regarding noncash investing activity related to the investment in Veritone, Inc. for the periods presented.

Subsequent Events (Notes)	12 Months Ended
Subsequent Events (Notes)	Dec. 31, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	SUBSEQUENT EVENTS On February 16, 2017, AIP Operation LLC, a Delaware limited liability company (“AIP”), and an indirect subsidiary of Acacia, adopted a Profits Interest Plan (the “Plan”) that provides for the grant of equity interests in AIP to certain members of management and Board of Directors of Acacia as compensation for services rendered for or on behalf of AIP. Each profits interest unit granted pursuant to the Plan is intended to qualify as a “profits interest” for U.S. federal income tax purposes and will only have value to the extent the equity value of AIP increases beyond the value at issuance. The equity interests are represented by units (the “Units”) reserved for the issuance of awards under the Plan. The Units entitle the holders to share in or be allocated certain AIP profits and losses and to receive or share in AIP distributions pursuant to the AIP Limited Liability Company Operating Agreement entered into as of February 16, 2017 (the “LLC Agreement”). In connection with the adoption of the Plan, a form of Profits Interest Agreement was approved pursuant to which Units may be granted from time to time. Units vest upon AIP’s achievement of certain performance milestones, subject to the continued service of the recipient, and are subject to the terms and conditions of the Plan, the Profits Interest Agreement and the LLC Agreement. Acacia owns substantially all of the equity in AIP and at all times will control AIP. Although AIP currently holds no material assets, Acacia from time to time may contribute to AIP certain assets or securities related to portfolio companies in which Acacia holds an interest. Units may be awarded as one-time, discretionary grants to recipients.

Description of Business (Details) - patents	12 Months Ended
Description of Business (Details) - patents	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Description of Business [Line Items]
Number of patent portfolios acquired	2	3	6	25

Summary of Significant Accounting Policies (Details)	12 Months Ended
Summary of Significant Accounting Policies (Details)	Dec. 31, 2016 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.00%
Fair Value Assumptions, Expected Term	3 years 22 days
Lag time in recognizing revenues from licensee's quarter	3 months
Fair Value Assumptions, Weighted Average Volatility Rate	53.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend	$ 0
Minimum [Member]
Period after quarter end licensees report activity	30 days
Patents, useful life	1 year
Maximum [Member]
Period after quarter end licensees report activity	45 days
Patents, useful life	10 years

Summary of Significant Accounting Policies Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2016
Furniture and Fixtures [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Furniture and Fixtures [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Computer Hardware and Software [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	3
Computer Hardware and Software [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5
Leasehold Improvements [Member] \| Minimum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	2
Leasehold Improvements [Member] \| Maximum [Member]
Property and Equipment [Line Items]
Estimated useful lives, years	5

Summary of Significant Accounting Policies Earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Net income (loss) attributable to Acacia Research Corporation	$ (10,611)	$ 7,082	$ (40,573)	$ (9,965)	$ (115,910)	$ (27,310)	$ (3,686)	$ (13,130)	$ (54,067)	$ (160,036)	$ (66,029)
Payments of Dividends									0	(25,434)	(25,039)
Dividends attributable to common stockholders under the two class method									0	24,740	24,313
Net Loss Available to Common Stockholders, Basic and Diluted									$ (54,067)	$ (160,730)	$ (66,755)
Weighted Average Number of Shares Outstanding, Basic and Diluted	50,237,784	50,124,302	50,015,869	49,925,550	49,749,941	49,630,369	49,423,472	49,212,207	50,075,847	49,505,817	48,658,088
Earnings Per Share, Basic and Diluted	$ (0.21)	$ 0.14	$ (0.81)	$ (0.20)	$ (2.33)	$ (0.55)	$ (0.08)	$ (0.27)	$ (1.08)	$ (3.25)	$ (1.37)
Anti-dilutive equity-based incentive awards excluded from the computation of diluted income (loss) per share									3,682,532	71,468	27,760

Short-term Investments (Details) - USD ($) $ in Thousands	12 Months Ended
Short-term Investments (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Available-for-sale securities, amortized cost	$ 19,403
Available-for-sale securities, gross unrealized gains	40
Available-for-sale securities, gross unrealized losses	0
Available-for-sale securities, fair value	$ 19,443
Investment Maturity Date	Dec. 31, 2017
Available-for-sale Securities, Gross Realized Losses	$ 1	$ 617	$ 2,188
Proceeds from Sale and Maturity of Marketable Securities	$ 43,232	$ 82,115	$ 182,115

Property and Equipment (Details) - USD ($)	12 Months Ended
Property and Equipment (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 147,000	$ 222,000	$ 304,000
Property, Plant and Equipment, Disposals	68,000	30,000
Gain (Loss) on Disposition of Property Plant Equipment	$ 3,000	$ 14,000

Property and Equipment Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Property and Equipment [Line Items]
Furniture and fixtures	$ 733	$ 739
Computer hardware and software	603	649
Leasehold improvements	131	145
Property and equipment, gross	1,467	1,533
Less: accumulated depreciation and amortization	(1,340)	(1,261)
Property and equipment, net	$ 127	$ 272

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Accounts Payable and Accrued Liabilities, Current [Abstract]
Payroll and other employee benefits	$ 1,593	$ 576
Accrued vacation	533	701
Accrued legal expenses - patent	6,564	10,135
Foreign taxes payable	3,150	3,960
Accrued consulting and other professional fees	1,967	1,592
Other accrued liabilities	476	383
Accounts payable and accrued expenses	$ 14,283	$ 17,347

Patents (Details) - USD ($)	3 Months Ended								12 Months Ended
Patents (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Patents [Line Items]
Patents, net	$ 86,319,000				$ 162,642,000				$ 86,319,000	$ 162,642,000
Patents, weighted average useful life									5 years
Payments to acquire intangible assets									$ 1,225,000	19,504,000	$ 42,746,000
Accrued patent acquisition related payments					1,000,000					1,000,000	16,700,000
Accelerated amortization expense									225,000	0	1,247,000
Accelerated amortization expense (termination)									0	380,000	2,702,000
Impairment of Patent-Related Intangible Assets	2,175,000	$ 0	$ 40,165,000	$ 0	74,731,000	$ 0	$ 0	$ 0	$ 42,340,000	74,731,000	$ 3,497,000
Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Acquired Finite Lived Intangible Asset, Useful Life									2 years
Maximum [Member]
Patents [Line Items]
Patents, useful life									10 years
Acquired Finite Lived Intangible Asset, Useful Life									10 years
Patents [Member]
Patents [Line Items]
Gross carrying amount - patents	444,362,000				444,137,000				$ 444,362,000	444,137,000
Accumulated amortization - patents	358,043,000				281,495,000				358,043,000	281,495,000
Patents, net	$ 86,319,000				$ 162,642,000				$ 86,319,000	$ 162,642,000
Patents [Member] \| Minimum [Member]
Patents [Line Items]
Patents, useful life									1 year
Patents [Member] \| Maximum [Member]
Patents [Line Items]
Patents, useful life									7 years

Patents Future Amortization Expense (Details)	Dec. 31, 2016 USD ($)
Patents [Abstract]
2017	$ 22,333,000
2018	21,256,000
2019	19,150,000
2020	6,707,000
2021	5,421,000
After Year Five	$ 11,452,000

Loan Receivable and Investment in Warrants (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Aug. 15, 2016	Dec. 31, 2015
Accounts, Notes, Loans and Financing Receivable [Line Items]
First Loan Warrant			$ 700,000
Time-sharing Transactions, Stated Interest Rate for Notes Receivable			6.00%
Maximum Investment in Veritone			$ 50,000,000
Secured Promissory Note Advance			10,000,000
1st Loan Warrant Condition: Proceeds from Private Financing		$ 10,000,000
Second Loan Warrant			700,000
Veritone Primary Warrant			50,000,000
Primary Warrant Condition: Offering Proceeds			15,000,000
Secured Convertible Promissory Note			$ 20,000,000
Unamortized loan discount	$ (1,384,000)
Fair Value Inputs, Discount for Lack of Marketability	7.00%
Fair value inputs recovery	100.00%
Loan receivable and accrued interest	$ 18,616,000			$ 0
Investment warrants	1,960,000			$ 0
Total Investment, Long Term	20,576,000
Interest Receivable	286,000
Accretion (Amortization) of Discounts and Premiums, Investments	576,000
Interest Income, Other	$ 862,000
Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate	50.00%
Fair Value Inputs, Probability of Default	75.00%
Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Fair Value Assumptions, Expected Volatility Rate	40.00%
Fair Value Inputs, Probability of Default	25.00%
First Loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)	20.00%
Second Loan [Member] [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)	9.00%

Income Taxes (Details) - USD ($)	12 Months Ended
Income Taxes (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Line Items]
Operating loss carryforwards, federal	$ 147,770,000
Operating loss carryforwards, state	32,821,000
Deferred tax assets, valuation allowance	102,627,000	$ 75,179,000
Federal NOL annual utilization limit	14,100,000
Net operating losses, unrecognized excess tax benefits, federal	1,928,000
Net operating losses, unrecognized excess tax benefits, state	37,771,000
Capital loss carryovers	3,423,000
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	83,323,000	71,494,000
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation	1,319,000	1,917,000	$ 2,713,000
Foreign tax credits, additional paid in capital benefit	52,224,000
Foreign tax credits utilized for financial statement purposes	$ 20,313,000
Tax Benefit From Reversal of the Net Deferred Tax Liability		$ 1,735,000
Effective Income Tax Rate Reconciliation, Percent	50.00%	3.00%	6.00%
Effective tax rate excluding valuation allowance	(28.00%)	(33.00%)
Unrecognized tax benefits	$ 1,355,000	$ 2,127,000
unrecognized tax benefits primarily associated with state taxes	85,000
Domestic Tax Authority [Member]
Income Taxes [Line Items]
Net operating losses included in deferred tax assets	0
State and Local Jurisdiction [Member]
Income Taxes [Line Items]
Net operating losses included in deferred tax assets	441,000
Capital Loss Carryforward Related to Business Acquisition [Member] \| Internal Revenue Service (IRS) [Member]
Income Taxes [Line Items]
Operating Loss Carryforwards	$ 29,318,000

Income Taxes Deferred Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets:
Deferred Tax Asset, Operating and Capital Loss Carryforwards and Credits	$ 83,323	$ 71,494
Stock compensation	2,416	1,385
Deferred tax assets intangibles and fixed assets	14,343	1,359
Basis of investments in affiliates	2,195	499
Accrued liabilities and other	422	442
State taxes	90	81
Total deferred tax assets	102,789	75,260
Deferred tax liabilities:
Fixed assets and intangibles	0	0
Other	(162)	(81)
Deferred Tax Liabilities, Gross	(162)	(81)
Net deferred tax liabilities	0	0
Less: valuation allowance	(102,627)	(75,179)
Net deferred taxes	$ 162	$ 81

Income Taxes Income Tax Rate (Details)	12 Months Ended
Income Taxes Income Tax Rate (Details)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation goodwill	0.00%	7.00%	0.00%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Statutory federal tax rate	(35.00%)	(35.00%)	(35.00%)
State income and foreign taxes, net of federal tax effect	50.00%	3.00%	9.00%
Foreign tax credit	(49.00%)	(3.00%)	(8.00%)
Noncontrolling interests in operating subsidiaries	1.00%	(1.00%)	0.00%
Non deductible permanent items	0.00%	0.00%	1.00%
Expired net operating loss carryforwards	0.00%	1.00%	0.00%
Valuation allowance	83.00%	31.00%	39.00%
Total	50.00%	3.00%	6.00%

Stock-Based Incentive Plans (Details) - USD ($)	12 Months Ended
Stock-Based Incentive Plans (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Apr. 26, 2016
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	$ 9,062,000	$ 11,048,000	$ 18,115,000
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.00	$ 16.72	$ 14.33
Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested in Period, Fair Value	$ 324,000	$ 480,000	$ 460,000
Ownership percent of voting stock	10.00%
Aggregate intrinsic value of options exercised	$ 344,000	751,000	518,000
Weighted average grant date fair value of restricted stock granted	$ 3.12
Number of shares of common stock reserved for issuance	7,445,000
Restricted stock awards with time based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	$ 0	$ 10,575,000	$ 17,631,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Weighted average grant date fair value of restricted stock granted		$ 12.83	$ 14.41
Aggregate fair value of restricted stock vested	5,243,000	$ 11,494,000	$ 21,490,000
Total unrecognized compensation expense for nonvested awards	$ 1,873,000
Weighted average period over which unrecognized compensation expense will be recognized	1 year
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Total unrecognized compensation expense for nonvested awards	$ 162,000
Weighted average period over which unrecognized compensation expense will be recognized	1 year
Restricted stock unit awards with time-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	$ 4,391,000	473,000	484,000
Restricted stock unit awards with performance based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	197,000	0	0
Stock options with time-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	1,316,000	0	0
Stock options with market-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	3,158,000	0	0
Stock options with performance-based vesting conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Non-cash stock compensation	$ 0	$ 0	$ 0
2007 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant	0
2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Aggregate shares available for issuance				4,500,000
Number of shares available for grant	1,754,000
Discretionary Option Grant Program [Member] \| Nonstatutory Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	85.00%
Stock Issuance Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	100.00%
2002 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Increase in number of shares available, percentage of outstanding shares on last trading day of prior December	3.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Increase	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Available for Issuance	20,000,000
Number of shares available for grant	0
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant	4,750,000
2013 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares available for grant				625,390
Less than 10% [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	100.00%
10% or More [Member] \| Discretionary Option Grant Program [Member] \| Incentive Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Percentage of fair market value on grant date, minimum exercise price	110.00%

Commitments and Contingencies (Details) - USD ($)	3 Months Ended								12 Months Ended
Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Rent expense									$ 1,795,000	$ 1,926,000	$ 1,523,000
Other	$ 0	$ 0	$ (1,242,000)	$ 1,742,000	$ 250,000	$ 3,465,000	$ 0	$ 426,000	500,000	4,141,000	$ 1,548,000
Partners' capital, authorized	250,000,000								250,000,000
Cash and other assets, IP Fund	1,118,000				7,740,000				1,118,000	7,740,000
Patents, net of accumulated amortization, IP Fund	0				147,000				0	147,000
Investments, IP Fund	2,933,000				5,829,000				2,933,000	5,829,000
Total assets, IP Fund	4,051,000				13,716,000				4,051,000	13,716,000
Accrued expenses and contributions, IP Fund	2,394,000				7,436,000				2,394,000	7,436,000
Net assets, IP Fund	$ 1,657,000				$ 6,280,000				1,657,000	6,280,000
Revenues, IP Fund									16,000	18,000
IP Fund, Operating expenses									572,000	1,617,000
IP Fund, Gain from Operations									(556,000)	(1,599,000)
IP Fund, Net Loss in Equity Method Investment									(1,013,000)	6,922,000
IP Fund, Net Loss									$ (1,569,000)	$ 5,323,000
Line of Credit Facility, Commitment Fee Percentage									1.15%

Commitments and Contingencies Operating Leases (Details) $ in Thousands	Dec. 31, 2016 USD ($)
Year:
2017	$ 1,279
2018	1,323
2019	1,369
2020	16
Total minimum lease payments	$ 3,987

Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
Supplemental Cash Flow Information (Details) - USD ($)	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplemental Cash Flow Information [Abstract]
Cash paid for state income taxes	$ 223,000	$ 211,000	$ 172,000
Foreign withholding taxes	$ 14,776,000	$ 4,421,000	$ 5,159,000